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This thesis examines the influence of medication counseling and the improve communication 
with General Practitioners (GPs) and community pharmacists (CPs) regarding discharge 
medication. The project addresses in particular the way in which patient medication adherence 
and knowledge can be improved by such counselling. By following-up patients post discharge 
any medication-related problems (MRPs) could potentially be identified and resolved by a 
visiting hospital based pharmacist particularly those problems related to interface issues. This 
project also attempts to describe a scheme of quantifying such MRPs. 
122 elderly patients to be discharged from a London teaching hospital with one or more 
regularly prescribed medicines were randomly allocated to two groups. The intervention group 
received intensive medication counselling supported with written information and details sent 
to the GPs and CPs while the control group received the usual discharging procedures. Patients 
were initially assessed using the Nottingham health profile and a patient's knowledge 
questionnaire. All patients were visited at home two and six weeks post discharge. The 
intervention group patients only were counselled and any MRPs identified resolved. Patients' 
knowledge, compliance, quality of life and satisfaction with information were assessed during 
these visits. MRPs were also identified and categorized using two different systems. 
Counselled patients showed better knowledge and adherence in comparison to the control 
group, but no further improvement was observed after the first home visit. While patients of 
the intervention group showed higher levels of satisfaction with the information provided. The 
intervention provided did show statistically better score for the NBP at two weeks, but there 
was little difference at six weeks due to a general improvement in both groups. 
Overall, the number of medication-related problems rated at two and six weeks were generally 
lower in the intervention group, although there were few instances of contraindications and 
drug interactions. Regarding the severity of problems, the intervention group demonstrated a 
reduction in moderate problems rather than the minor or severe MRPs between the first and 
second home visit. There were significantly fewer potential MRPs in the intervention group 
caused through a poor knowledge of health and medicine-related issues and this may be a 
reflection of the counselling process. The intervention group showed higher incidences of 
ADRs which may be due to improvement in patient knowledge regarding ADRs. 
25% of the patients in the control group had identifiable interface problems at two weeks 
interval after discharge where 12% of the intervention group had such problems. On the second 
visit only 10% of intervention patients and 12% of control patients had these problems. This 
may indicate that such problems are resolved post discharge but may be prevented by good 
communication with the GPs and structured counselling pre-discharge. Prescribers were 
contacted concerning MRPs for 34% of the intervention group patients after the first home visit 
and for only 10% for the second home visit. 
It is concluded that discharge medication counseling together with the relevant information 
sent to the GPs and CPs can reduce MRPs and improve patients' adherence to and knowledge 
about medication. Further domiciliary visits at two weeks can also further reduce MRPs, but 
has little benefits concerning adherence and knowledge of medication. The process can be 
conducted with relatively junior staff. 
2 
Table of contents 
Page Number 
Abstract 2 
Table of contents 3 
List of tables 9 





Chapter One: Background and Literature Review 22 
1.1 Drug in Elderly 23 
1.1.1 The National Service Framework for Older People 25 
1.1.2 Multiple Diseases in the Elderly 26 
1.1.3 Polypharmacy in the Elderly 26 
1.1.4 Adverse Drug Reactions in the Elderly 28 
1.2 Pharmaceutical Care 31 
1.2.1 Pharmaceutical Care and Medication Management 31 
1.2.2 Medication Review and Domiciliary Services 35 
13 Defining, Identifying and Classifying Medication-Related Problems 40 
1.3.1 Definition of Medication-Related Problems 40 
1.3.2 Identification of Medication-Related Problems 42 
1.3.3 Classifications of Medication-Related Problems 48 
1.4 Compliance and Patient Knowledge 57 
1.4.1 Compliance and Drug Knowledge in the General Population 61 
1.4.2 Compliance and Medicine Knowledge in the Elderly 68 
1.4.3 Assessment of Compliance 77 
1.4.4 Methods of Improving Compliance 82 
1.5 Medication Discharge Planning 91 
1.5.1 Non-intervention Studies Concerning Discharge Medication Issues 92 
3 
Table ofcontentc 
1.5.2 Intervention Studies Involving Pharmacist Pre-discharge Counselling 98 
Conclusion 114 
Summary 116 
Chapter Two: Methods 118 
2.1 Aims and Objectives 119 
2.2 Instruments Employed in the Main Study 120 
2.2.1 Mental Status Questionnaire 120 
2.2.2 Designing of the Counselling Check List 123 
2.2.3 Nottingham Health Profile 124 
2.2.4 Patients Knowledge Questionnaire 130 
2.2.5 Patients Compliance and Tablet Count 132 
2.2.6 Patients Satisfaction Questionnaire 136 
2.2.7 Classification of Medication-Related Problems 140 
2.2.7.1 PCNE Classification System 140 
2.2.7.2 Medicine or Service-Related Classification System 141 
Chapter Three: The Preliminary Fieldwork and Pilot Study 145 
3.1 Introduction 146 
3.2 Aims 146 
3.3 Objectives 146 
3.4 Research Tools Used in the Preliminary Field Work 147 
3.5 Survey of Current Discharge Process at St. Thomas' Hospital 147 
3.5.1 Aim 147 
3.5.2 Method 147 
3.5.3 Findings 148 
3.5.4 Conclusion 155 
3.6 Survey of the Opinions of the Health Care Professionals 156 
3.6.1 Aims 156 
3.6.2 Method and Findings 156 
4 
Table of contents 
3.6.3 Conclusion 157 
3.7 Assessment of the Counselling Check List 158 
3.7.1 Aim 158 
3.7.2 Assessment Process 158 
3.7.3 Findings 159 
3.8 Application for Ethical Committee Approval 159 
3.9 Pilot Work 160 
3.9.1 Aims and Objectives 160 
3.9.2 Sample Recruitment 160 
3.9.3 Method 160 
3.9.4 Results 160 
3.9.5 Summary and Implication for the Main Study 165 
Chapter Four: Plan of Work 167 
4.1 Introduction 169 
4.2 Aim 170 
4.3 Objectives 170 
4.4 Null Hypotheses 171 
4.5 Subjects 171 
4.5.1 Selection 171 
4.5.2 Patient Consent 172 
4.5.3 Patients Randomization 172 
4.5.4 Sample Size 173 
4.6 Assessment of Baseline Data 175 
4.6.1 Mental Status 175 
4.6.2 Demographic Data 175 
4.6.3 Nottingham Health Profile and Measurement of the Quality of Life 175 
4.6.4 Patients Knowledge 175 
5 
Table of contents 
4.7 Methods in the Main Study 177 
4.7.1 Phase I: St. Thomas' Hospital 177 
4.7.2 Phase II: Domiciliary Visit 179 
4.8 Confidentiality and Ethical Issue 181 
4.9 Monitoring Hospital Re-admission Six Months after Hospital Discharge 181 
4.10 Assessment of the Reliability of Medication-Related Problems Classification 
System 181 
4.11 Quantitative Data Analytical Procedures 181 
4.11.1 Data Entry and Handling 181 
4.11.2 Analysis of Frequency Tables 182 
4.11.3 Sample Distribution Tests 183 
4.12 Computer Software Packages 184 
Chapter Five: Results 185 
5.1 Recruitment and Patients Demographics 186 
5.1.1 Sample Recruitment 186 
5.1.2 Demographic Data 187 
5.2 Time Spent during counselling Sessions and the Home Visits 192 
53 Patients Knowledge Before and After Hospital Discharge 193 
5.4 Quality of Life and Nottingham Health Profile Scores Before and After Hospital 
Discharge 196 
6 
Table of contents 
5.5 Patients Compliance 198 
5.6 Patient Satisfaction with the Information Provided 201 
5.7 Identification and Classification of Medication-Related Problems 203 
5.7.1 PCNE Classification System 204 
5.7.2 MRPs Classified Using to Medicine and Service-Related Effects 212 
5.7.3 Inter-rater Agreement of MRPs Categories 217 
5.8 Hospital Readmission 216 
Summary 219 
Chapter Six: Discussion 222 
6.1 The Preliminary Fieldwork and Pilot Work 223 
6.2 The Main Study 223 
6.2.1 Patients' Characteristics 223 
6.2.1.1 Sample Size 223 
6.2.1.2 Age 225 
6.2.1.3 Gender 226 
6.2.1.4 Mental Status Questionnaire Scores 226 
6.2.1.5 Diseases and Medications 227 
6.2.1.6 Types of Community Pharmacists 229 
6.2.1.7 Other Characteristics 231 
6.3 Conduction of the intervention and assessment 232 
6.4 Domiciliary Visits 234 
6.4.1 Time and Duration of Home Visits 234 
6.4.2 Patients Compliance 236 
7 
Table of contents 
6.4.2.1 Results from present study 236 
6.4.2.2 Comparison to other medication discharge studies 238 
6.4.2.3 Conclusions 240 
6.4.3 Patients Knowledge 242 
6.4.3.1 Results from the Present Study 242 
6.4.3.2 Comparison to other studies involving discharge medication 246 
6.4.3.3 Conclusion regarding knowledge assessment 248 
6.4.4 Quality of Life and Nottingham Health Profile 249 
6.4.5 Patients Satisfaction with information Provided 251 
6.4.6 Identification and Classification of Medication-Related Problems 254 
6.4.6.1 PCNE Classification 256 
6.4.6.2 Medicine and Service-Related Classification 261 
6.4.7 Comparison to other similar studies 266 
6.4.8 Inter-rater reliability 269 
6.4.9 Community Pharmacists 271 
6.5 Rate of Hospital Readmissions 272 
6.6 Strategies to Limit Research Bias 273 
6.6.1 Selection Bias 274 
6.6.2 Observer Bias 275 
6.6.3 Participant Bias 277 
6.7 Ethical Issues 277 
6.8 The Implication of the Study for the Health Service 278 
69 The Limitation and Implication of the Study for the Future Research 282 
8 











List of Tables and 
List of Tables Page Number 
Table 3.1 Different Destinations of Patients Discharged from the Hospital during the 
General Survey 
............................................................................................... 15 0 
Table 3.2 Frequencies and Percents of the Most Commonly Diagnosed Medical 




Table 3.3 Percentage Distribution of the Different Medicines Dispensed as 
TTOs ................................................................................... 151 
Table 3.4 Information Provided to the Patients during Counselling Sessions............ 152 
Table 4.1 Interpretations of the Values of Kappa ........................................... 184 
Table 5.1 Total Numbers of Patients Recruited to Each Group and Number of Patients 
Dropped Out 
........................................................................... 186 
Table 5.2 Numbers of patients who dropped out of the Study as Categorised by Reason 
for Dropout before first and second visits ............................................... 187 
Table 53 Mean Age (SD) and Mean Mental Status Questionnaire Scores (SD) of 
Patients Recruited in Each Group 
.................................................. 
188 
Table 5.4 Frequencies and Percent of the Most Commonly Diagnosed Medical 
Problems .............................................................................. 189 
Table 5.5 Length of Hospital and Number of Medicines for both Intervention and 
Control Groups 
........................................................................ 190 
Table 5.6 BNF Categories and Frequencies of Medication Prescribed on Discharge 
191 ................................................................................. 
Table 5.7 Numbers and Types of Community Pharmacy Used ............................. 192 
Table 5.8 Time Spent by the Investigator on domiciliary visits Expressed as Total 
Number of Hours Over Whole Study and Mean Time (SD) in Minutes Spent 
with Each Subject ................................................................... 193 
Table 5.9 Mean Knowledge Score during both First and Second Home Visit.......... 195 
Table 5.10 Nottingham Health Profile Administered to both the Control and the 
Intervention Groups on the First and the Second home Visits ................. 198 
10 
List of Tables and Figures 
Table 5.11 Compliance (Mean Score Percent) as Estimated by Tablet Count on First and 
Second Home Visit 
.................................................................. 199 
Table 5.12 Compliance Level Described as Numbers of Subjects (%) Falling into One of 
Three Different Descriptive Categories 
........................................... 200 
Table 5.13 Classification of the Numbers of the MRPs between the Control and the 
Intervention Groups (according to PCNE) .......................................... 
205 
Table 5.14 Numbers of Problems in each MRPs Domains Identified in the Patients of the 
Two Groups during Both Home Visits (according to PCNE) 
.................. 
207 
Table 5.15 Classification of the Different Causes for the MRPs Identified in both the 
Control and the Intervention Groups (according to PCNE) ..................... 209 
Table 5.16 Numbers of Different Causes Domains for the Different MRPs Identified in 
Both Groups during both Home Visits (according to PCNE) .................... 
211 
Table 5.17 Classification of the Different Interventions Done after Hospital Discharge 
(according to PCNE) ................................................................. 
212 
Table 5.18 Classification of the Different Intervention Performed According to the 
Intervention Domains (according to PCNE) .................................... 213 
Table 5.19 Different Categories of the Identified Service-Related Problems... ........... 215 




Table 5.21 Rate of Hospital Readmission in a Period of Six Months ..................... 218 
11 
List of Tables and Figures 
List of Figures Page Number 
Figure 4.1 Diagram of the Plan of Work ....................................................... 168 
Figure 4.2 Patient Care Pathways and Intervention Pathway Clarifying the Process of 
Care or Each Group .................................................................. 
176 
Figure 5.1 Gender Distributions of the Intervention and the Control Groups ............ 
188 
Figure 5.2 Numbers of Patients Using Compliance Aids with their Medication from a 
Carer or Family ....................................................................... 
190 




Figure 5.4 Relation between the Number of Medications on Pre-discharge and the 
Composite Score of Patient's Knowledge ........................................ 194 
Figure 5.5 Nottingham Health Profile Administered to both the Control and the 
Intervention Groups before Hospital Discharge 
................................. 
197 
Figure 5.6 Patient Satisfaction with the Information Provided Measured by the SIMS 
Questionnaire during the First Home Visit ....................................... 
201 




ACEI: Angiotensin Converting Enzyme Inhibitor 
ADRs: Adverse Drug Reactions 
A&E: Accident and Emergency 
BMQ: the Beliefs about Medicines Questionnaire 
BNF: British National Formulary 
CPs: Community Pharmacists 
DIs: Drug Interactions 
DHC: Dihydrocodeine 
Doff: Department of Health 
DRPs: Drug-Related Problems 
GP: General Practitioner 
HCPs: Health Care Professionals 
HRQL: Health Related Quality of Life 
LSL: Lambeth, Southwark and Lewisham 
LSIA: Life Satisfaction Index 
LSLHA: Lambeth, Southwark, Lewisham Health Authority 
MAI: Medication Appropriateness Index 
MARS: the Medication Adherence Report Scale 
MRPs: Medication-Related Problems 
MSQ: Mental Status Questionnaire 
NHP: Nottingham Health Profile 
NHS: National Health Service 
NSAIDs: Nonsteroidal Anti-inflammatory Drugs 
NSF: National Service Framework 
OTC: Over the Counter 
PCGs: Primary Care Groups 
PCNE: The Pharmaceutical Care Network Europe 
PCTs: Primary Care Trusts 
PMR: Patient Medication Record 
POM: Prescription Only Medicines 
QoL: Quality of Life 
SE: Side Effects 
SES: Southampton Self-esteem Scale 
SF-36: Short Form 36 
SIMS: Satisfaction with Information about Medicines Scale 
SIP: Sickness Impact Profile 
SPSS: Statistical Package for the Social Sciences 




I would like to express my deep and sincere gratitude to my supervisor Prof. Larry T. 
Goodyer, for suggesting the subject of this thesis, his continuous and valuable supervision, 
his instructive discussions, unlimited advice and the great efforts he devoted toward the 
completion of this thesis. 
I am profoundly grateful to all the members of the pharmacy team and elderly care unit staff 
for their kind help through the development of this work. I extend my gratitude and deep 
appreciation for all teaching staff in the pharmacy practice group, department of Pharmacy, 
King's college, London, and all my colleagues who really helped and encouraged me without 
expecting rewards, other than the completion of this thesis in the best possible way. I would 
like to send a special acknowledge to my spiritual supervisor Dr. Russell Greene for his 
continuous support, encouragement, patience and generosity through the period of this 
research. 
A special thanks to all the patients who were so amenable, and allowed me to visit them in 
their homes and provide me with the information in order to develop insight into this 
research. Without their active participation, there would be no study. 
A special debt of gratitude, deep appreciation and sincere love is acknowledged to my dear 
beloved mother, father, my two sisters and all my friends in my beloved Egypt, for their 
encouragement, and all the facilities they offered me. I would like also to acknowledge all 
my friends I met in London, special Suzanne, Nashwa, Wafa, Amira, Shahira and Azza for 
their overwhelming generosity and for being a source of inspiration to me and for helping me 
to overcome all my home sickness periods. 
I greatly appreciate the opportunities offered to me by my Government, Arab Republic of 
Egypt to have this extensive contact with one of the top universities, and one of the best 
colleges in The United Kingdom and thank for the Egyptian Education and Cultural Bureau 




This thesis is divided into seven chapters. Chapter One is the introduction to the thesis and is 
composed of the background and the literature review. Chapters Two, Three and Four 
present the methods used to achieve the thesis aims, the fieldwork and the pilot study and the 
main study respectively. Chapter Five presents the results obtained from the main study. The 
last chapter interprets and discusses the results. 
Chapter One- Background and Literature Review 
The introduction to this thesis describes drugs in the elderly and their behaviour towards their 
medication. This chapter also discusses the importance of pharmaceutical care and the effect 
of medication review on improving patient's compliance and reducing the effect of different 
medication-related problems. A particular section is devoted to examining other similar 
studies to that concerned by this thesis. This chapter concludes by explaining the rationale of 
this thesis. 
Chapter Two- Methods 
The various methods employed to achieve the objectives are presented in this chapter. These 
methods vary from questionnaires (mental status questionnaires, patient's knowledge 
questionnaire, quality of life questionnaires and satisfaction with information instruments) to 
medication-related problem classification systems. 
Chapter Three-Preliminary Fieldwork and Pilot study 
The preliminary fieldwork in this chapter describes the demographics in St. Thomas' hospital 
where the first part of the study was conducted. It also describes a scoping study to explore 
the opinions of some healthcare professionals concerning the discharge procedures and the 
problems that may be faced during this process. The second section in this chapter describes 
the training for using the checklist system and for conducting structured medication 
counselling prior to hospital discharge. The last section describes pilot work to examine the 
use of the various tools and instruments used in the main study. 
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Chapter Four- Main Study 
The main study describes the following: recruitment procedure; patient group allocation; 
conducting structured discharge counselling and following the patients up after leaving the 
hospital through domiciliary visits to review their medication and to identify any medication- 
related problems. 
Chapter Five-Results 
This chapter outlines the characteristics of recruited patients and the effect of the hospital 
discharge counselling and information transfer during domiciliary visits on various patients 
outcomes. The last two sections quantitatively highlight the different identified medication- 
related problems and classify the problems according to two different systems. Also, 
described any interventions that occurred during the study concerning patients medication 
and the rate of hospital readmission during the period of this study. 
Chapter Six-Discussion, limitations and conclusion 





Older people have the right to be able to enjoy good health and remain independent for as 
long as possible. As people get older, remaining independent often relies greatly on services 
being effective enough to provide adequate support (National Service Framework for Older 
People DoH, 2001). 
Older people are considered the greatest consumers of health and social care services but 
sometimes services have not properly addressed their needs. In 1998/1999 the NHS spent 
about £4 billion which represented 40% of its budget on elderly over the age of 65 and in the 
same year social services spent nearly £5.2 billion (50%) on the over 65s. Older people are in 
greater need for health and social services than the young, so the majority of health and 
social care resources are directed to address this need (National Service Framework for Older 
People DoH, 2001). 
Older people experience a high incidence of medication errors with evidence suggesting that 
they do not take their medication as prescribed (Col et al., 1990). This may often result in 
poor disease control, drug wastage and can also contribute to hospital admissions. 
Compliance with a drug regimen is therefore a major issue among older people, particularly 
for those who live alone, are confused, or suffer from poor vision, impaired manual dexterity 
or a poor memory (Griffith, 1990). The benefits of medication education and self-medication 
programmes have been explored in various studies (Ascione and Shimp 1984 and Esposito, 
1995). Many of these studies have adopted a consistent approach to patient education by 
which all patients receive the same quantity and quality of information whilst only few have 
tailored education programmes to acknowledge the needs and motivations for different 
patients (Ryan and Chambers, 2000). 
Drug-induced disease in the elderly is under-recognized, and poor drug compliance plays a 
substantial role. It has been reported that about 5% of hospital admissions are due to drug- 
induced diseases and that a percentage of these admissions are related to the improper use of 
medication by patients. Many older people live with long-term illness and if they have been 
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provided with appropriate information, they may be able to better participate in managing 
their own conditions. Furthermore, it is also important to meet the general information needs 
of carers (National Service Framework for older people DoH, 2001). 
It has been recognized in Herrier's review (1995) that a patient's non-adherence to prescribed 
therapy is a major contributor to poor therapeutic outcomes in both short and long-term 
illnesses. An estimated 10% of hospital admissions in United State of America is due to non- 
compliance and that around 125,000 deaths annually in patients with cardiovascular diseases 
may be related to adherence issues. More than 100 billion dollars are spent annually to cover 
the economic costs of hospitalisation because of non-adherence, outpatient visits, emergency 
room visits and admissions to nursing home. 
The likelihood of adverse drug reactions is compounded in the elderly by mental impairment, 
multiple diseases, polypharmacy, and physiological changes (e. g., decreased renal and 
hepatic functions). Proper understanding and good compliance regarding medication is a key 
element to avoiding medication-related problems. Patient's compliance is affected by many 
factors, including patients' memory, knowledge of their medications, expectations and 
satisfaction, and the relationship between doctor and patient. Compliance is also affected by 
impairment of eyesight and manual dexterity which can make it difficult for medication self- 
administration especially for medicines in child-resistant containers. While it has been 
suggested that the majority of elderly patients can accurately repeat dosage instructions, up to 
75% make errors in dosage administration, 25% of which are potentially serious (Blenkiron, 
1996). 
It has been argued for many years that drug-induced errors could be reduced even in the 
highly confused patients if clinical pharmacist managed to interview and counsel elderly 
patients for about 15 minutes before discharge, to make sure that they understand and 
remember their drug regimes (MacDonald et al., 1977). Although pharmacists may answer 
patients' queries as they arise on ward visits and nurses may advise patients on an informal 
basis, there is often no formal method concerning delivery of this information. One aim of 
this study is to attempt to construct an intervention to enhance the quality and quantity of 
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information patients receive prior to their hospital discharge. A further aim of the study is to 
enhance compliance to prescribed medication post discharge. 
Interface issues are the other major factors concerning appropriate medication discharge 
planning. Generally speaking, there is usually formal communication between hospital and 
community pharmacists about individual patients to ensure that the correct information is 
being transferred to the community services and these are appropriately delivered (Smith et 
al., 1997). 
A potential scenario is that confusion arises regarding intention of changes to medication 
taken prior to discharge and the failure to understand these intentions by either the patient or 
general practitioner (GP). Such problems may cause therapeutic failures, increased incidence 
of medication-related problems and may end with hospital readmission. A study by Cochrane 
et al. (1992a) highlighted the discrepancies in treatment that may occur post discharge and in 
many cases these changes could not be attributed to a conscious clinical decision. Closer 
communications between the different healthcare professionals between the primary and the 
secondary care interface are therefore required to ensure this smooth continuity. 
The role of the community pharmacist in the United Kingdom has expanded from just 
dispensing related activity to treating minor illness, supervising medication in the community 
and advising general practitioners about cost-effective prescribing. Domiciliary 
pharmaceutical service can be an important part of this new role especially for patients who 
are unable to visit a pharmacy. Domiciliary pharmacy visits also provide the opportunity for 
the pharmacist to understand the patient's medicine-taking behaviour and to obtain an insight 
into the support system available to the patient (Begley et al., 1997). 
It is the purpose of the present study to investigate a discharge and follow-up programme 
conducted through hospital pharmacy services. This study will also contribute to developing 
and assessing methods of overcoming interface issues concerning discharge medication. 
Outcomes will be assessed in terms of patient quality of life, compliance, patient knowledge 
and patient satisfaction with the service they received. The other major outcome to be 
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assessed in this study is identifying and reducing the incidence of potential medication 
related problems that patients may be exposed to after their hospital discharge. 
This thesis comprises of seven chapters. The first chapter will include the background and 
literature review. Chapter two will include the scope of work, different aims, objectives and 
hypotheses. The third chapter will describe the different methods employed, questionnaires 
and instruments used to conduct this project. Chapter four and five will include the pilot 
study and the plan of the project including patient recruitment, hospital discharge planning 
and domiciliary visits given to the patients after their hospital discharge. The last two 
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CHAPTER I BACKGROUND& LITERATURE REVIEW Drugs in the Elderly 
CHAPTER ONE 
BACKGROUND AND LITERATURE REVIEW 
Aspects of different problems in the elderly related to medication compliance, drug 
knowledge, interface issues and medication-related problems relevant to the present study are 
reviewed in this section. 
1.1 Drugs in the Elderly 
Elderly people are those 65 years of age or older, and within this population, those over 75 
years of age represent one of the fastest growing categories (Higbee, 2000). The United 
Kingdom is considered an ageing society; since the early 1930s the number of people aged 
65 and over has doubled and today about 20% of the population is over 60 (National Service 
Framework for Older People DoH, 2001). People aged 65 years and over comprised 10.9% 
of the United Kingdom population in 1951 (Tinker, 1997). For 2001, estimates showed that 
16% of the national population are aged 65 and over, and this is forecast to rise to 21% by 
2026 (DoH, 2002), with an increase in the consumption of greater proportion of the NHS 
services and resources. This is of concern to healthcare professionals since those greater than 
75 years of age may suffer the most severe consequences of diseases and drug therapy due to 
significantly diminished homeostatic reserve (Vestal, 1997) and they are more susceptible to 
medication-related problems (MRPs) than younger patients (Bellingan and Wiseman, 1996). 
People aged 65 years and over, despite representing only 20% of the United Kingdom 
population, consume a significant amount of healthcare resources (Krska and Jamieson, 
2000). About 70-80% of those aged 75 and over are taking prescribed medicines, most are 
considered as long-term treatment (Blenkiron, 1996). Elderly patients account for 
approximately 25% of physician visits, about 35% of prescription drug expenditures and 40- 
45% of over-the-counter (OTC) drug sales annually (Vestal, 1997). Ninety per cent of the 
elderly in the community take at least one medication with an average of at least four drugs 
per patient and approximately 67% of elderly take at least one OTC. In addition, problems 
with concomitant use of herbal medicines should be considered and these problems may be 
attributed to two factors: little is known about the basic pharmacology of these botanical 
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agents and there is no standardized manufacturing process to assure safety and efficacy 
(Vestal, 1997). 
As mentioned above, inappropriate prescribing occurs more often in elderly patients and this 
can result in an inadequate response, side effects and toxicity that can interfere with the 
therapeutic outcomes. Polypharmacy is almost unavoidable with aging, adverse drug 
reactions may result in prescribing another medication to treat a side effect which may lead 
to increasing polypharmacy or stopping of a needed medication where a dose reduction 
would be the solution. This may stem from failure to recognize the particular needs of the 
elderly patient and a lack of data regarding the use of particular drugs in the elderly. The 
elderly are at risk for multiple reasons, which makes it imperative for the health care 
professional to focus on the elderly with regard to their specific profession (Higbee, 2000). 
The majority of the elderly live in their own homes, less than 5% are living in residential 
homes or institutional care and about 25% are unable to leave their homes without some sort 
of assistance. Therefore, some may be unable to visit their community pharmacy and the only 
source for pharmaceutical service is through carers (Begley et al., 1997). Due to several 
factors; multiple pathology, polypharmacy, altered pharmacokinetics and 
pharmacodynamics, reduced visual acuity, impaired cognitive function, and physical 
difficulties, elderly patients are very vulnerable to the effects of medication. This often 
influences patient adherence to the medication regimen (Begley et al., 1997). 
The role of the pharmacist in the healthcare system is expanding from the traditional drug- 
oriented function to a cognitive oriented function. The concept of pharmaceutical care is 
being advocated, which enables pharmacists to describe their further evolution as patient- 
focused health care providers (Hepler and Strand, 1990). 
The topic of seamless pharmaceutical care and the factors that influence this concept and 
drug therapy management in the elderly will be covered in this section. 
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1.1.1 The National Service Framework for Older People 
There is an emphasis on designing services around the needs of the patients so that they have 
quicker access to high quality health care (Secretary of State for Health, 2000). Much of the 
care that took place in hospitals is now taking place in primary care and in the patients' own 
homes. Secondary care now plays a supportive role to the work of primary health care 
professionals (HCPs) to manage individual requirements. 
A range of measures were introduced by the NHS to increase quality and decrease variations 
in service and one of these measures is the National Service Framework (NSFs) for older 
people. This particular National Service Framework is the pioneering strategy to ensure high 
quality and integrated health and social care services for older people. Many major diseases 
and conditions are more common in older patients. National Service Frameworks (NSFs) 
were established to improve services through setting national standards to improve quality 
and tackle existing variations in care. The NSF for older people is the third to be produced 
after the mental health and the coronary heart diseases and sets standards for the care of older 
people in all settings across health and social services. In addition, it focuses on those 
conditions, which are of particular significance for older people, and which have not been 
addressed elsewhere, e. g., strokes, falls and mental health problems. The NSF for older 
people is a 10 year programme of action connecting different services to support 
independence and promote good health, specialised services for key conditions, and culture 
change so that all older people and their carers are treated with respect, dignity and fairness. 
It sets out a programme of plans and actions to address the problems and deliver services of 
higher standards for older people. The plan also proposes more consultants, nurses and 
therapists working for older people. This framework is the result of extensive consultation 
with older people, their carers and the professionals involved in the care of elderly people 
(National Service Framework for Older People DoH, 2001). 
The NSF for older people has set certain milestones to be achieved, these milestones relating 
to medication include: 
" Annual medication review for all people over 75 and biannual medication review for 
those taking four or more medicines. 
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" All hospitals should have "one stop dispensing/dispensing for discharge schemes" 
and self-administration schemes for medicines for older people should be considered. 
" Every primary care group or primary care trust will have schemes in place so that 
older people get more help from pharmacists in using their medicines 
1.1.2 Multiple Diseases in Elderly 
There is an increased incidence of chronic disease with age, particularly after the age of 75. 
Multiple diseases are common in the elderly, with a high proportion having one or more 
chronic illnesses as compared to young adults (Vestal, 1997). 
The most frequently diagnosed diseases in elderly patients are arthritis, heart diseases, 
hypertension, hearing impairment, orthopedic disabilities, vision impairment and diabetes 
mellitus. Of these conditions, heart disease, hypertension, diabetes, arthritis, and visual 
impairment are the most frequently cited causes of disability (Higbee, 2000). 
1.1.3 Polypharmacy in Elderly 
Polypharmacy is "the concurrent use of several different medications used by the same 
individual, which in some cases can lead to medication-related problems" (Colley and Lucas, 
1993). Since the elderly exhibit a higher incidence of illness, then it follows that their 
medication use will also be consequently higher. The increased drug utilization in long-term 
care is explained by their increased acuity. Additionally, many common diseases in the 
elderly require multiple drug therapy in order to properly control and treat the disease e. g., 
congestive heart failure and diabetes mellitus. Thus, it follows that the elderly will consume a 
greater number of medicines (Higbee, 2000). 
This problem is widely recognized as an international problem, Titley-Lake and Barber 
(2000) showed in their study the patterns of medication use amongst the elderly where 
medication reviews were carried out on 50 of the elderly patients of the British Virgin Islands 
in the Caribbean. The average number of prescribed medications was 4.5 medicines (range 1- 
10) and about one-third of the patients used more than five medicines. Self-medication was 
very common among the recruited sample. The vast majority (98%) reported using OTC 
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preparation with an average of 4.7 products and 76% also used herbal remedies and natural 
products with an average of 3.3 products/patient. The most commonly prescribed medication 
for elderly patients were cardiovascular drugs (86%), followed by endocrine drugs (40%) 
used mainly in the management of diabetes mellitus. Many patients were also prescribed 
drugs used for nutrition and for blood disorders (28%), musculoskeletal and joint disease 
(26%) and eye conditions (18%). Vitamins and supplements were the most likely consumed 
products for OTC self-medication, as reported by 60% of the patients. Treating or preventing 
the disorders of the gastrointestinal tract was also a major reason for the use of natural 
products or herbal remedies. A high proportion of patients used these products for a wide 
range of ailments, including skin, eye and prostate disorders, infections, stress, insomnia, to 
boost the immunity system and to enhance memory. As this study was performed on a 
limited population (elderly in the British Virgin Islands) it is difficult to generalize the 
conclusion; however, it appears that the elderly are harbouring more diseases than younger 
patients and because of this, polypharmacy is the rule rather than the exception. A similar 
study was carried out in the UK by Blenkiron (1996) where four medications per patient was 
the commonest number of drug prescribed among 80 patients aged 75 years and above. The 
most widely prescribed medications were analgesics, diuretics, antacids, Glyceryl trinitrates, 
Aspirin, NSAIDs and laxatives. The agreement between the two studies indicates a true 
international perspective of the problem although in the second study, patients' compliance 
was also assessed using the self-reported technique which is normally provides overestimated 
results. 
There is good evidence that increasing the complexity of the drug regimen would lead to 
difficulties with medication utilization and that the incidence of medication errors can rise 
with as increased number of prescribed items (Eisen et a!., 1990). It was found that 
prescribing more than two medications per day can lead to a three-fold increase in the 
likelihood of self-reported non-compliance. It has also been found that about one quarter of 
elderly patients were taking an OTC medication for conditions also being treated with 
prescribed medication. Generally speaking, the aim of any treatment regimen should be 
simplification of that regimen and that any single medication is not prescribed more than 
twice a day (McElnay et al., 1997). 
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It can be concluded from the above that, polypharmacy is a major risk factor for drug-drug 
interactions and adverse drug reactions because their incidences increase exponentially with 
the number of prescription and OTC products being taken. Prescribing simpler regimens with 
fewer tablets to be taken each day and a small number of different medications may also 
reduce the patient's risk of non-adherence. 
As mentioned before, people aged 65 years and over are major users of medication. The 
greater the number of medications being consumed the higher the incidence of the adverse 
drug reactions. This will be discussed in the following section. 
1.1.4 Adverse Drug Reactions in Elderly 
Adverse drug reactions (ADRs) are defined as an "undesirable clinical manifestation 
consequent to and caused by the administration of a particular drug or interacting drugs, 
excluding overdose, substance abuse and therapeutic failure". These clinical manifestations 
may be presented as an abnormal sign, symptom or laboratory test, or a cluster of abnormal 
signs, symptoms and tests, but (except in a case of asymptomatic high drug concentration in 
the blood) it does not depend on laboratory test alone (Mannesse et al., 2000). 
Elderly patients are at higher risk of adverse drug reactions (ADRs) as a consequence of age- 
related physiological changes. It was reported that the rate at which the elderly exhibit ADRs 
was two to three times higher than those exhibited by younger adults (Higbee, 2000). ADRs 
have been estimated to be responsible for 10-13% of all hospital admissions of elderly 
patients (Nathan et al., 1999). In an observational cross-sectional study carried out by 
Mannesse et al. (2000) in five wards in the Netherlands, it was found that 12% of patients 
aged 70 and over were hospitalized because of ADRs. Risk factors for these medication- 
related problems are falls before admission, the presence of gastrointestinal bleeding or 
hematurea and use of three or more medications. Hospital admission due to fall may be the 
manifestation of severe ADRs in the older patients. It can be concluded from this study that 
medication-related hospital admission of elderly patients is an important problem and 
responsible for about 17% of the hospital admissions. 
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Col et al. (1990) interviewed 315 elderly patients (average age 76.6 years) who were 
admitted to an acute care hospital. Twenty eight percent of the admissions (89/315) were due 
to medication-related problems with 16.8% related to adverse drug reactions. Fifty-three 
patients (16.8% of all admissions) suffered 55 adverse drug reactions. Thirty were assessed 
as side effects, 15 were toxic reactions, 1 was an allergic reaction, 2 were idiosyncratic and 7 
were unclassified reactions. The drugs most commonly implicated in hospitalization due to 
adverse drug reactions were Warfarin and Prednisolone. It was also found that the greater the 
number of different medications prescribed, the greater the rate of admissions related to 
adverse drug reactions. In the same study by it was found that, adverse drug reactions were 
8.8 times more prevalent among those using two or more pharmacies than among those using 
a single pharmacy. Analysis of the results in this study found the following variables to be 
associated with hospitalization due to adverse drug reaction: the number of the medications 
prescribed; whether the patient suffered from any fall, and if the patient had received any 
follow-up on domiciliary visit. Also patients using two or more pharmacies had a slightly 
higher prevalence of adverse drug reactions than those who used only one (15.8% vs. 12.1%). 
Specific drug classes would certainly have a greater tendency to cause ADRs in the elderly, 
which may lead them to stop taking these medications. For example, psychotropic 
medications may cause sleeping disturbances and constipation may be caused as a 
consequence of taking antimuscarinic drugs. Other problems encountered are the therapeutic 
effects which may lead to an unacceptable alteration in patient's lifestyle. The well- 
recognized example for this is the problem imposed by diuretics, where the patient may omit 
drug dose on the days that he/she is away from home. Stewart and Caranasos (1989) pointed 
out in their review that, generally, compliance is likely to be reduced if medication requires 
some behavioural change in a patient 
Definition, identification and classification of drug-related problems will be discussed in 
more details in section 1.3 in this review. 
As mentioned previously, the aging process may result into physiological changes in both 
renal and liver function which in turn may lead to alterations in body composition and 
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alterations in drug pharmacodynamics and pharmacokinetics as well as impairment of the 
homeostatic mechanisms that regulate blood pressure, body temperature and intravascular 
volume which often contribute significantly to the increase of the incidences of ADRs in the 
elderly (Vestal, 1997). For example, Digoxin has a decreased volume of distribution and a 
decreased renal excretion with age. Therefore, elderly patients are at risk of overdose when 
prescribed the standard doses that are normally prescribed for younger adults. It is such 
situations that may lead health care professionals to inappropriately believe that the elderly 
are more "sensitive" to drugs (Higbee, 2000). 
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1.2 Pharmaceutical care 
The main purpose of this study is to use interventions that might improve the pharmaceutical 
care for elderly patients up to two months after their discharge from hospital. This section 
examines pharmaceutical care, particularly as it relates to the elderly. 
1.2.1 Pharmaceutical Care and Medicines Management 
One definition of seamless care which appears to reflect most closely the aspirations of those 
who work for the National Health Service is that suggested by Jackson et al. (1993): "The 
process by which patients are moved across the boundary between primary and secondary 
health care sectors with assurance that all their health care requirements, including 
information, can be communicated and maintained in a safe, timely, efficient and user 
friendly way and without experiencing any gap in the standard of their health management ". 
The term "pharmaceutical care" was initially developed to describe the pharmacists' 
potential role as patient-focused healthcare providers and direct their services from a product- 
oriented to service-oriented provision. The community based pharmacist will move into a 
clinically focused role, more which involves patients, doctors and other healthcare 
professionals, where appropriate (Anonymous, 1996). 
In 1990, Hepler and Strand provided another definition of pharmaceutical care as: "The 
responsible provision of drug therapy for the purpose of achieving definite outcomes that 
improve a patient's quality of life". They defined these outcomes as: 
" Curing diseases. 
" Eliminating or reducing patient's symptoms. 
" Stopping or slowing the disease process. 
" Preventing a disease or symptom. 
Pharmaceutical care involves three major functions on behalf of the patient (Hepler and 
Strand 1990): 
" Identifying potential and actual medication-related problems. 
" Solving actual medication-related problems. 
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" Preventing potential medication-related problems. 
The broad elements involved in pharmaceutical care process as reported by Jackson et al. 
(1993) are: 
9 Identification of patient's need for continuing professional input. 
" Collation of patients' details relevant to their requirements. 
9 Presentation of information in a format relevant to each health professional/ carer 
likely to be involved with the patient. 
" Professional interaction with the patient in his/her new environment. 
9 Recording of all relevant details in the most appropriate database. 
" Follow-up and monitoring of services those are currently being provided and may be 
required in the future. 
" Audit of cost-effectiveness of professional input. 
Implementation of a pharmaceutical care plan requires pharmacists to interact with both 
patients and healthcare professionals (Krska and Jamieson, 2000). Pharmaceutical care 
involves the process by which a pharmacist can meet a patient's drug therapy requirements 
and those of other healthcare professionals in designing, implementing and monitoring a 
therapeutic plan that will produce specific outcomes for the patient. In 1992, a policy 
statement on the pharmaceutical aspects of community care recommended that, prior to the 
discharge of patients with identified needs; hospital pharmacists should establish links with 
their community colleagues (Anon, 1992). 
When providing pharmaceutical care, pharmacists can learn more about their patients; their 
medicines; the way they see them and their beliefs about their health and medications. In 
addition to spending time with the patients, pharmacists need to ensure patients understand 
how to use their medications as well as making interventions to improve the outcome of the 
medication therapy. The aim for pharmacists in providing pharmaceutical care is "to identify, 
resolve and prevent drug therapy problems before they happen and to solve problems that 
have already happened" (Currie, 2003). 
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An important part of the patients' healthcare requirements is the management of their 
medicines; this role is incorporated in the pharmacist's range of professional responsibilities, 
embodied in the term of "pharmaceutical care". Hepler and Strand (1990) explained the term 
"Pharmaceutical care" as directing pharmaceutical input to the needs of the individual 
patient with the aim of improving the patient's quality of life. Thus a patient moving from a 
primary care setting into secondary care, or vice versa, should not be at a disadvantage in 
terms of the continuality, consistency or quality of the pharmaceutical care they receive. At 
present, pharmaceutical care is practised in hospital through available clinical pharmacy 
services, but these must be transferred to be practised in the community to prevent a waste of 
resources because of either unnecessary visits to the GP or readmission to hospital (Smith et 
al., 1997). Widely, the medicines management philosophy is not been practised in the 
community setting at the present time. 
"Medicine management" is a term that the Department of Health in UK has recently 
introduced, although in many situations this is very similar to the concept of the 
pharmaceutical care. One possible reason for introducing this term might be to embrace any 
health professional, whereas pharmaceutical care is often seen as pharmacist-related activity. 
Another possible reason may be political, where the concept of a new "care" based service 
might be seen for demand additional resources. It is certainly seen to embrace practice in the 
community 
A full definition is given on the managing medicines website as: "In full agreement with the 
doctors and patients concerned, pharmacists will be able to take the initiative in managing 
the medication of certain patients, dispensing repeat medication and varying prescriptions if 
necessary, all in accordance with pharmaceutical care plans. In the process, pharmacists 
will talk to patients regularly about their medicines and the progress of their condition (in 
pharmacies or patients' homes), monitoring use of medication, checking for side effects and 
interactions and referring back to doctors when needed. Pharmacists will ensure that 
patients have consistent packages of pharmaceutical care and that, in transfers between 
home and hospital (and within hospital) and is transferred uninterruptedly and managed 
smoothly. There will be joint consultations between doctors and pharmacists, appropriate 
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records will be fully shared and, in some cases, particular hospital or community 
pharmacists will specialize in complicated conditions and concentrate on helping those 
patients in greatest need" (managing medicines website, 2004). 
Tweedi and Jones (2001) offered another definition of medicine management "the systematic 
provision of medicines therapy through the partnership of effort between patients and 
professionals to deliver best patient outcome at minimized cost". This concept is built-up 
from four key-elements: clinical excellence, collaboration of participants, cost control and 
concordance. 
The overall goals of the Department of Health's Medicines Management Services Programme 
are (managing medicines website, 2004): 
" Identifying and addressing unmet pharmaceutical need 
" Helping patients to get the best from their medicines and thereby delivering real 
improvements in health 
" Developing innovative medicines management approaches that have the patients' 
needs uppermost whilst also improving service efficiency and reducing waste 
9 Providing convenient access to a range of medicines management services in 
different environments through multidisciplinary working which builds on the 
strengths of pharmacists 
In reality, pharmaceutical care is considered as a type of medicines management. Barber 
(2001) has compared the two concepts of pharmaceutical care and medication management 
and concluded that both were created from limited point of view, that of the care of the 
patient in the case of pharmaceutical care, and that of the healthcare provider in the case of 
medicines management. It may be that the Department of Health prefers the term "medicines 
management" because of the doctors' sensitivity. Medicines management allows for a variety 
of practice and process to fall within it and involves all the healthcare professionals and 
patients in the proper use of the medicines (Simpson, 2001). By using this term, the doctor 
becomes the director of an expanded primary healthcare team (Tweedie and Jones, 2001). 
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As the majority of the elderly people are taking one or more medicines, medicine 
management is an important requirement in each of the NSF standards as well as dealing 
with relevant medicines issues within the NSF itself. That is why this issue therefore forms 
part of the NSF for Older People (National Service Framework for Older People DoH, 2001). 
1.2.2 Medication Review and Domiciliary Services 
The follow-up of a patient's drug therapy is an important element in the practice of 
pharmaceutical care. Clinical medication review can be defined as "the process where a 
health professional reviews the patient, the illness and the drug treatment during a 
consultation. It involves evaluating the therapeutic efficacy of each drug, unmet therapeutic 
needs and the progress of the conditions being treated. Other issues, such as compliance, 
actual and potential adverse effects, interactions and the patient's understanding of the 
condition and its treatment are considered where appropriate" (Lowe et al., 2000a). This 
process can be performed by visiting a residential facility such as nursing homes or in the 
patients' own homes. Sometimes this may take the form of the "brown bag review" where 
the patients are asked to bring into the pharmacy all their medications for review. This 
concept was developed in the USA in 1982, consisting of a structured method of review of 
patients' medication conducted by pharmacists. It involves inviting patients to bring along all 
the medication they have at home (both prescribed and bought over the counter, any out of 
date products, or any medicines no longer used, and any reserve supplies) to the pharmacy or 
any other convenient setting to be reviewed by a pharmacist (Nathan et al., 1999). The brown 
bag concept aims to provide the patients with better understanding of all of their medicines 
and helps to identify and fill gaps in patients' knowledge about the purpose and the use of 
their medication. Another advantage of this scheme is to increase patients' confidence in 
their medicines. The extended contact between pharmacist and patients during the medication 
review can facilitate a better personal relationship and provide an opportunity for in-depth 
discussion rather than simply reviewing information from the point of the dispensing of 
individual medicines (Nathan et al., 2000). 
Recently, the National Service Framework for Older People (2001) has proposed that "all 
elderly patients on repeat medications should be reviewed annually and those on more than 
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four medicines should be reviewed twice a year". Because of the pressing priorities of GPs, it 
has been suggested that pharmacists might be the best candidates to perform medicines 
reviews of patients on repeat prescriptions (Petty et al., 2002). 
Petty et al. (2002) described the nature of the interventions made by pharmacists carrying out 
clinical medication reviews in general practices for elderly patients on more than one 
medication and responsible for administering their medication. Permission was obtained to 
make alterations to the patients' treatments in specified circumstances without the need to 
refer the patient to the GP but patients were referred to the nurses or GPs if necessary. Six 
hundred and eight elderly patients were recruited, 590 patients were interviewed, 258 (44%) 
received recommendations for changes in their medication which included consultations 
(29%), doctor referrals (5%), and nurse referrals (4%). Medication reviews were performed 
at the GP surgeries which would make the review more effective as the investigator had 
direct contact with both the patients' notes and the responsible GPs. It was concluded from 
this study that pharmacists can implement most of the interventions without the need to refer 
the patient to either a doctor or nurse. 
Another form of the medication review is the general practice medication consultation 
between the patients and pharmacist. In a study by Lowe et at (2000b), 161 elderly patients 
(77 in the intervention group) taking at least three medicines were assessed by a clinical 
pharmacist. A medication review was performed in the community to assess their 
understanding of their medication and compliance using a structured questionnaire. 
Intervention patients received medication review which aimed to reduce the dosage 
frequencies, stopping unnecessary medications and any modification of the medication 
containers. The medicine regimen of the intervention group was changed in approximately 
half the patients. Any changes in regimens were discussed with the patient. All patients were 
reassessed after a month. On reassessment, the average score for compliance for the 
intervention group was 91.3% compared to 79.5% for the control group. Eighty-eight percent 
of the intervention group correctly recalled the purpose of the medication they were taking 
compared to 70% of the control group. The researcher concluded from these results that 
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"Medication review and patient's education in the community can significantly improve 
patient's knowledge of and compliance with medication in the short- term" 
The third form of the medication review is the one represented by domiciliary visits. 
Domiciliary service should be one of the priorities of "care in the community" and a follow- 
up visit at home after discharge from the hospital would help in this process. The need for 
domiciliary visits was recognized by the Department of Health and the Pharmaceutical 
Profession Joint Working Party (1992), it was reported that "arrangements should be 
introduced to provide domiciliary pharmaceutical services for patients who are unable to use 
the pharmacy in person". Medication-related problems, which may include appropriateness 
of the treatment, interactions, ADRs and adherence could be identified and acted on. Also, 
any medication problems experienced in hospital could be monitored and followed-up in the 
community. In this way, pharmaceutical care would be continued and the number of 
medication-related readmissions to hospital due to non-compliance perhaps reduced (Cook, 
1995). 
In a study carried out by Schneider and Barber (1996), concerning the potential benefits of 
home visits made by community pharmacists to housebound people, a structured visit report 
was developed as the instrument of the data collection. Sixteen community pharmacists 
volunteered to visit the referred patients at their homes. Of the 39 patients that received 
domiciliary visits, 35 cases showed discrepancies in the patient's own medications between 
those they were currently taking and those listed in the GP patient medication record. 
Discrepancies were due to three main factors: non-adherence, medication hoarding, and 
adverse drug reactions. The visiting pharmacist perceived that the domiciliary visits had been 
of benefit to the patients, the GPs and the pharmacists themselves. Schneider and Barber 
(1996) summarized in this study the benefits of domiciliary service perceived by the 
pharmacists as: 
Benefits to the patient 
1. Receiving a full explanation of their medication, including administration and dose 
regimen. 
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2. Understanding of medication-related problems. 
3. Receiving advice on the most appropriate way of storing the medications and 
disposing unwanted or expired ones. 
4. Improving adherence and confidence. 
" Benefits to the General Practitioner 
1. Awareness of specific patients' problems. 
2. Feedback they received was appreciated for patient's medication assessment. 
3. It is quite helpful to have another health care professional visiting the patient at 
home. 
" Benefits to the pharmacists 
1. Greater understanding of patients' medication problems. 
2. Visits helped to improve professional role satisfaction. 
3. Visits helped to raise the role of the pharmacist in the community. 
4. Visits were important to improve the relationship between the prescriber and the 
pharmacist. 
The major weakness in this study is that the domiciliary visits were not performed by the 
patients' own community pharmacists; it may have been more realistic if the visits had been 
conducted by the community pharmacists used regularly by the patient due to their 
knowledge of the patients and their medication. The counter argument is that a dedicated 
trained pharmacist would have greater clinical skills than the average community pharmacist 
(Foulsham and Goodyer, 1999). Also, this study focused on only one group of patients i. e., 
housebound people with medical difficulties. It has been quite consistently observed that 
domiciliary visits for elderly patients can uncover a wide range of medication-related 
problems. This has not only been recorded by Schneider and Barber (1996), but also by 
Foulsham and Goodyer (1999). A pharmacoeconomic study has not yet been conducted 
which can truly identify the cost of providing such a service as compared to any health 
benefits to the patients. Such services are currently provided as according to primary care 
trust needs and often linked to a monitored dosage scheme. There are no schemes well 
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documented in the literature whereby a hospital based worker provides a discharge follow-up 
service regarding patient medication. 
The present project aims to study the influence of domiciliary pharmacy visits from a 
hospital-based worker on medication management in elderly patients recently discharged 
from hospital to their own homes and providing them with the most appropriate 
pharmaceutical care. Identification, classification and prevention of the medication-related 
problems are the core of pharmaceutical care and are discussed in the next section. 
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1.3 Defining, identifying and Classifying Medication-Related Problems (MRPs) 
In this section the definition, identification and classification of drug-related problems will be 
discussed. 
Maximizing efficacy, minimizing risks, reducing costs and respecting patients' choices are 
the main features of good prescribing of medicines (Barber, 1995). In reality, this does not 
occur because medicines are sometimes prescribed inappropriately (Cantrill et al., 1998) or 
because of inappropriate use of the prescribed medicines by the patients (McGavock, 1996). 
Medication-related problems (MRPs) can reduce the potential clinical benefits of treatment 
with medicines and waste NHS resources. 
Manasse (1989) reviewed the different causes for the adverse consequences of using 
medication and found that adverse drug reaction rates varied widely (0.66%-50.6%). There 
was no clear explanation for this great variation but it may be due in a large point to the 
different techniques used to identify these problems. In this review it was reported that the 
observed percentage of hospitalizations due to adverse drug reactions seemed also to vary 
widely. It was concluded that up to 10% on average of all hospital admissions might be 
caused by drug misadventures. 
The phrases "drug-related problems" . 
(DRPs) and "medication-related problems" (MRPs) 
will be used interchangeably throughout this project. 
1.3.1 Definition of Medication Related Problems 
There are various definitions of medication-related problems (MRPs). MRPs can be defined 
from a narrow perspective of adverse drug reactions and undesirable drug interactions which 
relate to the pharmacology of the medicine. Definitions may also describe the medicine- 
taking behaviour of the patient or their non-adherence to the treatment. From a wider 
perspective, MRPs could encompass adverse drug reactions, patient medicine-taking 
behaviour and problems initiated from the prescribing of medicines. 
There are a number of different, but nonetheless rather similar, definitions of MRPs. Hepler 
and Strand (1990) chose to define it as "an event or circumstance involving drug treatment 
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that actually or potentially interferes with the patient's experiencing an optimum outcome of 
medical care". This definition was modified by Strand and other co-workers (1990) to "an 
undesirable patient experience that involves drug therapy and that actually or potentially 
interferes with a desired patient outcome". With this definition, the MRPs can only exist if a 
patient is experiencing the disease or symptom and the condition is related to the medicine. 
This definition differed from others in that the main focus was to ensure that the medicines 
were appropriate. A shorter definition that more clearly includes problems detected by 
pharmacists, besides the ones presented by the patients, is the following by Segal (1996) "a 
circumstance of drug therapy that may interfere with a desired therapeutic objective". 
The Pharmaceutical Care Network Europe (PCNE), a network of researchers in 
pharmaceutical care, used a definition for DRPs which is quite similar to that expressed by 
Hepler and Strand "an event or circumstance involving drug therapy that actually or 
potentially interferes with desired health outcomes" (Van Mil, 1999). Some authors have 
preferred to use the term "medication-related problems" (Shimp et at, 1985). 
Treatment with medicines should have a patient-centered approach because "drugs are 
administered for the purpose of achieving definite outcomes that improve the patient's 
quality of life" (Hepler and Strand, 1990). Hepler and Strand highlighted the positive 
outcomes of treatment with medicines which were marked by a reduction, elimination, 
slowing or prevention of symptoms or diseases. For an event to be qualified as a DRPs, a 
patient must experience or likely to experience disease or symptom and the condition must 
have an identifiable or suspected relationship with the drug therapy (Strand et al., 1990). The 
main problems associated with treatment with medicines are inappropriate prescribing, 
inappropriate delivery, inappropriate behaviour of the patient, patient idiosyncrasy and 
inappropriate monitoring. Inappropriate monitoring was considered as the most important but 
the least appreciated, since many of these problems `can be detected by careful monitoring 
(Hepler and Strand, 1990). 
Drug-related problems were defined by Kaplan et al., (1994) as `problems related to drugs 
likely to cause clinically significant harmful effects to patients if not brought to the attention 
of the primary care physician". Similarly, Akwagyriam et al. (1996) in a study of MRPs 
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presenting to a causality department used criteria which included adverse drug reactions 
(ADRs), dosage problems, drug interactions (DIs), compliance problems, drugs not properly 
documented on an accident and emergency (A&E) card and any other MRPs identified by the 
A&E senior house officer. These definitions have relied on the clinical experience of the 
physician. 
Strand et al. (1990) proposed a patient-focused definition to enable the pharmacist to have a 
"tangible impact on actual patient outcomes". Similarly, other authors have concluded that 
the pharmacist has a professional responsibility to detect medication-related problems and 
contribute to patient outcomes. Granas and Bates (1999) defined MRPs in a study of repeated 
prescribing* as "any problem with the prescribed medication that the community pharmacist 
considered was not good prescribing practice". However, there has been some evidence that 
the clinical expertise of doctors and pharmacists has been shown to differ and there has been 
some evidence of disparity of both healthcare professionals have rated the severity of 
medication administration errors as stated by Dean (1999). This may be applicable to any 
medication-related problems not only on repeat prescribing, and it may be reasonable to 
involve both doctors and pharmacists in the process of identification and assessment of 
MRPs. 
This section has focused on the range of definitions of medication-related problems reported 
in literature. The following section will discuss the identification and classification of 
medication-related problems. 
1.3.2 Identification of Medication Related Problems 
As mentioned in the previous section, in order for an event to be identified as a MRP, two 
conditions must exist (Strand et al., 1990): 
1. Patient must experience or be about to experience a disease or symptom. 
2. These diseases or symptoms must be identified to be related to a drug therapy. 
*A repeat prescription is the issue of a prescription for a medicine, without a consultation, to patients on long- 
term medicines (Zermansky, 1996). 
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Lee and Beard (1997) reported the frequencies of patients with adverse drug reactions 
(ADRs) in the community. It was found that there was as wide variation between the 
estimates of the ADRs as 2.6-41%, but they did not report the sources of these figures and 
this variation may be attributed to the differences in the methods used to detect suspected 
reactions and differences in the definitions. Lower percentage of 2.6% can be attributed to 
MRPs identified during GP consultations. The frequency of patients with MRPs may be as 
high as 65% when the patients are interviewed in their own homes in comparison with 
reviewing the information from their records (Mulroy, 1973). 
Two literature reviews (Sullivan et al., 1990 and Einarson, 1993) which reported medication- 
related admission concluded that 5% of all hospital admissions were medication-related, 
despite using different definitions of MRPs. Sullivan et al. reviewed seven studies for non- 
compliance defined as overuse, underuse or erratic use of medicines. Einarson (1993) 
reviewed 36 studies for MRPs which were categorized as adverse drug reactions (ADRs), 
drug interactions (DIs), mistaken drug use, inadequate or improper therapy and exacerbation 
of disease resulting from medication non-adherence. Another study (Lamour et al., 1991) has 
reported a frequency of patients with MRPs to be as low as 2.4%. Lamour et al., (1991) 
found that 136 (2.4%) of 5,623 hospital admissions were attributed to ADRs. This low 
percentage was mostly based on detection of ADRs or restricted definitions of MRPs. A 
higher percentage was identified in a study by Col et al. (1990), who interviewed 315 elderly 
patients admitted to an acute care hospital to determine the percentage of elderly hospital 
admissions due to non-compliance with medication regimens or adverse drug reactions. 
Eighty-nine of the elderly admissions (28.2%) were drug related, 36 were due to non- 
compliance (11.4%) and 53 were due to adverse drug reactions (16.8%). This leads us to the 
conclusion that the variations in MRPs frequencies are related to the definition used and also 
can be related to the confusion between ADRs, MRPs and the compliance. 
Patient medication records (PMRs) and prescription monitoring is one of the methods that 
can be employed to identify any MRPs patients may experience. The position of pharmacists 
at the interface between distributing the medications and patients using them makes their role 
in preventing inappropriate prescribing problems important (Rupp et al., 1992). The 
pharmacist's ability to monitor prescriptions in order to detect incidents defined as "all 
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possible medication and prescription-related problems that might be encountered by a 
community pharmacist" including those arising from the purchase of OTC or pharmacy 
recommended medication was investigated by Greene (1995). A survey of prescription 
problems was conducted in 23 community pharmacies. A report form was designed for the 
community pharmacists to record each incident detected and was rated according to its 
clinical significance as: 0 for trivial incidents; 1 not serious; 2 serious and 3 very serious. 
These incidents included the frequencies patients presented with prescription, a changed drug 
or dosage form, a changed dose or timing, inappropriate dose or timing, a drug-drug 
interaction and a drug-condition interaction. Three hundred and forty incidents were 
reported, 16% were classified as very serious, 48% as serious, 26% as not serious and 10.9% 
were classified as trivial. The very serious incidents included haemorrhage from excess 
warfarin and uncontrolled hypertension with the risk of a stroke. The serious incidents 
included overdose and duplication. The less serious problems included prescriptions 
requested too early but with a reasonable explanation. Finally, examples of trivial problems 
included the change of the prescription from cream to ointment form. This study identified a 
higher frequency of serious incidents and this may be attributed to the design of this study 
encouraged pharmacists to record more serious problems. Note that the judgment for severity 
was made as a subjective assessment by the investigator alone. 
In a study by Rupp et al., (1992), the interventions performed by 89 community pharmacists 
to correct the prescribing problems they identified on new prescriptions were documented. 
Four types of errors were recognized. `Errors of omission' were defined as errors where the 
prescription lacked important information or the information was vague or unreadable. 
Examples of this type of error were inadequate specifications of dosage or strength, quantity 
or duration not specified and prescriptions being illegible. `Errors of commission' were 
defined as an incorrect strength or dose, and were potentially serious and harmful and 
represented a threat to the patient's health. Examples representing this category were the 
prescribing of an inappropriate dose or inappropriate strength, incorrect form or quantity or 
incorrect patient. The third form of error was drug-drug interaction or drug-disease 
interactions. The last form was Others which includes patients' concerns or fraud 
prescriptions. Community pharmacists managed to make interventions on 683 prescription 
errors out of 53,941 prescriptions dispensed in the community pharmacies. Three hundred 
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and twelve (46%) were errors of omission and 249 (36%) were errors of commission. Other 
errors identified were 8% drug interactions and 10% miscellaneous problems, which included 
any questions or concerns that patients had about their medicines. Only 1.9% of these 
prescriptions showed problems needed to be acted upon, this may be due to the fact that the 
review was performed on the new prescription orders. 
It is difficult to rely on the prescription monitoring by the community pharmacists as a sole 
tool for identification of MRPs, as patients may be filling their prescriptions from more than 
one community pharmacy. In addition, pharmacists do not keep any records of the patient's 
clinical diagnosis or laboratory results. The data stored on pharmacy records are mainly a 
reflection of the information presented on prescriptions and any information offered by 
patients. The information that appears on prescriptions should correspond to the information 
held on computerized medicine histories in GP surgery. Therefore, prescriptions can 
potentially be used to confirm the information held on GP surgery records and patient 
medical records in GP surgeries can be used as another tool for identification of N Ws. The 
main advantage of using GP surgery records to identify MRPs is that patients normally use 
only one GP surgery, therefore all their medical information is held at one location. GP 
surgery records can also provide data on the diagnosis for which the medicine was prescribed 
and the patient's clinical status. For patients who are on long-term treatment for chronic 
illnesses, repeat prescriptions are issued from GP surgeries. One disadvantage of using repeat 
prescriptions is that they may themselves resulting in NMPs due to inadequacies of GP 
records; for example, patients can restart medicines that have been already stopped (Corbett, 
1995). 
Granas and Bates (1999) reviewed 511 prescriptions for patients taking three or more 
medicines. One hundred and eighty seven prescriptions of the 511 (37%) were identified as 
having MRPs. Of those 187 prescriptions, 90 repeat prescriptions were assigned to a trial 
group with pharmacist intervention. Of those 90, the GPs agreed to respond to 77 (86%) of 
the pharmacist's recommendations. In this study the GPs agreed on a higher number of 
recommendations made by the pharmacist. This was possibly due to the prospective nature of 
the study which meant that prescriptions were written on the same day and they were able to 
assess what medicines the patients were actually being prescribed and were possibly taking. 
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This high agreement was attributed to the nature of the intimate relationship between the GP 
and the pharmacist where there was only one GP/pharmacist pair who took part in 
interviewing the major proportion of repeated prescriptions. 
In another study (Goldstein et al., 1998), volunteer pharmacists reviewed notes for patients 
with 6 medications or more who were referred by their GPs. Volunteer pharmacists received 
training to allow them to review confidently repeat prescriptions and systems. One thousand 
five hundred and sixty four patients who received six or more medicines were reviewed 
where 13,194 medicines were reported in the patients' records. Potential problems were 
identified for 9,762 (74%) medicines. Discussions addressing the identified problems and 
possible solutions were held between the pharmacists and GPs. Three months later the 
volunteer pharmacists reviewed GP notes to determine whether changes had occurred. The 
GPs agreed with 5,628 (58%) of the recommendations but implemented the advice given for 
only 3,132 (32%) medicines. The reasons why GPs did not always act upon the pharmacists' 
suggestions included: insufficient time for patient recall between pharmacists' suggestions 
and their follow-up visits, GPs reluctant to alter medication which they were not the original 
prescribers. A further reason was pressure from patients for medication which has been 
previously prescribed and had perceived benefit although not clinically required i. e., it was 
not worth upsetting a patient". The problems identified were categorized into 11 categories 
including duplicate prescribing, inconsistent/inappropriate quantities, drugs no longer 
needed, inappropriate directions, more reasonable alternative drug choice was available, 
possible drug interactions, suspected compliance problems, further investigation required, 
side effects and drugs prescribed outside their product license. This study did not investigate 
MPs due to poor patient knowledge. The high frequency of M_RPs identified by Goldstein 
et al. (1998) could be explained by the inclusion criteria, which targeted patients who were 
more at risk of MRPs because of taking six or more medications. The nature of the 
relationship between the GP and the pharmacist may have been less intimate compared to 
Granas and Bates (1999) since there was 47 GP/pharmacist partnerships formed in Goldstein 
et al. (1998) compared with the one GP/pharmacist pair in the Granas and Bate (1999) study. 
A review of patients' records kept at the surgeries relies on what has been documented which 
means that these records may not necessarily be able to reflect what patients are actually 
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taking in their homes or explain how they manage or store their medicines. Interviewing 
patients can be considered as a useful tool to find out what medicines they are actually using, 
how they use these medicines and how they store their medicines, how they respond to the 
therapy and consequently uncovering any medication-related problems. 
The previously mentioned `Brown bag' medication reviews can be used as an effective and 
potential cost-effective tool to uncover medication-related problems, which may not readily 
come to the attention of the GP. These reviews can enable the GPs and the pharmacists to be 
aware of problems that patients may encounter with their medicines. Interactions between 
prescribed medicines and OTC products is one of the areas that can be identified by such 
reviews, as GPs are normally not aware of what patients buy over the counter for self- 
treatment of minor ailments (Nathan et al., 1999). The main disadvantage of this scheme is 
that the efficacy of the review depends mainly on what the patients choose to bring with them 
to the session. 
Domiciliary visits can be another tool to identify MRPs that might be missed by other means. 
In one study (Foulsham and Goodyer, 1999), 90 patients (with age range from 26-96 years) 
received domiciliary visits. Patients were visited by the community pharmacist in response to 
referrals from GPs, social services or district nurses. Reasons for the referrals included a 
range of problems that were directly related to the use of medicines, for example, 
administration problems, taking three or more medicines or taking medicines on more than 
two occasions per day, or there was an evidence of poor adherence due to a lack of review. 
Other reasons for referring a patient included: recent hospital admissions, interface problems, 
the patients' need for explanation of the purpose of medication, or when repeat prescriptions 
were requested irregularly or not often enough. Eighty four (93%) of 90 patients visited were 
identified with one or more medication-related problems. A potential limitation of this 
method is that the identification of the medication-related problem can be influenced by the 
subjective view of the visiting pharmacist. Also, results of this type of medication review 
depend upon what the patients bring to the consultation. 
Similarly, Schneider and Barber, (1996) reported the medication-related problems identified 
by 16 community pharmacists who made domiciliary visits to 39 patients referred by 14 GPs. 
47 
CHAPTER I BACKGROUND& LITERATURE REVIEW Definition, identification & Classification ofMRPs 
Thirty-two patients were identified as having one or more discrepancies attributed to one of 
three factors. These factors were non-adherence, inaccurate medication record and hoarding. 
16 (41%) reported adverse drug reactions (ADRs). These ADRs included nausea, 
constipation, diarrhoea and stomach upset due to NSAIDs, Opioid analgesics and iron. Also, 
cases of incontinence caused by diuretics and drowsiness caused by benzodiazepines were 
reported. Eleven cases of drug interactions were identified by the community pharmacists. 
The majority of these cases included Paracetamol toxicity (due to taking more than one 
product containing Paracetamol at the same time); ulcer exacerbation (taking NSAIDs while 
taking H2- antagonist for the treatment of ulcer). Other problems reported in this study 
included: difficulties in reading labels, problems in opening child-resistant containers, using 
more than one container or package for the same medication and mixing or transferring 
medications in different containers. 
From the above, there are a wide variety of methods for identifying medication-related 
problems. These methods include reviewing patients' medication records, prescription 
monitoring in pharmacies, patient medical notes in GP surgeries and patient interviews either 
in their homes, or in the community pharmacies or any other convenient setting. It would 
appear that researchers construct their own classification systems making comparison 
between studies quite difficult. By far, the most important drawback concerning bias and 
generalisability of such studies is that the judgment concerning the presence of MRPs is often 
subjectively made by the researcher or team. This is particularly relevant when attempts have 
been made to assess the "seriousness" of MRPs. Therefore, the validity of the findings of 
many of these studies could be called into question. A potential solution might be to identify 
a classification scheme with precisely stated criteria that has been employed by a number of 
studies. A second important area to address is the judgment of the MRPs ideally by a panel of 
healthcare professionals but at least by one or two other independent observers. The 
following section examines these points. 
1.3.3 Classifications of Medication-Related Problems 
As mentioned previously, the "medication-related problem" is very broad in its definition. 
There is no universal classification of drug-related events but classification of MRPs is 
important when assessing the effectiveness of pharmaceutical care services. 
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There are a variety of ways in which MRPs have been classified. In some classifications, the 
causes of MRPs are separated from the problems. In other cases, classifications of the MRPs 
describe the causes behind these problems. Other classifications consider the interventions 
being employed to reduce these MRPs. The most widely used categorization system was the 
Strand et al. (1990) classification and is most often referred to as the `Strand Classification'. 
In this system, the term "drug-related problem" was introduced and divided into eight basic 
categories: 
1. There is a medical condition which requires medical therapy (indication) but the 
patient is not receiving any medicine for that indication. This category includes 
interruption of the drug therapy and not prescribing prophylactic treatment against 
certain condition. 
2. The patient has a medical condition but the wrong medicine is being taken. This 
category includes prescribing ineffective or less effective therapy or prescribing drug 
therapy when an allergy or contraindications exist. This category includes also 
prescribing the more expensive drug. 
3. The patient has a medical condition for which too little of the correct drug is being 
taken. This category includes prescribing drug with inappropriate dosing interval or 
for a period not long enough to achieve the desired outcome. 
4. The patient has a medical condition for which too much of the correct drug is being 
taken. 
5. The patient has a medical condition resulting from an adverse drug reaction. 
The patient has a medical condition resulting from a drug-drug, drug-food, and drug- 
laboratory interaction. 
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6. The patient has a medical condition that is the result of not receiving the prescribed 
drug. This category includes patient noncompliance, inability to buy the medication, 
indolence, technical problems with devices used and formulation problems. 
7. The patient has a medical condition resulting from taking a drug for which there is no 
valid indication 
This classification focuses mainly on the events that caused actual harm to the patients, 
which means it can not be used effectively to classify events that are likely to cause harm to 
the patients. This means that this system is not able to classify potential DRPs and to help 
prevent any harm a patient may be exposed to before the harm occurs. A further drawback of 
this classification is the failure to specify the causes (mechanisms) of the drug-related 
problems which is important to be able to prevent the recurrence of the problem itself. 
Finally, the system would not detect the presence of some important problems, like 
therapeutic failures, lack of knowledge and drug abuse. 
In a trial to overcome some of these problems, a further classification was suggested by Wills 
and Brown (2000). This classification highlights the relationships between different drug- 
related events (DREs). Drug-related event can be classified as "any incident involving at 
least one drug and a patient or healthcare professional" and classified into two major classes: 
A. Procedural DREs 
This class concerns the procurement of medicines and the procedures of supplying them, 
including prescription-writing requirements. For example, if a doctor forgets to sign a 
prescription, this may not cause direct harm to the patients, but the absence of the signature 
may cause a delay in delivering the medicines in time which in tam causes a delay in 
therapy. This class also comprises of errors in clinical trials documentation and drug 
administration records. 
B. Clinical DREs: 
This class concerns the events in which the drug itself is the corner stone that directly or 
indirectly affects the patients and their health. This class is divided into two main categories; 
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beneficial and detrimental DREs. The beneficial category includes (in contrast to normal 
classifications the useful events rather than the harmful ones) the actions (interventions) 
which are helpful to the patient's healthcare, e. g., successful response to a treatment, patient 
counselling, appropriate drug selection and accurate drug dispensing. The detrimental 
category includes the undesirable events caused by certain drugs. This category is comprised 
of eight basic types: adverse drug reactions, adverse drug interplays (drug interactions or 
incompatibilities), overdose (accidental or non-accidental), prescribing errors (drug choice, 
dose or frequency, route or method of administration, regimen changes or monitoring 
deficit), errors in interpretation of the prescriptions (administration errors or supply errors), 
non-compliance, unavoidable non-responses and abuse. 
This classification is meant to be simple, comprehensive and easy to understand and use. 
However, it is difficult for any system to be comprehensive as there are such a wide range of 
events to be included. The reasons for these difficulties stem from the fact that many of the 
events cannot easily fit into a `tree structure' classification which is one of the requirements 
to constitute a suitable classification system (Schaefer, 2002). The other reason for these 
difficulties is that individual events can be related to more than one cause, making its 
allocation in one category challenging. Another weak point regarding this classification is the 
absence of a category for the physical difficulties patients may suffer that could have a 
bearing on NWs. The last drawback of this system is the failure of this system to cover 
problems related to patients' knowledge about their medication. 
In Sweden, a different classification was employed in a study carried out by Andersson et al. 
(2003). This classification is based on linking the patients' MRPs to the pharmacists' 
interventions where a self-reporting system was used by pharmacy staff in Swedish 
community pharmacies. Medication-related problems and interventions were documented 
using a self-completed card; one side of the card being used for reporting patient's 
demographic data and drug-related problems. More than one problem could be marked on the 
same card but only one card can be used for each drug. The other side of the card was used to 
document the interventions by the reporting pharmacist and more than one intervention could 
be marked per card. Medication-related problems were defined as "a circumstance of drug 
therapy that may interfere with a desired therapeutic objective " and intervention was defined 
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as "any kind of measure taken by the pharmacy staff members to solve a detected drug- 
related problem ". MRPs were classified into 16 categories: 
" Uncertain purpose of the medication 
" Incorrect use or handling of drugs 
" Inappropriate self-care 
" Drug interactions 
" Side Effects 
" Lack of effects 
" Drug duplication 
" Prescribing errors 
" Difficulties in swallowing tablets 
" Difficulties in opening containers 
" Other practical problems 
" Under-dosage 
" Over-dosage 
" Language problems 
" Problems caused by the pharmacy 
" Others 
Interventions were classified into 11 categories: 
" Improving patient's understanding of " 
the therapy 
" Solve dosage problems " 
" Select appropriate medicine " 
" Contact prescriber " 
" Improving patient's practical handling " 
of medicine " 
Recommend patient to contact doctor or 
nurse 
Eliminate side effects 
Eliminate interactions 
Information in relation to patient's disease 
Problems not solved 
Others 
This classification is based on an earlier system from Sweden called the `Westerlund System' 
(Westerlund et al., 1999). The system includes an intervention classification and a manual for 
its use. This classification based on Hepler and Strand's (1990) definition of the MRPs as "a 
circumstance related to the patient's use of a drug that actually or potentially prevents the 
patientfrom gaining the intended benefit of the drug". 
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This system was classified to be used by different pharmacy personnel i. e., pharmacist, 
prescriptionist* or technician to detect MRPs in patients of all ages. A form of different 
options of types of problems, based on the principal investigator's own professional 
experience was constructed. A special data collection form was designed to document: 
" Type of problem (14 categories). 
" Type of intervention (11 categories). 
" The name of the drug causing the problem. 
" The way the problem was reported whether by the patient or by the pharmacist. 
" Patient's gender and age. 
" The number of prescribed medicines. 
" The time taken to respond to the problem. 
The form was produced as a postcard, printed on both sides and should be filled after the 
patient leaves the pharmacy. A card was used for each problem per patient. The different 
identified MRPs were categorized into 14 different classes: 
" Unnecessary aim of drug 
" Underuse of medication 
" Overuse of medication 
" Other dosage problems 
" Drug duplication 
" Drug-drug interaction 
" Therapy failure 
" Side effect 
9 Difficulty swallowing tablets 
" Difficulty opening container 
" Other practical problems 
" Language deficiency 
" Prescribing error 
" Other MRPs 
This system correlated the identified problems to the interventions performed to solve these 
problems. Interventions needing to be performed are classified into different 11 categories: 
. In Sweden, prescriptionists have shorter university education but have the same legal rights and obligations 
regarding prescribed medication as pharmacists. 
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" No intervention 
" Patient medication counselling 
" Practical ins+*uction to patient 
" Prescriber informed only 
" Prescriber asked for information 
" Intervention approved by prescriber 
" Intervention disapproved by prescriber 
" Switch of drug 
" Referral to colleague 
" Other intervention 
Another classification system was described in a study by Dean and Barber (1999) where 30 
healthcare professionals from four UK hospitals identified 50 medication errors. Three 
categories were used in this study; minor (very unlikely to have any adverse effects), 
moderate (likely to cause some adverse effects or may interfere with the therapeutic goal of 
the regimen but very unlikely to result in death or lasting impairment), and severe (likely to 
cause death or permanent impairment). This judgment was based upon the assessment by a 
panel of blinded healthcare workers. 
It is believed that inappropriate medication prescribing is a common problem among the 
elderly and has been associated with unnecessary medical expenditure e. g., adverse drug 
reactions, morbidity and health services utilization and drug-related hospital admissions and 
readmissions (Lindley et al., 1992). The Medication Appropriateness Index (MAI) was 
developed as a tool that "uses explicit criteria to make implicit judgments about medication 
appropriateness". The tool was designed to assess multiple elements of drug therapy 
prescribing and appropriateness of medications and requires that a medical history problem 
list and medication list is available for review. The index is made-up of ten criteria regarding 
medication indication, effectiveness, dosage, directions, drug drug interactions, drug-disease 
interactions, expenses, practicality, duplication and duration. These ten criteria are worded as 
questions such as "Is there an indication for the drug? ". The questions are answered using a 
four-choice scale where A is indicated, B is marginally indicated, C is not indicated and Z in 
not known and given a score between 0 and 18 is being increasingly inappropriate. The MAI 
comes with general instructions about the best way to use the index and to answer the ten 
questions (Hanlon et al., 1992). 
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The most recently published classification system is the one used by Sorensen et al. (2003) 
where a "quality use of medicines" coding system was developed to assess the 
appropriateness of pharmacists' medication reviews. A total of 19 codes were developed 
from literature based on previously identified medication-related problems. The coding 
system was evaluated for inter-rater reliability using three raters (Hospital pharmacist, 
pharmacist specialized in medication review in a nursing home and a research pharmacist). 
The codes used are: adverse response AR (+/-), interactions INT (+/-), contraindication CI 
(+/-), sub-therapeutic dosing ST (+/-), overuse/toxicity TOX (+/-), essential therapy ES (+/-), 
polypharmacy PF (+/-), good clinical pharmacy practice GCPP (+/-), mortality M (+/-) and 
clinical non-significant code CNS (+/-). To assess the practical effect of this coding system, 
it was applied to 216 medication profiles (111 interventions and 105 controls) by an 
independent clinical pharmacist with the aim to assess the appropriateness of pharmacy 
interventions. Although one medication can be involved in more than one intervention, 
underestimation of the number of interventions may occur as this system depended mainly on 
assigning one medication with one code. Also it was sometime difficult to identify whether 
the intervention was initiated by the doctor or the pharmacist. 
The last classification system adopted in the current study is the PCNE system which was 
developed by the Pharmaceutical Care Network Europe. Details of the classification itself 
validation and categories will be discussed in Chapter 3. 
In conclusion, it appears that there are various definitions given to drug-related problems. 
Medication-related problems include adverse drug reactions, drug interactions, inappropriate 
prescribing and patient's non-compliance. MRPs decrease the clinical effectiveness of 
medicine and consume NHS resources. There is no universal classification system for the 
medication-related problems and different systems have been developed and employed in 
various clinical situations. Some of the systems used, including the Strand classification, 
separated the causes of the problems from the problems themselves. The Wills and Brown 
system highlights the relationship between different drug-related events. 
WesterlundiAnderson systems link the patients' drug-related problems to the pharmacist 
interventions. MAI was developed to measure elements of appropriate prescribing. Then 
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there is the simple classification system used by Dean which classified the MEPs into three 
categories of severity. There is also, the Sorensen classification which evaluates the quality 
use of medicines and provides an assessment of pharmacist medication review 
recommendations. 
In the present study, patients will be visited in their homes and their medication will be 
reviewed to identify any possible MRPs and patients will be interviewed to identify the 
problems they suffer. The effect of improving the transfer of drug-related information from 
secondary to primary care on reducing the number of MRPs experienced by elderly patients 
will also be assessed. Two classification systems will be used in categorizing the MRPs 
identified through out this study. The Dean system will be used because of its simplicity, its 
clear definitions of its categories, the ability to score these categories and measure its severity 
in addition to its ability to measure service-related problems. PCNE will be used because of 
its ability to link the clinically identified problems to its causes and to the interventions. This 
is in addition to the fact that this system has been used and validated previously. 
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1.4 Compliance and Patient Knowledge 
One of the most common NWs observed in elderly patients is non-adherence to the 
prescribed regimen either intentionally or non-intentionally. This section will cover 
compliance from various aspects, including definition, factors, assessments and methods for 
improving compliance. 
Compliance has been defined as: "the extent to which a person's behaviour (such as taking 
medication, following diets, or changing lifestyles) coincides with medical or health advice" 
(Sackett and Hayes, 1976). With such a definition, patients have little say in the treatment 
they receive which is contrary to the current concepts regarding patient choice in healthcare. 
This definition of compliance implies that `the doctor knows best' and that his/her decision 
should be the final. The role of the doctor is to decide on the appropriate treatment and issue 
the relevant instructions, whilst the role of the patient is to comply with the doctor's orders 
(Home, 2001 a). The term `adherence' has been suggested to replace the term `compliance', 
implying that "it is acceptable that the patients can have the right to decide whether or not 
they will be able to follow the treatment regimen dictated by the prescriber" (Goodyer, 2002) 
and that failure to do so should not be a reason to blame the patient (Home, 2001 a). The two 
terms i. e., compliance and adherence will be used interchangeably the current study. 
Concordance is a new philosophy in the process of prescribing medicines and improving 
adherence. Concordance is defined on the concordance website as "an agreement reached 
after negotiation between a patient and a healthcare professional that respects the beliefs 
and wishes of the patient in determining whether, when and how medicines are to be taken. 
Although reciprocal, this is an alliance in which the healthcare professional recognizes the 
primacy of the patient's decisions about taking the recommended medications". This term 
has been used to indicate the degree to which the patient and the prescriber agree about the 
nature of the illness and the need for treatment (Home, 2001a). Concordance differs from 
both compliance and adherence in the that it focuses on the process and outcome of a medical 
consultation and has an underlying ethics of a shared approach to decision-making rather 
than just observing the patient's behaviour toward the medication (Weiss and Britten, 2003). 
Concordance is based on the principle that, patients' beliefs should be considered and 
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patients must be given the chance to decide the best approach to the treatment of the 
individual despite the difference between the patient's health beliefs, and those of the 
healthcare professionals. Concordance is a multi-task term, considering the patient and the 
doctor. The patient's task is to express health beliefs to the prescriber and the task of the 
doctor is to find an opportunity for this to happen and to convey his/her health beliefs to the 
patient Concordance aims at helping patients and prescribers to reach a common agreement 
about the diagnosis, treatment, benefit and risk and so to optimise the potential benefits of 
medical care (Royal Pharmaceutical Society, 1997). The concept of concordance has not 
been formally studied to any great extent and is still not widely accepted by the healthcare 
professions. 
Patient's compliance can be a difficult term to define and measure, as well as to determine 
the true extent and implications of observed compliance levels. It is also difficult to specify 
the level of compliance necessary to derive maximum benefit from treatment. Practically 
speaking, compliance is often quantified simply as the percentage of prescribed doses taken 
e. g., using tablet counts. However, unqualified percentage figures are reported, such as: 
`There was 75% compliance'. This may indicate either that the average level of patient 
adherence was 75%", or that 75% of patients were fully compliant with their regimens 
(Raynor, 1992). Ideally, levels of compliance should be specified, for each disease and 
treatment, below which the desired preventative or therapeutic result is unlikely to be 
achieved or the patient's condition is expected to show clinical deterioration. Determination 
of such levels is somewhat difficult especially as the majority of patients are prescribed 
multiple therapies. To overcome this problem, a general arbitrarily acceptable level of 
compliance has been proposed. It has been suggested that taking between 90 and 110% of 
doses is likely to produce the required therapeutic effect for most classes of the medicine 
(Lorenc and Branthwaite, 1993). Eagleton et al., (1993) considered 85-115% as an 
acceptable compliance level i. e., patient considered to be non-complier if he/she showed a 
15% or more deviation from the prescribed regimen. Monane et al. (1996) used 80% or more 
of days a patient had antihypertensive medication available (days covered) as the bench mark 
of good compliance. However, each study focused on a patient category and different 
purpose for which compliance was assessed. 
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Rather than using an arbitrary value, bands of compliance can be used and each band 
describes the proportion of the patients falling within that level. This method can be useful 
when analyzing the effects of an intervention to improve compliance, e. g., medication 
counselling. Pullar (1991) has categorized the patient's compliance into four categories based 
on four-percentage ranges. He suggested that those taking 90-110% of doses prescribed are 
fully compliant, 50-89 as sloppy compliers, 30-49% as low compliers and less than 30% as 
non-compliers. Anderson (1987) used less than 75% as a poor compliance level, 75-90% as 
fair compliance and greater than 90% as good compliance level. 
McElnay et aL (1997) reported a useful compliance description system: 
" Partial compliers: those who take between 40 and 80% of the prescribed dose 
and this is representing one third of the patients. 
" Satisfactory compliers: those who sometimes take more and sometimes take 
less than the dose prescribed and are representing one third of the patients. 
" Poor compliers: those who take less than 40% of doses prescribed at widely 
varying intervals and are representing one sixth of the patients. 
" Good compliers: people who hardly miss a dose and only occasionally take 
extra dose and are representing one sixth of the patients. 
The problem of poor medication compliance to the prescribed regimen and knowledge has 
been reported in numerous studies. There are many factors that may influence patient's 
compliance (Col et al., 1990): 
a. Patient's perception of the seriousness of the condition being treated and patient's 
beliefs regarding the risk inherent in their diagnosed disease compared with the 
benefit of treatment. 
b. Patient's satisfaction with the treatment regimen offered. 
c. The way the patients being supervised by their clinicians and reluctance to listen to 
their concerns. 
d. Complexity of the drug regimen. 
e. Adverse drug events patients may suffer and may discourage them to continue using 
their medication. 
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£ Package of the drugs (difficulties in opening bottles or taking the tablets out of the 
blisters) and difficulty in administration, particularly for complicated devices such as 
inhalers. 
g. Cognitive function and mental abilities of the patients. 
h. Advancing age. 
i. Patient's knowledge and information. 
J. Disability/physical function 
k. Using more than one pharmacy. 
Of all these, it is the complexity of the prescribed regimen which has been shown to have the 
greatest influence on compliance (Eagleton et al., 1993). 
Patients may be harmed due to their non-adherence due to receiving sub-therapeutic levels of 
the prescribed medications. In other circumstances, unnecessary medication may be 
prescribed because non-adherence to prescribed medication is interpreted by the prescriber 
who is unaware of the non-adherence as a need for more medication (Rosen et al., 2004). 
`Deliberate non-compliance' describes patients who consciously choose not to adhere to 
their medication regimens. Such behaviour is the most difficult to address, as patients cannot 
be forced to comply (Raynor, 1992). Attempts to identify and change the underlying factors 
which cause the patients to choose not to adhere are difficult and time-consuming. 
`Deliberate non-compliance' can sometimes be useful behaviour i. e., it may be in the 
patient's interest not to comply with the physician's directions for example, the use of 
analgesics, laxatives and sedatives only when needed, even if the medicines are prescribed to 
be taken regularly. This term leads to another term `intelligent non-compliance' which 
describes the patients who alter their prescribed therapy without suffering any adverse 
consequences. There are many reasons for this attitude: wrong diagnosis may be made, 
patients recover from illness despite poor compliance and patient's belief that the prescribed 
medication is causing side effects (Stewart and Caranasos, 1989). 
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Goodyer (2002) described in his review another teure `drug -holidays' which is used to 
describe the situation "when drugs may be taken strictly as prescribed then omitted 
completely for few days". This concept introduces another term referred to as `white-coat 
compliance' in which compliance improves for certain period before a scheduled medical 
examination (Feinstein, 1990). 
1.4.1 Compliance and Drug Knowledge in the General Population 
In this section of the review some of the studies which describe the extent, and some of the 
factors influencing drug compliance and knowledge will be examined in more detail. 
Studies Examining General Compliance Levels 
Non-compliance with prescribed medicines is widespread, and it significantly compromises 
the wellbeing of patients. Parkin et al. (1976) found in his study that, half the patients he 
recruited were deviating from prescribed treatment because of either non-comprehension or 
non-compliance or both. Deviation from prescribed treatment may be due to failure to 
understand the nature of the regimen (non-comprehension) or lack of adherence to the 
treatment even when the correct regimen is known (non-compliance). Interviewing patients 
can determine which of them do not know what drugs to take or when or how, but patients 
who are non-compliant may not admit the fact on interviewing. 
McElnay et al. (1997) carried out a study reporting patients' adherence with prescribed 
medications in a population of elderly patients prior to their hospital admission. Five hundred 
and twelve patients self-reported their compliance patterns, 13.7% of this population reported 
non-compliance. The percentage of under-compliance was 10.7% with 4.3% reporting over- 
compliance. However, it is well recognized that self-reported non-compliance is probably a 
gross underestimate of actual non-compliance. On the other hand, Blenkiron (1996) found 
when he interviewed 80 patients aged 75 years and over to assess their level of compliance. 
Patients claimed to be "good" compliers i. e., never miss a dose, for 77% of prescribed 
medication. Compliance may decrease in the intervals between visits to clinic or outpatient 
department, this reduction may be due to poor recall of information. In 20 epileptic patients 
monitored using hidden microelectronic device (Cramer et al., 1990) compliance fell from 
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86% just immediately after the visit to 67% one month later. Epilepsy is a chronic disease in 
which drugs must be administered over a long period of time, although seizure may be 
produced as a complication of the non-adherence of therapy. Even so, compliance levels as 
low as 39% for more complicated regimens have been reported. In another study carried out 
in cardiological department in a teaching hospital in Germany, it was reported that the most 
important factor leading to hospital admission for heart failure patients was non-compliance 
with the prescribed drugs. Non-compliance was reported in 23.5% of the monitored patients 
(Michalsen et al., 1998). 
Several factors combine to produce patient compliance. These factors will be discussed in the 
following section 
Factors Affecting Compliance 
Nonadherence to treatment occurs for a variety of reasons including: doubt over the expected 
benefits and its effectiveness; real or perceived barriers including side effects; unique 
demands of the regimen itself and lack of help and support from family members or carers 
(DiMatteo et al., 1993). Clinical depression also can be considered as one of the reasons 
behind non-adherence, probably because of the sense of hopelessness, social isolation, 
fatigue, and impairment in cognitive focus that accompany depression (DiMatteo et al., 
2000). Recent qualitative research also pointed to patients' identity and self-image, and the 
meaning of medication, as important factors affecting patient's adherence to medical advice 
(Lambert et al., 1997). 
The disease in which adherence and persistence have been best studied is hypertension, and it 
can serve as a useful model of chronic drug therapy. About half the people with hypertension 
receive drug treatment; around half of them have well controlled blood pressure and half stop 
taking their drugs during the first year of treatment Hypertension as a disease causes no 
symptoms and often needs more that one medication to control it with various adverse side 
effects (Bloom, 2001). Hypertension therapy in particular (Sackett, 1980) is identified as a 
disease with notoriously low level of medication compliance with only about one third taking 
adequate medication to control blood pressure. This author pointed out that the treatment of 
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hypertension carries all five of the major reasons for poor compliance: long duration of 
treatment; complex regimen; absence of symptoms; drugs with many side effects and adverse 
`health beliefs' regarding high blood pressure. On the other hand Bloom (2001) reported that 
compliance with antihypertensive drugs is better in older patients, women, and in those 
prescribed fewer drugs. Similar results were reported by McElnay et a!. (1997) where 
diuretics in particular were negatively associated with poor compliance. 
The seriousness of the condition as experienced by the patient is a particularly important 
factor. Diseases such as diabetes or chronic heart failure are conditions where the 
consequences of non-compliance may be obvious (Eraker et al., 1984). The perception of the 
seriousness of disease is well illustrated in a trial described by Krall (1991) where the same 
medicine was given to patients whether suffering from angina or hypertension. The health 
perception scores for hypertension are lower than those for angina and compliance in the 
hypertensive group was found to be correspondingly poorer. Patients with angina may 
perceive their heath as compromised while patients with hypertension may be believe that the 
hypertension has little impact on their health. 
Eraker et al. (1984) compared compliance behaviour to short-term medications and long- 
term medications. It was found that compliance in short-term medicines was around 90% 
compared to chronic medication at 50%. They argue that in many cases of poor compliance a 
health decision or belief model is adopted by the patient which will determine compliance. 
This will depend upon many factors: medication preferences; health and other beliefs; 
previous experience and knowledge and other sociological factors. 
It is always believed that the more complex the medication regimen, the less likely that the 
patients will comply i. e., the complexity of prescribed regimen may result in introduction of 
non-intentional non-compliance or `innocent' concept (Raynor, 1992). Forgetfulness is a 
natural human behaviour: the more complex is the drug regimen, the more difficult it is for 
the patient to remember or follow the instructions (Col et al., 1990). 
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The effect of the frequency of doses per day on adherence has been well examined and many 
studies summarized the effects of daily medication regimens on adherence and persistence 
with treatment. Blom et al. (1998) studied five hundred and twenty seven patients diagnosed 
with arthritis who were prescribed nonsteroidal anti-inflammatory drugs (NSAIDs). The 
study found an inverse linear relation between the numbers of doses administered daily and 
patient's adherence. Compliance was 78% for once a day dosing, 72% for twice, 64% for 
thrice, and 60% for four times a day. 
Similarly, Eisen et al. (1990) monitored the relationship between the prescribed dose 
frequency and the patient's adherence to the drug regimen. One hundred and five patients on 
antihypertensive medications were monitored for their compliance using special containers 
that record compliance electronically. Patients on a once-daily dose regimen were found to 
remove the prescribed number of doses on 83.6% of days, while patients on two- or three- 
times daily dose regimens removed the prescribed number of doses on only 74.9% and 59% 
days respectively. It was concluded in this study that the frequency of dosage had a large 
influence on compliance. These results supported those reported by Pullar et al. (1988) where 
pharmacological indicator (low-dose Phenobarbital) and tablet count were used to assess the 
effect of dose frequency on patient's compliance. Compliance was best on a once-daily 
regimen, but the compliance with a twice-daily regimen was very similar, and both were 
superior to dosing three times a day. These results would encourage the prescribers to select 
the drug regimen that provides the lowest daily prescribed dose to improve patient's 
adherence. 
Eagleton's findings (1993) suggested that the prescribing of complex regimens, when four or 
more medicines are prescribed, may be a factor associated with patient's non-adherence. The 
effect of the regimen on a patient's lifestyle, and the ease with which it can be 
accommodated into his daily routine, is another important factor (Raynor, 1992). 
Levy and Feld (1999) reported other factors which were found to affect the patient's non- 
adherence: 
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1. Inadequate skills or information required to complete assignment. This category 
includes: poor instruction, incorrect or inadequate information on medication or 
appointment, or loss of appointment slips. 
2. Patients do not believe that they will be helped by the prevention or intervention 
activity. This category includes: dissatisfaction with the prescriber or the treatment or 
the clinical procedures (e. g., long periods spent waiting to see the prescriber), 
believing that they were receiving inappropriate or incorrect medication treatment, 
contradictory advice from friends or contradictory information obtained (e. g., from 
the internet), believing that the treatment was not helping or making them worse (e. g., 
because of side effects), condition improvement and thus no further need for the 
treatment, alternative health care beliefs, and indifference or "lack of will power". 
3. The patient's environment is not supportive of, or interferes with adherence. This 
category includes: sickness, transportation difficulties, employment or housework 
interference, being asleep when medications should be taken, lack of family support 
or illness in the family, or medication loss or intrusive regimens e. g., dialysis. 
A model has been introduced that focuses on people's concerns regarding their medication 
together with the perceived necessity of the prescribed medication. As would be expected, 
those who appreciated the necessity of their medication were more likely to report higher 
adherence. Conversely, those who had concerns regarding their medication, e. g., harmful 
chronic effects tended to have lower adherence in a trial to minimizing suspected risk by 
taking less medication. It was found in one study (Lorenc and Branthwaite, 1993) that not 
taking tablets as prescribed was strongly related to fears of becoming addicted to the 
medication. This fording contradicts the role of fear in the health belief model, which 
positively correlated the enhanced compliance with the concern about the illness. 
Drug Knowledge 
Patients' understanding of their clinical conditions and drug therapy is the fundamental 
requirement for optimal compliance. Although there is no `gold standard' questionnaire with 
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which to test patient's knowledge about their medication, most methods involve asking 
questions about drug regimen, drug action and possible sides effects (Woroneick et aL, 
198-), 
There is a theoretical relationship between patient's knowledge and adherence, i. e., 
improvements in patient knowledge may lead to improvement in patient's compliance. 
Sackett (1980) showed little improvement in patient's compliance despite increasing drug 
knowledge amongst hypertension patients. Similarly, Physe-Phillips et al. (1982) found that 
urine levels of antiepileptic drugs remained unchanged despite improvements in patient's 
medication knowledge. Both authors reached the conclusion that poor knowledge might still 
encourage a tendency to poor compliance. 
Even if patients have good memories, they might not be given enough information to be able 
to adhere to their medication, even with a simple regimen. Generally speaking, verbal 
information is forgotten, and should be reinforced by written information (Raynor, 1992). In 
a survey in Southampton (Ridout et al., 1986), of the 188 questionnaires sent out, over 70% 
of those responded had no knowledge of the side effects of their drugs and 37% were 
unaware of how to dispose off their medications. Similar results were observed in a large 
national postal survey of patient drug knowledge (Busson and Dunn, 1986) which revealed 
general unsatisfactory levels of knowledge amongst the UK population regarding prescribed 
medicines. Of the 8000 questionnaires analysed, 55% did not know the exact details of their 
regimen and only 20% had been informed of potential side effects. In spite of this, patients 
rarely sought additional information. 
Levy and Feld (1999) revealed the relationship between inadequate skills or knowledge 
necessary to follow a regimen and non-adherence to that regimen. Reasons the patients gave 
for their non-adherence that fall into this category include: poor instruction; incorrect or 
inadequate information on medications or appointment, or losing the appointment slips. 
Patients can not follow the proposed regimen if they do not know what they are supposed to 
do, or know how or when they are supposed to do it. Prescribers should not assume without 
some form of checking, that a patients know how to carry out their treatment regimens. 
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A number of papers have described what type of drug information patients would like to 
receive, without addressing the question of the level of patient knowledge. Gardner et al. 
(1988) reported that patients highly valued the information provided regarding medication 
problems, but felt that much of the information supplied by physicians was unimportant. The 
attitude of patients towards being supplied with information is also important. McMahon et 
al. (1987) conducted a study on 154 patients in an outpatient clinic to determine what 
patients already knew about their medication and to study the extent to which patient were 
given verbal and written information. Most had good knowledge regarding their medication 
regimens, but knew very little about side effects and even fewer had been provided with any 
written information about their drugs. Dodds and King (1989) surveyed 500 patients in a 
community pharmacy and found that younger people were more likely to require additional 
information than older ones, and that women were more receptive to such information than 
men. In a study carried out by McElnay et al. (1997), it was found that full knowledge of 
medicines, i. e., names, indications and doses, was reported by 23.8% of the patients 
interviewed. A further 12.7% could only provide the name of the medicines. One quarter 
managed to give the purposes of their regimes, while a further 28.7% gave the colour, shape 
or dosage of tablets being taken Only 6.8% of the patients interviewed failed to provide any 
information about their medicines. 
One study investigated the relation between age and knowledge of diabetic patients and their 
adherence to medical advice (Yung et al., 1998). Patients were interviewed at the general 
medical clinic to assess their knowledge and adherence level. Patients' knowledge of 
diabetes mellitus and hypoglycemic symptoms and adherence to medical advice declined 
with age and time and it was stressed that elderly diabetic patients should receive a 
continuous education programme. 
It can be concluded that poor compliance may be induced by many factors but their relative 
importance and a consistent model has get to be fully defined. 
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1.4.2 Compliance and Medicine Knowledge in the Elderly 
Poor compliance would be expected to be an especially difficult problem in elderly patients 
(Stewart and Caranasos, 1989) as the elderly have significantly more compliance barriers and 
higher risk factors for non-adherence than the general population. In addition, they have a 
higher incidence of long-term illness that leads to higher rates of prescribing and consuming 
more medication and developing more complex drug regimens (Herrier, 1995). Hence, 
elderly patients are more likely to be described as non-compliant. Elderly patients also appear 
to be particularly vulnerable to the adverse consequences of drug non-compliance. 
General Level of Co, n liance in the Elderly 
As the proportion of elderly in the general population is expanding, so has the importance of 
medicine taken by them. Some studies have shown that the elderly are more prone to drug 
medication errors and none of the socio-demographic variables (e. g., age and social isolation) 
have been particularly helpful in predicting which patients would deviate from treatment. 
In a study by Blenkiron (1996), 80 patients aged 75 years and over were interviewed in the 
surgery or at homes to assess their level of knowledge, degree of compliance, and problems 
encountered with their medicines. Compliance was assessed by both monitoring the 
cumulative demands for repeat medicines and by interviewing the patients as well. Elderly 
patients were claimed to be `good' compliers (i. e., never miss doses) for 77% of drugs 
prescribed. When compliance according to computer records of repeat prescriptions was 
analysed, it was found to be inaccurate in 20% of cases. The consequences of non- 
compliance were reported and judged to be potentially serious or life-threatening 29% of the 
31 drugs identified by computer monitoring of the repeat prescriptions, but for only 8% 
based on self-assessed non-compliance. However, the computer based assessment does not 
reflect the actual usage of the medication by the patients. 
Earlier studies have considered compliance levels amongst the elderly post hospital 
discharge. Amongst studies describing good compliance in the elderly, Smith and Andrew 
(1983) showed an average compliance of 92% in 35 elderly patients. Patient compliance was 
assessed by tablet counts just 3-12 days following hospital discharge. It is possible that 
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compliance may decline considerably after this time. In addition, the population studied 
appeared to have closer communication than usual with the GP, 11 cases being visited very 
soon after their discharge. Other factors such as the policy of discharging patients with as few 
drugs as possible may also have played a role. A general poor level of drug knowledge was 
still recorded. Stewart and Caranasos (1989) reported that 65% of patients had made 
medication errors one week after hospital discharge and 26% had non-compliance scores 
greater than 15% and these results are similar to those reported by Eagleton et al. (1993); the 
risk of medication errors may be particularly high for many patients in the period 
immediately after a hospital stay. This may be attributed to the fact that patients were under 
intensive care and were not responsible of administering their medication. 
Wandless and Davie (1977) studied the effect of providing standard verbal instructions given 
to elderly patients during their hospital stay on their compliance using tablet count technique 
and gave an error rate of 28% among these patients. Those proven to have errors more often, 
made multiple mistakes rather than a single mistake with medication. Even elderly patients 
within a rehabilitation ward failed to take their tablets correctly unless they were carefully 
instructed. In another study (Crome et al., 1980) it was found that out of 51 patients studied 
only 33% took all doses as prescribed and 16% took none of the medication at all, resulting 
in an average error rate of 42%. 
Hospitalisation of elderly patients, for whatever reason, can be a critical juncture; while 
patients may be admitted on one drug regimen, they are often discharged on another. One of 
the crucial factors that may affect the effective medication management by elderly patients is 
the fact that the flow of information is, to a great extent, dependent on the patient 
him/herself, who is free to take the prescription to any pharmacy they chooses (Begley et al., 
1997). Oborne and Dodds (1994) reported that two out of three patients take their 
prescriptions to the same community pharmacy, and it was suggested that immediately after 
discharge from the hospital the likelihood of selecting the regular pharmacy may be reduced 
because the patient may be too ill to be able to collect his or her own prescription and 
depends on a family member, a carer, or a friend. 
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Factors A ecting Poor Compliance in the Elderly 
Over the past 25 years, numerous factors have been investigated in an effort to identify 
noncompliant patients. Factors investigated include demographic and sociobehavioural 
characteristics of patients, features of the illness, therapeutic regimens, and the patient- 
prescriber relationship (Stewart and Caranasos, 1989). 
A recent review (Balkrishnan, 1998) examined the relationship between elderly patients' 
non-adherence with drug therapy and various demographic, medical, behavioural, economic, 
social, and medical practice-related variables. Some of the demographic variables examined 
included age, race, gender, income level, occupation, education level, social class, and 
patients' marital status. Medical variables that have been studied included severity and 
duration of illness, number of co-morbid conditions, frequency of use of medical services, 
quality of care provided and patient satisfaction with health care provider. Medication-related 
variables investigated included type of medication prescribed, therapeutic regimen, drug- 
delivery system, and adverse effects that may be experienced. Behavioural variables include 
physician-patient relationship, patients' knowledge about their medical conditions and their 
medications, self-reported compliance, and attitudes and beliefs about their health. The 
present review examines selected variables separately, although in most cases it is the 
interaction of several factors that allows prediction of elderly patients' medication-adherence 
behaviour. 
The following section will discuss some of the factors that may influence patients' 
compliance to their prescribed medication regimen. 
a. Demographic and Social Factors 
No consistent relationship has emerged between a patient's compliance and gender, age, 
education level, socioeconomic status, occupation, race or marital status. Gender is not 
usually shown to be related to compliance issues, although a few studies have indicated 
that women may have more problems (Salzman, 1995). Col et al. (1990) also reported 
that elderly females were 3.3 times more likely than elderly males to be hospitalized for 
complications caused by mediation non-adherence. On the other hand, Coons et al. 
(1994) found no relationship between medication adherence to the prescribed medication 
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and the gender in a population of elderly adults taking various prescription medications. 
Similar results were reported by Monane et al. (1996) in a cohort of elderly outpatients 
starting on a new antihypertensive medication 
Most of the studies have focused on specific-age populations within a narrow age-range 
and therefore, the comparison are often between old and older patients rather than young 
and old patients. Most studies have used 60 or 65 years of age as a cut-off point, and no 
hard data exists specifically on the over 85s. A retrospective study by Monane et al. 
(1996) collected data from 4068 New Jersey Medicaid enrollees and demonstrated that 
advanced age (85 years) was associated with good adherence. The two possible reasons 
for this observation are that: 
1. The higher the chance of experiencing severe diseases, the better the motivation for 
elderly patients to adhere to their medication regimens. 
2. Elderly patients are more likely to be supported by carers 
Practically speaking, non-compliance is an issue for all ages, with each group having 
their own particular problems. However, the normal aging process involves a gradual 
decline in the cognitive abilities (visual acuity, memory, ability to understand and 
remember text) which are required by patients to take their medication properly (Raynor, 
1992). When a wider age range is taken into consideration, some studies then tend to 
support lower compliance with patients aged 70 and over (Stewart and Caranasos, 1989). 
Age was not an important predictor of medication adherence in many of the published 
studies. Coons et al. (1994) found no relationship between age and medication adherence 
in 1028 older adults who were interviewed about their medication-adherence behaviour. 
Sharkness and Snow (1992) reported similar results in a study of 125 hypertensive 
veterans. 
There is also some evidence that patients living with their families are more likely to take 
medication than those living alone (Evans and Spellman, 1983). This fact is supported by 
Lorenc and Branthwaite (1993), where elderly patients who were not living alone (on 
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both chronic and acute medication) tended to show the highest compliance level. 
Conversely, it was found in another study that there was no relationship between living 
alone and compliance, although it failed to assess whether or not there was help from 
outside agencies (Blenkiron, 1996). Education and social class show no firm link with 
compliance. 
Race may be significantly associated with medication adherence behaviour in the elderly. 
In a retrospective cohort study by Monane et al. (1996), whites were associated with 
significantly better medication adherence. In their study of veterans' views on 
hypertension and compliance, Sharkness and Snow (1992) also found white race to be 
significantly associated with better medication compliance. 
Discharge from the hospital may also present particular problems for patients in 
arranging adequate supplies of the correct medication. Although a one week supply of a 
new regimen may be given by a hospital, house-bound patients may need much longer 
time to receive new supplies through a general practitioner (Monane et al., 1994). Also, a 
being house-bound patient may result in losing communication with the community 
pharmacist. 
b. Medical Factors 
There is circumstantial evidence that general levels of adherence may be higher in some 
conditions than others. Sharkness and Snow (1992) reported that, elderly patients with 
one or more chronic illness requiring the use of multiple drugs were more likely to 
believe themselves in need of treatment and therefore were more likely to adhere to their 
medication regimens than those requiring therapy with only one drug. Monane et al. 
(1997) found that, patients prescribed more than one medicine for the same condition 
were as likely to be compliant as those taking single agents, while those patients who 
were prescribed multiple medications for different conditions showed significantly poorer 
compliance. These findings are in contradiction with the results of Coons et al. (1994) 
who found no relationship between the number of diseases and patients' adherence to 
their medication. Coons et al. (1994) found no association between elderly patients' self- 
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reported physical health and their medication adherence. However, they found a highly 
significant inverse relationship between psychological stress and adherence to the 
medication regimens. Similarly, adherence rates in acute conditions are often higher than 
in chronic diseases, especially when the chronic disease treatment seems to show little 
symptomatic improvement (Home, 2001 a). 
c. Medication-related Factors 
It was found that compliance to cardiovascular medication in the elderly, especially 
diuretics, is often quite high (Monane et al., 1994). Monane et al. (1997) found a 
significantly greater probability of medication adherence among users of angiotensin- 
converting enzyme inhibitors, calcium channel blockers and beta-adrenergic blockers 
compared to thiazide users as a reference group in a cohort of elderly hypertensive 
patients. Salzman (1995) reported the percent of intentional non-compliance in elderly to 
the different groups of drugs: psychotropics (13%); musculoskeletal (60%); antibiotics 
(35%) and gastrointestinal (18%). McElnay et al. (1997) found that prescribing 
bronchodilators was associated with under-compliance, while being prescribed analgesics 
was associated with an over-compliance pattern. Sclar et al. (1994) have shown that the 
use of sustained-release formulations of antihypertensive therapy permits considerable 
simplification of drug regimen which in turn would improve patient's adherence to 
therapy. 
Polypharmacy and non-compliance are major dilemmas for both physicians and elderly 
patients and both can mutually lead to each other. Polypharmacy may affect compliance 
which in turn may cause drug-related problems which may lead to prescribing more 
drugs. The best solution for this vicious circle is to try to reduce the number of 
medications prescribed, although elderly patients with multiple chronic diseases often 
require three or more medications. Within this group of patients, non-compliance leads to 
unsatisfactory clinical consequences which in turn may result in an increase in the 
numbers of drugs prescribed or changes in dosages of the already existing medicines 
(Murray et al., 1993). 
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It can be accepted as a fact that the more complex the treatment, the lower the adherence. 
Complexity of drug regimen can have several forms: prescribing a large number of 
medications; the need to take medication at frequent intervals, difficulties in taking 
medication or use the medication devices (Home, 2001 a). There is good evidence that the 
more complex the drug regimen the more difficult is the medication-taking behaviour and 
that drug errors can increase by up to 15-fold when the number of prescribed items 
increases from one to four drugs (Stewart and Caranasos, 1989). More than two 
medications per day can lead to a threefold increase in the likelihood of self-reported 
non-compliance (McElnay et al., 1997). 
Col et al. (1990) and Coons et al. (1994) found that the greater the number of 
medications prescribed for elderly patients, the greater the medication non-adherence. 
However, Sharkness and Snow (1992) found that patients who took more than one 
hypertensive medication were less likely to depart from the prescribed regimen than were 
those taking only one drug. Sclar et al. (1993) reported that patients who are initially 
prescribed an antihypertensive medication requiring once-daily or weekly dosing rather 
than multiple daily dose had less frequent changes to their therapeutic regimens and 
lower use of concomitant therapy for blood pressure control (6% of patients taking once- 
daily therapy, compared with 11 % to 16% of patients taking multiple daily doses). 
d. Physician-Patient Interaction 
There is increasing interest in the role of patient satisfaction as a mediator between 
information provision, recall and adherence (Horne, 2001a). Research has shown that 
patients who are more satisfied with their physician visit are more likely to adhere to their 
medication. Compliance with instructions is greater when patients feel that their needs 
have been met. Patient's adherence improves also when they feel that their physicians 
respect their beliefs, expectations and needs, and are able to provide them with 
information about their conditions and progress (Kunze, 1982). 
In a study involving 46 practising physicians and 357 patients with diabetes mellitus or 
congestive heart failure, Hulka et al. (1976) found that good communication of 
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instructions and information provided by the physician was associated with low levels of 
all types of medication error including non-compliance. Monane et al. (1997) reported 
that medication adherence was significantly better in patients who had more frequent or 
more recent visits to their physicians. Stewart and Caranasos (1989) reported in his 
review that the improvement in physician-patient communication is a factor in increasing 
compliance, especially when it is related to increasing understanding and satisfaction on 
the part ofthe patient. Patient dissatisfaction with the clinician's attitude or the amount of 
information provided may affect patient's motivation towards the treatment and act as a 
barrier to adherence (Home, 2001 a). 
e. Patients' Health-Related Knowledge and Beliefs 
The relationship between patient's knowledge of their medication regimen and their 
adherence to it, is by no means simple or clear-cut. It is believed that patients* knowledge 
and beliefs about their health affect their medication-taking behaviours. It would be 
assumed that patients with a better knowledge and understanding of the purpose of 
medication and prescribed regimen would be more likely to adhere. There has been a 
long-running debate concerning the relationship between information given to improve 
patient's knowledge regarding medication and whether this has any effect on their 
medication-taking behaviours. Sharkness and Snow (1992) reported that male veterans 
who knew they would require lifelong treatment for hypertension were 1.3 times less 
likely to depart from the prescribed regimen than were those who unaware of this 
information. 
The Health Belief model was proposed by Becker and Maiman (1975) to explain 
patients' behaviour regarding their medication. This model suggests that certain health 
beliefs, health-related motivations, perception of psychological and other costs 
recommended action, various aspects of the doctor/patient relationship and social 
influence can affect patient's medication-behaviour. The Health Belief model suggests 
that those who consider their condition to be the most serious tend to be better compliers. 
The model was originally constructed to account for compliance in general, and is not 
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specific for medication adherence. According to Cramer (1995) "no convincing model for 
predicting medication adherence has been developed". 
One study (Lorenc and Branthwaite, 1993) observed that compliance was reduced among 
patients because of fear of illness, which is contrary to the Health Belief Model. It was 
suggested by Lorenc and Branthwaite (1993) that "higher levels offear produced denial 
of illness". Compliance was also reduced when the patient had to wait a long time to see a 
doctor. This study also reported poor patient's compliance associated with poor patient's 
knowledge. 
There are many instances where patients may decide not to comply with their regimen. 
For example, they may be taking more medication in the belief that they will recover 
faster, or they may choose to stop or reduce a course of treatment when the condition 
starts to resolve (Salzman, 1995). 
Patient's medication non-adherence may be the result of a rational decision by the 
patient. The perceived views of others such as family, friends and doctors may also 
influence adherence (home and Weinman, 1999). Patients' concerns are usually 
associated with commonly held beliefs that "taking regular medication would result in 
harmful long-term effect or cause dependence and that having to take medication was 
disruptive" (Home, 1993). 
This section provided a variety of the factors affecting the behaviour of elderly patients 
towards their medication and the level of compliance. From this, it can be concluded that the 
highest risk factors that potentially lead to poor compliance are: poor knowledge, being 
female, polypharmacy and complex drug regimen, physical barriers and lack of home 
services. This study is focusing on improving patient's knowledge and identifying the 
barriers against improved compliance during the primary care stay. 
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L4.3 Assessment of Compliance 
A number of methods are available to assess the level of compliance. Measuring adherence 
adequately offers numerous challenges. Patient self-report, physician assessment, and tablet 
count are commonly used because of their practicality and low cost. Drug levels in the serum 
or urine can be used to estimate drug-taking behaviour, but are invasive and expensive 
techniques. All of these methods monitor adherence sporadically and have their advantages 
and disadvantages, none of which is perfect and applicable in all situations. These methods 
are briefly discussed below. 
Tablet Count 
This technique will be discussed in more detail in Chapter 2. 
Mood and Urine LeveUyfonitoring 
This method depends on direct assay (whenever possible) of a drug or one of its metabolites 
in blood or urine to estimate compliance. Drug concentration in the urine would only indicate 
whether or not the drug was taken within a certain time span depending on that drug's half- 
fife. The absence of the traces of drugs with long half-life (e. g., Chlopropamide) in the urine 
gives a good indication of non-compliance (Goodyer, 2002). Results from serial blood tests 
once the drug has reached a steady state may also be useful. 
The main three drawbacks for this method are: 
1. Difficulties in arranging accurate assays for drugs to be assessed. 
2. Difficulties in applying this method to medication with short half-lives. Steady state is 
achieved relatively quickly, so medication taken just a day or so prior to the visit may 
indicate adequate compliance. 
3. It is an invasive procedure and patients must give permission for blood tests. 
To overcome the first two problems the following method was devised. 
Tracer Methods 
One method of overcoming some of the problems encountered with the tablet count 
technique (will be discussed in chapter 2) is to ask patients to take another tablet containing a 
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small amount ofa pharmacological tracer such as a low dose ofPhenobarbitone (LDP) which 
can be detected and measured in blood samples. This technique was investigated by Puller et 
aL (1980), who coined the term "pharmacologic indicator' rather than simply "marker". The 
Pullar study was one of the most interesting studies using the LDP technique and comparing 
it with the tablet count technique. Using a tablet count, compliance of 90-100% was found in 
75% of the patients, but 32% of these patients had plasma Phenobarbitone levels which 
suggested less than 90% compliance. 
Phenobarbitone has a long halflife, and can determine compliance over the previous weeks 
rather than just days. Another advantage is that it shows relatively little inter and intra- 
individual pharmacokinetic variations. The dose normally used (I-Zing) does not appear to 
affect the central nervous system or cause any enzyme induction. However, the main 
disadvantage of such technique is that, either the patients have to take separate capsules of 
LDP, or special dose-forms incorporating LDP which have to be prepared specially for that 
purpose. Another weakness is that the blood samples must be taken which make it an 
invasive technique and may not be appreciated by many patients (Pearson, 1982). 
Electronic Recording 
A useful method for detecting lapses in compliance over a period of time is the use of 
electronic recording devices in the föhn of a medicine container incorporating a device for 
recording each time the container is opened. This may be either in the form of sensors 
concealed in a childproof cap (Cramer et at., 1989) or hidden in a specially designed box 
(Cheung et al., 1988a). The first devices were bulky and inconvenient to use, and because of 
the obvious difference in shape and size between them and the standard medicine containers 
they were unlikely to reproduce the natural setting, as it was difficult to carry or use in a 
flexible manner and to reflect the normal medication-taking behaviour (Rudd et a7., 1981). 
This was followed by the "medication compliance monitor", which consisted of two blister 
packs and a microprocessor in a plastic case (IScm X 6cm X 4cm). The limitations of this 
device included its big size and the 20 minutes needed to set it up and fill. A slightly smaller 
device (I Icm X 9cm X 3.5cm) was developed, which can measure the number of openings in 
any hour (Cheung et al., 1988b). 
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Finally, a device was produced which mimicked a normal container more closely. The 
"medication event monitor system (MEMS)" consisted of a standard container topped with a 
cap containing a microprocessor, which recorded each opening. Data can be retrieved by 
connecting the cap to a personal computer that reads the data from the tablet caps' 
microprocessor and generates a printout of the patient's recent bottle opening pattern (Rosen 
et al., 2004). Detailed reports of each dose event, intervals between the dose and the 
percentage of days when the correct number of doses are taken can all be produced. 
Medication monitors can be considered as the only method of measuring compliance that 
allows accurate assessment of the timing of doses. An obvious disadvantage is that the dose 
is not necessarily removed each time the bottle is opened i. e., patients may choose to open 
the containers without consuming any medication, so one cannot determine if and when 
medication is ingested. Also, multiple doses may be taken from one bottle opening i. e., 
morning and evening doses can be taken during the morning opening and electronic tablet 
caps will only record one dose taken (Rosen et al., 2004). 
Another drawback of this technique is that their use may interfere with the usual habits of 
patients who carry their medication with them because the caps are bulkier than small 
containers patients might normally use when carrying medication away from home (Rosen et 
al., 2004). Other problems related to patients' behaviour, like swapping the bottle caps or 
leaving the cap off altogether can interfere with collecting data. The device is expensive and 
is slightly different in appearance from a normal cap, meaning that patients need to be 
informed about it (Raynor, 1992). 
Despite all these limitations, electronically measured adherence has been more highly 
associated with clinical outcomes than self-report (Liu et al., 2001) and pill counts 
(Namkoong et a!., 1999), suggesting that electronic data more accurately reflects actual doses 
taken than the other alternative techniques. 
Compliance with antiepileptic therapy has been assessed by Cramer et aI. (1990) using such 
a monitor and results indicated that the tablet count technique overestimates compliance; also 
serum concentrations do not reflect the true compliance rate. There is also electronic device 
79 
CHAPTER 1 BACKGROUND &LITERATURE REVIEW Compliance and Patient Knowledge 
for use with an inhaler which records when an actuation has been made called the Nebuhaler 
Chronolog (Specter and Mawhinney, 1991). 
Patient Interview 
A very simple and convenient method of assessing compliance is by interviewing patients; 
simply asking the patients verbally (face-to-face interview) or by questionnaire if they have 
taken their medicines as prescribed. The questions should be phrased and asked in a non- 
threatening or embarrassing manner which can give some indication ofthe medication-taking 
behaviour. Generally, patients over-estimate their own compliance; those who are not 
adhering to the regimen are less likely to admit their poor compliance, but those who 
admitted to non-compliance tended to be telling the truth. It was suggested that a combined 
method of table count, interview and prescription record monitoring would give the most 
accurate indication of compliance. Col et al., (1990) found that 77% of elderly patients 
described themselves as good compliers, but when their compliance was measures using 
prescription records it was found that 20% of the cases were poor compliers. Lee et al. 
(1996) also reported that patients and physicians often overestimate patient adherence. 
In one study by McElnay (1997), compliance with prescribed medication was assessed in a 
group of 512 elderly patients just before their hospital admissions. Using the self-reported 
technique was used to assess patient compliance. It was shown in this study that self 
reporting of compliance is generally overestimated by patients. These results supported the 
results shown by Cot et of (1990) where 315 elderly patients were interviewed to determine 
their history of non-compliance in a non judgmental way. Since determination of patient 
compliance relied on self-admission, it was subjected to underreporting because of errors in 
recall and the patient's desire not to uncover incriminating information. 
Prescription ReklIs 
This method estimates compliance by monitoring prescription records to see if a repeat 
prescription is requested for at the appropriate time. The method depends on using the 
pharmacy computer systems to match up medicines prescribed to medicines actually 
collected. In practice, it is possible to use records to find out if patients collect their monthly 
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repeat prescriptions. The main disadvantage of this method is that the patient may use more 
than one pharmacy; however, many patients prescribed medication for chronic conditions 
will use the same pharmacy. 
Practically speaking, it is difficult to match the prescription issued from the GP surgery or 
hospital with those presented for an individual patient, although electronic prescribing and 
repeat prescribing schemes may change this situation (Steiner and Prochazka, 1997). 
Grymonpre et at. (1998) adopted four methods to assess non-adherence in 135 elderly 
patients who were 65 years and over and were on one or more prescription-only medicines 
(POM). These were tablet counts, self reporting interviews, reviewing manual databases 
available from the community pharmacies and the electronic data of POM details and 
dispensed medicines. The mean adherence calculated from the tablet counts (7411/o) was 
significantly lower than that calculated from the electronic databases (94.6%) or self-report 
(95.8%o), and from the manual database (107.6%). Researchers were unable to determine 
which method managed to provide the most accurate estimate of adherence which may lead 
to the conclusion that a gold standard to measure adherence to medication does not exist and 
that the best method depends on the aim of the study and purpose of the data to be analyzed. 
Only adherence calculated from the tablet counts and electronic databases were significantly 
different. It can be concluded from this study that patient's self-reporting can be a useful tool 
in assessing patient's non-adherence which is one type of the MRPs. The drawback of 
patients self-reporting and interviewing them at their homes is the inability to visit and 
interview large number of patients i. e., limited sample size of the study subjects and the time 
and the expenses to achieve these interviews including the traveling times and costs. 
It can be concluded that there is no one standard method that can be used to measure 
compliance in all situations. Different techniques are available to achieve this task: tablet 
count; patient interview; blood or urine level monitoring; tracer method; prescription refill 
rate and electronic monitor technique. In the present study, tablet counts will be employed to 
quantify patient's adherence to their medication. Details of this technique will be discussed in 
chapter two. 
81 
CHAPTER 1 BACKGROUND &LITERATURE REVIEW Compliance and Patient Knowledge 
I. 4.4 Methods ofImproving Compliance 
A plethora of research has been conducted to measure compliance and suggesting techniques 
to improve medication-taking behaviour. No simple solution exists to solve this very 
complex issue but enough practical knowledge has evolved to provide strategies that can 
improve compliance in the elderly. These include aspects of two approaches to promote 
medication compliance: educational and behavioural. Patients can be offered appropriate 
information about their medicines, their regimen simplified and the medication packaging 
individualized to their particular needs. Compliance improving strategies will be discussed in 
this section. 
Simplification of the Regimen 
The patient medication regimen should be as simple as possible. Simplification of the 
regimen to once- or twice-daily medication can improve adherence. The use of longer-acting 
or modified-release medication may be more appropriate to improve patient's compliance, 
but the possibilities of accumulation of those drugs with longer half-lives in the elderly must 
be considered (Herrier, 1995). 
For many drugs, single daily dosing will provide therapeutic effects comparable to multi- 
daily dosing and even with better adherence, fewer side effects, and maybe less cost. The 
medication compliance of 105 patients receiving antihypertensive medications was 
monitored from special pill containers that electronically record the date and time of 
medication removal. Compliance improved from 59% on a three times daily regimen to 
83.6% on a once-daily regimen (Eisen et al., 1990). These results confirmed the results 
observed in a an earlier study carried out by Jacobs et aL (1988) where compliance, defined 
as patients who consumed three quarters of the prescribed nonsteroidal anti-inflammatory 
agents given once-daily, was 65% while compliance for four times a day regimens was only 
37%. 
Many pharmaceutical manufacturers are beginning to package medication in convenient 
"calendar packages" to facilitate patient adherence. Another practice that should be 
considered to decrease confusions over medication is to prescribe the same brand of drug 
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consistently. Patients may get confused if they are dispensed a generic of different 
appearance each month. 
Patient Education and Counseling 
There has been much debate concerning the effect of patient knowledge on adherence to their 
medication regimen. Whether or not knowledge of medication can actually improve 
adherence, patients should be in possession of the necessary information if they are to take an 
active role in the discussion regarding their therapy. Educating patients about their diseases 
may not affect treatment compliance, but time devoted to educating patients about their 
treatment regimen may improve adherence (Stewart and Caranasos, 1999). Continual 
introduction of more complex medicines has increased the need for patients to receive more 
information on the way of using these medicines (Hayes and Livingstone, 1990). Correct, 
simple, clear and concise instructions, particularly if they are repeated at regular intervals, 
with a clear explanation of the need for therapy and questions concerning adherence to the 
treatment regimen, can generally improve adherence. Also, the fewer the number of 
instructions provided, the greater the chance that they will remember and recall. However, 
this is not an invitation for giving less information. Patients are more likely to remember 
items at the beginning and end of explanation than those described in the middle of a session 
(Kitthing and Jones, 1990). Instructions that are stressed to the patients are also better 
remembered (Stewart and Caranasos, 1989). It is strongly suggested that an incremental 
approach to patient education is the most effective technique and results in the desired long- 
term benefit (Herrier, 1995). 
Much literature described the influence of `counselling7 by different healthcare professionals 
(prescribers, pharmacists, nurses or any other healthcare professionals). True counselling 
service can be defined as `giving advice so that the patients may make their own decisions' 
or as "the provision of information on medications and related health issues" (Aslanpour and 
Smith et aL, 1997). Hayes and Livingstone (1990) suggested another definition for 
counselling in the community as "any verbal information relevant to the prescribed medicine 
given to the patient by the pharmacist or an assistant' and the process of patient education 
can be defined as "those communicative activities which have the objective of supporting 
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patients' drug therapy decisions' (Blom et a7., 1999). None of these definitions really 
described a counselling service in the true site of the ward, where the patients can explore 
their own feelings and beliefs. What seems to be offered in most descriptions of medication 
counselling is actually an education service, where the patient is also invited to comment on 
issues regarding difficulties associated with poor compliance, e. g., inability to take 
medication and adverse effects. It is within this remit that medication counselling is referred 
to in this thesis. 
There are two contexts in which patient education concerning medication-taking is 
performed; in the secondary care after dispensing prescription through outpatients or prior to 
hospital discharge at the patient bedside. Community Pharmacies also provide information on 
dispensing prescription or on selling OTCs. In both the primary and the secondary care 
settings, pharmacists, doctors and nurses may all be involved in providing information and 
monitoring the appropriateness of medication. Patients who are recently discharged from 
hospital may reasonably be expected to use their medicines most effectively if they are given 
information about the purpose of medication treatment and the anticipated benefits or 
problems. Patients discharged from hospitals should be able to manage their medication 
supplies correctly; they need to be provided with information and advice about the intended 
duration of treatment, how to maintain a regular supply of their medication, the best way to 
store these medicines and how to dispose of unwanted medication. There is a general 
agreement that patient education programmes aim to provide this type of information to 
promote better adherence (Cantrill and Clark, 1992). 
The provision of verbal advice on prescription medication is an accepted part of the 
pharmacist's role. The way the information is presented, both written and verbally, is very 
important. Proper communication skills between the patient and the information provider are 
required which allow better understanding by the patient (Kitching and Jones, 1990). The 
oral information and written instruction should be of the quality and the quantity that the 
patient needs, not necessarily those dictated by the manufacturer or what the prescriber 
prefers. Patient should be also given an explanation about any medication which is 
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discontinued or newly started (Cantrill and Clark, 1992). To enable patients to attain better 
adherence they need to understand the importance of adherence (Astrom et al., 2000). 
Any education programme aims to provide information of a reasonable structure and quantity 
that the patient is able to understand, digest and apply. Although written materials may be 
useful, effective oral communication is one of the most important aspects of patient 
education because it directly involves the patient and the health care professional in a two- 
way interaction; patient by asking questions and the health care professional by negotiating 
the treatment and checking their understanding (Anderson, 1987). 
It has also been found that the benefits of treatment in hospital may be lost if inadequate 
information is given to patients, carers or professionals. Patients, who do not follow the 
provided instructions or take their medications in the most appropriate way, have higher 
morbidity levels which may need more medication and longer and more frequent 
hospitalization (Milliken and Rea, 1997). 
fn a study carried out by Lowe et aL, (2000b), 161 elderly patients, taking three or more 
medications were recruited to study their behavioural pattern towards their medications and 
to determine the effect of an education programme on patient compliance. Intervention 
patients were informed about the proper a use and purpose of their medication regimen. The 
information was then summarized on a handwritten drug reminder chart. Patients' adherence 
to their medication was assessed using the tablet count technique. The mean compliance 
score for the intervention patients was 91.3% compared to 79.5% in the control patients who 
did not receive any medication counselling sessions. The study showed that combining 
medication review with deep patient education in the community can significantly improve 
patient knowledge of and their compliance with medication in the short-term and maximize 
the benefits patients gain from their medication. The main weakness in this study was the use 
of non-blind assessment, as the same person carried out both the intervention and the 
assessment. 
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There are many factors affecting patient's recall to the medication information, the way the 
information is presented to the patient and the active participation of the patient in the 
discussion -, with the health care professionals. Another factor is the terminology; health care 
professionals may use unfamiliar technical terms which are not suitable for most non-medical 
people. Since an understanding of words in a message needs the patient to process, learn and 
subsequently recall instruction, it is acceptable to assume a pharmacist's vocabulary will 
affect study outcomes. Cochrane, (I 992b) explained this with the following example, telling 
a patient that "alcohol ingestion superimposed upon inadequate dietary intake can 
precipitate acute hypogtycaemfa", is more unlikely to be understood and to improve patient's 
ability to recall than: "Do not drink beer, wine, or other alcohol on an empty stomach". The 
other factor which should be considered and may affect patient's ability to recall is the 
specific and "action-oriented" phrases which are more likely to be remembered by the patient 
than the general ones. Other factors are: the way the information is organized (including 
which instructions are given first); the location where the instructions are given (hospital, 
surgery, community pharmacy or patient's home); the level of patient's anxiety; the use of 
repetition, and the interest the pharmacist shows in a patient (Cochran, 1992b). 
T is method of improving patients' compliance to their medication will be discussed in more 
depth in Chapter 2 as it will be adopted in this project as one of the steps in enhancing 
patient's discharge from the hospital. 
Compliance Devices 
There are many types of devices that are easy to use an d are claimed to help patients 
remember to take medication especially for patients with compliance problems who have 
failed to respond to multiple interventions, or who have specific problems related to 
medication taking (Sprey, 1995). For the patients to benefit from these devices they need 
proper instructions and support in their correct use. The ideal device would have the 
following properties: 
" Portable and easy to open and use. 
" Safe and child-resistant. 
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" Does not require regular refilling. 
" Can maintain the integrity of the medication. 
The Multi-Compartment Compliance Aids (MCAs) are the most commonly used for patients 
recognized as having problems with taking medicines at home (Sprey, 1995). The aids hold 
seven days of a patient's medicines in 28 inner compartments, four for each day (such as 
Dossett and Medidos). These systems allow some degree of compliance monitoring by 
checking any tablets remaining in the system when returned to the pharmacy for refilling. 
Other medication reminders are Gompliapack or domiciliary pack, Medipalnner, Mediwheel, 
medsystem, Nomad controlled-dosage system for home use and Venalink (Sprey, 1995). Few 
can meet the specification ofthe ideal device and a device suiting one individual may not be 
appropriate for another (Walker et al., 1 990). 
No difference was found in the number of errors made by elderly women on a rehabilitation 
unit who were given Dossett boxes and those who used standard tablet bottles. This may be 
attributed to the difficulties elderly may have to manipulate them, which may cause further 
confusion (Crome et al., 1980). On the other hand, the opposite result was reported by 
Ascione and Shimp (1984). The investigator found that interventions involving the 
medication reminder package (seven compartment plastic package known as the Seven Day 
Pill Reminder) were statistically better than the other two interventions that focused primarily 
on providing information as oral instructions alone or with written handouts. 
Cards and Calendars 
It may be useful sometimes to supply the patients with a "reminder card" which is a clear 
written list of their medication, the names, the appearance and the dosage intended to be 
taken. Well designed reminder charts help with factors associated with poor compliance to 
drug regimens. They overcome forgetfulness by linking times for medicines to be taken with 
daily events to which most patients can relate i. e., they overcome problems arising from 
vague instructions on the timing of doses, such as "three times a day's, by giving specific 
times for medicines to be taken, e. g., breakfast, lunch and dinner time. In addition, they can 
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prevent the confusion on deciding which medicine to take that arises when many different 
medicines are prescribed i. e., relating the doses of each medicine to the others (Raynor, 
1992). ne information should include the names of medicines, the reasons for prescribing 
them, when they should be administered, any special instructions e. g., "after meals" and the 
most common side effects that may require immediate physician contact (Stewart and 
Caranasos, 1989). 
A study carried out by Raynor et at (1993) using individualized reminder charts, which 
listed each person's medicines and when they were to be taken, showed a significantly 
increased proportion of patients who correctly answered questions about their drug regimen. 
Patient Information Leaflets (PILs) are a useful backup to oral instructions. There is a 
perception that leaflets would improve patient's knowledge and understanding of prescribed 
medication, also they would help patients to remember what they have been advised verbally 
by health care professionals. In addition, these leaflets may be particularly useful to certain 
groups of people, e. g., those with hearing problems (Thompson and Stewart, 2001a). PILs 
should be carefully designed to be easily read and understood by the patient, the inclusion of 
simple diagrams being particularly useful when a method of administration (e. g., drops, 
suppositories or inhalers) is to be explained (Bailie and Bennett, 1987). However, they are 
thought to be a two-edged sword (George, 1987), as too much knowledge regarding 
medicines may be considered as a source of worries regarding side effects. There was also 
concern that leaflets may create confusion if conflicting messages were delivered by health 
care professionals (Thompson and Stewart, 2001 a). In one study, only 15% of 200 patients, 
who were asked about the patient information leaflet, said that if they were to receive a 
prescribed medication they had to use for the first time, a leaflet about that medication would 
be "very helpful". A further 15% were with the opinion that a leaflet would be "unhelpful" to 
them personally (Thompson and Stewart, 2001 a). 
Tailor the Rammen to Patient Lifestyle and Routine 
Most patients adopt certain strategies to help them remember to take their medication. A 
daily routine for taking medication should be developed that remains consistent. The 
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treatment pattern to be employed should be fully discussed with the patient, giving priority to 
the strategies which best fits their lifestyles e. g., making coffee early in the morning, mailing 
letters at noon, or making phone calls in the evening, so taking medications could be "built 
into" these activities (Stewart and Caranasos, 1989). In a study by Wallsten et al. (1995) it 
was found that most of elderly patients linked tablet-taking behaviour to specific daily 
activities involved in their every day routine. 
Weak memory is a two-sided problem, on the one hand, the patient can forget to take their 
medications, and the other is the patients may forget if they have actually taken them. In such 
cases, the pharmacist can cooperate with the patient to find a method to remind them if doses 
have been taken, e. g., laying the medication bottle on its side after taking the dose (Herrier, 
1995). 
Active l4 fnvofve Patients in Treatment Planning. Monitoring and Implementation 
Patients should be given the responsibility for taking their medication appropriately. Patients 
must be able to understand important information concerning the benefits and adverse 
responses they experience with their medication, as well as their particular medication 
preferences (Stewart and Caranasos, 1989). 
The first line methods of ensuring good compliance involve measures to be taken by the 
prescriber. Theoretically, if the patient wishes to accept less treatment and clearly 
understands the potential therapeutic consequences, then the treatment should be discussed 
with the patient rather than being dictated by the prescriber. Involving patients in all the 
aspects of their care strategy increases patient satisfaction and compliance with their 
regimens (Becker, 1985). Also, giving the patient the opportunity to be involved in the 
choice of their treatment is rapidly becoming the preferred approach of concordance. 
Involving patients in the process of measuring their blood pressure or their blood glucose 
level may also improve drug therapy compliance (Eraker et al., 1984). 
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Packages and Labels 
Some specific measures regarding the elderly are advised to enhance patient's adherence. 
Labels are an important source of information about how to use prescribed medication. For 
the elderly it is often been stressed on the importance of large labels with clear instructions, 
using normal non-child proof containers (Thompson and Stewart, 200Ia). Blister packs do 
offer a useful alternative to the child-resistant containers which are manageable by most 
elderly people. 
The advantages of large labels are obvious, especially for those with poor eyesight. A review 
by Salzman (1995) showed that up to 60% of elderly patients experienced problems reading 
labels. Many respondents in Thompson's study (Z60Ia) commented on the difficulties older 
people may have in reading labels because of the clarity of the labels and font size. 
Having discussed methods of improving compliance, it can be concluded that patient 
compliance with prescribed medication directions has been a growing concern. Elderly 
patients are thought to have more difficulties following instructions because they generally 
have more medication prescribed, often suffer from cognitive decline, and frequently have 
physical limitations such as failing eyesight and hearing. The above discussion suggests that 
the following measures should greatly improve response to drug therapy and decrease 
adverse reactions: providing clear adequate verbal and written instructions; simplifying the 
drug regimen to once a day administration; good clear label, ensuring that the patient can 
open the container and administer the medication, provision of leaflets and special 
containers. 
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1.5 Medication Discharge Planning 
This is on of the largest section in the chapter as it relates to the central theme of the thesis. 
The concept of "pharmacy discharge" has been suggested for describing the pharmaceutical 
services provided when patients leave hospital to return to the care of their general 
practitioners (Jackson et al., 1993). Within a pharmacy discharge, all the pharmaceutical 
needs of the patient, including information are delivered in a safe and effective manner. 
Patient discharge tends to be seen as the termination of hospital care process and the transfer 
of responsibility to the patients themselves, a carer or the general practitioner. Houghton and 
co-workers (1996) defined good patient discharge as: "Patient satisfaction with involvement 
in the process of discharge, the absence of problems after discharge, and the assessment, 
documentation, and meeting of needs for community care after discharge ". The decision to 
discharge a patient from the hospital is usually made during a ward round for a number of 
reasons, not least the patient's eagerness to get home. It has been recognized since the 1970s, 
as discussed below that, there are a number of problems associated with patient medication 
after discharge from hospital. First, there are a range of potential problems when 
communicating the changes to medication, referred to as interface issues: 
" Failure to discontinue medication. 
" Failure to change the regimen of medication to be continued. 
" Failure to record new medication. 
The Royal Pharmaceutical Society stated that "adequate communication between community 
and hospital pharmacists will ensure uninterrupted pharmaceutical care management" 
(Cook, 1995). Normally, during the hospital stay patients have a number of changes made to 
their drug regimes. These changes may lead to MRPs after the hospital discharge because of 
confusion over what has been stopped, started or changed and this in turn may lead to 
duplication of medicines or discontinuation of newly prescribed medicines (Cantrill and 
Clark, 1992). In some cases, there is simply a delay in the information reaching the GP 
before discharge medication runs out. 
Secondly, there are a number of problems that have been identified relating to patients 
understanding of their drugs and regimens, potentially affecting compliance. The interface 
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and patient factors are probably not unrelated in that good patient understanding may allow 
them to be better involved in their regimen and perhaps help preventing problems such as 
repeating old medication that they have been told has been. discontinued. 
The first section below considers studies that have attempted to quantify the problems 
associated with medication and discharge. The second section considers studies where some 
intervention strategies have been introduced and assessed to overcome the problems of 
discharge medication. Many of the studies describe a `counselling service' provided by 
pharmacists just before discharge and this has been briefly described in section 1.4.4 as a 
potential strategy to improve patient adherence and knowledge of medicines. Typically, a 
medication counselling session will involve discussing with the patients their regimen, 
checking understanding, and discussing other particular issues that may relate to poor 
adherence to medication. Often, a checklist is employed during the session, for instance a 
very comprehensive discharge checklist has been described by Coombes and Home (1994). 
This covers the following areas: 
" Review drug regimen: Are medications prescribed essential? Does the regimen suit 
the patient's routine? Would a memory aid help? 
" Packaging and supply: Can the patient obtain further supply? Can the patient open 
lids, pull out foil tablets etc.? 
" Information: Improve knowledge of medication regimen, side effects, purpose. Use 
verbal and written information. 
" Liaison: Carers, GPs, community pharmacists and other healthcare professionals. 
This checklist was designed for use in the elderly, but others have been investigated such lists 
for more specific patient groups e. g. for patients discharge from a medical/gastroenterology 
ward as developed by Cantrill and Clarke (1992). The session typically lasted 15-20 minutes. 
Such a service is usually well received by patients and hospital staff as described in a study 
by Milliken and Rea (1997), but staff time commitments may limit the service. There are 
probably few hospitals in the UK that involve pharmacists in discharge services as an 
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extension of routine counselling sessions from clinical pharmacists, as was found in a survey 
in one region (Brown and Brown, 1997). 
Most of the studies described below were undertaken on the elderly where medication 
discharge is of greatest importance in terms of the range of medications prescribed. They are 
described and analysed in some depth, being the basis for comparison in the discussion in 
Chapter 6. 
1.5.1 Non-intervention Studies Concerning Discharge Medication Issues 
There are a few non-intervention studies that attempted to quantify medication issues 
regarding the discharge process. Foremost in such problems is the communication of 
intended hospital discharge medication to the GP and of equal importance is that the patient's 
record is amended accordingly. 
A study by Cochrane et al., (1992a) investigated the difference between the discharge 
medication prescribed by the hospital and that being taken by the patients 10-14 days after 
discharge. This was assessed by visiting the patients in their own homes and noting any 
variation between what the patient was taking and that prescribed at discharge. The patients 
were questioned in some depth regarding their reasons for taking medication. One obvious 
deficiency in this study is that no reference was made to GP notes concerning the patient, 
making it difficult to identify the cause of the problems or verify if changes had been 
intended. Of the 50 patients surveyed 45 had some form of variation to the medication 
prescribed on discharge. In many cases the variations were quite superficial, for instance 25 
drug names were changed from generic to proprietary and most of the dose changes were in 
timings not having a large clinical impact. There were 29 new drugs started but it is unclear 
whether there were intended new drugs from the prescriber or simply drugs that should have 
been discontinued. The reason for this confusion is that in 20 of these cases the hospital was 
not aware that patients were taking the medication before admission, so patients simply 
continued taking the same medication on returning home. It could not be ascertained whether 
such medication would have been discontinued during admission and it represents another 
type of interface issue. Overall, it appears that only three drugs were discontinued but the 
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patients used old stocks on returning home. Although the study did highlight the range of 
problems, it did not clearly quantify the errors on the part of the GP to act on information 
received from the hospital. Although in this pilot study the researcher did not describe any 
form of interventions that could be performed and the study was conducted on small sample 
size, it managed to identify cases of deviation of the prescribed regimen following hospital 
discharge. The results would suggest the importance of patient follow-up and good 
communication with GPs and community pharmacists. 
The problems associated with medication post discharge have been investigated since the 
1970s. Parkin et al. (1976) conducted a survey of 130 patients discharged from a single 
hospital. Even though described as elderly, the mean age of the patients was just 66 years, 
reflecting the change in age profile in the last 30 years. Patients were interviewed at home 
10-14 days after discharge, knowledge of regimen was assessed and compliance measured by 
tablet count. The study categorized patients as making errors in the regimen due to non- 
comprehension if they reported to the interviewer an incorrect description of the regimen. 
However, if this was assessed without allowing patients to read their labels, as it appears 
from the methodology, it is possible that an overestimate of deviation from the regimen could 
be made. Sixty five percent of the patients did correctly describe their regimen. Compliance 
is reported as being below the 85% level for 25% of patients, in the region found in many 
subsequent studies. The researcher did not include in the estimate of compliance those with 
an apparently incorrect understanding of the regimen, though the reasons for this are not 
explained. Although the GP offered information on the intended changes they made to the 
hospital regimen, there was no attempt to investigate the interface issues and this may not 
have been perceived widely as a problem at that time. The paper reported that patients did 
tend to hoard medicines and revert to old drugs on discharge, but this problem was not 
quantified. 
The majority of studies on medication discharge tend to focus on the elderly. The study by 
Eagleton et al. (1993) concerned a wide range of patients between 15 and 75 years of age and 
reported on medication knowledge and compliance in 50 patients visited at home 12 days 
after discharge. The findings were similar to those found by others in an elderly population; 
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the mean compliance rate was 86% with 78% showing a compliance rate of greater than 
85%. More than 85% knew the details of the drug regimen, but only 10% knew the purpose 
and 18% the name of all medicines. Also only 30% could describe a single side effect 
associated with any of there medicines. 
A recent national survey by Sexton et al. (2000) aimed at identifying the services that 
hospital pharmacies were providing to contribute to seamless care during hospital discharge. 
To achieve this aim a postal questionnaire was designed containing both closed and open 
questions addressed to chief pharmacists in UK trust hospitals. Information was collected 
regarding hospital demographic data and the manner in which discharge prescriptions are 
generated and checked, pharmaceutical services provided at and after discharge and the 
manner in which the Trusts communicate with the GPs and the community pharmacists 
regarding the medication regimen. Sexton et al. (2000) summarized some of the problems 
preventing the smooth transfer of pharmaceutical care, which were reported in different 
studies at or after the hospital discharge: 
" Unexplained discrepancies between the medications prescribed on the take home 
prescription and the in-patient prescription chart. 
" Difference between the post discharge formal letter and the prescription the patients 
should be taking home and deviation between the prescribed drug regimen at 
discharge and those prescribed by GPs after discharge. 
" Lack of communication with the GPs and late arrival of information to the surgeries. 
Inabilities of the GPs to systematically visit patients at high risk after discharge, 
possibly due to their inadequate notification by hospitals. 
" Failure of GPs or their staff to act on information they receive from hospitals. 
" Disagreement between hospital and community prescribers about the exact drug 
regimen that a patient is meant to be following. 
" Failure to inform GPs of the reasons behind the changes made in drug regimen. 
" Insufficient quantities prescribed and dispensed by hospital on discharge to allow 
time to obtain further supplies from GPs. 
" Unavailability of hospital prescribed medication in community. 
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9 Errors in prescribing resulting from errors in transcription from discharge 
correspondence. 
" Illegibility of discharge correspondence. 
Possible limitations in terms of accuracy of the findings are that the pharmacists were asked 
to make subjective assessments of the extent of these issues rather than being based on any 
form of audit. The chief pharmacist was asked to pass on the questionnaire to the most 
appropriate pharmacists and so the type and seniority of the responders was not known. The 
conclusion to be drawn is that from the perspective of the hospital pharmacist there were a 
considerable number of problem areas relating to discharge medication in the year 2000. 
A study in Hampshire (Brown and Brown, 1997) about the existing oral and written 
communication channels between the primary and the secondary care pharmacists. Ten 
hospital pharmacists and 90 community pharmacists were interviewed using structured 
interviews. Results indicated that communication between primary and secondary care 
occurred infrequently. Both community and hospital pharmacists were aware of the 
importance of preventing problems at the primary/secondary care interface, but they were 
unable to put into practice the strategies that could ensure this outcome. There were a few 
findings of particular interest. The hospital pharmacists appeared to have comparatively little 
regular contact with community pharmacists, but identified important potential roles for them 
such checking patient's medication prior to a planned admission. The community 
pharmacists felt the letter to the GP was the most important item of information and stated 
that the patient's copy was useful to them in identifying interface issues. i"ney also put a 
great deal of emphasis on counselling by hospital pharmacists pre-discharge, but this was not 
routinely undertaken in the hospital surveyed. The community pharmacists could identify a 
number of examples where medication discharge issues had arisen of the type documented in 
other studies involving poor communication such as information on GP records and running 
out of discharge medicine. They also felt that the GP systems were more accurate than 
PMRs, though it is unlikely that they were fully familiar with the accuracy of GP records. 
Over 75% stated that they would like to be more pro-active regarding checking medication 
before admission and monitoring those recently discharged. However, it is doubtful that they 
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would routinely undertake such a role in addition to their usual duties, unless part of a 
contracted service. 
The need for discharge counselling was illustrated by Cantrill and Clark (1992) where 
provision of this service to 60 patients was assessed in terms of problems identified at the 
time of the counselling session. This was provided to patients discharged from one 
rheumatology and one gastroenterology ward. The most common problem identified was 
lack of information concerning medication in 40% of patients. Other areas were inaccurate 
prescriptions for 12 patients and problems in administration. The authors noted that 
pharmacists should maintain patient contact throughout the hospital stay, not just at 
discharge. 
An audit by Coleman et at. (2001) attempted to quantify the discrepancies between discharge 
advice notes and the GP records. In this study a hospital-based pharmacist audited the 
discrepancies in 6 medical practices involving 232 patients. The data presented relates to 
discrepancies rather than problems with prescriptions issued. It is possible that some of the 
problems would have been resolved before the patient received a prescription after discharge. 
Overall, 11 % of the discharge advice notes lacked some information that would have been 
important to the prescriber. This was the most frequent due to absence of dosing details and 
course length. From the GP notes 12% of discrepancies were caused by errors in transcribing 
information from the advice note into the records. The most frequent errors were duplication 
of drug class, changes not implemented and old medications not discontinued. The failure to 
stop medication in just 8 patients may be an underestimation as information regarding 
cessation was often not mentioned in the advice note, hospital doctors just tending to use the 
letters as an instruction to supply rather than a full list of intended therapy. It is also unclear 
whether the same patients were involved in problems with transcription as well as incomplete 
advice notes, making an overall estimate of problems difficult. The study seems to suggest a 
medication communication problem of some form in around 15% of discharge patients. 
A study by Bums et al. (1992) quantified the discrepancies at discharge through a direct 
examination of prescriptions issued by the GP. They noted that the 56 patients in the study 
97 
CHAPTER 1 BACKGROUND &LITERATURE REVIEW Medication Discharge Planning 
should have received a total of 128 prescription items from their GPs if this was simply a 
repeat of the hospital discharge medication. Of the total GP prescribed medicine 11% of 
drugs were new additions and 13% were omitted on the original list of 128. The authors 
admitted that they could not state with certainty whether omissions were intentional. This 
illustrated the difficulty of clearly quantifying the range of interface issues involved in 
medication discharge. Also, having more than one investigator assessing the different 
outcomes post hospital discharge, may introduce an extra source of bias affecting the results 
due to variation in the experience of the different investigators. A useful study might be to 
track prescriptions discrepancies back to the GP to see if an intended change had occurred 
and also to the hospital to identify if they were aware of certain medications being prescribed 
prior to admission. 
1.5.2 Intervention Studies Involving Pharmacist Pre-discharge Counselling 
There appear to be four important interventions that have been investigated concerning 
medication discharge planning: 
" Counselling of patients immediately pre-discharge. 
" Follow-up and counselling post discharge. 
" Provision of patient reminders and information cards. 
" Information letters to GPs and/or community pharmacists. 
Not included in this review are those studies from outside of the UK. The unique nature of 
the NHS often makes it quite difficult to draw comparisons to studies conducted in countries 
with different healthcare systems. For instance, the discharge process of communication 
between hospital and GP will be quite different. Also, the level of support offered to elderly 
patients in the community would vary in other countries; many would rely more on family 
support than the UK or US. The activities of the community pharmacist can be radically 
different even within the European Union and many countries have a far less clinically 
orientated role for pharmacists. Even though community pharmacist involvement in services 
such as domiciliary visiting and medicines management is not currently widespread in the 
UK, they will certainly become more mainstream NHS activities in the coming years and 
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would explain the growing number of studies in this area in the UK compared to other 
countries. 
For convenience, the studies have been categorized according to their age. The studies should 
be viewed in the context of the major changes to the NHS and delivery over the last 30 years. 
Those pre 1990 may have less relevance to the modem NHS with its emphasis on primary 
care. 
Post 2000 
Al-Rashid et al, (2003) conducted a recent study bearing perhaps the closest relationship to 
the subject of this thesis. This involved pre-discharge counselling with two objectives; to 
improve knowledge of medication and encourage greater compliance. Indeed these outcome 
measures are almost universally applicable to the various studies described in this section. 
Outcome measures therefore include an assessment of medication knowledge and measuring 
compliance by a tablet count. The study also included an assessment of unplanned GP visits 
after discharge as well as rate of readmission. Altogether, 90 patients were recruited from 
two wards in a care of the elderly unit, counselled on the use of their medicines and then 
followed up at 2 weeks and three months post-discharge, where medication knowledge and 
compliance were assessed in the patient's home. 
As the Al-Rashid et al. study is so similar to the present thesis it is worth considering the 
methodological shortcomings in some detail. There are some concerns regarding patients 
selection in that elderly patients were recruited if a clinical pharmacist felt that they could 
have problems with medication after discharge, but it is not stated what such problems might 
have been. This could introduce selection bias in the population studied if for instance there 
was a tendency to recruit patients of poorer drug knowledge into the control group, which 
could have been possible from the design described. The other major methodological 
problem, acknowledged by the authors, was that the one ward was chosen for recruiting 
control patients and another for those in the intervention group. It is possible that the range of 
medical conditions, types of medication or quality of the usual discharge procedures may 
differ between the two wards. The authors did not report any baseline data concerning these 
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points. It also appears that both control and intervention groups received medication 
reminder cards as well as discharge details being sent to GPs and community pharmacists. 
Therefore, the hypothesis was simply that a 30 minute session covering details of medication 
regimen, encouraging compliance and improving knowledge would impact on the outcome 
measures described above. 
An improvement in knowledge was claimed by the authors, but the data only supported such 
an improvement in the area of `drug use', whereas knowledge of regimen remained high in 
both groups. However, the authors did not describe the categories of knowledge within this 
broad heading. This theme of poor reporting of knowledge categories and scoring system was 
presented in a number of the studies described in this section. 
In terms of compliance, there were some remarkably big differences between groups 
reported. The compliance measure was presented as a percent of total number of items where 
compliance reached 85%-100% as estimated by tablet counts. By the second visit this was 
70% of items for the intervention group but just 16% for control. The results could be 
explained by the strict cut-off points. For instance, if the compliance level by tablet counts 
had been 80% in both groups at baseline and then improved by just 5% in the study group, 
then by the system described in this paper a false impression of the improvement would have 
been given. This illustrates the importance of presenting ranges of compliance, either as 
means with standard deviations or categorically at different levels. 
The paper described the study group as involving less GP visits and fewer hospital 
admissions. The reasons for admission or GP visit are not described so could be unrelated to 
poor compliance or drug knowledge and may be due to the previously stated selection bias. 
The other interesting finding was that patients passed on very few of their discharge letters to 
the community pharmacists, but tended to do so for the GPs. Finally, as with many of these 
types of intervention study the assessments were not blinded. 
There are a few studies that have investigated the influence of pharmaceutical care strategies 
initiated during hospital admission and then assessed their impact post discharge. One such 
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small study by Pickrell et al. (2001) assessed the influence of such care regarding 
discrepancies between medication prescribed in hospital and that prescribed by the GP. This 
was assessed on admission in terms of what the prescribing physician believed to be the 
patients' usual admission compared to that actually prescribed by the GP and whether this 
had been resolved at discharge. Fifteen patients were counselled both on admission and 
discharge and letters summarizing changes in their regimens sent to the patient's GP. 
Another group of 17 patients received only the standard hospital care. Of interest in the 
context of discharge counselling and communication with GPs is the number of discrepancies 
recorded at 2 weeks; 0.86 per patient in the intervention groups compared to 3.7 in the 
control group. However, the figures need to be considered in the context of the study 
limitations. This is described as a `qualitative' study, yet is based upon reporting of only 
quantitative data. Group allocation was not randomised but purposive and the study is 
described as exploratory involving only 411 patients. The method for identifying discrepancies 
at follow-up was unclear as it is stated that `prescriptions were compared' but it was not 
described how such prescriptions were identified or compared to GP records. The 
discrepancies may have been queried over the telephone interview with patients, a very 
inaccurate method of such an assessment. 
There are not many examples of multi-centre trials involving medication discharge planning, 
but one major study (Nazareth et al., 2001) failed to identify any benefits from the scheme it 
described. In this study pharmacists from four hospitals passed on detailed discharge plans to 
one of 29 community pharmacists who followed up patients in their own homes. This was a 
randomised controlled trial with the control group receiving no pharmacy visit. As well as 
compliance and knowledge, other outcomes such a readmission, outpatient attendance, 
general well being and numbers of deaths were assessed. Apart from a small improvement in 
patient knowledge in the intervention group no other significant differences to controls were 
found at two weeks, 3 months, 6 months post discharge. There are a number of important 
points concluded from this study: 
" Although community pharmacists were given some training it is possible that this was 
not adequate to familiarize themselves with the clinical issues. 
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" The elderly patients each had a number of chronic conditions contributing to 
morbidity and overshadowing any of the medication-related events leading for 
instance to readmission and death. 
" No discharge counselling was given prior to discharge and baseline was at 7-14 days. 
It is possible that such counselling by a hospital-based pharmacist would have 
prevented problems more effectively post discharge. 
9 The community pharmacists did make a large number of interventions regarding 
medication regimen, although these were mainly to provide the patient with 
information to dispose of unwanted medicines. 
" Compliance was reported as high in both groups but the method of assessment is not 
described i. e. is usually high if just relying on self reporting. Similarly, assessment of 
knowledge is not discussed 
The important message from this study is that, it is difficult to detect true clinical advantages 
from medication discharge planning and that home visits from community pharmacists in this 
context may have little added advantage. However, some of the secondary outcomes such as 
compliance, knowledge and level of intervention/potential medication-related problems were 
not properly investigated. 
One useful way of facilitating the discharge process is to use a dedicated hospital-based 
liaison pharmacist and one study (Brookes et al., 2000) claimed a reduced readmission rate in 
those receiving this service. However, the study was poorly controlled and not randomised. 
The claim for reduced admission was simply made by comparing the rate for those receiving 
the service (66 patients) to the average re-admission rates for the same age group within the 
entire hospital. The study also consisted of an intervention by the pharmacist on admission 
where a large number of MRPs were identified. A control group to compare identification of 
problems by a non-dedicated pharmacist is not present. Discharge information was 
communicated to the GP and community pharmacist by the dedicated liaison pharmacist but 
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any direct effects of such information was not assessed as patients were not followed up on 
discharge. A questionnaire sent to GPs and community pharmacists did indicate that they felt 
the information to be of use. 
The effective transfer of information is fundamental if pharmaceutical care is to be truly 
seamless. It would follow that if MRPs can be reduced by such a system then potential 
benefits could be identified. One of the difficulties is to standardize the reporting of such 
problems to obtain consistent reporting in order to compare studies. It may be the case that 
transmitting pharmaceutical care issues is even more important when involving a medical 
speciality rather than the general care issues in care of the elderly, as the non-specialist GP or 
community pharmacist will be less familiar with the specialized drug therapeutics. 
This was well illustrated in a study by Morrison et al. (2004), which was an uncontrolled pre 
and post intervention study involving discharge of patients from a specialist pediatric unit. 
The study involved initial focus groups of patients, GPs and community pharmacists to 
determine the range of pharmaceutical care issues in the patient group. The intervention 
consisted of the transmission of a detailed pharmaceutically related discharge letter to the GP 
and community pharmacist focusing on issues such as the use of unlicensed regimens, 
unusual doses, formulations and routes of administration. Outcomes were assessed by 
questionnaire sent to the GP covering satisfaction with the information received and to the 
community pharmacist covering types of pharmaceutical care issues and parents concerning 
the issues they encountered. There were 55 patients in the pre-intervention and 47 in the post 
intervention phase. The most interesting results were those reported by the community 
pharmacists, where a large reduction in pharmaceutical care issues were reported post 
intervention. These improvements were in those areas very much related to the speciality 
rather than general issues such as dosage information or reason for medication. In the main, 
the issues concerned simply reassuring the pharmacist that the prescription was correct e. g. 
not needing to contact the hospital to confirm an unusual regimen, rather than actually 
avoiding a potential clinical problem. Obviously, the pharmacist was not blinded so a very 
subjective view of the problem was given. Lack of a control group would question the 
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matching of the pre and post intervention groups and the group characteristics are not fully 
reported. 
Studies 1990 - 2000 
There are very few examples of studies that have attempted to asses the clinical importance 
of problems arising through discrepancies between discharge medication and that taken when 
the patient returns home. One small scale study by Smith et al. (1997) involved 53 patients, 
did investigate this aspect and was quite well-designed. Elderly patients were randomised 
into a control or counselled group, the visiting pharmacist was blinded to group allocation 
and a panel of clinicians judged the clinical relevance of any intervention or discrepancy 
identified. The design was quite simple in which all patients were visited at home 7-10 days 
after discharge to assess compliance by tablet count, knowledge of medication by interview 
and discrepancies to discharge medication. The pharmacist made interventions for both 
groups on any discrepancies found. The visiting pharmacist contacted the GP concerning 
such discrepancies and obtained further details for the panel assessment. One group of 
patients received medication counselling by one of a number of clinical pharmacists before 
discharge and also provided with a pharmaceutical care plan to pass on to their doctors or 
community pharmacists. 
Unfortunately, reporting of results in this study is somewhat lacking and it is difficult to draw 
many useful conclusions. Compliance is simply reported in terms of numbers of patients 
where this was felt to be a . NW, no absolute levels being provided even though tablet counts 
were performed. Similarly, incorrect use of medication is reported without specifying any 
further details. In terms of compliance and drug use problems though, the counselled group 
did perform significantly better than controls. The total number of discrepancies where a GP 
was contacted totalled 31 and there was no difference between the two groups. This would 
suggest that the intervention did not necessarily reduce the incidence of interface issues. The 
panel noted that the largest number of discrepancies, 16 in total, `restored the efficacy of 
discharge medications' but no details were given as to the precise meaning of this 
classification. All of the interventions assessed did result from unintentional continuing of 
pre-admission medication. 
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A key element to discharge planning is the transfer of accurate information to the primary 
care setting. Some UK studies have attempted to utilize the community pharmacist in this 
context by communicating to them details of discharge medication. The patient is asked to 
nominate the pharmacy to which the information is sent, the theory being that they are then 
in a position to identify discrepancies in terms of unintentional changes to the discharge 
medication, particularly when it reverts back to pre-admission medication unintentionally. 
One of the most detailed examinations of this type of system was conducted by Duggan et al. 
(1998), although not without some flaws and limitations. It is worth considering in some 
detail as although it did not exclusively involve older patients, the study did attempt to 
quantify the impact of this type of intervention. The study design was a prospective 
controlled trial in which patients were assigned either to an intervention group to whom 
community pharmacists were sent a discharge letter or controls where no letters were sent. 
Two weeks after discharge both groups were visited at home by an investigator who noted 
discrepancies between the intended hospital discharge medication and those obtained via the 
GP at this point. 
The group allocation was not randomised and although some data was presented to indicate 
matching, it is not described how well they were matched concerning discharge medication. 
In addition, the investigator was not blind to group allocation. The discrepancies noted in the 
visits were then presented to a panel of hospital consultants to grade as none, possible or 
definite adverse effect on the patient. This exercise was conducted rigorously with a retest of 
the same panel one month later. As with all such studies the panel decision is limited to the 
information provided. In this study no reference was made to GP records and therefore no 
information could be provided to the panel from this source. In addition, the visiting 
pharmacist was required to make an assessment of `unintentional changes' even though no 
check was made that this was the case from the prescriber's perspective. The authors also 
argued that the panel were uncertain of the classification of some potential into the definite 
category due to lack of information The reverse case could also be true as with more 
information potential or even definite changes might be downgraded as being less important. 
Further possible criticism are that only the actual discharge medication appears to have been 
transmitted to the community pharmacists without other details such as those drugs that 
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CHAPTER I BACKGROUND &LITERATURE REVIEW Medication Discharge Planning 
only 15 patients were visited to assess compliance and drug knowledge. Eleven had 100 % 
compliance and knowledge had improved in 13 patients when compared to baseline taken on 
admission. It is not stated how knowledge was assessed. The figures are broadly similar to 
other intervention studies of this type. The major limitation of this study is an absence of the 
control group. The recommendations made in the care plan may have been initiated 
independently by the GP or pharmacist and knowledge scores also improve throughout 
hospital stay. The authors described a number of specific cases where important information 
was conveyed and acted upon which may not have occurred in the absence of such 
information. The most interesting aspect of the study is that changes initiated by the GPs post 
discharge need not necessarily be unwarranted or of high importance. Of the 105 changes 
noted, a high proportion simply related to a less specific dosing regimen e. g., labels reading 
once a day instead of in the morning when timing was not necessarily critical. Any name 
changes in medication were simply related to proprietary names and most of the regimen 
changes initiated did appear logical. It might be concluded from this study that very detailed 
pharmaceutical care plans concerning patient specific details may not be worth conveying to 
GPs or community pharmacists. There were some cases of patients being inappropriately 
reinitiated on medication discontinued by the hospital. Therefore, descriptions of discharge 
medication and specific instructions regarding previous medication to be discontinued may 
be the most important areas of information to be passed to GPs and community pharmacists. 
Although not involving pharmacist in patient counselling, it is of interest to note another 
scheme involving a form of patient counselling throughout hospital stay through a patient 
self-medication programme. In this type of scheme patients administer their own medicines 
and are educated and given increased responsibility through their hospital stay. The study by 
Lowe et al. (1995) investigated the impact of this scheme on elderly patients in terms of drug 
knowledge and compliance by tablet count. The study was controlled but not randomised and 
the assessor may have been aware of the group allocation. A total of 88 patients were 
recruited and assessment was made by tablet count and home interview 10 days after 
discharge. The effect on compliance was similar to that seen in other pre-discharge 
counselling studies; 95% for the intervention group and 83% for control. The somewhat high 
figure for controls may be due to the fact that they were also given reminder cards. 
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Knowledge was only assessed in terms of patients knowing the purpose of medication; 46% 
correct for control and 90% correct for intervention. 
The study by Begley et al. (1997) primarily investigated the effect of a domiciliary visiting 
scheme but is included in this section as elderly patients were recruited from the hospital and 
visited at only one or two days post hospital discharge for medication counselling. These 
patients were allocated to one of three groups; receiving home visits and counselling, home 
visits only for assessment and one which received visits only at the end of the study period at 
one year. Intervention patients were counselled and assessed at the first visit then re-assessed 
at weeks 2,4,12 and one year for drug knowledge, patient dexterity in administering 
medication, storage of medicines, contact with GP and compliance by tablet count. No details 
were provided regarding the scoring system employed to assess drug knowledge. It was also 
described that interventions regarding MRPs were made, but the results do not appear to have 
been reported. The group allocation was not randomised and the investigator was not 
blinded. The knowledge score did improve at two weeks after counselling (mean score 82%) 
but thereafter declined by 12% over the year to reach the same level as the control. The same 
picture consistent with other studies regarding mean compliance rate was reported; 78% at 
two weeks for control compared to 94% for the intervention group. Compliance levels held 
quite well at one year with 86% for the intervention group and 76% for control. This would 
appear to challenge the conventional view that compliance is relatively high just after 
discharge then declines. Also, the effect of just one counselling session has maintained 
compliance for a whole year. One possible explanation is that the regular visits may have 
maintained compliance even though no specific counselling was given. This explanation is 
supported by the fact that the third group only had a compliance rate of 69% at one year. 
Unfortunately, no baseline visit was made for the third group making it difficult to support 
this hypothesis. Other useful findings were a reduction in hoarded drugs and better storage of 
medication for the intervention group. The counselled patients appeared to have less contact 
with GPs, but this was only significant at 12 months. As patients were only asked directly 
regarding GP contact investigator bias cannot be ruled out. 
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Raynor et al. (1993) carried out a detailed investigation concerning the use of a reminder 
card for discharged patients that was computer generated and individualized. The 197 
patients recruited were randomised into four groups; receiving brief nurse counselling, 
receiving brief pharmacist counselling, nurse counselling plus card and pharmacist 
counselling plus card. The patients were visited at home 10 days after discharge for tablet 
counts and testing of knowledge of their medicines. No difference was observed between the 
two groups who had received the reminder chart and the same for the two groups who had 
not received charts and these were combined for analysis. One of the most interesting aspects 
of this study is the efforts taken to blind patients concerning tablet counts. This was achieved 
by removing the tablet supply and counting them away from the patients and a later date, 
with the explanation that they were being taken to replace with fresh tablets. In addition, 
excess quantities were supplied to minimize patients adjusting numbers in the bottle just 
before the interview. Despite these measures results were consistent with other studies; the 
mean compliance was 86% in the control compared to 95% in the intervention group. This 
translated to 63% of patients achieving greater than 85% compliance in the control group 
compared to 86% in the intervention group. The 10% difference in mean compliance rate is 
less than the 15% found in many other studies. This is probably due to the relatively brief 
counselling session, although the affect of the reminder card was found to be significant 
using factorial analysis. Knowledge of the regimen also improved in this study; 47% 
correctly explained the regimen in the control group compared to 74% in the intervention 
group. However as with many studies of this type the investigator was not blinded. 
An abstract by Home et al. (1995) described a prospective controlled trial of a pharmacy- 
related hospital discharge programme. In this study, pharmaceutical care needs were checked 
prior to discharge including knowledge of medication, adherence issues, suitability of 
regimen and liaison with the community. It is unclear from the abstract what type of 
information was given to the intervention group. The interviewer was not blinded to the 
group allocation and made assessments both pre discharge and post hospital discharge at 2 
and 8 weeks. Despite a variety of outcomes possible the authors only reported on compliance 
level and medication knowledge. Also, details regarding the calculations made on tablets 
counts were not included. At 2 and 8 weeks the intervention group reported a significantly 
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higher compliance level; 67% and 60% for control compared to 76% and 70% for 
intervention. They also reported no difference in the knowledge score at any stage, although 
details of the knowledge assessment and scores were not presented. If knowledge was not 
improved then the greater compliance rate may have resulted from some other factor in the 
counselling session, but the details of the session were not given. It is probably an 
overstatement by the authors that the benefits of pharmaceutical care are apparent 8 weeks 
after discharge. 
Pre 1990 
One of the earliest studies to examine the effects of counselling for elderly patients prior to 
discharge is that by MacDonald et al. (1977), where changes in compliance was the main 
outcome measured. This was a controlled trial but not randomised with consecutive patient 
allocated to one of three groups; 60 patients were counselled before discharge, 45 counselled 
and given a compliance aid and the control group patients were not counselled. No details 
were given regarding the type of counselling offered. Compliance was assessed and 
categorized in the following way: 
" Under dosing as measured by tablet count on returning for an outpatient visit one and 
two weeks following discharge. This was categorized as taking less than half of the 
week's tablets medication at the visit. 
" Overdosing if during a spot check at home they had taken the week's medication in 
four days or less. 
" Consuming old stocks of medicines or other individual's tablets. 
Estimation of compliance only by tablets returned is prone to inaccuracy as tablets from old 
stocks may have been consumed. The use of 50% compliance is not very stringent and the 
standard is now accepted as being below 75%. In addition, the age of the study may make it 
less relevant to current clinical practice. For instance, nearly a quarter of the underdosing 
errors related to slow release potassium therapy, which involved taking quite large numbers 
of tablets and this is only now rarely prescribed in clinical practice. The findings did appear 
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to reduce self-medication errors in the categories described, although 80% of errors had 
occurred in the first week. This indicates that counselling improved such factors as taking 
other medication or using old stocks. In general, it is difficult to compare this to latter studies 
due to the way in which compliance is categorized. Knowledge was assessed crudely by 
clinical pharmacists at 12 weeks and was classified as being good, moderate or poor. This 
was a subjective assessment only and no details were given regarding the questions asked. 
Surprisingly, a correlation was made between knowledge and compliance but it is not stated 
if pharmacists were blinded to group allocation. The study identified no particular advantages 
for using compliance aids in relation to the various outcomes. One unique feature of the 
study was the inclusion of patients with very low mental status scores. Even in these patients 
modest and statistically significant improvements in compliance were observed, though to'°a 
lesser degree compared to those with a MSQ greater than 12. The inclusion of all patients 
regardless of frailty or cognitive ability may mean that some were not self-medicating and 
were helped by carers. As the study is over 30 years old, the type of support offered in the 
community would be different to the present. 
Another early large study to focus on the effect of pharmacist counselling pre-discharge was 
that conducted by Sweeney et at. (1989). This was of the usual design where patients (109 in 
total) were assigned to either a counselled or control group. The intervention group patients 
were counselled by a number of different clinical pharmacists and then visited at one week 
and six weeks post discharge by a single researcher who performed tablet counts. The 
findings were consistent with other similar studies at one week post discharge; 75% of 
patients were more than 85% compliant in the control group compared with 95% of patients 
in the intervention group. This level of compliance remained the same for both groups at six 
weeks. The other finding was a significant relationship between compliance and regimen 
complexity. There are two methodological aspects worth considering in this study. Firstly, it 
was not randomised, the control group being recruited consecutively before the counselled 
group. This could obviously introduce some bias into group allocation, and although 
apparently matched in some aspects, aspects such as mental status and clinical condition 
were not assessed. The reasoning for this design was that if randomised, nursing staff may 
influence the control group level of counselling when they were aware of the pharmacist 
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activity. This is a valid argument but such a phenomenon has not been assessed formally. 
Furthermore, it is unlikely that nurses would have routinely spent the extra 15-20 minutes on 
detailed medication counselling if this was not part of their allocated duties. The researchers 
rejected using a different ward as control as they were mixed sex wards. The other 
methodological aspect to consider was that a new medication stock was supplied at home 
visits and presumably the tablet counts performed away from the patient. It is not stated 
whether or not patients were aware of the tablet count process. 
The study by Edwards and Pathy (1984) has been one of the few to compare the effects of 
discharge counselling delivered by different healthcare professionals in terms of differences 
in levels of compliance achieved by patients. The study appears to be well designed, being a 
randomised and controlled trial with patients allocated to receive counselling by a nurse, 
pharmacist, doctor (129 patients) or no counselling (44 patients). The counselling session 
was delivered on the day of discharge by a blinded healthcare worker. Knowledge was not 
assessed directly and no description was given concerning the range of medication prescribed 
or clinical conditions making it difficult to assess matching of groups. The only other 
criticism is that six days post discharge may be too soon to assess the longer term effects of 
counselling. No attempt was made to address interface issues. The results presented are 
consistent with many studies of this type; the control group achieved a 75% mean 
compliance rate at this short time after discharge compared to that in the counselled group of 
90% i. e., a 15% improvement. There was no difference between the outcomes for 
counselling by the three healthcare professionals. The authors noted that counselling did not 
stop the taking of drugs that should have been discontinued, but this was not quantified in 
any way by the results present. 
Typical of a variety of small scale studies that have attempted to improve knowledge of 
medication prior to hospital discharge is that from Davidson and Hall (1989). In this 
randomised controlled study counselling by a pharmacist was given two days prior to 
hospital discharge and knowledge was assessed 2-3 months post discharge. The abstract did 
not describe whether the pharmacist assessing knowledge was blinded. Only 18 patients were 
recruited into each group, and those in the intervention group received counselling covering 
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knowledge and ability to self-administer the medication. The abstract described an 
improvement in total knowledge score, with the biggest improvement in knowledge of side 
effects and reason for taking medicine but no test of significance performed. The scores for 
individual aspects of knowledge were not given and the scoring system also was not 
described. 
A small scale study to examine the effects of pharmacist discharge counselling to elderly 
patients was conducted by Johnston et al. (1986). This consisted of just 27 patients in total 
but was randomized, controlled and blinded with respect to patient assessment. Counselling 
was conducted over 15 minutes on the day of discharge by a pharmacist and the assessment 
of knowledge was made by a blinded psychologist. The control group received no 
counselling and was assessed in the same way. The researchers also took precautions to 
ensure that the groups were matched in terms of ability to receive information using an 
information/orientation scale. The paper is only a short report so very little detail was given 
regarding the individual scores for the categories of knowledge tested. Overall, the 
counselled group had far higher levels of knowledge of their medication. Apart from the 
small sample size, the other main weakness is that the psychologist only tested recall latter on 
the same day of counselling, giving little impression of medium or long-term recall. 
This review does not consider studies from outside of the UK for the reasons explained 
above but it is worth looking at one study from Australia as a comparison. The study by 
Anderson (1987) consisted of the usual design involving groups of elderly patients, one of 
which was counselled just before discharge. The patients were visited in their own homes 
about one week after discharge and levels of compliance and knowledge assessed. The study 
did not identify a significant improvement in compliance even though there was a trend in 
this direction in the intervention group. This may have been an artifact of the analysis as 
compliance was assessed as poor (<75%), fair (75-90%) and good (90-100%). If mean 
compliance had been measured a different outcome may have resulted. In addition, 
combining groups for chi-squared analysis did show a significant difference; counselled were 
90% above 75% compliance compared to control only 58% at this level. This finding for the 
counselled group is similar to the UK studies. Knowledge was only assessed in subjective 
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terms of sufficient/insufficient. The intervention group did appear to have greater knowledge. 
The authors did note that the main reasons for poor compliance were unpleasant side effects 
and discontinuation due to self-evaluated improvement in condition. 
Conclusion 
In summary the problem of medication discharge planning has been known and studied since 
the 1970s. Schemes to overcome problems have been piloted, most involving pre-discharge 
counselling and/or communication to the GP/community pharmacist. Most of these have 
some form of methodological short comings. These include: 
" Non randomization or poorly controlled in a large proportion. 
" Nearly all involved just one hospital site. 
" Often involved relatively few patients. 
" Most but not all did not blind the assessor. 
" Most only examined the effects of the intervention up to two weeks post discharge. 
In many cases this is probably a reflection of the poor national funding available for this type 
of work so that the projects were mainly funded by local trusts and hospitals from a limited 
perspective. 
In a large number of the papers there is inadequate information or it is presented in such a 
way that makes it difficult to compare the results across the studies. This is particularly true 
of assessments of knowledge of medication where no consistent methodology is used. Also, 
the presentation of interface issues and medication-related problems is often difficult to 
compare across studies in those where this has been assessed. 
Many studies examined the influence of counselling in terms of changes in compliance and 
drug knowledge. There seems to be a clear picture emerging regarding compliance up to two 
weeks after discharge as having a mean rate of 75% that can be improved by counselling to 
over 90%. Knowledge also improves by counselling but as described above, baseline and 
levels of improvement are difficult to quantify. 
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There are a number of areas where there is knowledge gap regarding discharge and 
medication: 
Although there are a large number of studies where a liaison pharmacist has visited 
patients post discharge to assess compliance and knowledge, there are very few 
studies where such a worker has offered further counselling, which would be an ideal 
opportunity, and then returned on a follow up visit to assess progress. 
The area concerning the broad range of medication-related problems following 
discharge has not been well studied. Some have examined the interface issues but few 
have examined the effects of interventions such as counselling on reducing the 
incidence. A full classification of medication-related problems and the impact on 
these of interventions does not seem to have been attempted in the context of 
discharge medication. 
" No studies have attempted to examine health status or quality of -life and only few 
considered satisfaction with information. 
Very few examples of studies could be found where patients were counselled before 
discharge, letters sent to both GP and community pharmacist and then followed up in their 
own homes. Those that did follow such a system are either small scale or uncontrolled-and do 
not describe a full range of outcomes. There were no examples where a hospital-based 
visiting pharmacist further counselled patients post discharge and the effects of such 
counselling assessed. It is the primary aim of this thesis to address these gaps in knowledge. 
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Summary 
a. The extent of the problems of poor adherence and patient knowledge has been 
reviewed and various factors which influence these two areas identified. Although it 
is recognized that compliance and knowledge amongst the elderly can be poor, it is 
uncertain whether or not it is any worse than in younger patients. There are a number 
of special factors which may contribute to poor adherence in elderly. 
b. Assessment of compliance is traditionally performed by tablet counting which has a 
number of disadvantages. There are many other methods that can be used to measure 
compliance, but none of these methods is ideal for every circumstance. A 
combination of two or more methods may be an ideal way to assess compliance. 
c. Patient counselling appears to be the best way to improve patient's adherence in using 
the medicines, and for best results, the use of written information as a backup. 
d. MRPs include adverse drug reactions, drug interactions, non-compliance and 
inappropriate prescribing. MRPs decrease the clinical effectiveness of medicines and 
consume NHS resources because they waste medicines and increase the NHS spend 
on medicines. 
e. Pharmaceutical care involves the process by which a pharmacist can meet a patient's 
drug therapy needs and other health care professionals in designing, implementing, 
and monitoring therapeutic plans that will produce specific therapeutic outcomes for 
the patients. Pharmaceutical care is an important part of health care, and should be 
integrated with other elements. 
£ The role of the pharmacist in the health care system is expanding from the traditional 
drug-oriented function to cognitive functions. A domiciliary counselling service 
should be one of the priorities of "care in the community" provided by the 
pharmacist. 
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The overall aim of this research study is to assess the effect of medication counselling on 
various outcomes including patients' knowledge, quality of life, satisfaction with the 
information and compliance and to identify problems concerning elderly patients discharged 
from hospital, and suggest possible solutions. Another aim of this study is to identify the 
MRPs elderly patients may suffer from after hospital discharge and suggest different 
interventions to overcome these MRPs. To quantify this part of the study it is proposed to 
develop ways of classifying these XWs. In the following chapter the various instruments 




CHAPTER 2 METHODS 
CHAPTER TWO 
METHODS 
All hospitals in the UK have a policy of supplying patients with a -small supply of 
medications on discharge. It is usual for nursing or pharmacy staff to explain and discuss the 
regimen with the patients, although the time spent and details discussed are variable. This 
study compares the outcomes of a standard medication counselling procedure at St. Thomas' 
Hospital, London with a full discharge counselling and follow-up system. 
2.1 Aim and Objectives 
The main aims and objectives of the study are given in full in Chapter 4 but briefly 
summarized here. The overall aim of this project is to investigate the influence of a novel 
discharge and follow-up scheme that could provide a smooth seamless pharmaceutical care 
for elderly patients across the secondary/primary care interface. 
The project has the following objectives: 
1. To design and implement a tool for providing structured medication counselling. 
2. To examine whether structured medication discharge planning and patient counselling 
improves elderly patients' knowledge, adherence to medications, quality of life and 
satisfaction with the information provided. 
3. To develop and assess methods of overcoming interface issues concerning discharge 
medication in terms of improved communication with GPs and community pharmacists. 
4. To explore the implementation of domiciliary visit scheme by a hospital liaison worker for 
elderly patients post discharge. 
5. To implement a scheme capable of identifying the different MRPs post hospital discharge 
and investigating the effect of the pharmaceutical service provided post hospital discharge on 
reducing these problems. 
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To achieve these objectives, a variety of questionnaires and instruments were adopted to 
conduct this project. This chapter will discuss this in some detail. 
2.2 Instruments Employed in the Main Study 
Questionnaires are considered the most common method of collecting subjective data either 
self-administered or conducted by an interviewer. The choice of the instrument depends on 
various factors including: 
1. The target population and whether they suffer from any reading, cognitive or dexterity 
difficulties. 
2. The length of the instrument, the longer the instrument the more time will be consumed to 
conduct the study and to perform the analysis. 
3. Availability of simple and easily applicable scoring system or a method of weighting of 
the instrument. 
Bowling (1995) has listed the most important criteria to be considered when selecting an 
instrument. These criteria include: reliability, validity, responsiveness, interpretation, 
alternative forms, burdens, practical experience of its use and the cultural and language 
adaptations. Some of these criteria will be explained in more detail in Section 2.3.3. 
2.2.1 Mental Status Questionnaire 
The primary aim of this study is to improve patients' awareness and their adherence to 
medication and to ensure that patients must therefore be capable of understanding and 
digesting the information provided to them. Mental impairment can be defined as "memory 
impairment and loss of intellectual abilities of sufficient severity to interfere -with social 
functioning". Interview or observation of the patient involving an informant has been 
considered the most common method for assessing mental impairment (Engedal et al., 1988). 
During the past four decades, a number of assessment scales have been developed for 
screening the mental capacity. 
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Most of the instruments currently in use to assess patient's cognitive function contain quite 
similar items and some may be interchangeable (Stuss et al., 1996), being developed for the 
classical symptoms of cognitive impairment: apraxial, aphasia2 and agraphia (Engedal et al., 
1988). Dimensions usually include orientation in time, place and person, short and long-tern 
memory, and ability to concentrate. Items reflect a different approach to the same question or 
a different scoring system. 
Many different screening instruments can be used to assess the. degree of cognitive 
impairment. The main problem in selecting the most appropriate tool is their multiple and 
coinciding measurement purposes; affective functioning, cognitive functioning, functional 
abilities and mental status (McDoughall 1990). Mental status and cognitive function were 
assessed in this study using the Mental Status Questionnaire (MSQ) before recruiting any 
patient. This questionnaire was selected as it was designed, developed, tested, standardized 
and validated to be used as a screening tool. Reliability of this scale has been assessed for its 
internal consistency (by calculating the Cronbach's alpha), inter-rater reliability (by 
calculating Cohen's coefficient of Kappa) and the validated by a logistic regression model 
(Engedal et a1., 1988). The MSQ is a powerful discriminator of mental status in elderly 
patients and an adequate predictor of competence in simple self-care (Wilson and Brass 
1973). The MSQ seems to be a suitable tool for the detection of mental failure in patients of 
old age, being easily administered by any clinician or researcher in different settings (office 
or hospital). 
The test is composed of 26 questions as shown in Appendix I represent several different 
domains assessing memory functioning (short-term memory and long-term memory), 
orientation to surroundings (time, place and persons), information about current events, and 
serial mathematics abilities. In this study patients were assessed for their mental status by 
interviewing them face to face using the MSQ and any score under 20 being indicative of 
' Total or partial loss of the ability to perform coordinated movements or manipulate objects in the absence of 
motor or sensory impairment. 
2 Partial or total loss of the ability to articulate ideas or comprehend spoken or written language, resulting from 
damage to the brain caused by injury or disease. 
3A disorder marked by loss of the ability to write. 
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some cognitive dysfunction. Patients were not approached for entry into the study if dementia 
or other cognitive impairment had been already recorded in patient's notes. 
A criticism of the questionnaire is that mild or early dementia may score as normal and vice 
versa i. e., mildly affected individuals may be falsely labeled as having dementia.. It can not 
be used where there is dysphasia, deafness, depression, disturbed consciousness, native 
language difficulties and severe illness when the person cannot cooperate (Health 
Information Website, 2000). 
The MSQ was used over any other systems (Global Deterioration Scale, Blessed Dementia 
Scale, Clinical Dementia Rating, Cognitive Levels Scale and Cognitive Capacity screening 
Examination) as it is considered the most established system in clinical researches of this 
type in the UK. 
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2.2.2 Designing of the Counselling Checklist 
An essential part of this study was to attempt to improve patient's compliance and drug 
knowledge. Thus, a structured counselling technique was designed to achieve this and any 
counselling system used must be workable. This section describes the process by which this 
was achieved. Counselling checklists used in a similar context to. that. in the present study 
have been described in section 1.4.4 and section 1.5. There does not appear to be any single 
well validated tool but that by Coombes and Home (1994) does seem reasonably 
comprehensive and also was reported as workable in the context of medication counselling 
for the elderly. The system used in this study is similar to that by Cantrill and Clark (1992) 
with some modification in terms of layout and being able to capture baseline data. 
The aim was to design a tool that could be employed to collect the data necessary for 
effective medication discharge planning and act as an aide-memoir regarding medicine 
information to be given to the patient The checklist was designed as a two-sided A4 sheet 
(Appendix I>). The first side included all the patient's background details (name, age, gender, 
ward, bed number, date of admission, reasons of admissions, allergy. status, past medical 
history, drug history, name and addresses of GP and community pharmacist and social 
status). In addition, this side contained all the information regarding the patient's discharge 
procedure (date of planned discharge, destination to which the patient will be discharged to, 
help received at home and medication on discharge). 
On the second side of the checklist, there are small boxes to be ticked by the investigator; 
each box corresponding to a piece of information needed to be covered by the investigator 
during the counselling session. There is also a space in the checklist. to note down problems, 
questions or concerns the patient may have during the counselling session. Another section is 
a checklist to ensure that the patient can recall the information provided. The last part of the 
checklist was designed to indicate the patient's physical ability to administer medicines e. g., 
open bottles, remove the tablets or capsules out of the blisters or to use an inhaler device. 
This checklist was designed to be easily used by hospital staff other than the ward 
pharmacists e. g., nurses, pharmacy technicians or pharmacy students. 
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2.2.3 Quality of Life and Nottingham Health Profile 
The goal of healthcare is to prolong the lives of people and to improve the quality of their 
lives and with an increasing incidence of chronic diseases ways of measuring and assessing 
quality of life is an important area. Clinical measurements do not tell the whole truth about 
the way people cope with their conditions and the quality of their lives, because these matters 
have not often been investigated in relation to people's everyday life and environment. 
Quality of life measurements have emerged as an increasingly important criterion for 
evaluating the outcomes of treatment interventions. The concept "quality of life" 
encompasses a wide range of physical and psychological characteristics and limitations 
which describe that person's ability to function and to derive satisfaction from doing so. 
Quality of life is defined as "the individual's perception of their position in life in the context 
of the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns" (WHOQoL Group, 1993). 
Quality of life is a broad concept which is affected in different ways by the person's physical 
health, psychological state, level of independence, social relationships, and their relationships 
to salient features of their environment (Bowling, 1995). Quality of life reflects life 
experiences, significant life events and the current phase of life. The factors defining quality 
of life include. sex; socioeconomic status; age and generation (Farguhar, 1995). Quality of 
life instruments have a number of uses and one of these is in evaluating the health services 
particularly as endpoints in clinical research, such as assessments of the influence of 
interventions (Velanovich, 1999). However, total quality of life is difficult to measure and 
may not always be necessary, so the narrower concept of "health-related quality of life" is 
often used. Self-administered questionnaires and structured interviews are the two most 
commonly used techniques to assess patient's quality of life (Jenkinson and Fitzpatrick, 
1990), 
In order to be useful for research and clinical applications, health-related quality of life 
measures need to have 5 essential characteristics that determine their quality (Velanovich, 
1999 and Francis, 2001) although some of these are true of any questionnaire: 
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1. Reliability: which describes the extent to which the instrument yields the same number 
or score each time it is administered. It can be measured either by test-retest scores or by 
test-retest agreement on repeat administration under identical conditions or measuring 
degree of agreement between halves of the instruments as a single administration. 
2. Validity: refers to the degree to which the instrument reflects what it is supposed to 
measure rather than something else. Validity can be content or face validity, i. e., cover 
the areas of interest, and show similar (convergent validity) or opposite (divergent 
validity) relationships with other appropriate measurements and to be able to discriminate 
groups of people (discriminative validity). 
3. Responsiveness or sensitivity to change: which measures the extent to which scores 
change when the concept under study improves or deteriorates i. e., the ability of a tool to 
detect small but clinically important variations. 
4. Appropriateness: where the instrument must be appropriate for the health problem and 
the likely range of effects of the treatment being investigated. 
5. Practicality: which refers to the ease with which the instrument can be used. 
There are three basic types of quality of life instruments: generic (addressing all aspects of 
HRQL), disease specific (dedicated to a particular disease or group of patients) and symptom 
severity (Velanovich, 1999). For the purpose of this study it is more appropriate to use a 
generic instrument because of its ability to be broadly applicable across a wide range of types 
and diversity of illness and across different medical treatments or health interventions 
(Velanovich, 1999). Generic health measures focus on functional status and well-being and 
are used in studies where one wishes to draw conclusions about general outcomes. One of the 
advantages of these measures is their ability to cover broadly different areas of life which 
maximizes the opportunity for detecting unexpected or iatrogenic effects (Francis, 2001). No 
one quality of life instrument fits all situations but the instrument chosen must be reliable, 
valid, responsive, practical and previously applied in a sample of elderly patients. With these 
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characteristics only a few instruments can be considered and one of these instruments is the 
Nottingham Health Profile (NHP). 
The Nottingham Health Profile (NHP) was -developed by a team in the department of 
community health at Nottingham University in the late 1970s (McEwen, 1993). The 
Nottingham Health Profile is a questionnaire, which measures the subject's health status in 
38 statements that best reflect problems with health cover six areas; physical mobility (8 
statements), sleep (5 statements), pain (8 statements), emotional reactions (9 statements), 
social isolation (5 statements) and energy level (3 statements). Within each area statements 
have been weighted using Thurstone method of paired comparison. This allows empirical 
judgments to be based on perceived differences (McEwen, 1993). 
The following advantages have been recognized for NHP: 
a. Suitability for wide range of situations from individual clinical interviews to large 
scale postal survey. 
b. Can be self- or interview administered and has been used in postal surbeys. 
c. High reliability and validity. 
d. Short, easy and cheap to use and is highly acceptable to respondents. 
e. Easy to score and compute. Particularly suitable for experimental analysis using the 
Statistical Package for the Social Sciences (SPS S). 
f. Because of the indirect nature of the questions, it is more likely to pick up people who 
are ill or at risk but who do not perceive their problems as being related to health. 
g. Scores provide profiles which differ for different medical conditions. 
h. Can be of use to measure both general perceived health status and for specific 
medical conditions. 
i. Age, sex and social class `norms' are available for comparison. 
j. NHP makes relatively small demands on patients' time 
McDowell and Newell (1987) described the NHP and reviewed the different validation 
studies. The test-retest reliability was performed in studies on patients with arthritis and 
peripheral vascular diseases and it is proved to be of high value (0.75-0.8). 
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The validity of the NHP instrument in measuring the quality of life in elderly patients has 
been evaluated, where construct validity was assessed by observing the power of the scores 
to discriminate between four groups of elderly with different health status (Hunt et al., 1980). 
The first group was composed of 50 physiologically fit men; the second had 28 fit 
participants, the third had 49 subjects suffering from some degree of disability and the fourth 
comprised of 86 chronically ill patients. To overcome the problems of eyesight or failure to 
mark the appropriate boxes, subjects were asked to read the questions while the researcher 
read the statements loudly to them. Statistical analysis of the data showed significant 
difference among the four groups in the six sections of the profile. 
The general Nottingham Health Profile instrument was chosen for this study because it can 
be used to compare the quality of life with different diseases and comparisons can also be 
made with the general population. The application of the instrument in this study involves 
asking the patients to answer 38 questions regarding their health (Appendix III). Subjects are 
asked to judge each statement in a section against every other statement in that section in 
terms of which condition or situation they considered to be worst. The respondent is asked to 
reply "YES" if the general statement applies to his/her current status and "NO" if the 
statement is not true. The scores are weighted and added together within each section to give 
maximum of 100 for any group. A patient who has no health problems on the pain 
dimension, for example, is given an index value of 0 on this dimension, while a patient who 
has all the health problems mentioned on that dimension receives a total of 100. Thus a score 
of 100 means that all the questions within a group were affirmed (McDowell and Newell, 
1987). 
There has been much debate concerning the most accurate tool to be used in assessing quality 
of life. As the patients recruited in this study were suffering from various medical problems 
and were discharged with different prescribed medication, a generic tool would seem the 
most appropriate to assess the quality of life. Due to large variations between the different 
instruments that can be used to measure quality of life (QoL) and variations in the domains 
that each instrument covers, together with the difference in the techniques used to assess 
127 
CHAPTER 2 METHODS Nottingham Health Profile 
reliability and validity of different instruments, comparing these instruments can be quite 
difficult. Also different instruments have different ways of scoring their domains. Of those 
other instrument that could have been adopted in this study and is proven to be reliable and 
valid, is the Short Form Health Survey Questionnaire (SF-36). SF-36 is a self-administered 
generic 36-item instrument which measures eight health concepts that are categorized into 
three major health attributes: 
1. Functional status (i. e. physical functioning, social functioning, role limitations due to 
physical problems, role limitations due to emotional problems). 
2. Well-being (mental health, vitality, bodily pain). 
3. General health perception (an overall evaluation of health). 
It also includes a global evaluation of health. Score for each of the eight health concepts are 
standardized to range from 0 (poorest well-being) to 100 (highest well-being) (Bouchet et al., 
2000). The SF-36 has been widely validated in the English language (McHorney et al,. 
1994). 
Prieto et al. (1997) reported that the SF36 is more reliable than NHP in that the discriminant 
validity of the two instruments was comparable in the cases of patients presenting chronic 
respiratory disease. Others (Essink-Bot et al., 1997) reported that the internal consistency of 
the SF-36 was higher than the NHP scales and the SF-36 exhibited the best ability to 
discriminate between groups. Essink-Bot et al., (1997) also favoured the SF-36 because of its 
psychometric properties when used in health population. The main advantage of the NHP 
over SF-36 for this study was mainly in the ease of administration of NHP where the elderly 
patients need to answer with only YES/NO rather than a 5-point Likert Scale for the SF-36, 
although some (Kind and Carr-Hill, 1987) have criticized the NBP as having lower 
sensitivity to change, probably owing to its use of the binary responses (0 or 1). This 
instrument was not used in the present study due to the difficulties of explaining the 5-point 
Likert scale, i. e., similar to the problems identified in the pilot study for the SIMS (Section 
3.9.4). 
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In the present study and because of the nature of the patients and the use of different 
questionnaires and interviews, it was important to consider only short instruments. Because 
of this, the Sickness Impact Profile (SIP) was not considered although it is proven to be 
reliable, valid, practical and sensitive. SIP may take longer time to complete it and may 
increase the numbers of patients dropping out the study. This was crucial in view of the quite 
lengthy assessment protocol to be employed. This instrument covers 12 aspects (ambulation, 
mobility, body care, social interaction, emotional behaviour, alertness, communication, work, 
sleep/rest, eating, home management and recreation) represented in 136 weighted statements 
describing behaviours related to health. 
The SIP was developed in the USA with similar objectives to the NHP to provide a broad 
measure of self-assessed health-related behaviour. Unlike the NHP the SIP asks the 
respondent to make a judgement as to whether a problem is health-related. This may be 
difficult for elderly people uncertain of the distribution between effects of ill health and 
"natural" consequences of aging. The advantage of the SIP is that it is comprehensive and 
includes dimensions especially relevant to elderly people in the community (Fletcher et al., 
1992). 
Another instrument used previously in this field is the Southampton Self-esteem Scale (SES). 
There is insufficient experience with this instrument at present and especially relating to 
responsiveness to change. Life Satisfaction Index (LSIA) is another instrument developed in 
the USA and it has been extensively used in elderly populations. The main disadvantage of 
this tool is the number of variants of the scale, the overall face validity of the questionnaire as 
an evaluation instrument and the lack of responsiveness to change in randomized trials. Both 
instruments are unidimensional subjective tools (Fletcher et aL, 1992). It would be of interest 
to assign a study to identify the most suitable tool for the elderly chronically ill population. 
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2.2.4 Patient Knowledge Questionnaire 
The general area of attempting to improve and assess compliance and drug knowledge was 
discussed in chapter 1. An essential part of the present study is to attempt to improve patient 
compliance and drug knowledge; thus it was important to determine the patient knowledge 
baseline during his/her hospital stay and before receiving any counselling sessions. 
A structured verbal questionnaire was used to elicit information about medications. Wherever 
possible all medications held by the patient at the time of the visit were inspected, including 
those prescribed before hospital admission if available and those obtained from the general 
practitioner after discharge, together with any OTC products. The prescription issued on 
discharge and the medicines actually being taken by the patient at home after discharge were 
compared. 
There is no one universally recognized and validated form or questionnaire available for 
assessing patients' knowledge about their medication. Studies involving the assessment of 
medication knowledge have been fully discussed in sections 1.4 and 1.5. It was concluded 
that no well-validated questionnaire exists and each appears to be individualized for the 
purpose of that particular study. The aim of this study was to measure the change 
(improvement or decline) in patients' knowledge rather than measuring the absolute patients' 
knowledge. For this purpose it was important to use a questionnaire which is capable of 
covering the most important areas of information. 
After identifying the potential candidates, all the patients were interviewed to elicit patients 
understanding of their medication regimen including names, purposes, shapes, colour, 
strength, doses, dosage frequencies, administration time, duration of treatment, special 
instructions and side effects for each of the prescribed he/she was taking at the time of 
admission. The questions in the structured questionnaire used to assess patient's 
understanding of the purpose of their medication, were based on one used in a previous study 
(Ryan and Chambers, 2000) which appeared to cover the most important points. The 
questionnaire used is composed of 29 questions as shown in Appendix IV. The accuracy of 
the information was assessed by comparing the details provided by the patients with the 
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information supplied by the hospital or from the information printed on the container labels if 
available as well as TTO transcripts. 
A further reason for adopting the questionnaire was that it is one of the few tools where at 
least some validation of content has been attempted (Ryan and Chambers, 2000), where the 
researcher conducted a study to evaluate the effectiveness of an individualized education 
programmed on the knowledge of older patients regarding prescribed medication. This 
questionnaire was piloted on 15 patients in an Assessment and Rehabilitation Unit in 
Northern Ireland. Before applying this questionnaire on the actual patients, content validation 
was conducted by sending six copies to six experts in this field. Five experts replied back 
with some recommendations for revision suggesting that the questionnaire can be used as a 
valid tool to measure patient's medication knowledge. The questionnaire was also initially 
piloted on five patients which resulted in further minor changes to the structure and the 
wording of the questionnaire. The questionnaire used in the present study was piloted on ten 
patients and again only minor changes in the formatting and wording were required, for 
instance, patients found it difficult to understand the term "contra-indication". 
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225 Patients Compliance and Tablet Count 
Compliance was defined as "patient's adherence to directions on the prescription container 
label'. When the patients do not take the medication as prescribed, the behaviour was 
considered non-compliant (Wolfe and Schirm, 1992). 
Tablet count is the traditional method for assessing compliance and one of the easiest to 
arrange. Tablet counts have for many years been the `Gold Standard' by which compliance 
levels have been measured and usually involve the counting of dosage units left in the 
container after a certain period of time following dispensing. The compliance percentage is 
then defined as a percentage ofthe prescribed medication intended: 
% Compliance= Number dispensed-Number Remaining x100 
Number that should have been taken 
Tablet counts can provide a measure of patient compliance and are accomplished by 
requesting the patient to bring their medication containers with them to their next 
appointment or show all the medication they keep at home during a domiciliary visit. Some 
researchers have also found it more desirable to contact the patient by telephone in their 
home and ask them to count the remaining tablets or capsules in the container. 
The main advantages of using this technique are: 
a. Simple, cheap and easy to apply. 
b. Suitability for patients on various and numerous medications. 
c. Makes relatively small demands on patients' time. 
d. Provides quantitative results which can be used for further comparisons. 
e. It allows compliance to be tested without the patients being aware that they 
were under close observation. 
The widely used tablet count method (or more accurately a dosage unit count) has a number 
of well-recognized potential defects: 
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a. Dumping: Although tablets may have been removed from the container, they 
may not have been administered and disposed or hidden from the investigator 
before the next assessment. 
b. Tablet counts give little impression of timing of doses or drug-free intervals. To 
overcome this problem, patients should not be supplied with the precise number 
of doses needed but with excess number of tablets (Raynor, 1992). 
c. Drift in therapy: If tablet counts are performed at monthly or longer intervals, 
there may have been periods when compliance was very low and others where it 
was very high or even excessive. Tablet counts only measure whether the 
correct number of tablets has been taken, and do not measure compliance with 
dose or dose frequency. The patient could always underdose and then overdose, 
yet appear to be compliant. 
d. Time consuming process and may rely on patients bringing back their tablets. 
e. Results may be confused if medication is obtained from more than one source 
e. g., GP and hospital. 
f. Mislaid or forgotten bottles, which may actually have been deliberately left 
behind by the patient before the visit. Visiting patients at home would minimize 
the numbers of bottles not available for counting and the counting process is 
best performed in the patient's own home where all supplies can be located and 
accounted for. Even in this situation there is a possibility of patients not 
disclosing all supplies. 
The Drifts in therapy have been described in one study (Rudd et al., 1990) involving weekly 
tablets counts with hypertensive patients. Although the mean rate of compliance over the 
twelve-week study period approached 100%, there was considerable inter- and intra- subject 
variability in the weekly counts, which seemed consistent with `tablet' dumping. Similar 
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drifts in compliance have been detected for tuberculosis therapy and treatment of urinary 
tract infections (Cheung et al., 1988a). 
Despite these drawbacks, many estimates of extent of compliance come from tablet counts 
(Raynor, 1992). Pearson (1982), stated in a review of methods for assessing compliance, 
while concluding that no method is completely effective "though the corollary does not 
necessarily hold true, one single fact remains a beacon: if the tablets are in the bottle, they 
are not in the patient". He concluded that tablet counts were useful, providing their 
limitations were recognized. Tablet counts correlate well with other methods of 
measurement. It is probably the most appropriate quantitative method of measuring 
compliance in patients taking several drugs (Raynor et al., 1993) 
To assess the effect of patient counselling on their compliance, tablet counting was used i. e. 
the percentage of prescribed doses, which were actually taken. A tablet count was used in 
this study as it is the only practical method when large numbers of patients taking a wide 
variety of medicines are investigated. Compliance assessed by the tablet count is based on 
the assumption that all the tablets were taken from the containers and none other were 
consumed by the patients and none given to someone else. The dosage units of each item 
dispensed were obtained from the label on the container if applicable and comparing it with 
the patient's copy of the TTO. 
An alternative method to estimate patients adherence is the self-reporting questionnaire e. g., 
Medication Adherence Report Scale MARS. Although this tool has been proven to be a 
reliable and valid method to assess patient's medication taking behaviour, it was not the most 
suitable technique to be employed in this study for various reasons: 
a. Time consuming for both the investigator and the patients. 
b. Quite subjective in nature. 
c. Patients normally overestimate their adherence to their medication. 
d. Elderly patients are often taking a large number of medications and it would be 
too time consuming to estimate each one. 
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Other questionnaire methods of assessing compliance are not well-validated. The electronic 
methods of compliance assessment were not within the resources of this study and would 
also not be practical for monitoring larger numbers of medicines in each patient. Likewise, 
blood level monitoring would not have been practical. Prescription refill monitoring is not a 
useful method in this situation where compliance needed to be assessed two weeks after 
reviewing discharge medication. 
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Z. Z. 6 Patient Satisfaction 
Providing patients with information about their prescribed medicines (e. g., instructions for 
use, dose, route of administration, precautions, side effects and details of action to be taken in 
the event of wrong doses or accidental overuse) is essential to facilitate their appropriate use 
and an understanding of the likely benefits and risks (Baker et al., 1991). 
Patient information is an essential component of any effective treatment for chronic diseases. 
An important outcome of the effective medication education process is the extent to which 
the individual's needs have been met and they are satisfied with the information has been 
provided. It is important that the patient be satisfied with the information as it can be an 
indicator for quality of care. Assessing patients' satisfaction with the amount of medication 
information provided is one of the requirements for partnership in the use of medication (The 
Royal Pharmaceutical Society, 1997). Moreover, identifying the reasons behind patients 
dissatisfaction provides a key for interventions designed to tailor information provision 
schemes according to individual needs (Ali and Hone, 1996). 
Although a certain minimum level of basic information is required by all the patients (e. g., 
how to take the medicine), the absolute amount required will vary from patient to patient and 
from case to case. Patient reaction towards the information provided can also vary greatly. 
While some patients may be actively involved with the treatment process and seek detailed 
information about different aspects such as the possible side effects of their medicines, others 
will carefully respond, trying not to think about their illnesses and depending on carers to 
take the charge, finding additional information unhelpful or even confusing (Weinman, 
1990). Providing patients with written information in a standardised form does not mean that 
the patient will follow the instructions of use the medication in the most appropriate way 
(Peveler et al., 1999), as ideally the provision of information should be tailored to meet the 
needs and requirements of the patient. 
One study conducted in South Thames (Ali and Home, 1996) used a validated questionnaire 
known as the `Satisfaction with Medicines Information Scale' (SIMS) to evaluate patients' 
perceptions of whether they have received sufficient information concerning the various 
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criteria that cover patient's needs. The SIMS questionnaire offers a novel method for 
measuring the degree to which the patient's information needs have been met. This scale can 
be used to identify the quality of information about medicines which needed to be provided 
to the patient. The SIMS could also be used to report patients satisfaction with the 
information they have received as part of their routine care and to identify improvement 
targets (Home et al., 2001b). 
The SIMS can be considered as a valid and reliable tool for investigating the effect of 
interventions on satisfaction levels with information provided about medicines. Both in and 
outpatients were recruited from hospitals in London and Brighton to assess the SIMS validity 
and reliability. Criterion related validity of SIMS was performed in terms of relationships 
between scores on the SIMS and existing self-report measures of adherence called the 
Medication Adherence Report Scale (M RSA and patient beliefs about medicines (the Beliefs 
about Medicines Questionnaire (BMQ)) using Pearson correlation. The scale demonstrated 
acceptable internal consistency among patients from a variety of diagnostic categories 
(Cronbach's alpha was calculated and found to range from 0.61-0.91). Test-retest reliability 
was satisfactory in most of the groups tested. The acceptability of the tool was proven to be 
as high as 81% of respondents (Horne et al., 2001b). 
The SIMS has other advantages relevant to this study: 
" It is broadly predicts self-reported adherence. 
It is simple, quick to administer and easy to record the finding. 
Individual variations between patients' own views about the medication information they 
have received were considered when this scale was designed, rather than measuring the 
absolute value or quality of that information. This can help prescribers in tailoring individual 
education sessions that meet the needs of the every patient. SIMS is not just a research tool 
and the developers have suggested that it can be used in practice to identify the patients' 
information needs. Patient's level of dissatisfaction with the information can also be 
measured and addressed (Home et a7., 2001 b). 
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The SIMS consists of 17 items dealing with different types of medicines information that 
patients should receive to improve medication-taking behaviour. Each item is phrased in the 
form of a question that a patient might typically ask about their medication, e. g., How to use 
it; for how long will I need to take this; what to do if I forget to miss a dose; what are the 
common side-effects. 
Patients are asked to rate the amount of information they have received about each item on a 
five-point Likert type scale: none needed, about right, too much, too little, none received. 
The responses can be analysed in various ways. One way is using a total satisfaction rating 
that is calculated by summing the scores for all the items. When patients express satisfaction 
with the information covering a particular medication criteria, they are given a score of 1 i. e., 
with a rating of `about right' or `none needed'. If the patient is dissatisfied with the amount 
of information received i. e., with a rating of `too much', `too little' or `none received', this is 
given a score of zero. Scores range from 0 to 17, with high scores indicating a high degree of 
total satisfaction with the amount of medication information received. Another way of 
analyzing the score is calculating two sub-scale scores that includes identifying patients' 
satisfaction with information about the action and usage of medication (items 1-9), and the 
potential problems of medication (items 10-17). The final method is a detailed medicine 
information profile, which can be performed by examining the ratings for each individual 
item, to identify individual information that needed (Horne et al., 2001b). 
Other instruments to measure satisfaction have been developed and tested. A self-assessment 
questionnaire was developed specifically for a study by Haggmark et al. (2001) in order to 
test the efficacy of various information inputs among three different groups receiving 
radiotherapy: standard information plus group and repeated individual information, standard 
information plus brochure, and standard information only. Visual analogue scales were used 
to allow the patients to describe on a 0-100mm line, their satisfaction with the information 
ranging from "not at all satisfied" to "completely satisfied". This instrument was composed 
of seven questions concerning satisfaction with information concerning radiotherapy. 
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The SIMS has been used in its entirety for this project (Appendix V). The total score rating 
will be adopted as the most reasonable way of analyzing the patients' answers as all the 
patients were taking more than one medication and it would be difficult to calculate the score 
for each individual medicine. 
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2.2.7 Classification of Medication Related Problems 
Two different classification systems were used to categorize the different medication-related 
problems reported in this study. The PCNE system was chosen because of its ability to 
classify the problems, their causes and the interventions performed to solve the identified 
problems. Also, this system is more detailed in pinpointing a broad range of problems due to 
large numbers of sub-categories included in this system. The PCNE system cannot assess the 
problems according to the degree of severity. Also, some of the identified problems did not 
have direct clinical impact on the patients and could not be classified according to a severity 
scale or even according to the PCNE system. That is why the second system was chosen, 
because of its ability to rate the identified problems according to the degree of the severity or 
according to the source of the problems whether clinical or non-clinical in origin. 
2.2.7.1 PCNE System 
This system was originally created in 1999 by the pharmacy practice researchers during a 
work conference of the Pharmaceutical Care Network Europe (PCNE) in a trial to develop 
and standardize a comprehensive and useable classification system. This system has an 
advantage over other existing systems that it separates the problems from the causes and the 
interventions. The following definition of MRPs is the basis on which this classification was 
designed: "being potentially harmful to the patient's health or which may prevent the patient 
from achieving the full therapeutic effect of the drug used" (Schaefer, 2002). The validation 
of this scheme focused on the following criteria: internal consistency, content and construct 
validity, inter-rater reliability, and the usability in research and practice settings. Construct 
validation of this system was performed by handing the standardised questionnaire to 
different research centers in different countries. Completed forms were returned to the 
national research centre where data was analysed. Reliability of the system was assessed 
using inter-rater reliability, internal consistency and international reliability. The system was 
well received by different users proving its practicality (Van M'iI, 2001). 
Classification system version 1.2 was adopted and adjusted (following PCNE approval) for 
the pilot intervention of pharmacy based disease management programme (DM) in Portugal. 
Version 3 appeared in 2002 on the intemet after a revision by experts from different 
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countries. Version 4 was first published in 2003 on the internet again after it had been 
validated in Portugal, Northern Ireland and Malta. The current version is V5 is compatible 
with previous versions although new items have been added. 
The basic classification has six primary domains for problems (Appendix VI), six primary 
domains for causes (Appendix VII) and five primary domains for interventions (Appendix 
VIII). Each problem should be coded separately, but there may be more than one cause or 
intervention related to the same problem (PCNE website). 
PCNE system depends mainly on classifying the MRPs of clinical effect rather than any 
service related effect, and because of the inability of this system to measure the severity of 
the identified MRPs, the following system is adopted to overcome these two problems. 
2.2.7 
.2 
Medicine or Service Related Problems Classification System 
This classification is a novel system inspired from another classification used in a study 
carried out by Dean and Barber (1999) and Gordon et al. (1999). This classification divides 
MRPs into two major classes; those with medicine-related effects and those with services- 
related effects. Each class is divided into various subclasses. Each subclass is given a score 
which will be used to weigh the MRPs quantitatively. 
I. MRPs with Medicine-Related Effect on the Patient 
This class is divided into three categories; minor, Moderate, and severe. 
a. Minor: 
Definition: Very unlikely to have any adverse effects. 
Score -71 
This category includes all the MRPs that may be threatening patient's care with little effect, 
self-limiting, can be avoided by dose or regimen modification or by admixing another 
medication. Any problem belonging to this class is given a score of one (e. g., constipation 
caused by DHC or cold Extremities with Atenolol). 
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b. Moderate: 
Definition: Likely to cause some adverse effects or may interfere with the therapeutic goal of 
the regimen but very unlikely to result in death or long-lasting impairment or patient's 
hospitalization. 
Score=2 
This category includes all the MRPs that may be threatening patient's care but it is not life 
threatening, persistent, may need to stop that medication and to use an alternative medication. 
It may affect patient's compliance or affect the patient's quality of life. Any problem 
belonging to this class will be a given a score of two (e. g., nausea and vomiting caused by 
Digoxin, diarrhoea caused by many medicines). 
c. Severe 
Definition: Likely to cause death or long-lasting impairment or patient's hospitalization. 
Score=3 
This category includes all the MRPs that may be threatening patient's life, may cause 
hospital readmission, or long-term effect on clinical efficacy. Any problem belonging to this 
class is given a score of three (e. g., using NSAID with a history of peptic ulcer, or using 
Metformin in renal impairment or bleeding caused by Warfarin). 
II. MRPs with Service-Related Origin 
There is a potential problem but it is not affecting the patient's quality of life. This class is 
divided into seven categories. 
a. Polypharmacy: This includes all patients' concerns or confusion because of using many 
medicines. 
b. Interface Issues: this includes all the problems regarding the transfer of the information 
between the secondary and the primary care, with consequences of mistakes in medications 
142 
CHAPTER 2 METHODS Classification of Mediation Related Problems 
to be prescribed in the community (e. g., repeating old medications being discontinued in the 
hospital or not re-prescribing newly prescribed medicines during the hospital stay). 
c. Patient Knowledge: This covers all the problems related to patient knowledge or 
information regarding their medication which may affect their medication-taking behaviour 
(e. g., taking medicines before or after food. ) 
d. Physical Difficulties: This covers all the difficulties in opening bottles, swallowing the 
tablets or getting the tablets out of the strips, reading the label or using the inhalers. 
e. Mistakes in the Labels: Discrepancies in the instructions written on the medicines 
containers or bottles or unclear instruction. 
f. Compliance and Memory Problems: Forgetfulness which may lead to either under or over 
usage of the medication (non-intentional compliance). Also this includes the possibility of 
intentional non-compliance. 
g. Storage Problems: Poor storage conditions (e. g., keeping the medicines under the sink, or 
mixing all the strips of one medicine in one box, or taking all the tablets from the strips and 
putting it in one bottle). 
Each problem which was categorised under any of the above classes in the service-related 
category was given a score of 1. Each problem was given a code which describing the class 
and the subclass. This code is composed of a roman number representing the main category 
(I. represents medicine-related category and II. Represents service-related) and this roman 
number is coupled with another English letter which represents the subclass e. g., (la. ) 
represents minor medicine-related problem and (Ilb) represents interface service-related 
problem. Some problems can be given more than one code e. g., taking Aspirin on an empty 
can be considered as a moderate problem (Ib) and at the same time it can be considered as a 
knowledge problem (Ile). This simple method of classification was developed to have a 
quantitative measure to compare the effect of the discharge and follow-up scheme on 
minimizing the incidence of the MRPs. 
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As this is a novel model, it has not been validated previously and the reliability of this system 
was assessed by peer review. A case summary was written for each patient describing all the 
MI2Ps identified (Appendix IX). An electronic copy of these case summaries was given to 
the main supervisor (LG) who was invited to assess and rate the significance of the MRPs as 
identified for each case and give each problem a code using the above coding system. The 
second rater (LG) was completely unaware of the allocation of the patients to the two groups. 








This chapter describes the preliminary fieldwork that contributed to the development of the 
protocol of the main study. Part of this work took place in the four wards of the Elderly Care 
Unit in St. Thomas' Hospital, London and the other part took place in the area covered by 
Lambeth, Southwark and Lewisham (LSL) primary care trust. This scoping study was 
undertaken to provide baseline data concerning the current provision of discharge services. 
The researcher was an Egyptian qualified pharmacist who had recently finished her MSc. 
The undergraduate curriculum at her University contained little clinical pharmacy. 
Furthermore, clinical pharmacy is not widely practised and the healthcare system is very 
different in the primary/secondary care setting. The researcher therefore undertook clinical 
pharmacy training by attending relevant modules in the subject at King's College London. 
Intervention of some of the fieldwork described below was to help familiarize the researcher 
with the UK NHS system, particularly as it related to hospital discharge. 
3.2 Aims 
One aim of this preliminary fieldwork was to familiarize the researcher with the UK system 
regarding hospital discharge, the services provided, the various professions involved and the 
transfer of the service across the primary/secondary care interface. 
3.3 Objectives 
The main objectives of this preliminary fieldwork are: 
1. To familiarize the investigator with the local discharge system and issues related to 
discharge medication and identify the current situation regarding patient discharge 
system at St. Thomas' Hospital, London. 
2. To examine the range of medication-related problems presented to healthcare 
professionals concerning the hospital discharge of elderly patients. 
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3. To validate the investigator's ability to perform patient's counselling and deliver the 
required information. 
3.4 Research Tools used in the Preliminary Fieldwork 
Non-structured interviews were used to examine number of issues relating to the elderly 
patients, their hospital discharge and medicines. These interviews allowed the interviewees to 
freely express their views under the guidance of the interviewer. It was unnecessary to use 
structured or in-depth interview since greater detail was not required at this stage. This was 
not constructed as a true qualitative study, but simply a broad scoping exercise. 
3.5 Survey of the Current Discharge Processes at St. Thomas' Hospital 
Patients who are discharged from hospital may reasonably be expected to use their medicines 
most effectively if they are given information about the purpose of drug treatment and the 
anticipated benefits. To manage their medication supplies correctly they may also need 
information and advice about the anticipated duration of treatment, the source of continuing 
supply, the storage of medicines and disposal of unwanted medication (Cantrill and Clark, 
1992). For the purposes of the current study, it was important to identify any patient 
medication counselling service offered to patients on discharge from St. Thomas' hospital. 
3.5.1 Aim 
The aim of this survey is to explore the discharge services provided by the ward pharmacists 
at St. Thomas' Hospital. 
3. S. 2 Method 
The project investigator carried out this survey in the four elderly care wards in St. Thomas' 
Hospital. Because the data required was related to the services that the ward pharmacists 
should normally provide to their patients during the process of hospital discharge, they were 
not informed about the actual aim of the project. They were only informed that the project is 
concerned with the general discharging procedures carried out in the wards. 
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Collecting the data for this survey depended upon joining (observation study) one of the 
elderly care ward pharmacists or one of the MATeam (Medical Advice Team) while 
preparing the patient for hospital discharge and observing them collecting and checking the 
To Take Out (TTOs) medication forms as well as observing any counselling sessions with 
the patients. Pharmacists varied in their grades from C-grade to basic grade pharmacists. Part 
of this survey involved monitoring any counselling was performed by any of the nursing staff 
when this was feasible. 
The investigator maintained list of patients for whom a discharge date had been arranged. All 
the relevant demographic data (name, age, gender, allergy status, date of admission, address, 
name of GP, address of GP, reasons for admission, past medical history, drug history and 
date of discharge) was noted, in addition to details of all medication on the drug chart prior to 
discharge. After the ward pharmacist revised the TTO prescriptions for certain patients, four 
copies were printed out; one to be kept in the ward and filed in the patient's note, the second 
to be sent to the pharmacy, the third to be sent to patient's GP, and the last copy was given to 
the investigator. From this copy of the TTO the investigator listed all the medicines for 
discharge and compared them with those written in the patient's drug chart. After collecting 
all this data and after the medicines had been dispensed, the investigator joined the 
pharmacist during the medicine counselling sessions given to the patient. During these 
sessions, the investigator took notes on the information provided to the patients (name of the 
medicines, strengths, doses, side effects, special instructions and if there was any new 
medicine prescribed) and also the time the pharmacist spent with each patient during the 
counselling sessions was recorded. 
3.5.3 Findings 
This survey was conducted in a period of three months from May 2001 till August of the 
same year and it took place in the four wards of the Elderly Care Unit in St. Thomas' 
Hospital, London. 
Several techniques can be used to estimate the extent of patient counselling including: self- 
completion questionnaires, diaries and direct observation. Direct observation being used in 
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this pilot work as it is considered the most reliable method. The main advantage of this 
method is that it allows the investigators to `see for themselves' which overcomes any bias 
can be precipitated in the self-reported questionnaires. This method may also give the 
investigator the chance to discover any "behaviours or routines of which the participants 
themselves may not be aware". The weakness of this technique is that the presence of the 
investigator may influence the participants' behaviour i. e., encouraging them to perform 
more counselling (Aslanpour and Smith, 1997), sometimes referred to as the `Hawthorne 
Effect'. 
There were usually two pharmacists in the elderly care wards, a C-grade pharmacist and a 
basic grade pharmacist as well as occasionally a pre-registration student. The investigator 
was not able to monitor all the patients who were prepared for discharging as each 
pharmacist could potentially be involved at the same time. Also, due to the unplanned 
discharge, only half of those actually discharged were monitored by the investigator. This 
was in addition to those TTOs being prepared by the Medical Advice Team (MATeam) 
which is a team consists of C-grade pharmacist, basic grade pharmacist and a pharmacy 
technician. This team is responsible for any unplanned or delayed discharge taking place 
after 2: 30pm. 
Fifty five patients were monitored from a total of 90 who were discharged during the period 
of the survey. Out of those 55 patients, 37 (67.3%) were females. The mean length of their 
hospital stay was 29.84 (S. D=34.9) days with a range of 2-134 days, and the mean age was 
82.02 years (S. D=8.78) with a range of 68-96 years. Although this survey was conducted in 
the elderly care unit there was one patient included in this survey aged 46 years who was 
admitted to the stroke unit which is one of the elderly care units. 
Table 3.1 indicates the various destinations of patients following their discharge, from which 
it was noticed that more than half of the patients went to their own homes. The rest were 
discharged to other places, including nursing homes, residential homes, community centers 
or another hospital. 
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Table 3.1 Destinations ofpatients discharged from the hospital during the general survey 
Destination Home 
Nursing Residential Community Others Unknown Total 
Home Home Center 
No. of Patients (%) 32(58) 11(20) 1(1.8) 1(1.8) 1(1.8) 9(16.4) 55 
The investigator listed the various medical problems patients suffered before admission. 
Table 3.2 describes the different medical problems for which patients were receiving 
prescribed medication. The medical problems were categorized into seven major groups as 
shown in the table and most patients suffered from more than one medical problem. The most 
common reason for the hospital admission were falls. 
Table 3.2 Frequencies and percents of the most commonly diagnosed medical problems 
among elderly patients in the elderly care unit in St. Thomas'hospital (N= 55) 
Disease No. of patients (%) 
Cardiovascular Problems 44(80.1) 




Respirator Problem 11(19.9) 
COPD2 7(12.7) 
Other respiratory diseases 4(7.2) 
Infections 21(38.4) 
UT3 9(16.4) 
Chest Infection 7(12.9) 
Other Infectious Diseases 5(9.1) 
Musculoskeletal Problems 14(25.5) 
RA4 6(10.9) 
OAS 5(9.1) 
Central Nervous Problems 18(32.7) 
Confusion 7(12.7) 
Other Central Nervous Diseases 11(20) 
Endocrinological Problems 13(23.6) 
Diabetes 7(12.7) 
I CVA= Cerebrovascular Accident 
2 COPD= Chronic Obstructive Pulmonary Diseases 
3 UTI= Urinary Tract Infections 
4 RA= Rheumatoid Arthritis 
5 OA= Osteoarthritis 
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Disease No. of patients (%) 




The patients left the hospital with an average number of 5.8 (S. D=2.9) medicines per patient, 
ranging from 1 medicine to 14 medicines. The 319 medicines were classified into thirteen 
major classes according to the British National Formulary (BNF) as shown in table 3.3. The 
most commonly prescribed medicines for elderly patients were anticoagulants and 
antiplatelets. 
Table 3.3 Percentage distribution of medicines dispensed as TTOs (N=319) 
Medicine Class No. (%) 
Gastrointestinal System 
Laxatives 32(10) 
Proton Pump Inhibitors 15(4.7) 
Other gastro-intestinal medicines 3(0.9) 
Cardiovascular System 
Diuretics 17(5.3) 
Beta blockers 6(1.8) 
Drugs affecting rennin-angiotensin systems 7(2.2) 
Nitrates 9(2.8) 
Calcium channel blockers 9(2.8) 




Other respiratory medicines 8(2.5) 
Central Nervous System 
Hypnotics 7(2.2) 
Antipsychotics 5(1.6) 
Antidepressant drugs 9(2.8) 
Non Opioid Analgesics 20(6.3) 
Opioid Analgesics 7(2.2) 
Antiepileptics & Antiparkinsonism 7(2.2) 
Infections 
Antibiotics and other anti-infection drugs 8(2.5) 
Antidiabetics 8(2.5) 
Other endocrine medicines 11(3.5) 
Gynaecology & Urinary Tract 5(1.6) 
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Medicine Class No. (%) 
Musculoskeletal and Joints 5(1.6) 
Nutrition & Blood 
Vitamin D 16(5.0) 
Other Vitamins 9(2.8) 
Antianaemic medicines 6(1.9) 
Food 6(1.9) 
Others 29(9.1) 
Eye Medicines 6(1.9) 
Of the 55 patients discharged from the elderly care wards during this survey, 27 patients 
(49.1%) were counselled with an average time of 2.05 (S. D=3.12) minutes spent in 
counselling, 17 patients did not have any cognitive problems (as reported in patients' notes) 
and in spite of that they were not counselled before their hospital discharge. One patient was 
Turkish and did not speak English. Most of the medication counselling was carried out by 
one of the ward pharmacists or by one of the MATeam pharmacists, who generally prepare 
the TTOs for unplanned discharge. A minority of the counselling sessions were performed by 
the ward nurses (2 out of 55 patients were counselled by the nurses). 
Table 3.4 Information provided to the patients during counselling sessions (N=27) 
Information 
Number of Patients (%) 
All Medicines Some Medicine 
Names of medicines 5 (18.5) 17 (63.0) 
Purposes of medicines 4 (14.8) 18 (66.6) 
Doses of medicines 19 (70.4) 6 (22.2) 
New medicines prescribed 9 (33.3) 5 (18.5) 
Side effects - 1(3.7) 
Among the counselled patients only 14% were offered an explanation about the purpose of 
the medication they were taking and 18.5% were verbally told the names of all the 
medications. The majority of the counselled patients (70%) were informed about the doses 
and frequencies. Thirty four (61.8%) patients out of the 55 were prescribed new medicines to 
take home and only 14 (51.9%) were informed that these medications were new. 
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Regarding the communication between the hospital (secondary care) and the community 
(primary care), a copy of the TTO with a case summary should be normally sent to the GP 
after hospital discharge by post. This copy is normally posted by the ward clerk and the time 
of sending depends on the clerk's work load. Communication with the community 
pharmacist is not part of the routine hospital discharge scheme and this fact was confirmed 
by the ward pharmacists. 
During this survey, three basic grade pharmacists (two were males) in addition to the C-grade 
pharmacist (female) shared in preparing the patients for the discharge process. The 
investigator noticed great variation in the activities between the different pharmacists who 
carried out the counselling sessions during this period of time. They varied in the amount and 
the type of information they provided and the time they spent with the patients. The 
investigator noticed that the female pharmacists were much keener to carry out the 
counselling and to dedicate extra time to the patients. It was also observed that the ward 
pharmacists were involved in more than one task (patients' admissions, clinical rounds, 
patients' discharges and/or MATeam) at the same time, which was a barrier for some of them 
to give sufficient time for patient counselling. Members of the MATeam generally had less 
time to spend with the patients as they had to prepare more than one patient from different 
wards for discharge at the same time. 
Below are three examples of the counselling sessions, which took place between ward 
pharmacists, and some patients before their hospital discharge; all the data and dialogues 
were recorded by the investigator during this survey. These examples indicate the somewhat 
superficial nature of these sessions. 
Patient 41 
Age: 82 years. 
TTO: 
Aspirin 75mg OD 
Becotide Inh. 100 mcg 2 Puffs BD 
Amlodipine 5mg OD 
Salbutamol Inh. I00mcg 2 Puffs QDS 
Information provided by the pharmacist: 
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"Hi, have you gotyour inhalers? 
If you use this inhaler regularly, it won't relieve the attack but it will prevent the 
attack. 
These tablets are for your blood pressure, take it for ten days, and then stop it' 
The patient brought her own Amlodipine with her but it was in a different package to that 
provided by the pharmacist, so the pharmacist said: "This is the same as yours but in 
different package, it is the same & the same dose as yours". 
It is clear from the example mentioned above that, inhaler technique counselling was not 
checked before leaving the hospital. Also, the pharmacist relied on the fact that the patient 
had been taking all these medications before her admission and assumed that the patient was 
aware of the important details regarding her medicines. 
Patient 45 
Age: 95 years. 
TTO: 
Lansoprazole 15mg PD/OD 
Ferrous Sulphate 200mg PO/OD 
Pharmacist put the medication in patient's locker and no counselling was performed. It is 
very clear from this example that the patient did not receive any sort of medication 
counselling by the ward pharmacist, although the patient did not suffer from any cognitive 
problems and was totally independent. 
Patient 52 
Age: 87 years. 
TTO: 
Aspirin 75mg OD 
ISMN 60mg OD 
Frusemide 40mg OD 
Amlodipine 10mg OD 
Zopiclone 3.75mg NOCT. 
Amiodarone 100mg OD 
Adcal D3 2 tab OD 
Information provided by the pharmacist: 
"You've got fresh supply of everything except the Amlodipine as you have it at 
home as 10mg tablets which we don't have here, so you took your 10mg tablet this 
morning & from tomorrow use what you have at home 
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This is your water tabletfor your heart. 
Calcichew is being switched to Adcal D3 both are the same & no differences 
Zopiclone we don't have it in the hospital so make sure that you have it' 
It is clear from this example that neither the doses nor frequencies or the reasons for taking 
those medicines were mentioned to the patient before going home. 
3.5.4 Conclusion 
From all the findings above and from the provided examples, there appears to be no 
structured patient counselling taking place in the elderly care wards in St. Thomas' Hospital. 
Insufficient time was allocated to provide enough information about each medicine a patient 
would be taking and realistically speaking, the 2 minutes on average is unlikely to achieve 
anything other than very superficial information exchange. More time should be spent with 
each patient to examine his/her abilities to open bottles and to take the tablets or the capsules 
out of the blisters or to use the inhalers properly. Patients also should be given the chance to 
ask questions and to query anything they do not understand and express their concerns 
regarding their medication. Also, from the informal discussions with nursing and pharmacy 
staff, it appeared that little formal patient medication education was undertaken during the 
patient's stay in the hospital. Finally, there was an obvious lack of communication between 
the hospital and the community pharmacists for sharing any information regarding the 
patient's medicines. 
It was clear to the investigator that there was a great variation between the different 
pharmacists carried out the discharging processes, and these variations depended mainly on 
the availability of the staff and also on their enthusiasm. 
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3.6 Survey of the Opinions of the Healthcare Professionals 
The second part of this preliminary scoping survey examines opinions of healthcare workers 
concerning seamless care related to medication and transfer of the information between 
primary and secondary care. 
3.6.1 Aim 
To identify some of the problems that may face the healthcare professionals in the 
community concerning the medication of patients following hospital discharge 
3.6.2 Method and Findings 
Informal appointments were arranged with a community pharmacist, members of the 
Lambeth practice group team, a district nurse and a member of the delayed discharge team in 
Guys & St. Thomas' Hospital, London. Opinions of these healthcare members were obtained 
through open non-structured interviews. The interviews began by one simple question: "what 
are the major problems you may face concerning discharge medication after patients leave 
the hospital? " and then asking them what would they suggest to overcome these problems 
from their point of view. During these interviews all the responses were reported by hand. 
The interviews were not audio-taped. 
Poor communication between the primary and the secondary care professionals was the 
major problem the community pharmacist faced during his career: "lack of communication 
between the hospital and community pharmacies represents the major problem, it is very 
useful to send a copy of the TTO to the community pharmacist to be aware of any changes 
that may occur to my customers, especially the regular customers and I keep a medical 
record for them': He also mentioned the importance of informing the patient of any new 
medications they are taking or any changes in their regimen and providing them with written 
materials supporting this information "The hospital can give a copy of the TTO to the 
patient to be aware of any changes that may occur to their medications". 
Members of Lambeth Practice Group agreed that the major problem is the poor 
communication between the primary and secondary healthcare members and the lack of 
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information provided to the primary care team "consultants do not describe in their letters 
why they made those changes in the patient's medications and whether the new medication 
is to be continued or not!!! ' 
When the district nurse was asked to give her opinion concerning the problems she observed 
during the visits to her patients after their hospital discharge, she commented on the lack of 
complete information provided to the patients or their carers about their medicines. Also, the 
lack of communication between primary care and the secondary care was another problem, 
from her point of view, which she used to face every time the patient leaves the hospital "we 
hardly receive complete information concerning patients' medication and the changes 
occurred to them during their hospital stay' 
Finally the members of the delayed discharge team in Guy's hospital commented that one of 
the main problems after the hospital discharge is lack of the information provided to the 
patients prior to hospital discharge. 
3.6.3 Conclusion 
After meeting these professionals and discussing the problems they face after patients are 
discharged from hospital, the following can be concluded: 
a. Patients leave hospital with insufficient information regarding their medication. 
b. There is a lack of communication between primary care (GPs mainly) and secondary 
care professionals due to delay in sending the TTO in time, which may result in re- 
prescribing the old discontinued medications. 
c. There is a lack of communication between the ward pharmacists and the community 
pharmacists. 
From those three areas together with the problems identified after carrying out the general 
survey in the hospital, there is a potential need to improve patients' and/or their carers' 
knowledge of medicines and the links between the community and hospital healthcare 
professionals. 
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3.7 Assessment of the Counselling Checklist 
After the checklist was designed, a validation exercise was carried out to examine whether it 
was practical for the investigator to cover all the aspect described on the form. In addition, it 
was important to ensure that the checklist was an accurate reflection of the information 
actually given to the patients. 
3.71 Aim 
Assessment of the investigator's skills and abilities to perform patient's counselling using the 
counselling checklist. 
3.7.2 Assessment Process 
The counselling procedure was piloted on ten different patients. Patients were selected from 
the elderly care wards in St. Thomas' Hospital. The criteria for entry were; elderly patients, 
over 65 years, prescribed at least one medication, mental cognition score sufficient for a 
conversation to take place and being capable of managing their own medicines by themselves 
or with minor support by carers. 
Counselling was performed by the investigator using a standard protocol involving verbal 
instructions concerning the patient's regimen. The investigator was trained by the project co- 
supervisor (LC), who was the senior ward pharmacist in the same hospital on the correct use 
of the counselling protocol before starting the counselling sessions. The investigator 
rehearsed the actual counselling session in the presence of the senior pharmacist before 
talking to the patients. For each patient, two copies of the checklist were issued, one was 
given to the senior pharmacist in the elderly care unit in the hospital and the second copy was 
kept by the investigator. Each patient was counselled for about 15 minutes. The investigator 
counselled the patients using the checklist as a guideline for counselling procedure and for 
the information needed to be given to each patient. While the investigator was counselling 
the patients, the senior ward clinical pharmacist (LC) observed the investigator, using her 
checklist copy to mark all the points that she felt were correctly covered by the investigator. 
The investigator used her own copy to mark the areas she covered during the counselling 
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session. The two copies of the checklist were compared to identify which areas were 
adequately covered and if any item needed to be changed or edited. 
3.7.3 Findings 
The differences between the two checklists were compared (Appendix X) and discussed with 
the senior pharmacist to find out the reasons for any discrepancies. In some cases, it was 
inconvenient to cover all the categories for all the drugs e. g., discussing all the possible side 
effects may confuse the patients, or it may sometimes be unnecessary to describe the strength 
of the medication. Also, because the assessment was sometimes performed on inpatients not 
yet ready for discharge, there might be no reason to inform them of the duration of the 
medication, disposing of the old medications, or other various instructions. In some cases no 
special instructions needed to be given to the patients regarding their medications. 
During the assessment sessions, the senior pharmacist directed the researcher on the best way 
of providing the information to the patients, which expressions to use and which to avoid e. g., 
using tummy rather than stomach, water tablets rather than diuretics, medicine to move your 
bowel rather than using the term laxative, and how to approach different patients in different 
ways according to the individual situation. 
After piloting the checklist on ten patients and discussing the various points identified, the 
senior pharmacist affirmed the researcher's competence to undertake the counselling 
sessions. By the 10"` patient, it was very clear from the observed similarities between the two 
checklists that a good level of competence had been achieved. 
3.8 Application for Ethical Committee Approval 
After conducting the pilot work and the general survey, an application was made to the ethics 
committee in St. Thomas' hospital. All the application forms were filled by the investigator, 
revised by the main supervisor (LG) and the senior hospital pharmacist (LC) and applied for 
approval from the hospital committee (Appendix Xl). 
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3.9 The Pilot Work 
The instruments to be employed in this study consisted of patient knowledge questionnaire, 
tablet counts, the Nottingham Health profile, SIMS questionnaire and the home visit 
checklist. This section describes a pilot study to assess the usability of these instruments 
before utilization in the main study and that the study protocol was practical and achievable. 
3.9.1 Aim 
The primary aim of this pilot study was to ensure that the tools for use in the main study were 
workable and practical in the setting in which they were to be used. A secondary aim was to 
identify any problems associated with the conduct of the study. 
3.9.2 Sample Recruitment 
Elderly patients were eligible for inclusion in the study if they were admitted to one of the 
four Elderly Care Unite wards in St. Thomas' hospital, English speaking, mentally stable, on 
more than one regular medication and gave informed consent to participate in the study. 
Patients were approached by the researcher and were given verbal details of the research. 
Patients were invited to take part; those who agreed to participate signed a consent form 
(Appendix XFI). Recruited patients were randomly allocated to either intervention or control 
group. It was decided to randomize 10 patients for the purposes of the pilot and then follow 
through the entire study protocol. 
3.9.3 Method 
After seeking consent form approving to take part in this study, the 10 recruited patients 
therefore were followed in the same general scheme as described in the main study (Chapter 
VI), and involved the same assessment instruments. These are discussed in Chapter II and 
described in the corresponding appendices. 
3.9.4 Results 
The instruments piloted are those that would be significantly influenced by the counselling 
process which includes patients' knowledge, adherence to their medication regimen, 
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satisfaction with the information provided, quality of life and numbers and natures of 
medication-related problems. 
Out of the 10 recruited patients, 5 were allocated to each group. Two patients failed to 
complete the second home visit. One patient refused to continue the study and the second 
patient was admitted to the hospital before the second assessment. This 20% dropout rate was 
used to inform calculations for the total number of patients to be recruited for the main study. 
Full results for each of the assessment parameters are not shown as the data would have little 
meaning as expressed as means for each group, owing to the small numbers of patients 
involved. 
Compliance Assessment 
The tablet count technique (Chapter 2) was used as the sole method for calculating patients' 
compliance to their medication 2 and 6 weeks post hospital discharge. The compliance score 
percent was calculated by dividing the actual number of tablets taken by the number that 
should have been taken multiplied by 100. It was difficult to assess compliance level for 4 
control patients during the first home visit because they were using old stock they kept at 
home before their hospital admission. During the second home visit, the intervention group 
showed a compliance score of 80.7% compared to 73.0% reported for control group. 
Although it was difficult for the researcher to assess the compliance during the first home 
visit, this visit was essential to provide a baseline data for the types and the numbers of 
medication patients had at home and facilitate the tablet count for the second assessment. 
Medication Knowledge 
Patients of both the control and the intervention groups were assessed for their knowledge 
level concerning their medication during their hospital stay and two and six weeks post 
hospital discharge. Most of the questions used to assess patients knowledge were easily 
understood by the patients except a question regarding contra-indication as patients did not 
understand the word and the investigator had to explain its meaning for every patient. 
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Patients in the intervention group did improve their composite knowledge score (mean of 8 
questions asked) between the baseline at 22.4% and the first visit at 45.2%, with little 
additional improvement by the second home visit. The control group did also appear to 
improve, but owing to the low numbers involved it is possible this result was an artifact. 
Different methods can be used to express the patients' knowledge level and one of these 
methods is to calculate the percentage of the patients answering correctly for all of the 
questions about their medicines. The drawback of this method is its inability to measure its 
extent to which patients know about their medication. The second method that can be used to 
express the level of knowledge is to calculate the mean percent of the correct answers 
patients provided e. g., when a patient gained a score of 100% concerning drug names, the 
patient had a full knowledge of all the names of drugs prescribed. This latter method is 
adopted in this study. 
The questionnaire itself did not need any sort of editing except increasing the space provided 
for each question to include 10 different medications rather than six only as it was found that 
five patients out of the ten were taking more than six medications. 
Quality of Life and Nottingham Health Profile (NHP) 
The NHP was administered to the patients of both groups by a single interviewer using a 
standard technique. Patients were asked to answer the 38 questions of the profile regarding 
their health (Appendix III). Replies were weighted and then summed to give the final score 
for each of the six sections. The maximum score for each of the topics covered by the NHP is 
100. Because of the both visual and physical difficulties patients may suffer, it was more 
convenient to read the questions to the patients and ask them to answer with YES/NO rather 
than asking them to fill the profile themselves. 
Patients of both groups did not have any problems understanding the questions and 
answering them, although some of them expressed that it would be more convenient to have 
"SOMETIMES" as a third option. To overcome any confusion regarding answering the 
questions patients were advised to base their answers on the current situation on the day of 
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administering the questionnaire. Quite large standard deviations in scores were obtained so 
no conclusion could be drawn regarding any likely change in score as a result of counselling. 
Patient Satisfaction with Information 
Providing patients with information about their medication is an essential element of any 
successful therapy. One of the tools that can be used to assess the effectiveness of medication 
counselling process is to measure the extent of patient's satisfaction with the information 
provided during the education programme. The SIMS questionnaire (Appendix V) was used 
to assess the level of satisfaction with the information provided to the patient prior to their 
hospital discharge. Patients were asked to rate the amount of information they received 
concerning each of the 17 items of the questionnaire using one of five answers: about right, 
too much, too little, none needed or none received. 
Some of the patients found it difficult to remember the five different answers they needed to 
rate their level of satisfaction. Therefore, five small cards (13cm X 8cm) were used to print 
the five scales using font 32. These cards were handed to the patients during the 
administration of the questionnaire to facilitate the process of answering the questions. The 
ten patients expressed embarrassment when they were asked question No. 16. The composite 
score for the intervention group was higher (mean 9.2, SD 6.1) than that of the control (mean 
3.2, SD 2.2). 
Identification and Classification of the Medication-Related Problems 
During both the first and the second home visits, patients of both groups were asked to show 
all the medications in their possession. In a non-structured interview patients could express 
their concerns regarding any problem they thought might be related to their medication. After 
completion of the pilot study, a preliminary analysis was conducted on the MRPs identified. 
These categories were re-examined and refined. It was established that due to the wide range 
of problems, the MRPs could not be confined to a few categories. The problems were a 
summation of both what the patients expressed and what the investigator identified by 
reviewing the patients' medication and by asking the patients the questions that the 
investigator thought were the most relevant to their medication. Sixteen problem categories 
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investigator thought were the most relevant to their medication. Sixteen problem categories 
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were identified during the first home visit (8 problems in each group), this number decreased 
to 3 problems during the second visit (all in the control group). The problems mainly 
concerned side effects, dosage errors, stopping necessary medication, duplication of 
medication, compliance problems, physical difficulties and label problems. Because of the 
small number of the patients and wide range of problems identified in this pilot study, it was 
difficult to form a classification system at this stage. 
Conduct of study 
No particular problems were identified in the recruitment process. It was established that 
attendance of the researcher at the hospital was required for five days a week to visit the 
wards and identify those to be discharged. It did not appear to be crucial regarding the time 
of attendance as ward staff were usually able to give sufficient warning concerning planned 
discharge. At the rate of recruitment it was possible to plan the domiciliary visits. After 
recruiting the first few patients of the pilot it became apparent that the rate would be too low 
for the timescale of the project if only relying on the Elderly Care Unit. An approach was 
made to the general medical wards where it was identified that patients were admitted who 
met the inclusion criteria and a proportion of these were also under the care of the 
geriatricians. With this additional source it would be possible to reach the sample size. 
All the interviews were planned to be audio-recorded, but with recruiting the first patient, it 
was found that this idea was totally unacceptable and was confirmed by the rest of the ten 
patients. When patient consent, assessment and counselling was attempted in a single session 
before discharge it was found that the length of time required could be in excess of 45 
minutes and this was unacceptable to some patients. Therefore, after two patients had 
undergone this process another system was instituted where consent and the Nottingham 
Health Profile where administered on the day prior to discharge, with counselling and 
knowledge assessments on the day of discharge. This reduced any one session to a maximum 
of around 30 minutes. Time taken during the home visits did not appear to be an issue for the 
patients in the pilot study, those who were more socially isolated appreciated the time the 
researcher spent talking to them. It is probable that the more relaxed and social setting of 
their own home helped improve communication with the researcher. It was feared that the 
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control patients would wish to discuss medication with the researcher, but this did not appear 
to be a significant problem. 
Travel to patients' homes was achieved by public transport which meant that no more than 
two visits could be undertaken in a day. Also, due to the project limited time, all the home 
visits were arranged to be in the afternoon. 
For the data collection information sheet, it was more convenient to design it in the simplest 
way to be easily used by any hospital staff including technicians. No editing or formatting 
took place to this form. Regarding the letters to be sent to the community pharmacists, it was 
advised by one of the contacted community pharmacists to add the name and contact number 
for the patient's GP. 
3.9.5 Summary and Implication for the Main Study 
The results from this preliminary fieldwork were used to inform the main study. By 
application of the different instruments on 10 different patients using the actual experiment 
setting, it was found that very minor modifications in wording and formatting of the various 
tools needed to be employed to produce the final form for the main study. The findings that 
informed the main study were: 
1. Due to difficulties in getting a reasonable number of patients within the 
specified inclusion criteria from the Elderly Care Unit it was more convenient 
to extend the recruitment by including the elderly patients admitted to the 
general wards. 
2. Due to visual and physical difficulties, all the questionnaires and interviews 
were administered by the investigator rather than using self-administration. 
3. Due to similarities between the five different scales of the SIMS questionnaire 
and difficulties for the patients to remember them, five small cards were 
designed showing the five answers and these cards were handed to the patients 
to assist them answering the questions. 
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4. No one MRP classification system was chosen for use at this stage and the 
process of choosing one system was left until completion of the main study. 
5. Differences in compliance and SIMS between the control and intervention 
groups after counselling did suggest that the study was appropriately powered 
concerning the numbers planned to be recruited. 
6. One question regarding `contraindications' was removed from the knowledge 
questionnaire. 
7. More space was added to the knowledge questionnaire to accommodated ten 
medication per patient rather than six. 
8. GP's name and contact number was added to the letters sent to the community 
pharmacists. 
9. The pre-discharge sessions were managed over two days per patient rather 
than a single session on the day of discharge 
These modifications are reflected in the final methodology for the main study in Chapter 4. 
Owing to the minor nature of these modifications it was reasonable to include the results 
obtained from the ten patients of the pilot study in the main study. 
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CHAPTER 4 PLAN OF PROJECT 
CHAPTER FOUR 
PLAN OF PROJECT 
4.1 Introduction 
This project is designed to examine the effect of a hospital discharge and follow-up scheme in 
improving elderly patients' adherence and knowledge of medications, as well as identifying and 
reducing the identified medication-related problems (MRPs). 
In addition to the pharmacist's task in monitoring the drug therapy of patients during their stay in the 
hospital, the ward pharmacist should also aim to take more responsibility in bridging the gap between 
the secondary and the primary care during patient discharge in order to ensure that the patient receives 
seamless care. Few studies have reviewed the liaison between the community and hospital 
pharmacists. This study took place in St. Thomas' hospital, London in the four wards of the Elderly 
care unit and three general wards. The post-discharge part of the study took place at patients' homes 
most in the Lambeth, Southwark and Lewisham (LSL) Care trust. The study approved by St. Thomas' 
Hospital Ethics Committees (Appendix XI). 
A main focus of this study is to follow-up the patients post hospital discharge by carrying out 
domiciliary visits that enable further patient education and address poor adherence. The effects of 
patient education during the visits are presented in terms of adherence with prescribed medication, 
patient knowledge of their medicines, and patient satisfaction. 
The central part of this study involves identifying, classifying and reducing potential medication- 
related problems in elderly patients soon after they leave the hospital. This has not been attempted 
within this context in other studies and therefore, represents the novel nature of this work as a 
contribution to existing knowledge concerning hospital discharge. The data from part of this study has 
been presented at both national (HSRPP) and international (HP) conferences (Mohammed Safwat 
2003a and b). 
The project assesses a number of parameters used and one of the most important is the way in which 
patient's adherence can be improved by counselling. Linked to the area of patient adherence is the 
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measurement of changes in patient knowledge, patient satisfaction and quality of life. The second area 
involves monitoring the effect of the domiciliary visits on detecting the MRPs that develop post 
discharge and how hospital-based liaison pharmacists could intervene such problems. 
The main study is a controlled randomized trial which is designed to demonstrate the effects of the 
patient medication counselling on elderly patients and the liaison with the healthcare professionals in 
the primary care setting to overcome the medication-related problems. 
4.2 Aim 
The overall aim of this project is to investigate the influence of a novel hospital discharge and follow- 
up scheme and try to smooth the transfer of the pharmaceutical care from the secondary to the primary 
care regarding the elderly patients' medications and any MRPs by assessing a number of variables that 
may be influenced by such scheme. 
43 Objectives 
The project has the following objectives: 
1. To examine whether structured medication discharge planning education improves elderly patients' 
outcomes concerning knowledge and adherence to medications. 
2. To develop and assess methods of overcoming interface issues concerning discharge medication in 
terms of improved communication with GPs and community pharmacists. 
3. To explore whether the implementation of domiciliary visit schemes for elderly patients post 
discharge conducted by a hospital-based pharmacist liaison worker has any additional benefits over a 
pre-discharge counselling services. 
4. To assess schemes for identifying, classifying and reducing potential MRPs experienced by elderly 
patients after hospital discharge. 
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4.4 Null Hypotheses 
1. Patients who undertake structured discharge scheme have no better compliance to medication two 
and six weeks post hospital discharge compared to the control group. 
2. Patients who undertake structured discharge scheme show no improvement in their quality of life 
two and six weeks post hospital discharge compared to the control group. 
3. Patients who receive intensive education session prior to and two weeks after hospital discharge 
show no improvement in their knowledge about their medication two and six weeks post hospital 
discharge in comparison to the control patients who receive no further education. 
4. Structured planned discharge scheme has no effect on a patient's satisfaction with information 
regarding their medicines for the intervention group compared to the control group two weeks post 
hospital discharge. 
5. Patients who receive a structured discharge scheme show no difference regarding the numbers and 
the types of the medication-related problems they experience compared to the control group two and 
six weeks after hospital discharge. 
4.5 Subjects 
4.5.1 Selection 
LSLHA was selected for the study because it was large health authority in south London that could 
provide the study with a diverse population. It has a population of various socio-economic status and 
ethnic cultures. This would provide the study with a sample of patients with a wide range of 
characteristics. Also, the geographical location ensured easy access to patients' homes. The following 
inclusion and exclusion criteria were used as guidelines to select the most appropriate candidates for 
this project. 
Inclusion Criteria 
a. Elderly patients were deemed eligible for the study if they were aged 65 years or over and admitted 
to one of the four elderly care units or one of the three general wards in St. Thomas' Hospital. 
171 
CHAPTER 4 PLAN OF PROJECT 
b. Patients must be responsible for administering their own medication and not regularly supervised 
by relatives, friends, carers or district nurse. This would mean that the patient was not visited by a 
nurse more than once a week or that a relative/ friend did not prompt every dose of medication. 
c. The patients must be taking more than one regularly prescribed medication. 
d. The patients must speak English. 
e. The patients must be discharged to their own homes (not to institutionalized settings where they 
receive daily supervision). 
f. The patients must agree to receive their medications from only one pharmacy of their choice. 
Exclusion Criteria 
a. Mental status questionnaire (MSQ) scores of less than 21. 
b. If the patient was hospitalized less than 24 hours. 
c. Patients discharged without any medication or when required only medication. 
4.5.2 Patient Consent 
All patients were consulted for written informed consent before entry to the study. The form 
(Appendix XII) was read out and explained for each patient before asking them to sign it. 
4.5.3 Patients Randomization 
Those giving written informed consent were independently randomized using computer-generated 
random numbers. Patients were assigned to either an intervention or control group. Recruited patients 
were unaware as to which group they had been allocated. 
a. The intervention group (patients themselves and/or their carers) received a structured medication 
education (Appendix XIII) supplemented by a written aid (Appendix XIV) prior to hospital 
discharge. Patients were educated about the correct use of the medication and concordance issues. 
Where appropriate, MRPs were addressed and resolved. 
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b. The control group received the usual pharmaceutical care and discharging procedure provided 
in the hospital (Pharmacists and nurses are undertaking the usual activities). 
Although not strictly a question of bias, it is possible that the randomization process adopted failed to 
identify enough individuals falling into the extremes to allow for a better understanding of the strength 
of the intervention. For example, compliance was generally very high so it would be difficult in the 
chosen design to assess the true benefits of counselling to these fewer individuals with poorer 
compliance. The answer would have been to stratify the randomization into appropriate numbers of 
poorer compliers to each group. This stratification technique as mentioned was not possible as baseline 
compliance was not known. Another approach would have been to use the NHP as a health status 
measure for the stratification i. e., examining the benefits of the discharge process on those with either 
poorer or better health status. This would have been difficult as the total NHP score across all of the 
areas has no validity and stratification across the individual area would require a greater population. In 
addition, any cut-off point would have been purely arbitrary. Similar argument would have existed for 
the knowledge assessment. The final argument for the system is that it was not possible to power the 
study for health status regarding NHP or knowledge. A power calculation demands evidence from 
other studies regarding the confidence intervals of the findings and these were not available for these 
measures unlike compliance as assessed by tablet counts. A pilot study may have been able to power 
such a study, but the standard deviation from the NHP may indicate that the pilot would need to have 
been almost as large as the main study to confidently predict numbers of subjects. 
4.5.4 Sample Size 
The sample size was determined using the conventional value of five percent as the level of 
significance ("a" error). The outcomes to be measured in this study are: 
Compliance. 
Patient knowledge. 
Patient satisfaction with the information provided. 
Quality of life. 
The identified medication-related problems. 
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Sample size was based upon tablet count rather than either the medication-related or health-related 
outcomes mentioned above. The Nottingham Health Profile could have been used but this was rejected 
because it was difficult to identify any similar studies from which to predict the variance as described 
above. The pilot study was too small on which to base any accurate power calculation. It was decided 
that the outcomes of the NHP would not be one of the primary outcome measures and not suitable for 
basing the power calculation. The medication-related problems could also have been used, although 
again the literature did not contain many similar validated studies upon which to base a calculation. In 
view of the large range of potential MRPs it would have been unreliable to use a small pilot study for 
the calculation. As constructing total MKPs score would have little meaning and be invalidated this 
was also rejected. The same reason was applicable for the knowledge score. It was also difficult to 
calculate the sample size counting on the SIMS score as it has not been used in the same context of this 
project. Over 20 similar studies were identified that had assessed compliance tablet count and this was 
used for the calculation. 
The sample size recruited for this study was based on the following information: 
1. According to studies a 5% difference in compliance between the control and the intervention 
groups would suggest significant difference between the two groups. Most observed mean 10-15% 
differences and recorded a standard deviation. 
2. A drop out rate of about 20% was reported in the pilot study and was also reported in similar 
studies (Begley et aL, 1997). 
3. Recruitment of 120 patients would provide the study with a sample size that could be managed 
by one investigator within the time frame of the study. 
4. The sample size of the patients would fulfill the primary objective, i. e., the sample would be 
large enough to show difference in compliance between the two groups that could be statistically 
and qualitatively analysed. 
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This would suggest that 52 subjects in each group would produce statistically significant results in 
terms of compliance. When including the potential dropout rate, 61 subjects per group would obtain 
statistically significant results at P<0.05 level. 
4.6 Assessment of Baseline Data 
4.6.1 Mental Status 
Patients' cognitive functions and their suitability to take part in this project were assessed using the 
Mental Status Questionnaire (MSQ) which was described in chapter 3. 
4.6.2 Demographic Data 
Basic demographic information was collected (name, address, age, gender, name and address of the 
general practitioner, name and address of the community pharmacist). These details were documented 
from the patient's medical notes. Medical records were used to obtain other data including date of 
admission, the admitting diagnosis, drugs on admission, patient's medical history, patient's drug 
history, date of the planned discharge, the planned discharge medication, other diagnosis and level of 
care to be received in the community were all reported. 
4.6.3 Nottingham Health Profile (NHP) and Measurement of the Quality of life (QoL) 
In this study, health-related quality of life was approached in terms of patient's subjective health status 
using the Nottingham Health Profile (NHP) instrument. The NHP was administered to both groups by 
a single interviewer using a standard technique (Appendix III). 
4.6.4 Patients Knowledge 
After identifying the potential candidates, and prior to discharge from the hospital, patients were 
questioned regarding different medication aspects, to assess their knowledge levels in a variety of 
areas. Questions also include details of whether they had been informed about the number of the days' 
treatment supplied on discharge, whether they had been advised to obtain further supply from their 
general practitioner before the drugs provided by the hospital were finished and whether information 
had been supplied about the purpose of their drugs, when to take them, or possible side effects 
(Appendix IV). Questions were administered by face to face interview and the answers were recorded 
by the investigator. 
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Figure 4.2 Patient care pathways and an intervention pathway clarifying the process of 
care for each ggroup (intervention pathway shaded) 
Patients in St. Thomas' Hospital 
Medication review through daily clinical rounds by the consultant, or one of the senior medical team and the ward pharmacist 
Decision for discharge made by the consultant 
Prescription for medication to take out (TTO) written by senior house officer 
On the day of discharge 
I TTO to be checked by the ward or MATeam pharmacist 
TTO prepared by hospital pharmacist- 14 
days usually but not strictly happens 
Patients received structured medication counselling v 
Patients may or may not received brief written information sheet. Ability to recall information & 
counselling by either hospital pharmacist administer medication was tested. Concerns medicat 
or one of the staff nurses diG ]I M 
On the discharge day (post discharge) 
GP sent a copy of the TTO by the ward clerk GP & community pharmacists are sent a copy of TTO & 
information about the changes to the patients' medication 
during the hospital stay 
Two weeks post discharge- collect repeat medication 
Patients may or may not see the GP II Domiciliary visits, medication re-counselling & 
review by the investigator 
Six weeks post discharge GP or community pharmacists 
contacted by the investigator 
required 
Patients may or may not see the GP Domiciliary visit & medication review 
by the investigator 
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4.7 Methods in the Main Study 
The study was divided into two phases: 
The first phase of this study was conducted at St. Thomas' Hospital, in one of the four wards 
of the elderly care unit or one of the three general wards. The second phase of the study was 
conducted in the subjects' homes two and six weeks after hospital discharge. Prior to hospital 
discharge all the patients were assessed for the inclusion and exclusion criteria mentioned 
previously. The study is considered as a prospective randomised trial, with patients receiving 
the enhanced package of medication discharge services or receiving the currently provided 
services. 
4.7.1 Phase I: St. Thomas' Hospital 
Using the method described in Appendix (XIH) patients from the intervention group were 
educated regarding the correct use of their medication and adherence was encouraged 
appropriately. Prior to hospital discharge the intervention patients received one-on-one pre- 
discharge counselling session using standardized structured checklist concerning their 
medication (Appendix II). The importance of regular dosage and reasons for taking the 
medications was emphasized. Patients were informed about the most commonly occurring 
side effects. They were also told that they would receive only a 14 day supply of medication 
from the hospital and to ensure continuity of treatment, patients were informed about the 
importance of obtaining a further supply of medications from their GPs not later than 
fourteenth day after discharge. Patients were also advised about the regular visits to their 
GPs. The investigator asked the patients to stop using any medication they kept at home 
before the hospital admission and return them back to their pharmacist or their GPs. The 
importance of compliance was stressed together with the consequences of under or overuse 
of their medicines. The counselling session was carried out on the actual day of discharge by 
the patient's bedside. This time was selected in order for the researcher to discuss with the 
patients the medication they were to be taking home. 
All the problems identified, actions taken and the length of time required for the interview 
were recorded. Patients in the intervention group were given the chance to ask any question, 
they were also tested for their ability to open the bottles, use the inhalers, and use the blister 
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packs. The researcher asked the patients appropriate questions to ensure they had 
remembered the information. 
In addition to the verbal instructions provided, all the patients in the intervention group were 
supplied with written information on each of their prescribed medication (Appendix XIV). 
This contained information concerning the generic name (if applicable) for each medicine 
prescribed, the purpose, major side effects, the number of doses together with the time of the 
day correlating to patients' meals and any other important instructions. Normal discharge 
procedure was provided to the patients of the control group as in figure 4.2 which describes 
the usual care pathway for those discharged from St. Thomas' hospital (i. e., the control 
group) compared to that for the intervention group. 
On discharge, all the control and the intervention group patients were informed that the 
researcher would contact them to arrange a visit at their homes to `check how they were 
coping with their medicines'. 
Post hospital discharge, GPs for both intervention and control groups were sent a letter 
informing them about the nature of the study and asking for their permission to include their 
patients (Appendices XVa and XVb). GPs and community pharmacists for the intervention 
patients were also contacted by phone to inform them about the nature of the study, and then 
letters were send to them confirming participation of their patients in the study and to 
describe the study together with any information that may help them in identifying any 
changes to their patients' medications during their hospital stay (Appendix XVI). Three 
copies of the TTO (To Take Out) were issued for the intervention patients, one was sent to a 
community pharmacy of the patient's choice, if they failed to elect a particular pharmacy 
they were either excluded or considered as control patients. The second copy was given to 
the patient to keep or to show it to his/her GP before requesting further supplies of 
medication. Third copy was sent to the GP, together with a letter informing them that the 
patient has entered the study. Together with the TTO copies, blank forms of the written 
information sheet were sent to the community pharmacists to fill in with any modification in 
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the patient's regimen after leaving the hospital, which was to be handed to the patients when 
they/or their carers came to collect the prescription. 
4.7.2 Phase II: Domiciliary Visit 
The objective of this part was to follow-up patients discharged from the hospital into the 
community to observe whether their drug regimens have been changed, to investigate the 
information given to patients by healthcare professionals with respect to drugs and identify 
any medication-related problems and any other areas that needed to be improved. A further 
objective was to identify communication issues between healthcare professionals which 
could benefit the patient. 
All patients were telephoned at home the day before a visit to confirm they were still willing 
to participate. At the home visit, each patient was interviewed in a standard manner using 
prepared questionnaires. The questionnaires were completed by the researcher to determine 
the following outcomes. 
a. First Visit 
The investigator visited the patients at home between 15 and 22 days after discharge from the 
hospital that is, after the initial supply of drugs provided by the hospital had ran out and a 
further supply obtained from the general practitioners. If applicable, any of patients' carers 
(including friends, relatives or neighbours) who helped with their medicines were invited to 
attend. 
Assessment ofPatient Compliance 
Tablets counts were used as the sole instrument to calculate patient's adherence to their 
medication. Tablet counts as with most of the compliance measure instruments, have their 
drawbacks described in chapter 3, but the main drawback in this study is the fact that, 
patients might remove the tablets from other containers they kept at home, or they might 
adjust the number of tablets in the containers. Therefore, patients were not told before hand 
that their medication would be counted and were advised not to use any of the medication 
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they already had at their home. As the patients were visited at home, there was less chance 
for the patients to claim that they have forgotten or lost their medication. 
Assessment ofPatient's Knowledge and Quality of Life 
During this visit, assessment of participants' knowledge of prescribed medicines was carried 
out using the questionnaire described in Section 2.3.4 as well as the quality of life using NHP 
instrument (Section 2.3.3). 
During this knowledge assessment, patients of the intervention group were re-counselled 
again on their medication, and were informed about any changes to their medication initiated 
by their GPs after they left the hospital. They also were given the chance to ask any question 
and express and address any concern. 
Wherever possible all medication held by the patient at the time of the visit was inspected, 
including those prescribed before hospital admission and those obtained from the general 
practitioner after discharge. The prescription issued on discharge and the medicines actually 
being taken by the patient at home after discharge were compared and if there were any 
discrepancies then GP was contacted (for intervention group only). 
Assessment ofPatient Satisfaction with the Information Provided 
The previously (Section 2.3.6) described Satisfaction with the Medication Information 
Questionnaire (SIMS) was used to assess patient's satisfaction with the information provided 
to them during their hospital stay. 
Monitoring Medication RelatedProblems 
Medication review was conducted for all the patients in both groups to identify any 
medication-related problems as described in section 2.3.7 including any interaction between 
medication. Patients were also asked about any problems they suffered from during the 
period of the study and were given the chance to describe any dissatisfaction with prescribed 
medication. Patients of the intervention group were informed about any problem observed 
and the best way to avoid these problems. GPs or community pharmacists were contacted by 
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the researchers concerning such problems and action taken as necessary for the patients in the 
intervention group. 
b. Second Visit 
The same outcomes were assessed (except patients' satisfaction with the information) as in 
the first home visit two months after hospital discharge. 
4.8 Confidentiality and Ethical Issues 
The confidentiality and anonymity of patient information was assured during the process of 
recruitment and during the home visits. Any potentially harmful MRPs identified during the 
homes visits were reported to the clinical pharmacist in St. Thomas' hospital. By the end of 
second domiciliary visit, the investigator discussed the potential problems that could cause 
harm in the control patients and were advised to review their medication with their GPs. 
4.9 Monitoring Hospital Re-admissions 
All the patients were monitored for the rate of the hospital readmissions at six months after 
hospital discharge. Patients' details stored on the hospital computer system were reviewed 
for the number of admissions and the reasons for the readmissions. 
4.10 Assessment of the Reliability of Medication-Related Problem Classification System 
The main supervisor was invited to assess the MRPs classification used in this study. A soft 
copy of case summaries were made and handed to the rater who was asked to code each 
problem according to the coding system described in section 2.3.7.2. 
4.11 Quantitative Data Analytical Procedures 
4.11.1 Data Entry and Handling 
Before the data could be analysed, a case summary describing demographic data, compliance 
levels, knowledge score, NHP scores, SIMS score, and the different MRPs identified was 
made for each study subject. The data for the baseline interview, first and second visits was 
coded in accordance with a coding frame using SPSS. All the data was coded after 
completion of the two home visits for all study patients. The data was then transferred into 
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the SPSS, entered as groups of variables consisting of a number of measured attributes each 
describing a set of observations, being extracted from the different instruments, 
questionnaires and tools. Each variable represents one criterion to be analysed and each 
subject was entered as a case. Data was checked for errors during the process of data entry as 
cases by a second individual checking random pieces of entered data against the original case 
summary. Data checking was also carried out after data entry was completed. Missing data 
and blank cells were examined against the original data to identify any discrepancies. Also, 
randomly selected cases were then reviewed with the original data to check for any 
discrepancies. 
Various statistics were used to summarize and describe the data set to meet the different 
objectives, i. e., mean, median and mode. Standard Deviations (SDs) were used as an estimate 
of the data variability around the mean. To minimize type I error ap value equal to or less 
than 0.05 was taken as cut-off level for the level of significance. The smaller the p value the 
less the chance of rejecting the Null Hypothesis while it is true which would minimize any 
errors occurring by chance. 
Different statistical tests being used to analyse data extracted from this study. These tests 
included 
4.11.2 Analysis of Frequency Tables 
Pearson's Chi-squared (X2) Test 
The chi-squared (X) test for categorical data organizes two or more categorical variables in 
contingency table. This test is used to identify by how much the two observations differ and 
also whether this difference is more than might reasonably be expected to occur in sampling. 
To perform this test, the expected number in any group should not be less than 5 (if it is, two 
groups can frequently be pooled). The total number of observations should not be less than 
20 and the test should be carried out on the actual numbers, not percentages (Altman, 1991). 
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4.11.3 Sample Distribution Tests 
a. Two Independent Samples Analysis Tests 
T-test for nominal continuous data was used to assess the probability of the samples having 
come from the same population. It is a parametric test that assumes the sample being 
analysed is from a population with specified normal distribution. The T-test can be used to 
compare two independent groups of observations. If the non-normal distribution was 
assumed the non-parametric Mann-Whitney U-test was used. It is a non-parametric 
alternative to the t-test for comparing data arose from two different groups of observations. It 
depends on ranking all the data from both observations as if they came from one sample. 
b. Paired Samples Analysis Tests 
A paired sample t-test was used to compare the observed mean difference of the data arising 
when the same individuals are studied more than once, usually in different circumstances 
e. g., before and after. The Wilcoxon's signed rank test is the non-parametric equivalent, 
which uses both the magnitude and the direction of the changes in the data but not their 
actual values. Ranks are assigned to the differences between paired observations, regardless 
of whether the differences are positive or negative (Altman, 1991). 
c. Reliability Measure and Degree ofAgreement 
The reliability of a measure refers to its reproducibility. One of the methods of assessing 
reliability is inter-rater reliability which depends on measuring the degree of agreement 
between different raters. By measuring the degree of agreement it is possible to compare the 
ratings of two observers for the same group of objects. The Kappa statistics is used to 
measure the extent of the agreement between the evaluations of different raters when each is 
rating the same sample, i. e., inter-rater agreement. Kappa is based on two categorical 
variables arranged in contingency table and both categorical variables have to use the same 
category values in order to have the same number of categories. In the context of this study, 
the main supervisor (LG) who was completely unaware of the patient's allocation in the two 
groups coded each class of MRPs based on the data presented in the patient proforma by the 
researcher. The blinded rater coded the MRPs recorded on the proforma according to a 
predefined system of service-related or clinical-related problems. In addition, the rater 
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categorized the degree of the MRPs as mild, moderate or severe. It must be stressed that in 
the main, the nature of the MRPs was actually stated on the proforma as in most cases this 
could only be identified from a discussion with the patient. The process of coding by the 
second rater was performed independently for every patient for each home visit. The purpose 
of the second rater was simply to categorise types and severity of the problems. The rating 
performed by the main supervisor (LG) and the researcher (NMS) were compared for any 
agreement. The Kappa test was performed to specify the degree of agreement and compare 
the ability of the two raters to classify these problems. Values of Kappa have no absolute 
definitions but there are certain guidelines (Table 4.1) that can be used for interpretation of 
these values (Altman, 1991). 
Table 4.1 Interpretations of the values of Kappa 





0.81-1.00 Very Good 
4.12 Computer software packages 
The following computer software programmes were used to organize data in this study: 
1. Microsoft Office Word XP, for word processing. 
2. Microsoft Office Excel XP, for simple descriptive statistics and charting quantitative data. 
3. Statistical Package for Social Science (SPSS), version 11 a package providing a range of 
simple and complex statistical procedures to analyse quantitative data. 
This chapter ends the methodology section. The next two chapters will report the results and 
the discussions of the main research study. Data as collected using the different instruments 
will be analysed according to its nature whether categorical or numerical data and whether 
scores or percentages and represented as appropriate summary tables and figures. As 
described earlier in Chapter 3, different analytical procedures will be employed to conduct 
the comparison between the two groups. Data will be coded to be entered into the SPSS for 




CHAPTER 5 RESULTS Before Hospital Discharge 
CHAPTER FIVE 
RESULTS 
This chapter reports the results of the research study described in chapter four and is divided 
into eight main sections. The first section reports the patients' demographics. The second 
section presents time spent conducting the home visits and the counselling. Third to seventh 
sections represent the different outcomes assessed before and after the domiciliary visits. The 
last section describes the rate of hospital readmission for the recruited patients in a six-month 
period from the discharge date. 
A comparison between the control and intervention groups has been made using a variety of 
statistical techniques. Student t-test, paired data t-tests and Mann-Whitney tests were used for 
group comparisons of interval/continuous data. Chi-squared and Wilcoxon tests were used to 
compare the distribution of patients with respect to categorical data. Kappa test was used for 
calculating the degree of agreements between different raters. 
5.1 Recruitment and Patients Demographics 
This section includes patients' demographic description of the patients recruited to the study. 
5.1.1 Sample Recruitment 
From the seven different wards visited by the investigator on a daily basis, 122 patients were 
recruited. Table 5.1 summarizes the number of patients recruited 
Table 5.1 Total numbers of patients recruited to each group and numbers of patients who 
dropped out 
Number of Patients (%) 
Categories 
Control Intervention Both 
Recruited 61(50) 61(50) 122 
Dropouts* 22(36) 21(34) 43(35) 
* Dropouts refers to number of patients who failed to complete a second home visit 
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Due to the large number of patients who were approached daily by the investigator to 
participate in the study it was quite difficult to record all the patients who refused to take part 
in the study. Not to have strangers visiting the patients at home was main reasons given by 
the patients who refused to take part in the study. 
Table 5.2 Numbers of patients who dropped out of the study as categorised by reason for 
dropout before first and second visits 
Number of Patients 
Reasons of Dropping Out Before 1st visit Before 2"d visit 
Control Intervention Total Control Intervention Total 
Died 2 2 4 0 0 0 
Hospital Readmission 6 5 11 8 7 15 
Moved Outside London 2 2 4 0 1 1 
Refused to Continue 1 2 3 1 1 2 
Others* 1 0 1 1 1 2 
Total 12 11 23 10 10 20 
*The category others included unobtainable patients (researcher failed to re-communicate with the patients) 
Twenty three patients (15 females) gave permissions to take part in the study but dropped out 
before the first assessment at home was conducted. Twelve were in the control group and the 
rest were from the intervention group. Out of the 122 recruited patients, 99 patients (49 in the 
control group) managed to complete the first assessment. Seventy nine patients completed 
both assessments (39 in the control group and 40 in the intervention group). 
The reasons for refusing to continue participation in the study were either because of the 
length of the questionnaires or because the patients became confused after a while and forgot 
they had volunteered to take part. It is clear from table 5.2 that the two groups were quite 
similar in the dropout rate but it was difficult to carry out any statistical comparison between 
the numbers of patients dropping out during the study due to the low number involved. 
5.1.2 Demographic data 
This section reports the different demographic data for the patients in the two groups and the 
normality of distribution and any differences between the two groups at baseline just before 
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hospital discharge. Table 5.3, figures 5.1 and 5.2 show characteristics of the 122 recruited 
patients. 
Table 5.3 Mean age (SD)* and mean Mental Status Questionnaire Scores (SD) of patients 
recruited in each group 
Category Control (SD) Intervention (SD) 
No. of Patients 61 61 
Mean of Age in Years 77.0 (7.6) 79.4 (6.7) 
Mean of Mental Status Questionnaire Score 23.4 (1.8) 23.8(l. 4) 
* SD= Standard Deviation 
The average age of the patients was 78.22 (SD=7.2) years, ranging from 65 years to 96 years 
(Median= 79 years). The distribution of ages over the two groups passed tests for normality. 
Patients' cognitive function was assessed during their hospital stay using the Mental Status 
Questionnaire (MSQ) described previously in Chapter 2. The mean scores for patients in 
each group are shown in table 5.3. There was no significant difference between the means of 
the (MSQ) scores between the patients of the two groups (P<0.05, two independent sample t- 
test). 
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* Numbers on bars refer to the number of patients belong to each gender category in each group 
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When the patients were tested for their general sex distribution it was found that the sex 
distribution (Figure 5.1) as Male: Female for the control group was 1: 1.7 and the distribution 
for the intervention group was 1: 1.8. The average age for the females was 79 (7.2) years and 
for males was 76.9 (7.1) years. 
More than half (61%) of the patients were living alone while the rest were living with either 
families or friends. About 16% of the patients were receiving irregular help either by a 
member of the family, carer or district nurse. This help was limited to either filling dossette 
boxes, or arranging prescription and collection of medication. 
Table 5.4 Frequencies and percents of the most commonly diagnosed medical problems 
Disease 
Number of Patients (%)* 
Control Interven Both 
Cardiovascular 114(34.2) 130(40) 244(37.1) 
Gastrointestinal 27(8.1) 32(9.8) 59(9.0) 
Respiratory 26(7.8) 25(7.7) 51(7.8) 
Infectious 34(10.2) 26(8) 60(9.1) 
Musculoskeletal 24(7.2) 21(6.5) 45(6.8) 
Central Nervous 10(3.0) 9(2.8) 19(2.9) 
Endocrinological 23(6.9) 13(4) 36(5.5) 
Fall 9(2.7) 10(3.1) 19(2.9) 
Renal 10(3.0) 9(2.8) 19(2.9) 
Anemia 10(3.0) 6(1.8) 16(2.4) 
Miscellaneous 46(13.8) 44(13.5) 90 (13.7) 
Total No. of Recruited Patients 61 61 122 
Grant Total 333 325 658 
*Column percent calculated by dividing the total number of patients in each disease category by the total number of patients 
in each study group. 
Table 5.4 represents the numbers of patients with the different conditions as identified during 
their hospital stay, for which treatment was currently prescribed. Most of the patients 
suffered from more than one condition. Cardiovascular problems represented the highest 
percent of problems suffered by patients in both groups. More than half the numbers of the 
patients in the intervention group and about half of the control group patients were diagnosed 
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with hypertension followed by angina and myocardial infarction. Infections were the second 
most likely conditions elderly patients suffered specially the urinary tract and chest 
infections. Hiatus hernia and ulcers was presented equally in both groups. About one third of 
the patients had COPD and Asthma (for detailed data see Appendix XVIII). 
Table 5.5 Length of hospital stay and number of medicines for both intervention and control 
groups 
Characteristics 
Hospital Stay (in Days) 
No. of Medications Taken 
Control Intervention 
Mean (SD) Range Mean (SD) 
15 (13.5) 
8.3 (3.2) 





The average length of the period the patients stayed in the hospital was 15.4 days ranging 
from 1-110 days. Patients were discharged from the hospital with total number of 909 
medicines. Patients left the hospital with an average number of medications of 7.8 
drugs/patient, ranging from 2 medicines to 20 medicines. The two groups were well matched 
with regard to the number of the medication between the two groups on discharge. 
Figure 5.2 Numbers of patients in using compliance aids and help with medication from a 
Carer ofr family 
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When the patients were asked about the sources of help they could be receiving regarding 
their medication, it was found that 13 (10.9%) of the 122 recruited patients left the hospital 
with Dossett Box as a memory aid (Figure 5.2). About 17% of the total number of patients 
was receiving some help with their medication either through their families or through carers 
or nurses but not on a daily basis. No significant differences were observed between the two 
groups regarding the different types of helps. 
Table 5.6 BNF Categories and frequencies of medication prescribed on discharge 
Tb .. n (n tnnnrwr ar 
Number of Medication (%)* 
1Jl Ug VQLV UI3 Vl <. IaJJ 
Control Interventio Total 
Cardiovascular 176 (36.7) 196 (45.6) 372 (40.9) 
Central Nervous 56 (11.7) 47 (10.9) 103 (11.3) 
Gastrointestinal 58 (12.1) 49 (11.4) 107 (11.8) 
Respiratory 72 (15.0) 61 (14.2) 133 (14.6) 
Musculoskeletal 10 (2.1) 12 (2.8) 22(2.4) 
Topical Preparation 11(2.3) 14(3.3) 25(2.8) 
Endocrine 35(7.3) 17(4.0) 51(5.6) 
Obstetrics, Gynaecology and Urinary Tract 6 (1.3) 4 (0.9) 10 (1.1) 
Miscellaneous 55 (11.5) 30(7.0) 85 (9.4) 
Total 479 430 909 
*The percentage was calculated by dividing the numbers of medicines identified under each category by the total numbers 
of medications in each study group. 
The 122 recruited patients reported using 909 dispensed medicines on discharge which were 
classified into ten major categories according to the British National Formulary (BNF). The 
number and type of each category is shown in table 5.6. Cardiovascular agents counted for 
the majority of the medications consumed by the participants; anticoagulants and 
antiplatelets and diuretics were prescribed most frequently. Respiratory medications 
especially steroid preparations were the second to be prescribed. Laxatives, PPIs and non- 
opioid analgesics represented more than 5% of the total prescribed medicines (for detailed 
data see Appendix X). 
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Table 5.7 Numbers and types of community pharmacy used 
Category 
Category (%)' 
Control (n=59) Intervention (n=59) Total (n=118) 
Number of Pharmacies Used 
One Pharmacy 49 (83.1) 51 (86.4) 100 (84.8) 
>One Pharmacy 10(17) 8(13.6) 18 (15.3) 
Type of Pharmacy 
Independent Pharmacy 43 (72.9) 40 (67.8) 83 (70.03) 
Multiple Pharmacies 8(13.6) 19 (32.0) 27 (22.9) 
Unknown 8 (13.6) 0 8 (7.09) 
*Column percent calculated by dividing number of patients in each category by total number of patients in each study group 
Table 5.7 describes the use of community pharmacies to collect prescribed medicines. Four 
patients in the control group said they definitely used more than one pharmacy and six said 
that they normally use one pharmacy but sometimes a second pharmacy can be used. For the 
intervention group, two of these always used more than one pharmacy and the rest said they 
sometimes used another pharmacy. Patients in the intervention group admitting using more 
than one pharmacy were asked to choose just one pharmacy for obtaining their medication 
during the period of the study. 
5.2 Time Spent during counselling Sessions and the Home Visits 
While patients of the intervention group received structured educational sessions on the 
discharge day, patients of the control group received the normal discharge procedures 
provided in the hospital, which may or may not include patient education by either the ward 
pharmacist or one of the nursing team. The time spent with each patient was recorded by the 
investigator from the moment the patient was approached till the end of session and this time 
varied according to the number of medications the patient was prescribed. The mean time 
spent in educating the intervention group patients was 23 (SD=12.57) minutes. 
Out of the 122 patients 99 completed the first home visit and 79 patients completed the 
second home visit. The time of each home visit was reported to the nearest five minutes 
(Table 5.8). 
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Table 5.8 Time spent by investigator on domiciliary visits expressed as total number of hours 
Over whole study and the mean time (SD) in minutes spent with each subject 
Categories 
Time 1' Assessment 2 °d Assessment 
Control Intervention Control Intervention 
Total Time in Hours 38.8 34.5 21.8 22.8 
Mean Time/Patient in Minutes (SD) 45.6 (15.3) 44.0 (16.1) 31.2 (11.5) 35 (15.5) 
The total time spent conducting both the first and second home visits was about 118 hours; 
73.25 hours for the first home visit, and about 45 hours for the second home visit. When the 
two groups were compared for the mean time spent with every patient during both the first 
and the second home visits, no significant differences were observed between the two groups 
at level of 95% during both visits (Two sample t-independent test, P<0.05). 
53 Patients Knowledge Before and After Hospital Discharge 
Patients were interviewed by the investigator to assess their level of knowledge. Patients 
were questioned about the name, purpose, shape, strength, dose, frequency, special 
instructions and the side effects of the medication on discharge and at each home visit. For 
the intervention group patients, this was performed before they were counselled. Patients 
were not allowed to refer to any written information to answer the questionnaires e. g., labels. 
193 
CHAPTER 5 RESULTS 
Figure 5.3 Patient medication Aiirni (edge scores` assessed hef) c hospital discharge 
Vises 
*The scoring system for each question was calculated (as percentage) by dividing the correct answers (for the total number 
of medicines for each patient) by the theoretical required correct answers x 100. 
Figure 5.3 describes the mean of the scores for medication knowledge for each of the eight 
questions before hospital discharge. The general knowledge of the patients about their 
medicines was high in both groups (more than 50%), except for the names, side effects, 
special instructions and the strength of the medication (For detailed data see Appendix XX). 
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When the correlation between the total numbers of prescribed medication in both groups and 
the composite score of patient's knowledge was studied, it was found that there was no 
significant correlation between the two variables for both the control and the intervention 
groups (Spearman's Rank Test R= 0.08 and 0.18, P= 0.5 and 0.2 respectively). 
The patient's knowledge questionnaire was administered during both first and second 
domiciliary visits to assess patients knowledge concerning their medication and the effect of 
the planned discharge counselling on patients knowledge levels. 
Table 5.9 Mean knowledge score during both first and second home visits 
Mean Score % 




















5. Frequency 76.8 86.3" 71.5 86.8" 
6. Strength 21.8 34.8 16.2 31.7 
7. Special Instructions 16.4 33.8" 15.2 37.2" 
8. Side Effects 3.1 11.5" 2.0 10.7" 
Composite Score 48.5 61.1 47.8 60.6 
*Statistically significant, Mann-Whitney U -test, p<0.05 between the two groups at each home visit 
**Statistically significant, Mann-Whitney U-test, p<0.001 between the two group at each home visit 
As mentioned previously, there were no significant differences between any of the patient's 
knowledge criteria before discharge (Figure 5.3). Table 5.8 shows the percentage of means of 
the knowledge score as assessed by patient interview. 
When the study subjects of the two groups were compared for the level of knowledge, it was 
found that there were significant differences (Table 5.9) between the two groups for all the 
questions except the knowledge concerning the drug strength during the first . assessment, 
while during the second home visit, significant differences (patients of the intervention group 
showed better results) were shown for questions numbers from 4,5,7 and 8. 
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Within the group, the improvement in all the knowledge aspects reached level of significance 
for the patients in the intervention group two weeks (1 " assessment) after their hospital 
discharge (P<0.001, Wilcoxon Signed-rank test for questions 1,2,5,6 and 7, and P<0.01, 
Wilcoxon Signed-rank test for the remaining three questions3,4 and 8). 
Improvement in patient's knowledge was observed and reached level of significance for the 
control group for questions 3,5 (P<0.01, Wilcoxon Signed-rank test) and questions 4,6 
(P<0.05, Wilcoxon Signed-rank test) during the first assessment. When the change was 
calculated while moving from the first home visit to the second home visit for patients in 
both groups, an improvement in intervention patients' knowledge concerning medicine 
shape, dose, time of administration and the special instructions was observed but these 
improvements did not reach any level of significance. Patients in the control group showed 
decline in their knowledge concerning medicine strength, dose, time, special instructions and 
side effects during the second assessment. This decline was statistically non-significant 
except for drug strength (question 4) and drug frequency (question 6) (Wilcoxon Signed-rank 
test P=0.01 for booth criteria). 
The total score was calculated by summation of the score of the eight questions for every 
patient and calculating the mean percent for the total number of patients in each group during 
each assessment. This score was significantly higher for the intervention group during both 
first and second visits (P<0.001, Mann-Whitney U-test). The improvement of the total score 
reached significance for both control and intervention groups on the first assessment 
(Wilcoxon signed-rank test, P= 0.007 and P=0.000 respectively). The control group showed 
significant decline in the composite score during the second assessment (Wilcoxon signed- 
rank test, P= 0.03). 
5.4 Quality of Life and Nottingham Health Profile Before and After Hospital Discharge 
As mentioned previously (Chapter 4), patients' quality of life was measured using the 
Nottingham Health Profile questionnaire which was administered before and after hospital 
discharge. 
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Figure 5.5 Nottingham Health Prqfile administered to both the control and the intervention 
groups before hospital discharge 
Different NHP Areas 
'The maximum score for each of the areas covered by the Nottingham Health Profile is 100. The lower the score the "better" 
the status in each category 
There was no significant difference (Figure 5.5) between the control group and the 
intervention group in any of the criteria of the NHP (P<0.05, Mann-Whitney U-test), except 
for the physical mobility (Mann-Whitney U-test and P=0.005) and energy (Mann-Whitney 
U-test and P=0.038) criteria where a higher score was achieved by the control group (for 
detailed data see Appendix XXI). 11.1 
The Nottingham health profile was re-administered during the domiciliary visits to study the 
changes quality of life post hospital discharge. 
i0 
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Table 5.10 Nottingham Health Profile administered to both the control and the intervention 
groups on the first and the second home visits 
Mean Score % (SD) 
Area 1'` Assessment 2" Assessment 
Control Intervention Control Interventio 
Pain 35.0(30.2) 21.5(30.1)` 28.4(26.3) 20.2(24.5) 
Energy 56.9(39.8) 36.8(39.1)` 40.6(38.2) 34.7(36.1) 
Emotion 25.0(27.1) 16(21.3) 24.7(27.0) 16.3(21.7) 
Sleep 38.6(34.6) 19.9(26.4)" 28.2(27.9) 20.2(26.2) 
Social Isolation 38.4(138) 10.6(19.9)` 28.2(28.7) 20.2(19.4) 
Physical Mobility 47.4(22.3) 30.8(27.4)" 41.7(23.9) 31.2(29.1) 
*Statistically significant Mann-Whitney U-test, p<0.05 between the two groups at each home visit 
**Statistiealiy significant, Mann-Whitney U-test, p<0.01 between the two group at each home visit 
When the patients in both groups were compared for any difference between the areas of the 
NHP during the first domiciliary visit, significant differences were observed (intervention 
patients showed lower score, i. e., better quality) for all the tested criteria except emotion, 
therefore showing better quality of life post hospital discharge. No significant difference was 
observed between the two groups during the second home visit. 
Friedman test was used to study any changes in the Nottingham Health Profile scores for 
either baseline, first or second assessments at a level of 95%. It was observed that there was a 
significant difference between the points of assessments for the patients of the intervention 
group regarding the area of sleep. The Wilcoxon sign rank test (P<0.05) was used to identify 
the position of this difference. It was found that the significant difference was observed 
during the fist assessment i. e., there was a significant improvement in the sleep pattern for 
the patients of the intervention group immediately after leaving the hospital. 
5.5 Patient's Compliance 
Patient's adherence to their medication was measured whenever possible using tablet counts. 
Compliance could not be measured for topical preparations, liquids, inhalers, eye-drops, 
medicines taken on "when required" basis and for antibiotic courses which had been 
completed before the visit, unless the patient admitted to non-compliance. 
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Percent adherence was calculated by determining the number of tablets that should have been 
taken in the interval between hospital discharge and the first home visit after two weeks (first 
assessment) and that between the first and the second home visits after four weeks (second 
assessment). The numbers of tablets that were actually taken between the intervals were then 
divided by what should have been taken theoretically multiplied by 100. 
Table 5.11 Compliance (Mean Score Percent)' as estimated by tablet counts on first and 
second home visits 
Categories 
Compliance % 1" Assessment 2°d Assessment 
Control Intervention Control Intervention 
No. of Patients 40 







*The average adherence score percent for all drugs was calculated by summing percent adherence for all drugs and dividing 
by the total number of drugs the person was taking X 100 
A number of tablet counts were missing owing to non-availability of tablets to perform an 
assessment at the time of the visit. Assessment of compliance during the first visit was 
impractical for a number of the patients. The main reason for this was that some were using 
their old stock of medication they kept at home before their hospital admission. Other 
patients mixed their tablets (from the hospital and the community pharmacy) together in one 
container, one patient kept some of his medication at his daughter's home. 
Compliance for patients using dossette boxes was calculated and included within the 
compliance calculated for patients without these aides. Compliance was considered to be 
100% for patients using memory aids e. g., Dossett boxes and where the correct number 
appeared to have them removed at the time of the visit. 
The two groups were compared for the level of compliance at the first and second home 
visits (Table 5.11). The intervention group had a higher compliance score compared to the 
control group two weeks post hospital discharge. The total score of compliance was 
significantly higher for the intervention group than the control group during the second 
assessment (P<0.05, two sample t- independent test). 
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There was a slight significant improvement in the compliance level for the counselled 
patients while moving from the first to the second home visit (P<0.05, T-test for paired 
sample). Patients of the control group showed a decrease in the compliance score during the 
second assessment but this decline was statistically non significant (P<0.05, T-test for paired 
sample). 
Table 5.12 Compliance level described as numbers of subjects (1%j falling into one of three 
different descriptive categories 
Number of Patients (%) 
Compliance Categories 1d Assessment 2"d Assessment 
Control Intervention Control Intervention 
Total No. of Patients 40 45 37 37 
Underuse 15 (37.5) 7(15.6) 14 (37.8) 8(21.6) 
Compliant 22 (55.0) 33 (73.3) 17 (46.0) 29 (78.4) 
Overuse 3(7.5) 5(11.1) 6(16.2) 0(0) 
-Column percent calculated by dividing the total number of patients in each compliance category by the total 
number of patients in each study group 
Patients' behaviour towards their medication was classified into three categories. Table 5.12 
describes the different compliance categories assessed by tablet count as follows: a) underuse 
-<85% compliance, b) overuse-115% compliance and c) Compliant- 85-115% compliance. 
The deviation of 15% (100+/-15%) was used in accordance to that used in other studies 
(Wood et al., 1992) and (Eagleton et al., 1993). 
For the first assessment, there were higher numbers of compliant patients in the intervention 
group than those in the control group. Intervention patients who were classified to be 
underusing their medication were less than half the number of the same category in the 
control patients during the first assessment. 
It was difficult to carry out any statistical comparison between the two groups during the 
second visit on the level of the overuse alone (cell had zero value), so over and underuse 
categories were combined to form non-compliant class and a comparison was recalculated 
between the intervention group and the control group on the basis of compliers or non 
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compliers. 78% of the intervention group patients were described to be compliers in 
comparison to only 55% of the control group. A significant difference was obtained on these 
basis during the second assessment (Chi squared test, DF=l and P=0.004). 
5.6 Patient Satisfaction with Information 
The SIMS questionnaire was used to assess patients' satisfaction with the information they 
received during their hospital stay. This questionnaire was administered to the patients during 
the first home visit. Patients who did not remember if they have been counselled were given 
a score of zero. 
Results shown in figure 5.6 suggested that in general, there was higher level of satisfaction 
with the medicine information provided to the patients of the intervention groups in 
comparison with those of the control group. The total score was calculated regarding 
satisfaction with information received for all medication. Patients of both groups were mostly 
satisfied regarding the medicine name, purpose and how to use the medicine. 
Figure 5.6 Patient satisfaction with the information provided measured by the SIMS 
questionnaire* duy/ng the . 
fü ct home visit 
q 
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Patients of the intervention group were satisfied about the previously mention areas together 
with the information concerning obtaining further supply and the action needed to be taken in 
case a dose was forgotten. There was a significant difference between the two groups in the 
scores of all the questions except question number 16 (P<0.05 Mann Whitney U-test). 
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5.7 Identification and Classification of Medication-Related Problems 
During the home visits, patient's medication was reviewed by the investigator to identify and 
classify medication-related problems (for the patients in the intervention group) and resolve 
them wherever possible. Also the patients were given the opportunity to express their 
concerns regarding their medication regimen. 
An initial assessment was made by the investigator regarding the MRPs identified. The 
problems were categorized into 16 different classes: 
" Therapeutic failure 
" Side Effects 
" Drug interaction 
" Contraindication 
" Interface issues 
" Dosage problems 
" Knowledge problems 
" Compliance problems 
" Running out of medication 
" Stopping of necessary medication 
" Repeating stopped medication 
" Duplication of medication 
" Using unnecessary medication 
" Storage problems 
" Physical problems 
" Others 
The category others included the usage of expired medication, difficulties in reading labels 
or label mistakes. 
A total of 226 medication-related problems were identified in both groups (101 problems 
assigned to the intervention group) at the first home visit with a mean of 2.3 (S. D= 1.56) 
MRPs/patient. More than half of these problems were assigned to the patients of the control 
group. This total decreased to 152 problems (55 problems identified in the intervention 
group) during the second visit with a mean of 1.92 (S. D= 1.25) MRPs/patients. When the 
percent of the total number of MRPs identified in the intervention group was calculated it 
was found that, the percent of the medication-related problems for the intervention group 
(101/226 x 100) decreased from 45% during the first home visit to 36% during the second 
visit. There was an observed but non-significant difference between the two groups regarding 
the mean of MRPs during the first home visit but a significant difference was observed 
during the second visit (Mann Whitney U-test, P= 0.001). It was difficult to carry out further 
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statistical analysis on the individual categories as the number of observations in each cell was 
very small. To analyse more precisely the true effect of programme of subcategories of 
MRPs, the data was reclassified and analysed using the validate PCNE system described in 
section 2.7. 
5.71 PCNE Classification System 
As described in chapter 2, the PCNE system was chosen as a classification system in this 
study because of its ability to identify the clinically related MRPs and relate them to causes 
and interventions performed, i. e., the system uses three classes; problems, causes and 
interventions. Each category has different basic domains; six primary domains for problems, 
six primary domains for causes and four primary domains for interventions. Each problem 
reported was coded separately; more than one cause or interventions can be correlated to 
each problem. 
5.7.1.1. Classification of the Problems Identified 
Problems were classified under the main six domains and these six domains were re- 
categorized again into 17 different problems (Appendix VI). The percent, calculated by 
dividing the number of problems identified in each category by the total number of problems 
identified in each study group, of the identified problems in each category was calculated to 
make the process of comparison easier. 
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Table 5.13 Classification of the number of the MRPs between the control and the 





Number of Problems (%) 
Visit 2"d Visit 
Intervention Control Intervention 
(n=50) (0=39) (n=40) 
Side effect 21 (15.7) 24 (22.6) 11 (10.8) 15 (24.6) 
Inappropriate drug or form (not most appropriate for 3(2.2) 2(19) 3(2.9) 2(3.3) 
indication) 
Inappropriate duplication of therapeutic group or 1(0.7) 3 (2.8) 2 (2.0) 1(1.6) 
ingredient 
Contra-indication for drug 5 (3.7) 2 (1.9) 2(2.0) 2 (3.3) 
No clear indication for drug use 2 (1.5) 0 (0) 2 (2.0) 0 (0) 
No drug prescribed but clear indication 8 (6.0) 4 (3.8) 3 (2.9) 0 (0) 
Drug dose too low or regimen not frequent enough 12(9.0) 10(9.4) 13 (12.7) 8(13.1) 
Drug dose too high or dosage regimen too frequent 6 (4.5) 5 (4.7) 7 (6.9) 2 (3.3) 
Drug not taken/administered at all 20 (14.9) 12 (11.3) 10(9.8) 11(18) 
Wrong drug taken/administered 12 (9.0) 6(5,7) 9 (8.8) 5 (8.2) 
Potential interaction 2(1.5) 4(3.8) 2(2.0) 2(3.3) 
Patient dissatisfied despite taking drugs correctly 7 (5.2) 8 (7.5) 7 (6.9) 4 (6.6) 
Insufficient awareness of health and disease 25 (18.7) 18 (17.0) 19 (18.6) 4 (6.6) 
Unclear complaints, clarification necessary 6 (4.5) 7 (6.6) 7 (6.9) 4 (6.6) 
Therapy failure for unknown reason 4 (3.0) 1(0.9) 5 (4.9) 1(1.6) 
Total Number of Problems 134 106 102 61 
*Column percent calculated by dividing the number of problems in each category by the total number of 
problems of all the categories in each study group X 100. 
Table 5.13 shows the distribution of the different numbers of MRPs among the patients of 
both the control and the intervention groups at the two domiciliary visits. Some of the 
problems could not be classified under any of the specified problem categories (e. g., storage 
problems and using out of date medication) those problems were classified under "unclear 
complaints, clarification necessary". 
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A total of 240 problems were reported during the fist home visit, 134 (56%) were assigned 
for the control group. The percentage of the identified MRPs in the control group increased 
to 63% (102/163) during the second home visit. Intervention group patients had 106 
problems (44%) during the first home visit and this number went down to 61 problems (37%) 
during the second home visit. The average numbers of problems identified in both the 
intervention and the control groups during the first home visit were 2.1 and 2.7 
problems/patient respectively. This value was almost the same (2.6problems/patient) for the 
control group, but decreased to 1.5 problems/patient for the intervention group during the 
second assessment. 
Side effects were the main problem (19%) patients suffer during the first home visit followed 
by insufficient awareness of the health and disease (18%). The opposite was true for the 
control group during the same domiciliary visit. Side effect kept the same main problem 
intervention group suffered during the second visit. The main contribution to the difference 
observed during the second home visit appears to be "insufficient awareness of health and 
disease" for the control group. 
The total number of identified problems was significantly lower for the intervention group 
during the second home visit (Chi-squared test, DF=1 and P=0.03) but there was no 
difference between the two groups at the second domiciliary visit (Chi-squared test, DF=1 
and P=0.18). Numbers of problems in individual category were too low for performing any 
statistical analysis. 
The problems identified had all arisen since discharge. Inappropriate drugs or regimens all 
related to the taking of medication not on the discharge list e. g., taking of old stock, interface 
issues concerning GPs prescribing and new prescriptions issued by the GPs. Similarly 
interaction/contraindications occurred due to problems with non-discharge medicines. Other 
problems such as side effects are related to both discharge and other medication taken at 
home. 
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Because one patient may suffer form more than one MRP for the same drug, the numbers of 
patients experiencing different problems were investigated according to the PCNE system 
and the results are shown in Appendix XXII. Overall, the incidence follows the same pattern 
as was obtained from table 5.13. 
Table 5.14 Numbers of problems in each MRPs domain identified in the patients of the two 
groups (according to PCNE) 
Number of Problems (%) 
Category 1" Visit 2"" Visit 
Control Intervention Total Control Intervention Total 
P 1. Adverse reaction(s) 21(15.7) 24(22.6) 45 (18.8) 11(10.8) 15 (24.6) 26 (16.0) 
P2. Drag choice problem(s) 19(14.2) 11(10.4) 30(12.5) 12(11.8) 5(8.2) 17(10.4) 
P3. Dosingproblem(s) 18(13.4) 15(14.2) 33(13.8) 20(19.6) 10(16.4)` 30(18.4) 
P4. Drug use/administration 32(23.8) 18(17.0) 50(20.8) 19(18.6) 16(26.2) 35(21.5) 
PS. Interaction(s) 2(1.5) 4(3.8) 6(2.5) 2(2.0) 2(3.3) 4(2.5) 
P6. Others 42(31.3) 34(32.1) 76(31.7) 38(37.3) 13(21.3) 51(31.3) 
P7 (P5+P6) 44(32.8) 38(35.8)* 82(34.2) 40(39.2) 15(24.6)`" 55(33.7) 
Statistical Significant at p<0.05, Chi-squared test 
*Statistical Significant at p<0.01, Chi-Squared test 
According to the PCNE classification system, each group of identified problems is a subclass 
of one of six major domains (Table 5.14). Category domain (P6) Others was the main 
domain patients of both groups experienced during both the first and the second home visits. 
"Drug interaction" problems (P5) was the least frequent problem during both assessments for 
both the intervention and the control groups. More patients from the control group suffered 
from "drug choice and dug use/administration" problems than the patients of the intervention 
groups during the first assessment The numbers of patients in the control group suffering 
from the "dosing problems" and "others" was almost double the number in the intervention 
group during the second home visit. Although there was a small increment (5%) in the 
number of the "dosing problems" in the patients of the control group while moving from the 
first to the second domiciliary visit, this increment was statistically significant (Wilcoxon 
Signed-rank test, P> 0.05). 
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The Chi-squared test was used to compare the difference between the number of problems in 
the control and the intervention with regard to each domain during each assessment. Because 
problem domains P5 has cells with expected counts less than five, a new problem domain 
category (P7) was created by combing P5 and P6 together. 
During the second home visit, the number of the problems in the dosing problem domain for 
the control group were significantly higher than those of the intervention group (Chi-squared 
test, P= 0.02, DF=I ). Adverse drug reactions were experienced by more patients in the 
intervention group than the control group during the two home visits. 
When P5 and P6 were combined together forming P7, a significant difference was observed 
between the control and the intervention groups during both the first (Chi squared test, P= 
0.04, DF=1) and the second assessments (Chi squared test, Pß. 003, DF=l) i. e., patients of 
the control group had more problems than those in the intervention group during both home 
visits. 
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5.7.1.2 Classification of the Causes for the Identified Problems 
Identified problems had 24 different causes to be correlated and these 24 causes are re- 
categorized again under 6 main cause domains. 
Table 5.15 Classification of the different causes of the MRPs between the control and the 
intervention groups (according to PCNE) 
Category 1 
Control 
Number of causes 




Inappropriate drug selection 8(4.3) 4(3.5) 4(2.7) 3(6.2) 
Inappropriate dosage selection 2(1.4) 3(3.5) 3(2.7) 1(1.5) 
Pharmacokinetic problem 4(3. ) 5(3.5) 2(2.7) 3(4.6) 
Synergistic/preventive drug required 4(3.6) 2(2.6) 4(2.7) 1(0) 
Deterioration/improvement of symptoms 2(1.4) 1(0.9) 4(3.6) 2(3.1) 
Manifest side-effect, no other cause 20(14.3) 24(20.7) 7(6.4) 13(2.0) 
New symptom or indication 0(0) 0(0) 0(0) 1(1.5) 
revealed/presented 
Drug underused/ under-administered 8(6.4) 4(2.6) 8(5.5) 6(9.2) 
Drug overused/over-administered 5(5.0) 3(2.6) 7(10.0) 2(3.1) 
Therapeutic drug monitoring required 0(0) 3(2.6) 0(0) 1(1.5) 
Drug abused 1(0.7) 0(0.9) 2(1.8) 0(0) 
Patient unable to use drug/form as 10(7.1) 3(3.5) 7(5.5) 2(6.2) 
requested 
Instructions for use/taking unknown 21(13.6) 12(11.2) 13(12.7) 2(3.1) 
Patient unaware of reason for drug 8(3.6) 5(4.3) 7(4.6) 1(3.1) 
Lack of communication between health 14(12.1) 7(5.2) 9(10.9) 3(6.2) 
professionals 
Patient has difficulties 
0(0) 2(2.6) 1(0) 1(0) 
reading/understanding PIL*# 
Patient forgets to use/take drug 7 (5.0) 10(6.9) 6 (7.3) 7 (9.2) 
*Column percents were calculated by dividing the number of causes in each cause category by the total number 
of causes in each study group X 100. 
**Patient Information Leaflets. 
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Table 5.15 continued classification of the different causes of the MRPs between the control 
and the intervention groups (according to PCNE) 
Category 
Control 
Number of Causes (%) 




Patient has concerns with drugs 2 (1.4) 8 (6.9) 3 (2.7) 3 (4.6) 
Patient suspects side-effects 3 (2.1) 3 (2.6) 3 (2.7) l (l. 5) 
Burden of therapy 0 (0) 0 (0) 0 (0) 2 (3.1) 
Prescribing error (slip of pen) 1(0) 1 (2.6) 0(0) l (o) 
Dispensing error 4(2.9) 4(3.5) 7(6.4) 4(6.2) 
Other reason 3(2.1) 4(3.5) 2(0.9) 2(3.1) 
No obvious reason 15 (9.3) 5 (4.3) 9 (8.2) 1(3.1) 
Total No. of Causes 142 113 108 63 
Total No. of Problems 134 106 102 61 
Table 5.15 shows the distribution of the number of the causes for the different MRPs within 
the control and the intervention groups during the two home visits as classified by the PCNE 
system. More than one cause can be assigned for each problem. There were a total of 255 
causes reported during the first home visit (average of 1.06causes/problem). The main cause 
for the MRPs identified during the first home visit was the "manifested side-effects" (17.5%) 
for both the control and the intervention groups. This was followed by "unknown instructions 
of use and/or administration of the medication". "Lack of communication between health 
professionals" was the third common cause in the control group during the first home visit. 
During the second home visit, 171 causes were attributed to the MRPs with an average of 
1.05 causes/problem. The "lack of instructions of how to use medication" was the main cause 
of the MRPs among the control group followed by "lack of communication between the 
healthcare professionals". Patient education and liaison with the primary healthcare 
professionals managed to overcome many problems in the intervention group. Drug underuse 
and the forgetting to take medication were the second two causes for MRPs after manifested 
side effects. A non-significant difference was observed for the total number of the causes 
between the control and the intervention groups during the first home visit i. e., the number of 
causes were higher in the control group compared to the intervention. A statistically 
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significant difference was observed between the two groups during the second visit (Chi- 
squared test, DF= 3, and P= 0.001). 
The number of causes as classified by the PCNE system decreased dramatically between the 
first and the second home visits for the patients in the intervention group, and this change 
was proven to be statistically significant (Wilcoxon Signed-rank test, P= 0.000) and this was 
expected as the total number of problems decreased as well from the first to second 
assessment. There was an increase in the percent of the causes for the control group from the 
first assessment to the second assessment. 
Table 5.16 Number of different causes domains for the different MRPs identified in both 
groups during both home visits (according to PCNE) 
Number of Causes 
Category 1It Visit 24Visit 
Control 
Cl. Drug/dose selection(s) 40(28.2) 
C2. Drug use process 24(16.9) 
C3. Lack of/or wrong infonnation 43(30.3) 
C4. Patientsfpsychological related 12(8.5) 
Intervention Control Intervention 
39(34.5) 24(22.2) 24(38.1) 
13(11.5) 24(222) 11(17.5) 
26(23.0)" 30(27.8) 7(11.1)** 
21(18.6) 12(11.1) 13(20.6) 
C5. Logistics of drug supply 5(3.5) 5(4.4) 7(6.5) 5(7.9) 
C6. Others 18(12.7) 9(8.0) 11(10.2) 3(4.8) 
No. of Patient 49 50 39 40 
Total No. of Cause Domains 142 113 108 63 
*Cclumn percent was calculated by dividing the number of causes in each cause domain category by the total number of 
causes in each study group X 100. 
** Statistical Significant at p<0.05, Chi-squared test. 
*** Statistical Significant at p<0.001, Chi-squared test. 
When the two groups were compared for any change in the number of cause domains (Table 
5.16) during both visits, a significant difference was only observed for "the lack or wrong 
information "P where the problems caused by "lack of information" in the control group were 
higher than those in the intervention group during both home visits. 
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The percent of the domain C3 "the lack or wrong information" decreased to almost the half 
for patients in the intervention group while moving from the first (23%) to the second home 
visit (12%). This decrease was proven to be statistically significant (Wilcoxon Signed-rank 
test, P= 0.001). For the patients in the control group, there was a significant increase in the 
number of causes of the fifth "logistics of the drug supply" domain between the first and the 
second assessment (Wilcoxon Signed-rank test, P= 0.03). 
5.7.1.3 Classification oflnterventions Performed 
Interventions performed can be classified under one of ten different intervention classes, and 
these ten classes can be combined under four main domains according to the level of the 
intervention. 
Table 5.17 Classification of different interventions after hospital discharge (according to 
PCNE) for the intervention group 
Category Number of Interventions (%)* 
1' Visit (n= 50) 2"d Visit (n=40) 
Prescriber informed only 19 (19.6) 2 (7.7) 
Prescriber asked for information 4 (4.1) 2 (7.7) 
Intervention proposed, approved by prescriber 4(4.1) 0 
Patient medication counselling 62 (63,9) 21 (80.8) 
Spoken to family member/caregiver 4 (4.1) 0 
Dosage Changed l (l. 0) 0 
Other interventions 3 (3.0) 1(3.8) 
Total No. of Interventions 97 26 
Column percent calculated by dividing the numbers of interventions in each intervention category in the study group by the 
total numbers of interventions during each visit X 100% 
Most of the interventions performed (Table 5.17) during both the first and the second home 
visits were either "the patient medication counselling" or "informing the prescriber" about 
the medication-related problems and then the category others. 
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Table 5.18 Classification of the different intervention according to the intervention domains 
(according to PCNE) 
Number of Interventions 
Category (%)` 
1s` Visit 2"d Visit 
11. At prescriber level 27(27.8) 4(15.4) 
12. At patient (or relative) level 66(68) 21(80.8) 
13. At drug level 1(1.0) 0 
14. Others 3(6.1) 1(3.8) 
No. of Patient 50 40 
Total No. of Interventions 97 26 
Column percent calculated by dividing the numbers of interventions in each intervention domain in the study group by the 
total numbers of interventions during each visit X 100%. 
Interventions were performed during the first home visit mainly to overcome two major 
problems; knowledge and interface issues. Interventions at the patient (or carer) level were 
the highest compared to the others during both first and second home visits (Table 5.18). The 
main intervention at the prescriber level was "informing the prescriber" about the changes to 
the patients' medication during their hospital stay to overcome any interface problems and 
resulting from discrepancies between the medication prescribed on discharge and those being 
prescribed post discharge. 
The decrease in the numbers of the intervention domains for the patients in the intervention 
group between the first assessment and the second assessment was statistically significant at 
both prescriber and patient level (Wilcoxon Signed-rank test, P=0.005 and 0.000 
respectively). This decrease agrees with the decrease in the number of problems needing 
interventions from the first to the second assessment. 
5.7.2 MRPs Classification Using Medicine or Service-Relate Effects. 
Because the PCNE system does not quantify the severity of the identified problems and 
because of its inability to consider the service-related problems, medication-related problems 
were further classified using a novel system. This system categorizes the MRPs according to 
its severity into minor, moderate and severe and according to it sources into two categories, 
medicine-related and service-related classes (Section 2.3.7.2). Patients in both intervention 
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and control groups were compared for the rate of the MRPs and the effect of the medication 
review on this rate. 
Figure 5.7 Different categories of the identified MRPs* 
I Control (1 s` visit) 
M %finor   Nloderate Q Severe 
-Numbers on each sector represents the numbers of identified MRPs in each category 
Medicine-related problems were classified into three categories according to the degree of 
the severity to minor e. g., Constipation caused by DHC, patient was not taking the correct 
dose of Lactulose, repeating old Frumil rather than newly prescribed Frusemide, moderate 
e. g., vomiting caused by Tramadol, uncontrolled pain while on Paracetamol, interaction 
between cardiovascular medication and severe e. g., potential overdosing, bleeding while on 
Warfarin, blood pressure was not controlled with the prescribed medication after leaving the 
hospital and dependency cause by Rohypnol). 
When the patients of the two groups were compared for the numbers of the MRPs identified 
in each group, it was found that the total number of problems was higher in the patients of 
the control group compared to the intervention group during both domiciliary visits. When 
the mean numbers of problems was calculated, it was found that the mean numbers of the 
MRPs in the control group (1.73 problems/patient) was higher than that in the intervention 
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patients (1.48problems/patient) during the first home visit .A statistical 
difference was 
observed between the mean numbers of the problems in each group during the second home 
visit (Mann Whitney U-test, P= 0.02). It was difficult to carry further statistical analysis on 
each category due to the small number in each cell, but when the total number of problems 
were compared during both home visits, there were significant differences between the two 
groups (Chi-squared test, P= 0.05 and Pß. 01 respectively). 
The mean numbers of the problems decreased to almost two thirds for the patients in the 
intervention group (0.98 problems/patient) between the first and the second home visit. When 
each group of patients was compared for the changes in the MRPs from the first to the 
second assessment, it was found that there was a significant decline in the number of the 
moderate problems for the patients in the intervention group (Wilcoxon Signed-rank test, 
P=0,004). The number of problems in the other two categories declined as well. The analysis 
as expressed as numbers of patients experiencing one or more problems is shown in 
Appendix XXIII. 
Table 5.19 Different categories of the identified service-related problems 
Category 1', 
Control 






Polypharmacy 0 6 (8.5) 2 (2.5) 1 (2.8) 
Interface Issues 17 (19.8) 6(8.5) 6(7.4) 4(11.1) 
Patient Knowledge 27 (31.4) 29 (40.8) 27 (33.3) 9 (25) 
Physical Difficulty 8 (9.3) 7 (9.9) 7 (8.6) 3 (8.3) 
Label Problems 3 (3.5) 3 (4.2) 6 (7.4) 2 (5.6) 
Compliance and Memory 25 (29.1) 17 (23.9) 26 (32.1) 16 (44.4) 
Storage Problems 6(7.0) 3(4.2) 7(8.6) 1(2.8) 
Total Number of Problems 86 71 81 36 
No. of Patient 49 50 39 40 
Column percent calculated by dividing the numbers of the problems identified in each problem category in 
each study group by the total numbers of problems of the same study group during each visit X 100% 
The second class of this classification system is the service-relate problems. Interface issue 
problems represented problems caused due to poor or lack of communication between the 
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hospital and the primary care professions and lack of explanation for medication changes 
from hospital. This often results in reverting to pre-admission medicines or new medication 
prescribed during hospital stay not being prescribed by the GP e. g., prescribing discontinued 
Frumil instead of the newly prescribed Frusemide and different brands of the same drug 
being used e. g., using both Gliclazide and Diamicron. Physical difficulties included problems 
with opening child-proof containers, taking the tablets out of the blisters e. g., using knife to 
remove Omeprazole capsule from the blisters, difficulties in swallowing tablets e. g., 
Paracetamol tablets and difficulties in using inhalers. Label problems included wrong name, 
strength, dose or frequency on the printed label. Storage problems included improper storage 
conditions (keeping the medication under the sink) and using expired medication. Knowledge 
problems include patient's poor knowledge about their medication e. g., stopping DHC 
because the patient thought she was prescribed it to control sickness not to control pain. 
The mean numbers of problems for the patients in both the control and the intervention 
groups during the first home visit were 1.76 problems/patient and 1.42 problems/patient 
respectively and this difference was not significant (Mann Whitney U-test, P= 0.18). The 
mean number of problems for the control group (2.07 problems/patient) was almost two fold 
the equivalent value in the intervention groups (0.9 problem/patient) during the second visit 
with an obvious statistical difference between the two values (Mann Whitney U-test, P-- 
0.00). 
There was no significant difference between the numbers of problems for the patients of the 
control group in both home visits (Wilcoxon Signed-rank test, P=0.38) but there was a 
significant decline in the number of these problems between the first and the second 
assessment for the intervention patients (Wilcoxon Signed-rank test, P=0.00). 
For completeness, the numbers of patients with one or more service-related problems is 
shown in Appendix XXIV. 
About twenty seven percent of the patients in the control group had identifiable interface 
issues at two weeks after discharge, but only 12% of the intervention group had such 
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problem. However, on the second visit 10-12% had such problems in either group. This may 
indicate that such problems are generally resolved post discharge but may be prevented by 
good communication. 46-49% of the patients in both groups had problems related to their 
lack of knowledge regarding medication. This percent decreased dramatically for the 
intervention group during the second home visit which reflects the effect of counselling and 
patient education the during the first home visit 
5.7.3 Inter Rater Agreement of Medication Related Problem Categories 
As the previously described classification is novel, inter-rater reliability test was used to 
validate this system. 
Table 5.20 Degree ofAgreement between the two raters expressed as mean Kappa score 
Mean Kappa Score 
Category 
Medicine-Related Problems 
(Mean score for both groups) 
Service-Related Problems 
I' Visit 2"° Visit 







(Mean score for both groups) (0.79 Good) (0.77 Good) 
Tables 5.20 represents the rating and the degree of agreement for the different medicine- 
related problem identified in both the control and the intervention groups during both the first 
and the second home visits. Each category was rated independently to identify the degree of 
agreement between the two investigators. It was worth calculating the degree of agreement 
for each group independently to ensure that the investigator was not biased while coding the 
identified problems as she was not a blinded rater. 0.53 was the average kappa value for the 
medicine-related problems indicating a moderate degree of agreement between the two 
raters. Regarding the service-related problems an average kappa value of 0.78 indicating a 




5.8 Hospital Readmission 
Hospital Readmission 
Patients of both intervention and control groups (122 patients) were compared for the effect 
of the hospital discharge planning and medication review on their rate of the hospital 
readmission in a period of six months from the first date of the discharge. 
Table 5.21 Rate of hospital readmission in a period of six months 






Total No. of Patients Readmitted 
Total No. of Patients Readmitted due to MRPs 
Total No. of Females Readmitted 
Total No. of Recruited Patients 
Number of Patients (%) 
Control Intervention 
35 (57.4) 34 (55.7) 
12 (19.7) 14(23) 
8(13.1) 6(9.8) 
3 (4.9) 2 (3.3) 
3 (4.9) 5 (8.2) 
26 (42.6) 27 (44.3) 
6(9.8) 3 (4.9) 
16 (26.2) 18 (29.5) 
61 61 
Table 5.21 represents the number of the patients readmitted to the hospital in a period of six 
month from the date of hospital discharge. The percent was calculated by dividing the 
number of patients admitted by the total number of recruited patients in each group. When 
the patients of the two groups were compared for any difference in the rate of their hospital 
readmissions, it was found that there was no significant difference in this rate (Chi-Squared 
test, DF=1, P<0.05). 
Two third of the readmitted patients in both the control and the intervention groups were 
women. Nine (7.4%) patients were readmitted because of medication-related problems. 
Because of this small number, it was difficult to do any correlation analysis between this 
number and other factors e. g., number of medication, type of medication, gender, patient's 





¢ No statistically significant differences were found between the characteristics of the 
two groups and they were similar in the rate of dropout and other baseline data. 
¢ No statistically significant differences were identified between patients of both the 
control and the intervention groups with respect to their knowledge about their 
medication at baseline. 
> No statistically significant differences were observed between patients of both the 
control and the intervention groups with respect to most of the criteria of the NHP at 
baseline. 
¢ Patient education on discharge resulted significant improvement in patients' 
knowledge and compliance scores as a result of counselling at discharge but further 
education on domiciliary visits resulted in little additional benefit. 
¢ Enhanced discharge planning and patients education showed significant but small 
improvement of some areas of patients' quality of life at two weeks, but there was 
little difference at six weeks. 
¢ Patients receiving structured education about their medications showed significantly 
higher level of satisfaction with the information they received. 
¢ The total numbers of problems was higher in the control group compared to the 
intervention group during both home visits using both the PCNE classification system 
and the medicine and the service-related classification system. 
¢ There was a decline in the number of the MRPs for the patients of the intervention 
group from the first to the second home visit and this number increased in the patients 
of the control group. The major contribution to this difference occurred due to 
improving patient knowledge and compliance. 
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¢ Identified MRPs were classified according to two classification systems; PCNE 
which is a validated system and the medicine and service-related system. The latter 
was validated for reproducibility. 
> Medication review for the patients of the intervention group during the first home 
visit had a significant effect on reducing the number of the MRPs. 
> The main causes for the MRPs were the manifested side-effects, poor understanding 
of instructions of use and/or administration of the medication and lack of 
communication between healthcare professionals. 
> For the intervention group the prescriber was contacted concerning MRPs for about 
34% of patients during the first home visit and about 10% for the second home visit. 
> Medication review for the patients of the intervention group during the first home 
visit had a significant effect on reducing the number of the causes behind the MRPs, 
i. e., interventions performed at the first visit had the most benefit and most of the 
interventions were at the service-related level (knowledge, compliance and interface) 
rather than the clinical level. 
¢ The main interventions performed during the domiciliary visits were the patient 
medication counselling followed by informing the prescriber about the MRPs. 
> The intervention group demonstrated a significant reduction in the moderate NWs 
rather than the minor and the severe problems from the first to the second assessment. 
> Twelve patients of the control group suffered form interface issue problems during 
the first home visit while only half this number in the intervention group suffered 
from the same problem which reflects the importance of the liaison performed by the 
investigator with the GPs immediately post hospital discharge. 
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> Lack of knowledge and poor compliance were the main problems identified using 
medicine and service-related classification. 
¢ Number of patients in the intervention group suffered from knowledge problems 
decreased from 23 during the first home visit to only 8 during the second visit while 
this number kept almost the same for the control group which indicates the positive 
effect of the patient education during the first home visit. 
¢ Medication review for the patients of the intervention group during the first home 
visit had significant effect on reducing the mean number of the MRPs and the total 
number of patients suffering from these problems in the second home visit. 
¢ There was from moderate to very good agreement between the raters of the medicine 
and service-related classification systems which indicates its feasibility to be used as 
a valid classification system. 





CHAPTER 6 DISCUSSION 
CHAPTER SIX 
Patients Characteristics 
In the introduction to this thesis, existing approaches used to improve the services provided 
at the interface between the primary and the secondary care were reviewed in the literature. A 
number of limitations were highlighted and it was concluded that there was a need to develop 
a practical methodology and tool with which to improve the service. This chapter discusses 
the results identified and presented in Chapter Five. 
6.1 The Preliminary Fieldwork and Pilot Work 
The preliminary fieldwork set out to identify and use existing systems available in order to 
improve the pharmaceutical care service provided to elderly patients on their discharge from 
the hospital. This research also set out to identify a practical and feasible methods and tools 
for identification of MRPs which could be utilized by any healthcare member to review 
patients' medication at home. At an early stage, the testing of the method and tool under the 
conditions proposed for this research study, clearly demonstrated that it could be used to 
assess different patients' outcomes. 
6.2 The Main Study 
6.2.1 Patients Characteristics 
The demographic data and its characteristics were examined in Chapter Five in some detail 
mainly to ensure that the study subjects in both groups were well matched. The following 
discussion highlights any differences between the two groups, comparing the results with 
other similar studies in order to assess the generalisability of any findings. 
6.2.1.1 Sample Size 
Due to the twelve-month time-frame allocated for data collection in the main study, a 
manageable and workable sample of patients was recruited according to the time schedule. It 
was difficult to recruit all the patients from the Elderly Care Unit due to the nature of this 
unit, as patients admitted to this unit may be admitted because of factors other than clinical 
e. g., social arrangements required, and their stay and subsequently their discharge depended 
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on resolving such problems. Because of this, the three General Wards were sought to recruit 
further patients. In all, 122 patients met the various inclusion criteria described in Chapter 
Three; sixty one patients were allocated to each group (Table 5.1). The sample size of the 
recruited study subjects in each group was similar to other comparable studies (Begley et al., 
1997 and Mannesse et al., 2000). 
Of the 18 studies that investigated interventions to improve discharge medication issues as 
described in section 1.5, only four contain larger numbers of patients. However, two of these 
(Nazareth eta!., 2001 and Duggan eta!., 1998) did not involve pre-discharge counselling and 
another (Begley et al., 1997) concerned counselling by community pharmacists. The Raynor 
et al. (1993) study did involve counselling and greater numbers of patients, but the patients 
were randomised into four groups and also did not examine the affect of a follow-up 
counselling session. This is therefore one of the largest UK studies involving randomised 
controlled trials of pre-discharge medication counselling. One failing with hindsight was that 
no note was made regarding patients who refused to participate in this study or their reasons 
for refusal. This would have helped to identify any bias in recruitment. However, none of the 
intervention studies in this area reported rates of refusal or described any details of the 
process. 
It was unlikely that any bias was introduced during the sampling process because there were 
no statistical differences between study subjects that completed the study and those who 
dropped out (further discussion in Section 6.6). The dropout rate in this study was quite high 
(35.25%) but this rate was similar to that reported by Sweeney et al. (1989) which also 
studied medication counselling and patients compliance. This dropout rate was higher than 
expected and than what was calculated in the pilot study (20%) which was used in 
calculating the study sample size. This may suggest that more patients should be recruited to 
overcome this difference between the expected dropout rate and the actual rate to make the 
sample size more representative for the whole population. 
The reasons for dropout were the same for both groups and no significant differences were 
reported in the number of patients who completed the study (Table 5.2). Not all of the 
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intervention studies involving medication discharge reviewed in section 1.5 described dropout 
rates. The 19% dropout rate in the first visit in the present study is mirrored in a number of 
other reports; Nazareth et al. (2001) at 20%, Smith et al. (1997) at 20%, Lowe et al. (1995) 
at 11%, Sweeney et at. (1989) at 15% and Anderson (1987) at 16%. Only Begley et al. 
(1997) had a very much lower rate at 7%, whilst that from Home et al. (1995) reported a 
dropout of 33%. There are comparatively few studies that have followed up patients for a 
period more than 14 days and amongst those that did so the present study had a similar 
dropout rates to the 35% by the second home visit, Sweeney et al. (1989) at 34% and 
Nazareth et al. (2001) 28%. The other follow-up study by Begley et al. (1997) has a very low 
rate at only 8%. The reasons reported for dropout in other studies are very similar to those 
described in the present study, with death very high in the list of reasons, as would be 
expected in this patient population. Overall the dropout rate is within the same range as other 
similar studies and no particular bias in the patient population should exist, validating the 
comparison with other studies. 
Four percent of the total number of the present study subjects refused to complete the study 
after signing their consent forms which was somewhat lower than those reported by Walker 
and Pennington (1989) at 24%, although the latter study focused mainly on compliance 
among the elderly in the community rather than the recently discharged patients. The main 
reason given by the patients in the present study for their refusal to complete the study was 
the lengthy pattern of the questionnaires (2 patients). The other reason, was patient's refusal 
to have strangers visiting them at their homes after leaving the hospital (2 patients) and one 
patient became confused and forgot they had entered the study. 
6.2.1.2 Age 
The age range (65-96 years) of the study subjects (Table 5.3) was almost the same as that 
investigated by Bums et al. (1992). In this non-controlled study 56 elderly patients (age 
range 65-98 years) were counselled prior to their hospital discharge by one of the 
pharmacists and then were visited at home five days post discharge for medication review. 
The home visits were performed by either another pharmacist, hospital doctor or hospital 
sister to report the new prescription issued or any changes happened to the patients 
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medication post hospital discharge. The involvement of more than one investigator in the 
home visit may cause the introduction of extra source of variation due to the experience 
variations of the different investigators which in turn would be another variable to be studied. 
The mean age (78 years) in the present study was similar to average ages in other studies in 
the elderly to which this one could be compared. As discussed previously, the studies carried 
out in the 1970s did tend to show a slightly younger range of patients described as elderly, 
owing to the lower age profile at that time, 
6.2.1.3 Gender 
The majority (63%) of the study subjects in this project were females (Figure 5.1) and this is 
also found in other studies examining the area of pharmaceutical care and drug compliance 
which draw on a random population of elderly patients (Grymonpre et al., 1998, Lowe et a7., 
2000b, Thompson and Stewart, 2001b). In all these studies the ratio of male to female varied 
between 1: 2 and 1: 3. The same ration (1: 3) was reported by Enato et al. (2003) although this 
study was carried on the general Nigerian population rather than elderly patients specifically. 
Other studies involving patient medication discharge counseling showed a similar ratio. 
6 2.1.4 Mental Status Questionnaire Scores 
Patients' cognitive function and mental status were assessed in this study using the Mental 
Status Questionnaire (MSQ). The MSQ was designed to be used as a screening tool and any 
score under 21 indicates some cognitive dysfunction. Patients' notes were reviewed to 
exclude those with any recognized cognitive problems or dementia. The main reason for 
excluding this category of patients was that their cognitive problems may affect their ability 
to respond to the questionnaires and they will be unlikely to respond to any intervention to 
directly improve compliance and knowledge. The other reason is that this group might be 
receiving more intensive home care and supervision and they will not get any benefit from 
the counselling sessions provided. Patients in the both control and intervention groups did not 
show any significant difference in their MSQ scores (Table 5.3). 
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6.2.1.5 Disease and Medication 
Patients Characteristics 
Table 5.4 describes the pattern of diseases for which medications were prescribed. The table 
describes the total number of study subjects suffering from different diseases. Cardiovascular 
conditions were the main problems diagnosed in both groups. Similar results were shown in a 
study by Thomson and Stewart (2001a) where elderly patients were interviewed to explore 
their opinions about their receipt of prescription drug information from GPs and pharmacists 
and to determine the medicine information requirement of elderly patients. In this study, 
cardiovascular conditions were also the most commonly identified problems. 
Comparison to other similar studies in terms of the range of medications prescribed is not 
easy as only two of the studies reviewed in section 1.5 gave appropriate details (Begley et al., 
1997 and Duggan et al., 1998) and even they failed to report fully the range of medicines. 
They did describe a similar rate of cardiovascular prescribing at around 50% of patients. The 
two studies reported much higher rates for gastro-intestinal medicines (28-59%) and 
respiratory (45%). Both studies also examined prescribed medication in the patient's 
possession just after discharge and just over half of the medications in the study by Duggan 
et al. (1998) were laxatives which in many cases would have been prescribed by the GP. This 
may also have been true of inhalers used only occasionally and perhaps not prescribed in 
hospital. It is therefore difficult to compare the precise range of medication-related problems 
following discharge in these patients to other studies, but this aspect has not been well 
reported. 
Around half of all the study subjects were diagnosed with hypertension. Infections were the 
second most likely conditions. More than 10% of the study subjects suffered from various 
arthritic conditions which may be a factor affecting patients' physical ability to administer 
their medication which in turn may affect patients' adherence. 
It was common for the study subjects to suffer from more than one condition; the actual 
permutations of the combinations were too large for reasonable analysis to be done but the 
simple Chi-squared test did show that there was no significant difference between the two 
groups for the type and the number of conditions. 
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The study subjects had in their possession an average of seven (range 0-17) prescribed 
medicines on admission. The average number of medications prescribed by the hospital for 
patients to take home was eight (range 2-20). Therefore, the stated aim of achieving fewer 
medication on discharge compared to admission, particularly in the elderly, does not seem to 
have been achieved. The intervention in this study was to counsel patients after discharge 
medicines had been issued, rather than attempt a drug review and potentially contacting the 
prescriber before discharge medication had been arranged. Such a service may have some 
benefits in this group of patients, if only to review the number of medications being taken 
and would be a reasonable area for future research. Some schemes have described a service 
of pharmaceutical care from admission that did consider reducing medication on discharge. 
The study by Pickrell et al. (2001) which attempted such an approach found no reduction in 
number of medicines. Cantrill and Clark (1992) identified a slight increase in number of 
medications on discharge from 3.8 to 4.8. 
In terms of numbers of medications prescribed at discharge compared to other studies, the 
value is in the upper range. Of the 11 studies involving discharge medication where numbers 
of medication are reported, two described a mean of 2-3, six reported 4-5 and three reported 
6-8 medications. The two studies reporting the lowest range were conducted in the late 
1970s-1980s. This may indicate the expansion of therapeutic options since that time. 
The most frequently implicated classes of medications were cardiovascular medication (anti- 
coagulants and diuretics of different types), followed by nonsteroidal anti-inflammatory 
medicines (NSAIDs), then proton pump inhibitors (PPIs) and beta agonists and different 
types of laxatives. Patients were taking fewer OTC medicines than might have been 
expected. This is possibly due to the fact that the types of drugs normally purchased over-the- 
counter were likely to have been prescribed for these category of patients by their GPs 
(Appendix X1X). 
There was no difference between the patients regarding the two groups in the number of used 
Dossett Boxes on admission. These boxes were normally filled by either the patients 
themselves, carers (family or health carer), or their community pharmacists. Patients were 
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using Dossett Boxes mainly because of dexterity or sight problems and inability to take the 
tablets out of the blisters. The other reason for using these boxes is confusion due to 
polypharmacy and patients being unable to take a number of medicines from the blister each 
time. The last reason to consider was patient's poor memory, and from a personal point of 
view, Dossett Boxes may not always help patients with memory problems. This is because of 
the observed tendency for such patients to forget to take any of their medication for a whole 
day, for instance, one of the stroke patients forgot to take her medication which included 
Warfarin from the box for several days, putting her at a very high risk of another stroke. 
6.2.1.6 Types of Community Pharmacists 
The majority (85%) of the patients were dealing with only one community pharmacy, and it 
was either the nearest to their accommodation, the closest to their GPs or the availability of a 
prescription collection services from. This percentage (85%) is similar to that reported by 
Cook (1995) who studied the transfer of information between hospital and community 
pharmacy. In Cook's study, patients who were recently admitted to the hospital were 
interviewed regarding their community pharmacy. Cook reported that 85.8% of the 
chronically unwell patients always use the same community pharmacy. One of the reasons 
for using more than one pharmacy in the present study was the inability of the patients to go 
to the pharmacy by themselves and depending on one of the relatives or carers to collect the 
repeat prescription from any pharmacy. A patient said she would go to Boots in case her 
local chemist would not have all her medication. 
Most of the pharmacies involved in this study were independents (as type of business). 
Patients preferred to deal with such pharmacies rather than the multiples because of a more 
personal services provided. It was commented that they are normally more familiar with their 
customers than the multiple pharmacies, where the pharmacists in charge may change 
frequently. 
Unfortunately, none of the studies involving community pharmacists involved in discharge 
schemes gave any indication of their demographics. For instance, it is possible that regions 
with a high proportion of independent community pharmacies may not be able to offer the 
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type of service compared to those where multiples formed a larger proportion. In terms of 
group matching it does appear that the intervention group involves a higher proportion of 
multiple pharmacies, but the difference is quite small compared to the overall proportion of 
independents. It may have been useful to collect details concerning the type of pharmacist 
running the pharmacy e. g., age, experience etc. as well as their opinions on the advantages of 
the discharge information that they were sent. This is particularly in the light of the 
apparently low level of involvement of the community pharmacists in this study. 
When the community-based pharmacists were contacted to inform them about the nature of 
the present study, it was clear that most of the independent pharmacies kept an accurate 
patient medication record (PMR) for each patient, which was not the case with the multiple 
pharmacies who may be keeping PMRs but not updated versions. The other problem that 
encountered with the multiple pharmacies in this study was dealing with locum pharmacists 
who were there for a short period of time and were not familiar with the regular patients so 
they were not that interested to offer help and if they showed interests, they could not offer 
too much help in the study because of the nature of their jobs. Although the majority of the 
community pharmacists contacted showed interest in the study and a desire to help, of the 58 
pharmacists contacted, only four pharmacists (three independent and one multiple) filled the 
blank medicine information sheet sent to them with the TTOs and gave it back to the patients 
when they were collecting their repeat prescriptions. 
It was not assessed in this study the extent to which the community pharmacists may have 
prevented certain interface issues. They may have been involved in resolving some of these 
problems in the intervention group and have played some part in reinforcing information to 
the patients. It would have been useful to ask the pharmacists to record any involvement with 
the discharge patients. Although this area has been investigated (Begley et a7., 1997 and 
Duggan et al., 1998) more work is needed to quantify their real use of discharge information 
sent by the hospital. 
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62.1.7 Other Characteristics 
Patients Characteristics 
Those patients supervised by carers may have fewer problems (Evans and Spellman, 1983), 
although other studies have not confirmed this observation (Wandless and Davie, 1977). In 
the present study, those patients not predominantly responsible for their medication were 
excluded. None of the study patients including the 13 patients, who admitted receiving help 
from family or carers (Figure 5.2), were totally reliant for day to day assistance. Some 
received an occasional reminder to take medicine or to have the prescription refilled or the 
dossette box prepared. Similarly, for those who received help from a district nurse, only 
those who received visits less that once a week were included in the study. It is worth 
mentioning that most of the patients were living alone, and there was no difference between 
the two groups in this respect. 
This general approach is that taken by nearly all of the other studies concerning discharge 
medication. It would be interesting to construct a study that examined counselling given to 
the patients' carers. In that way it may be possible to examine the schemes that also included 
the elderly with poor cognitive function, a group very rarely studied in this context. 
In general, the patients recruited to this study do have the characteristics of those in other 
published studies concerning discharge medication in the elderly. It is therefore justifiable to 
draw comparisons to such studies 
One of the major drawbacks to generalizing the findings is that the study was conducted in a 
single London teaching hospital and patients were visited in the main in just one Health 
Authority - Lambeth, Southwark and Lewisham (LSLHA). However, patients in the present 
study were recruited from various geographical locations within this health authority to 
ensure diversity. 
With one exception, all the UK studies that examined discharge medication were also only 
conducted through a single site. The patients' characteristics and many of the findings were 
not dissimilar to that found in other studies and it can be argued that the present study is 
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generalizable to other settings in the UK, There is an obvious need for multi-centre studies 
but this is true of much pharmacy practice research. 
63 Conduction of the intervention and assessment 
The process of discussing and reviewing medicines with patients is often termed 
"counselling". Spacing enough time for patients to be counselled by one of the pharmacists 
prior to hospital discharge was a standard discharge requirement in St. Thomas' hospital. 
Practically speaking, pharmacists failed to fulfill this requirement and most of the study 
subjects in the control group admitted receiving no in-depth counselling by the ward 
pharmacist. This may be attributed to various reasons. Firstly, there was a shortage of 
pharmacy staff covering the four elderly wards unit, as there was only one permanent C- 
grade pharmacist and one basic grade pharmacist who is normally rotating in different areas 
for period not longer than nine weeks. Another reason might be the rushed unplanned 
discharge, which does not give pharmacy staff enough time to carry out the counselling 
sessions. A further reason to consider is the pharmacists' beliefs that the patients were on 
these medications for a long time and they did not need any sort of education. 
Asking patients of the control group about the counselling they received and who provided 
such counselling was the only way to gather the information as it was very difficult to keep 
shadowing the ward pharmacist while they were preparing for the discharge. Shadowing the 
pharmacists or asking them directly about their counselling activity may cause some bias and 
at the same time may affect the pharmacist's normal counselling rate by making them 
carrying out more counselling sessions. For the intervention group, each in-patient 
counselling procedure took an average time of about 23 minutes. Thus, to counsel the 61 
patients, it would have involved approximately 24 hours of staff time. It is worth mentioning 
that many patient were observed to be anxious to leave the hospital and they were unsettled 
and sometimes unresponsive to the information provided at the time of discharge, therefore 
providing written information was an effective means of supporting the verbal information. 
Of the intervention studies in the literature very few either describe the structure of the 
session in any detail or noted accurate timings of the session. The counselling sessions 
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themselves seem to be very much of a similar pattern to that used in this study (Appendix II 
and III). The counselling strategy by Cantrill and Clark (1992) covered almost the same 
format and was reported as being delivered in a median of 10 minutes (range 5-40minutes). 
Sweeny et al. (1989) did not employ a checklist, the process seeming to be left up to the 
pharmacist to decide on `explaining the regimen in detail' and no time taken is described. 
Edwards and Pathy (1984) simply stated that they used a `standardized counselling 
procedure'. Similarly, Johnston et al. (1986) mentioned a `15 minute tablet instruction 
session'. Begley et al. (1997) on the other hand described details of the areas covered and 
appeared to include the same material as the present study. A qualitative study by Ryan and 
Chambers (2000) utilized an educational model for conveying information to patients 
concerning their medication. This is based on Knowles principles of adult learning (Knowles, 
1990) where attempts were made to motivate the learners' readiness to learn i. e., discussing 
why it is important that people are aware of certain information regarding their medication. 
The approach was adopted where possible in the present study. No other studies involving 
discharge medication counselling have attempted to describe a model of education. 
Therefore, the approach to medication counselling does appear similar to other discharge 
counselling studies where this has been described, although of a slightly longer duration. It is 
difficult to tell if the extra time would have a great impact of outcome. Most studies also 
included written patient information cards of some form. It could be argued that what is 
being achieved during such sessions is not counselling but simply patient education. A strict 
concordance approach was not adopted, which is closer to a traditional counselling model as 
it addresses the patients own issues regarding medication. This was because such an 
approach would have entailed tailoring the patients' regimen at the point of discharge, which 
would be impractical and outside the remit of this study. The researcher did not attempt to 
explore the patient's feelings towards medication as it would affect compliance. 
It is apparent from the literature that the process of `Discharge Medication Counselling' has 
not been well studied or formalized and does not appear to be grounded in any theoretical 
framework. Further useful educational research could be undertaken in this area. 
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6.4 Domiciliary Visits 
The need for home services was recognized in the Department of Health and Pharmaceutical 
Profession joint working party (DoH, 1992). which stated that "arrangements should be 
introduced to provide domiciliary pharmaceutical services for patients who are unable to use 
the pharmacy in persons", In this section the effect of the structured discharge counselling 
performed prior to hospital discharge and during the home visits is discussed and compared 
with other similar studies. 
6.41 Three and Duration of Home Visits 
Out of the 122 recruited study subjects, 99 patients received one domiciliary visit and 79 
patients managed to complete both the first and second visits. The first home visit was 
planned two weeks after patient discharge from the hospital as every patient received 
medication sufficient for only two weeks. The second home visit was performed four weeks 
(six weeks after the discharge date) after the initial visit as many of the patients would obtain 
a repeat prescription on a monthly basis. 
The total time spent (Table 5.8) to complete all the domiciliary visits (first and second) was 
about 118 hours (about 45 minutes per patient for the first visit and 33 minutes per patient for 
the second follow-up). The first domiciliary visit for the control group took about 39 hours 
(average of 45 minutes per patient) and 22 hours (average of half an hour per patient) for the 
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suffered. It was anticipated that there could be ethical issues concerned with not acting upon 
medication-related problems of the control group patients. To overcome this issue the 
investigator reported any serious problems in the control group to the senior clinical 
pharmacist in the Elderly Care Unit in St'. Thomas' Hospital. In practice, very few MRPs of a 
serious clinical nature, other than poor medication knowledge were noted in either group and 
most of these serious problems were potential rather than actual so that the senior clinical 
pharmacist did not feel that immediate action needed to be taken. During the second home 
visit, the investigator informed the patients of the control group regarding the most serious 
problems and the action needed e. g., contact the GP. 
The second home visit was of shorter duration for both groups, as less time was needed by 
the investigator to be introduced to the patients, and no time was needed to give patients any 
education (for the intervention group only) at the second home visit, which was mainly 
designed for assessment rather than for further education, In a similar study by Al-Rashid et 
al. (2002) where patients recently discharged from hospital were followed-up in their own 
home and an estimate made of the time spent, being one of the few studies where patients 
were counselled both before and after discharge. The pharmacist gave domiciliary visits to 43 
intervention patients and 40 control patients and those visits took approximately 24 hours and 
40 hours respectively excluding travelling time. In Al-Rashid's study, more time was spent 
with the control group patients i. e., one hour per patient because they were given more time 
to correct the mistakes regarding administering their medication, as the researchers 
considered it to be unethical not to correct wrong or missing information. This extra time 
was needed as patients in this group had not been counselled pre-discharge. 
Time spent during the domiciliary visit is critical for economic viability and 30-35 minutes 
seems to be the norm for this type of service offered to the elderly. However, the full cost 
should include an estimate of travel time which does not appear to have been estimated in 
any other studies, and perhaps should have been done so in the present study. It would 
however, have been difficult to generalize the findings as the researcher used public transport 
in London, a situation unlikely if actually delivering a domiciliary service. 
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6.4.2 Patients Compliance 
vbits 
One of the aims of this study was to ensure that some changes to compliance was brought 
about through the discharge procedure and domiciliary visits rather than measuring the 
absolute compliance values. Patients' adherence to the medication regimen was assessed in 
this study using tablet counts and it was calculated as the mean percent score of the total 
number of medicines administered to every patient. 
6.4.2.1 Results from present study 
Compliance is one of the most widely used measures to assess the effectiveness of 
medication counselling and is also used as an outcome measure in other studies involving_ 
medication discharge counselling. Table 5.11 describes the results obtained from tablet 
counts during the first and the second home visits. Compliance was quantified as the 
percentage of the correct amount of medication being administered by the recruited patients. 
The other expression used in this study to quantify compliance was the percentage of the 
compliant or non-compliant patients. There has been much debate concerning the most 
acceptable level of good compliance. 
In the present study, the study subjects were categorized according to their behaviour towards 
their medications into three categories; compliant, overuse and underuse classes. A range of 
85-115% compliance level is adopted as an acceptable range to describe good compliers. 
Study subjects were asked to show all the medications they had at home for the purpose of 
reviewing these medications and they were not informed that their tablets would be counted 
to measure their adherence. Despite the lack of consistent baseline data in the present study 
during the first home visit, the counselled group did appear to do slightly better than controls 
on the initial assessment. The assessment of compliance during the second home visit should 
be accurate as baseline home-stocks were available (from the first home visit) and detailed 
prescribing and dispensing data was available. 
From table 5.1 I, it can be observed that, the mean compliance scores are very high in both 
groups at the various stages of assessment. This has been the finding in a number of other 
studies described in section 1.5 and will be further discussed below. The assumption is that 
236 
CHAPTER 6 DISCUSSION Domiciliary Visits 
patients recently discharged from hospital will have a higher adherence level which declines 
over time as perhaps motivation is reduced. This is not a universal finding and has not been 
properly investigated. The translation of improvement in compliance to clinical benefit is 
also difficult. There are some drug groups and conditions where a tight compliance band is 
important and others where it is of less relevance. 
Table 5.11 does indicate that a 10% better level of compliance compared to control is 
achieved through pre-discharge counselling. After further counselling on the first home visit 
the compliance level by this measure had increased by only a further 5% in the intervention 
group and remained unchanged in controls. In view of the already high compliance level 
there would seem to be little advantage in counselling during a follow-up visit at two weeks. 
It has been described in section 1.4 that there is a consensus that good compliance is within 
the range of 85-115% i. e., outside of this range could have a detrimental effect. If the data is 
analysed as in table 5.12 there is a dramatic effect such that only 55% of control group 
patients are compliant compared to over 70% of the intervention group by this definition. 
The data does seem to support a decline, though non-significant, in the control group over 
time. It also supports the observation that further counselling for the intervention group 
during the home visit provides little added benefit The figures should also be taken in 
context in that although outside the range of 85-115%, many of these patients were just a few 
percent below or above the cut off point, making the true clinical significance difficult to 
quantify. 
No association was found between the number of medications study subjects were prescribed 
on discharge and patients' adherence to their medication during the first home visit. This 
finding supports those found by Blenkiron (1996) where 80 patients aged 75 years and over 
were interviewed to assess their compliance level. However, this study focused mainly on 
patients' compliance in the community. This finding does not support the hypothesis that the 
multiple pathology of aging encourages polyphamiacy which in turn is associated with poor 
compliance (Bums et al., 1992). Age also showed no link with patient's adherence to the 
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medication regimen and this supports the phrase "Non-compliance is a problem for all ages, 
with each group having their own particular problems" (Raynor, 1992). 
5.4.2.2 Comparison to other medication discharge studies 
When comparing these findings to other studies that involved discharge medication 
counselling, a fairly consistent picture is seen of generally high levels of compliance, 
improved still further by the intervention. Not many have examined the effect of a second 
follow-up visit in which counselling also takes place, as in the present study. The identified 
UK studies are discussed below and should be taken in the context of their many 
shortcomings as described in section 5.1. 
Of the non-intervention studies Parkin et al. (1976) reported that, 75% of patients were 
within the 85%-115% compliance level two weeks after hospital discharge, but they did not 
include those who did not understand their regimen, explaining the somewhat higher value 
than the present study. Similarly, Eagleton et al. (1993) reported 78% of patients compliant 
by this definition. This can also be explained as Eagleton et al. (1993) included younger 
patients (age range of 5-75 years) in their study. 
As mentioned previously, Al-Rashid et al. (2002) was one of the few studies to include 
further counselling on a post discharge visit. They chose to express compliance somewhat 
differently as a percent of all items prescribed where compliance fell between 85-115%. The 
problems of using such a method are described in section 1.4, and it is not as useful as 
presenting the data as a mean with standard deviation/confidence intervals or percent of 
individuals reaching a certain mean range with the entire regimen. Using their system, Al- 
Rashid et al. (2002) observed a 30% improvement as a result of further counselling and 
concluded that a follow-up visit was worthwhile. Their compliance rate for controls at second 
visit was just 16% compared to 70% in the intervention group. The first visit only measured a 
50% compliance rate in the intervention group, which is very much lower than any other 
study. 
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The study by Nazareth et al. (2001) did not include discharge counselling as part of the 
intervention, and although patients were visited at home by community pharmacists there 
was no counselling procedure described although they were instructed to correct adherence 
problems. A decline in mean compliance rate was seen being 75% 1-2 weeks after discharge, 
52% at 3 months and 45% at 6 months. This is a similar picture to the control group in the 
present study and supports the observation of declining compliance following discharge. 
Smith et al. (1997) only described competence in terms of the pharmacist `feeling there was a 
problem'. This crude estimate resulted in 85% of patients being rated as compliant in the 
control group and 95% in the intervention group and the 10% difference again reflected in 
the present study. Binyon (1994) only assessed 15% of patients in their prospective single 
cohort study and 73% appeared to have 100% compliance as a result of discharge 
counselling, indicating reasonable levels of compliance. Lowe et al. (1995) calculated a 
mean compliance score in a similar way to the present study showing 95% compliance 10 
days post hospital discharge for the intervention group and 83% for controls again consistent 
to the findings described in this study. 
Although Begley et al. (1997) study involved post discharge counselling using community 
pharmacists their finding were consistent with the present and other studies. Compliance was 
94% at two weeks after the counselling session compared to 76% for controls while the study 
subjects in the present study showed a compliance score of 85% for the intervention subject 
in comparison with 75% for the control group during the first home visit. The community 
pharmacists subsequent visits seemed to show no further effect on compliance as might be 
expected at this very high level. The same findings were identified in the study by Raynor et 
al. (1993) which involved pre-discharge counselling and a great emphasis on information 
sheets. Again mean compliance rates were approximately 10% better in the intervention 
group; 95% compared to control at 86%. One of the reasons explaining the difference in the 
compliance level between the Raynor et al. (1993) study and the present study may be due to 
the difference in age range; while the present study focused on elderly patients, Raynor's 
study recruited a younger population. Also, the study was blinded and tablet counts made 
without the knowledge of the patients. The similar findings to the present non-blinded study 
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go some way to validating the results. Also, if blinding was significant then a generally 
higher compliance level would be expected in the present study. Another explanation for the 
difference in compliance levels between this study and the Raynor's study may be the 
inaccurate assessment of the compliance during the first home visit, due to the possibility of 
using or mixing old and new medications. Other reasons may be the absence of the original 
packs or the original labels with the actual dispensed amounts or keeping more than one 
stock in different locations. This inaccuracy was avoided in the Raynor's study by taking all 
the old medications patients had away and reducing the possibilities of their obtaining a 
further supply from their GPs by providing them with fresh supply. Although there is 
difference between the two studies in the compliance percent, both percent considered to be 
high. An important factor in these relatively high levels of compliance is that the patients 
were recently discharged from the hospital and may be more motivated to adhere to their 
regimens. The study by Edwards and Pathy (1984) also conformed to the usual findings at 
75% for controls and 90% for intervention groups at one week. 
Sweeney et al. (1989) also observed somewhat higher levels of compliance than in the 
present study, measuring this as percentage of patients falling in the 85-115% range. The 
observed 75% of patients compliant at one week post discharge in the control group 
compared with 95% in the intervention group. This 20% difference using patient numbers is 
similar to the 20% difference in the present study though at a lower rate. They observed no 
decline in numbers compliant at six weeks, unlike other studies. 
Horne et al, (1995) reported slightly lower general mean compliance levels at 2 weeks post 
discharge; 67% for controls and 76% for the intervention group, but again a 10% difference. 
Also, consistent with the present study both groups showed a 10% fall at two months, no 
counselling being given at the first home visit. 
6.4.2.3 Conclusions 
In fact, for the stated aims of the present research i. e., to determine the effects of counselling, 
an accurate tablet count to show individual changes in compliance was not required. As both 
groups were randomly allocated and tablets counted in the same way, any errors in 
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assessment of compliance would have been distributed randomly over the whole study 
population. Accordingly, it was more important to determine whether or not the counselled 
group showed any improvement in their adherence level. There was still a small but 
significant improvement in compliance level for the counselled patients six weeks after 
leaving the hospital. This may be attributed to the supported education sessions provided to 
this group two weeks after hospital discharge which emphasized the importance of adherence 
to the medication regimen. While intervention patients showed an improvement in their 
compliance levels, control group patients showed a decline in their adherence level with time 
and this decline in compliance rate over time was also reported in a previous review (Eraker 
et al., 1984). 
Despite the limitations to tablet counts described in section 1.4, the findings regarding 
discharge counselling is very consistent with an improvement of 10-20% at 1-2 weeks post 
discharge. The higher figure is often achieved if compliance is rated by the number of 
patients falling in the range 85-115%. This is despite some studies not being blinded, non- 
randomised and sometimes poorly controlled. Thus, despite the potential sources of bias in 
the present study, consistent results have been found. 
One other limitation of the present study was that only one method of assessment of 
compliance was employed. It would have been more useful also to assess compliance in 
another way such as by questionnaire to further validate the findings. This would however 
have placed an increased burden on the interview time with patients, which was already very 
high. In addition, arrangements to count tablets away from the patients and provide new 
supplies could have reduced bias, but was logistically difficult to arrange. 
In addition to the previously mentioned inaccuracies, tablet counting measures only the 
amount of a drug taken, not whether it was taken at the right time or not. The investigator 
therefore, asked the patients how many times a day they took their medicines, how many 
doses and the actual time they took the medicines. Also the tablet counts were performed 
unblinded by the same investigator (NMS) who delivered the counselling sessions. Although 
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this is a main source of bias, it was impossible to get help from another worker to perform 
the tablet counts and home visits for time and funding reasons. 
Of course the clinical significance of these changes could be debated and will depend on the 
clinical situation. The generally lower levels of compliance in the present study compared to 
some others are difficult to explain, but may be related to the higher numbers of drugs 
prescribed (Section 6.2.1.5). The conclusion is that pre-discharge counselling does improve 
compliance, perhaps maintained by a subsequent home visit, but in terms of a service from a 
dedicated liaison pharmacist such home visits are probably not worthwhile. 
There are further studies that need to be undertaken regarding the most appropriate 
intervention to maintain adherence post discharge. It may well be more appropriate for a 
primary care worker to visit patients some months after discharge to identify those with the 
poorest compliance levels. As mentioned previously, little is known regarding motivations to 
take medication post discharge and the factors contributing to a decline in adherence. 
6.4.3 Patients Knowledge 
6 4.3.1 Results, from the Present Study 
Patients knowledge was assessed by interviewing the patient at his/her bedside using the 
structured questionnaire described in Appendix W. This was calculated as the mean of the 
scores for medication knowledge for each of the eight questions asked divided by the total 
number of medicines prescribed for each patient. The mean score for all the patients in each 
study group was calculated for final comparison between the two groups. The assessment of 
participants' knowledge at the beginning of the study and before starting any education 
programme proved to be a useful method of obtaining key information and base-line 
medication knowledge. 
It is apparent from Figure 5.3 that the study subjects of both groups were well matched in 
their knowledge level before counselling. Results indicate that patients' awareness of 
medication strength and side effects was very poor. These results together with those 
described in previous studies (Williamson et al., 1992, Eagleton et al., 1993 and Thompson 
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and Stewart, 2001 a) have shown information about medication-related side effects to be a 
priority for elderly patients. Patients knowledge regarding the medication name, use, shape 
and dose was quite high (more than 50%) for study subjects in both groups during their 
hospital stay. The main conclusion for these results is the importance of tailoring education 
programmes to meet the needs of the older people including the name, purpose, some of the 
most common side effects, storage and dosage of the drugs. 
The number of medicines patients were taking during their hospital stay did not significantly 
influence (Figure 5.4) the patients knowledge score, i. e., no correlation between the 
composite score of patient knowledge and the total number of medications for each patient, 
but it was observed that those taking 15 medicines showed the lowest level of knowledge and 
patients on two-medicine regimens showed the highest knowledge level. 
At the time of this study, St. Thomas' Hospital approach to providing drug-related 
information to patients for discharge was unstructured and with no standard counselling 
protocol. In addition to the fact that in a busy hospital like St. Thomas' with high patient 
turnover, patients may be inadequately prepared for the discharge and handed their medicines 
immediately prior to discharge, most of the time by the ward nurse. This situation was found 
in other hospitals in the UK e. g., Kent and Canterbury Hospital (Oborne and Dodds, 1993). 
For these reasons, structured counselling sessions were planned for each study patient 
according to his/her needs and enough time was provided for questions and concerns. 
This study was designed to assess discharged patients' behaviours towards the medication- 
related information they received prior to their hospital discharge. The total knowledge score 
was calculated for the total number of patients in each group by summation of the eight 
questions and calculating the mean percent. The patients in the two groups were well 
matched at the baseline level (Figure 5.4) during their hospital stay; there was no significant 
difference between their scores. When the total score for the patients in the two groups 
(Table 5.9) was re-assessed after hospital discharge, it was found that patients' recall of the 
drug regimen was significantly better in the counselled patients in comparison with the 
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control patients, i. e., the total score was higher for the intervention group during both the first 
and the second assessments. 
Patients of the intervention group showed an improvement in the total score during both first 
and second assessments, but this improvement only reached level of significance during the 
first assessment. These results suggest the importance of providing counselling sessions prior 
to hospital discharge rather than during the domiciliary visits. Patients of the control group 
showed a significant decline in the total score in the second assessment. 
When the study subjects were compared for each drug information criterion individually, it 
was observed that in both groups, knowledge concerning the medicine name, purpose and 
shape was high as might be expected in patients who had been taking the same medication 
for a long time. Patients in the intervention groups showed a higher knowledge level with 
regard to all the knowledge criteria except the knowledge about the drug strength on the first 
assessment in comparison with the control group patients (Table 5.9). When the two groups 
were compared for any difference during the second home visit, significant improvement was 
shown for intervention patients' knowledge about their medicine strength, dose, frequency, 
special instruction and side effects. 
When the patients were monitored for any changes in the level of their knowledge after 
leaving the hospital, it was observed that intervention patients showed improvement in all the 
knowledge aspects which reached a level of significance two weeks after their hospital 
discharge. Patients awareness of medications' side effects and special instructions was very 
poor before leaving the hospital i. e., study subjects of both groups showed a very low 
knowledge score regarding side effects and the special instructions prior to the hospital 
discharge. When these two aspects were reassessed during the first home visit, patients in the 
intervention group showed 100% increments in these two aspects. The improvement in these 
scores is probably due to the fact that the investigator focused to a greater extent on these two 
criteria during the counselling sessions. 
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This improvement in intervention patients' knowledge scores after hospital discharge 
indicates the importance of providing patients with structured education sessions prior to 
hospital discharge and tailoring these sessions according to their needs. 
When changes in patient's knowledge were calculated while moving from the first home visit 
to the second home visit, an improvement in intervention patients' knowledge about 
medicine shape, dose, time of administration and the special instructions was reported. 
However, these improvements did not reach any level of significance. Patients in the control 
group showed a decline in their knowledge about medicine strength, dose, time, special 
instructions and side effects during the second assessment. This decline was not statistically 
significant except for drug strength and drug frequency. It might be inferred from this data 
that counselling to improve medication knowledge prior to hospital discharge has some 
benefit, but further counselling after discharge may have a lesser impact. 
No clear association was observed between the number of medicines patients were prescribed 
on discharge and knowledge scores. Also, no linear relationship was demonstrated between 
the adherence pattern and knowledge level. It is interesting to note that patients counselled in 
this study showed increased knowledge and compliance levels, but no relation was proved to 
exist between them. Studies on counselling patients about their medication have shown 
variable effects on both patients adherence and knowledge. Some studies reported an 
increase in both patients knowledge about medication and compliance level (McDonald et 
al., 1977 and Edwards and Pathy, 1984). Another study reported that the poor patient 
knowledge about their medication did not adversely affect their compliance level (Eagleton 
et al., 1993). Similarly, patients in the Michalsen et al. study (1998) showed the highest level 
of understanding for Coumarin and Frusemide; however, their knowledge level was not 
significantly correlated with their compliance with drug treatment. 
Because it is believed that elderly patients suffer from memory problems, it was quite useful 
to provide them with the written information to support the verbal session. Although written 
information cannot take the place of discussions between patients and pharmacists, providing 
patients with written information reinforces these discussions. This may be another reason 
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that the counselled patients in this study showed a higher level of knowledge in comparison 
with the control group patients. 
6.4.3.2 Comparison to other studies involving discharge medication 
As stated previously, it is very difficult to compare studies that report the effect on 
medication knowledge as a result of discharge counselling. This is because of the very 
different scoring and assessment processes employed by the various researchers. Within this 
limitation a comparison to other studies is described below. 
Al-Rashid et al. (2002) noted a high knowledge score (above 85% in their system), for the 
knowledge of medication regarding `dose interval' and `dose taken' at the first visit post 
hospital discharge. They did not assess knowledge at baseline in these two areas and the 
counselled group scored about 10% higher. This equates to the findings in the present study 
regarding the dose and frequency scores. Also, as in the present study no changes in such 
scores were seen between the first and second home visits. The meaning of their term `drug 
use' is not defined but probably relates to special instructions. If this is the case then the 
overall difference of about 30% between groups that they observed is in line with the present 
findings, although their overall scores in this category is very much higher. As this is the only 
study examining directly the influence of a post discharge counselling session, it would seem 
to support the conclusion that knowledge is not improved as a result of the first home visit 
The study did not assess categories such as adverse effects, purpose of medication etc. 
The study by Lowe et al. (1995) focused on knowing the purpose of medication as a marker 
of drug knowledge, although the intervention in this case was a self-administration scheme 
whilst in hospital. This reached the same level as the present study on the 10 day visit at 90% 
correct, but the control group scored just 40% and it is unclear from the paper how the 
percent score was calculated. Although Begley et al. (1997) also offered no detailed 
description of the scoring system used, the control group patients showed a mean of 73% at 
the baseline. It is of interest to note that two weeks after the counselling session there was a 
mean difference of 10% between control and counselled groups, but at one month this had 
246 
CHAPTER 6 DISCUSSION Domiciliary VL its 
not changed despite further counselling. Without knowing the scoring system it is difficult to 
comment on the higher mean level, but the findings are broadly in line with the present study. 
Raynor et al. (1993) assessed knowledge by describing numbers of patients correctly 
answering three questions regarding their regimen; frequencies, dose and correct timing. In 
the present study, timing was not explicitly asked but considered as the frequency of 
administering medication e. g. three times a day, twice a day etc. The composite score seemed 
to show quite a low value of 47% for controls compared to a similar calculation in the 
present study. This improved by over 20% in the intervention group in the Raynor's study. 
This is possibly the result of a more sophisticated individualized information card provided. 
One of the few studies to report no improvement in knowledge was that by Home et al. 
(1993), but no details are provided in their brief abstract. Edwards and Pathy (1984) reported 
better knowledge of regimen after counselling patients recently discharged, but again no 
details were provided on the way that this was assessed. This problem of identifying 
knowledge scores was well illustrated by the abstract from Davidson and Hall (1989) where 
knowledge was just one element of a total `ability score' to manage medicines. They did find 
significant improvements in the score as a result of discharge counselling and reported the 
biggest improvement in knowledge of side effects and knowing the purpose of medication. 
Again, no figures were presented so comparisons are difficult. Even more difficult to 
compare is the study by Anderson (1987) who made a subjective assessment of knowledge as 
being `sufficient', finding that pre-discharge counselling improved the numbers in this 
category. 
Eagleton et al. (1993) provided a useful baseline with which to compare the results in the 
present study. They observed that after discharge more than 85% of patients knew the dose, 
frequency and route of administration only about 10% higher than in the present study. They 
also noted a low level of knowledge of side effects, as only 30% could name a single side 
effect a finding which was reflected in the present study. 
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6.4.3.3 Conclusion regarding knowledge assessment 
visits 
From the limited data available, it does appear that other studies support the findings of the 
present study; knowledge improves as a result of pre-discharge counselling. This is one of 
the few studies that fully examined the influence of further counselling in the patient's own 
home and this seems to have little additional benefit. Future studies will be needed to validate 
a standardized method of evaluating knowledge and clearly define the areas of knowledge 
most difficult to improve or of greatest importance. For instance, although side effects appear 
to be the area of poorest knowledge, the importance of patient awareness of potential side 
effects has not been well evaluated. 
The main limitations of the knowledge assessment involve the non-blinding of the 
interviewer, which applies to most of the assessments in this study. However, the consistency 
of the results compared to other studies would indicate that this may not be a source of bias. 
The system used to assess knowledge was not fully validated, but this is also true of most 
similar studies. It is also the case that patient knowledge was tested without patients looking 
at labels or information cards. It is possible that patients would have taken the tablets 
according to the regimen in practice by reminding themselves of the correct instruction with 
reference to the written information. 
Calculating the percent of the knowledge and compliance for the total number of medicines 
each patient was administered may not have been the most accurate way to describe the data, 
due to the great variation among the number of the medicines each patient was prescribed. 
For instance, if a patient was on two regular medicines and was taking only one medicine 
regularly, this would mean that the average compliance level would be 50%, and if another 
patient was on ten regular medicines and was taking only five out of those ten correctly, 
again the patient compliance would be 50%, but if both patients decided to increase their 
adherence to their medication by taking another one medicine, the first patient compliance 
would be I00% but for the second one it would be only 60%. The same example can 
represent the situation with patient knowledge. This represents one of the limitations against 
generalizing the results in this study. The only strategy that could be employed to overcome 
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this problem is to recruit patients on certain number of medications but this would require a 
longer time to recruit a suitable sample size. 
It can be concluded that, hospitalized elderly patients who received pre-discharge medication 
counselling supported by written information showed more knowledge of the medication 
regimen than their uncounselled counterparts. Post discharge counselling at home did not 
show a significant improvement in patient's knowledge. Ideally, all patients should be 
counselled about their medication before leaving the hospital in order to reduce patient errors 
in medication taking behaviour and improve understanding of the medication regimen. A 
10% improvement in knowledge score was seen in most areas except the special instructions 
where a slightly greater improvement was seen. The poorest area of knowledge was side 
effects and this was only improved by 5% as a result of counseling. 
6.4.4 Quality of Life and Nottingham Heallh Profile 
For the Nottingham Health Profile score, counselled patients showed a lower score (better 
quality) for the following areas. physical mobility, pain, sleep, energy, and social isolation in 
comparison with the control group patients during the first assessment post hospital 
discharge. The scores of the different NHP areas for the two groups were kept more or less 
unchanged during the second assessment (Table 5.10). 
There was no consistent pattern for the changes in the quality of life criteria for the recruited 
patients after leaving the hospital. The absolute differences in scores for pain and physical 
mobility between the two groups at the first visit were not large i. e., only 10% and so it is 
unlikely that in any meaningful sense the patients would have experienced a better health 
status for these parameters. It would have appeared that significant and possibly meaningful 
differences did occur in the areas of sleep, social isolation and energy. It could be argued that 
the greater input in the counselling sessions and follow-up with home visits could have made 
some differences to feelings of social isolation. On the other hand, the control group also 
received home visits and an assessment before discharge. It might be concluded therefore 
that the reduction in medication-related problems at 10 days after discharge contributed in 
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some way towards a sense of well being. However, an examination of the actual medication- 
related problems as in section 2.3.7 does make it difficult to support such a hypothesis. 
Many of the problems are concerned with issues that might not directly affect the patients' 
clinical condition such as medication knowledge, storage etc. rather than major issues such as 
the appropriateness of the regimen side effects or interactions. It is possible that some of the 
interface issues and differences in compliance may have had an influence on the difference in 
the health status of the two groups. It is also difficult to explain why no difference is seen at 
the second visit in what appears to be a worsening of the scores for the intervention scores 
and a slight improvement in the score for social isolation in the control group. Furthermore, 
the improvement in scores, except for sleep, for the intervention group between baseline and 
first home visit failed to reach statistical level of significance. All the study subjects in both 
groups showed a decrease in the sleeping score, which means an improvement in the sleeping 
pattern after leaving the hospital. This improvement was significant for the intervention 
patients only. A common complaint for majority of the patients was inability to sleep during 
their hospital stays. This may be attributed to the fact that patients were sharing the ward 
with at least another seven patients with different sleeping patterns and different needs which 
was reflected on the study subjects' sleeping behaviours. The other reason for the 
improvement in the sleeping pattern was the general improvement in the patients' health by 
the time they were ready to go home. 
Comparison to similar studies is not really possible as the Nottingham Health Profile has not 
been used in the context of medication discharge counselling. Goodyer (1992) did examine 
the effectiveness of counselling given at home to patients recruited through outpatient clinics. 
No change was seen in the scores for the two groups, although the baseline scores were very 
similar in value to those noted in the second assessment in the present study. This does add 
weight to the evidence that the discharge counselling and liaison process in some way 
affected health status. 
A working hypothesis might be that that a combination of fewer MRPs and interface issues 
and improved compliance did lead to an improved health status compared to control group at 
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2 weeks after discharge. It is possible that after this stage other longer term factors regarding 
health status unrelated to the discharge mask any influence of the medication-related issues. 
For instance, sleep in the control group becomes normalized and that for the intervention 
remains at the same level. The lack of statistically significant changes within the intervention 
group from baseline does tend to weaken this argument. On the current data no statistical 
analysis was possible to identify the relationship between these factors and the various NHP 
scores. This is because of the very large standard deviations observed for each of the 
measures, requiring large numbers of patients for statistical comparisons. For the reasons 
explained in section 2.3.3 the NHP was not powered to examine such correlations. These 
results should therefore be taken as pilot data to inform more detailed work in this area in the 
future. 
6.4.5 Patients Satisfaction with Information Provided 
Patient satisfaction is an important measure of how well services are provided and a minor of 
the effectiveness of the programme adopted. It was noted that patient satisfaction is one of 
the important indicators of the quality of care because it reflects whether or not the given 
service is meeting patients' expectations and is consistent with their values (Kucukarslan and 
Schommer, 2002). The Satisfaction with Information about Medicines Scale (SIMS) was 
therefore developed, validated and piloted (Home et al., 2001b). 
Results in Figure 5.6 suggested that, in general there was a very high level of satisfaction 
with the service provided to the patients of the intervention group before and after hospital 
discharge, i. e., study subjects of the intervention group showed a significantly higher level of 
satisfaction with the information provided. Patients of the intervention group scored a median 
of 9 on the SIMS in comparison with a median of zero for the patients in the control group. 
These results differ from those found in a study by Patel et al. (2002) aimed to compare 
patients satisfaction with their medicine information and beliefs about medicines between 
groups of patients who did and did not attend an education clinic provided by a rheumatology 
specialist pharmacist. The SIMS tool was used to measure patient satisfaction with the 
information they received about medicines. Although this study was not randomized, there 
was no significant difference in the patient satisfaction between the two groups where 
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patients in the clinic group scored a median of 14 and those in the non-clinic group scored 
12.5. No definite explanation was given for the similarity between the two groups in SIMS 
score, but it is clear from the high scores reported by the control group (12.5) that the patients 
were already satisfied with the information which means that the education clinic did not add 
very much to what already patients knew regarding their medication. 
Patients of the intervention group were least satisfied with the information provided about 
how to tell if the medicine is working, how long it takes to show an effect and how long they 
need to be on that treatment. Most of the patients in both groups were surprised to be asked 
about the effect of the treatment on their sexual function and a few were embarrassed to be 
asked. 
No apparent relationship between patients satisfaction with the information they received 
about the prescribed medication and either the quality of life or adherence to the drug 
regimen was shown. This may be attributed to the fact that many of the patients had been 
taking medication for many years and their adherence pattern was influenced by the long- 
term use rather than the satisfaction or dissatisfaction with the information. These results 
differ from the findings of Kendrew et al. (2001), which measured satisfaction with 
information in patients with chronic pain. In this study the SIMS questionnaire was used to 
assess the degree of satisfaction with the information. Patients with chronic pain (average age 
of 54 years) were most satisfied with information about obtaining a further supply, how to 
use their medication and its purpose. Self-reported adherence was significantly related to 
satisfaction with the information provided. In this pilot study, patients from the general 
population were assessed and it focused on only one category of patients (patients with 
chronic pain). 
Intervention group considered counselling sessions and the written information provided to 
them to have been helpful. Many of the patients expressed their appreciation that someone 
was keen enough to provide them with such information. Patients of both groups were 
particularly appreciative of the follow-up service they received, as it showed that the hospital 
was still caring about their health, even after they had been discharged. 
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Because the investigator who performed the patient counselling was the same person 
administering the SIMS questionnaire, it has to be taken into consideration that this might 
have influenced the views of some of the participants and their desires to please the 
investigator. It was difficult to ascertain whether the questionnaire measured satisfaction with 
the programme per se or alternatively with the key role played by the investigator in the 
delivery and the management of the programme. This limitation is common to many patient 
satisfaction questionnaires and the only solution to overcome this problem is to have another 
blind interviewer to administer the questionnaire. Due to limited resources it was difficult to 
employ another investigator and the researcher had no alternative but to administer the 
questionnaire herself. In spite of this potential bias, the great difference in patients' 
satisfaction between the control and the intervention patients probably shows a real 
satisfaction and demonstrates success of the education sessions provided to the intervention 
group patients. The other weak point regarding using SIMS in this study is that the score is 
normally calculated for each medicine but because of the fact that the patients in this study 
were taking an average of 8 medications it was difficult to administer the questionnaire for 
every single medicine. Therefore, a single administration to express an average satisfaction 
score for the information about the whole lot of medication patients were taking was 
performed. 
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6.4.6 Identification and Classification of Medication Related Problems 
This study aimed at identifying MRPs in the elderly and classifying them to resolve or 
prevent such problems. Using a non-structured face-to-face interview was an important 
element to identify MRPs in this study. The extent of use of medicines seems to be high as 
expected in this population and the use of prescription drugs seems to be associated with 
substantial incidence of medication-related problems. On an initial assessment for all types of 
MRPs, 16 categories of MRPs (Section 5.3) were identified with a total of 226 problems in 
both groups during the first home visit with an average of 2.3 (S. D= 1.56) MRPs/patient. 
This number went down to 152 problems during the second visit with an average of 1.92 
(S. D=1.25) problems per patient. 
The finding of an average of 2.3 MRPs/patient is lower than those reported in other studies 
using the same methods. It must be stressed on the fact that, this level of problems does refer 
to that found at two weeks post hospital discharge and not problems concerned with 
medication at the point of discharge, which for the purposes of this study were considered as 
zero. For instance, referring to table 5.13 the classification inappropriate drugs, inappropriate 
duplication of therapy, contra-indication and no clear indication means that in the main that 
the patient was taking old stocks of medicines they had at home and do not refer to the 
discharge medications. Also, the cases referring to the drug dose to low/high actually mean 
that either the patient was self-medicating with an inappropriate dose or a GP prescription 
may not have been appropriate. 
In a study carried in the British Virgin Islands (Titley-Lake and Barber, 2000), where a 
comprehensive medication review was carried out on 50 elderly patients, there were 5.9 
problems/patient. In another study carried in USA on 53 non-institutionalized elderly 
patients, there were i1 potential problems/patient (Shimp et al., 1985). The low average of 
the MRPs reported in the present study may be attributed to the fact that patients in this study 
were recently discharged from the hospital and were stabilized on the medication they were 
prescribed. Another reason for these variations in the average number of problems per patient 
from one study to another is the variability of the definition of the MKPs employed in each 
study and the variability of the classification being used to screen these problems, in addition 
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to the use of structured questionnaire as a tool of identifying the different MRPs. The 
different sittings from where the patients were recruited can cause some variation, as the 
patients of the two other studies were recruited by using social services records as the main 
source of identifying the patients. Different community with different medication pattern 
may be another factor. In Shimp et al., (1985) the social drugs (smoking and alcohol) were 
also included in the screening process. Finally, the limited clinical experience of the 
investigator compared to that of the clinical pharmacist or an expert panel used to identify the 
problems may be another contributing factor. This is an important point as the investigator 
was an overseas pharmacist with relatively little clinical experience. Before undertaking the 
project she was trained to UK graduate level in clinical pharmacy by joining the final year 
module at King's College London on that subject. In addition, she took some part time work 
as a pharmacy technician. Therefore, the clinical competence must be viewed as that of a 
newly qualified pharmacist or technician. The advantage of this is that the system was 
assessed assuming the minimal level of seniority involved with the delivery of the service, 
which has large implications for the cost of such a service. The researcher did however refer 
any clinical decisions to the clinical supervisor at St. Thomas' hospital. 
The 16 categories developed in this screening were not designed to be a definitive set of 
categories, but aimed to integrate all the types of MRPs identified. 
As mentioned previously, two different classification systems were employed in this study. 
The PCNE system was chosen because of its ability to classify both the causes and the 
interventions related to the identified problems. Also, this system is more detailed in 
pinpointing a broad range of problems due to large numbers of sub-categories included in 
this system. The PCNE system cannot assess the problems according to the degree of clinical 
severity and for that reason a minor, moderate and severe classification was developed. Some 
of the identified problems did not have direct clinical impact on the patients and could not be 
classified according to a severity scale or even according to the PCNE system. While the 
PCNE system has already been validated, the second system was introduced solely for the 
purposes of this study and the reliability of this system was confirmed as part of this study. 
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6.4.6.1 PCNE Classification 
This hierarchical system comprised separate codes for problems, causes and interventions. 
According to this system, MRPs are defined as "an event or circumstance involving drug 
therapy that actually or potentially interferes with desired health outcomes" (Van Mil, 2003). 
Up to the time of writing this section and after searching the internet using the full Medline 
database through PubMed, Pharm-line website, RPS ePIC Database and the PCNE website, 
there has been no published article concerning the use of the PCNE classification system in 
UK, or using PCNE classification system for classifying of the MRPs identified in elderly 
patients recently discharged from the hospital. 
This system depends mainly on classifying the identified problems on the basis of the 
problems, their causes and the interventions suggested solving these problems. After 
identification of the different problems, each problem was given a code according to the 
PCNE codes. Most of the problems were clear enough to be coded using the system codes, 
but some of the problems failed to be categorized under any of the system problem classes 
(e. g., using expired medications and storing the medicines under the sink in the kitchen). For 
these problems, the investigator had to classify them under the category "others ". This 
problem arose because the system was based mainly on problems with clinical effects. 
Some problems could be classified under more than one problem code, in these situations, 
the system designer (Van Mil) was consulted by sending him the different cases and a 
common code was reached between the investigator and the designer. 
Because each patient may have more than one problem for the same medicine, and also may 
have the same problem because of more than one medicine, classification was performed on 
two bases, according to the number of the problems identified (whether for the same 
medicine or not) (Table 5.13) and according to the number of patients suffering from certain 
problems (Appendix XXII). 
Table 5.13 gives the best summary of the clinically-related MRPs and the effect of the 
intervention. Study subjects of the control group had a higher incidences of MRPs than the 
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patients of the intervention group, and this finding was observed during both the first and the 
second home visits which indicates the importance of introduction of the pharmacist-initiated 
drug regimen review. 
Insufficient awareness of health and the disease was the most common group of problems 
patients in the control group suffered during both the first and the second visits. The 
percentage of knowledge-related problems decreased significantly in the intervention group 
from the first visit to the second visit. During the second home visit, the percentage of this 
problem in the control group was almost three times higher than that in the intervention 
patients. This difference could be attributed to the education and counselling sessions 
patients of the intervention group received prior to hospital discharge and was reinforced 
again during the first home visit. 
Side effects have a relatively high incidence, surprisingly, higher in the patients of the 
intervention group during both visits (22.6% and 24.6% respectively) and no obvious change 
was observed between the first and the second assessments. A likely explanation is that this 
group has been educated and received information regarding side effects which may have 
affected their beliefs about the occurrence of these effects, facilitated recognition of such 
effects and made them more likely to report them. Providing patients with information 
regarding side effects was a sensitive issue as it is widely believed that patients may wrongly 
claim to have certain side effects if they receive any warning about them and this may affect 
their compliance. Shimp et a?. (1985) carried out a study in the field of MRPs and offered 
two valid reasons why side effects in the sample he was studying remained high. First, the 
nature of the symptoms may cause many side effects to be mistaken for symptoms of medical 
illness, and, second, the likelihood that a patient will experience side effects is increased as 
the number of possible offending agents increase. Also, counselling itself may raise patients' 
awareness of side effects. 
These results were similar to those reported in a preliminary analysis of 321 medication- 
related problems identified by Paulin et al. (2002) in 189 patients recently discharged from 
the hospital. The nature and the frequency of MRPs for recently discharged patients in 
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community pharmacies in different countries (Austria, Denmark, Germany, Netherlands, 
Spain and Portugal) were examined. Structured questionnaire was used where the 
pharmacists documented the different interventions performed. The most commonly 
identified problems were uncertainty or lack of knowledge about the medication and side 
effects. Because it was only an abstract, no further details were provided about the nature of 
the problems or the details of the interventions performed to solve the identified problems. 
Many problems such as inappropriate drug/form, drug choice, contraindication, interactions 
and therapeutic failure showed a very low incidence. This low incidence of clinical problems 
can be attributed to the recent hospital review of medication and good attention to 
pharmaceutical care prior to discharge. The higher percent of the absence of a clear 
indication for the medication administered the problem of wrongly prescribed drug and the 
dosage problems among patients of the control group are also reflection of the interface 
issues. They could be attributed to the poor communication between the primary and 
secondary care professionals as many of the GPs were not aware of the changes to patients' 
medication during their hospital stay, which resulted in repeating the old prescriptions or not 
prescribing the new medicines during the hospital stay. 
The PCNE classification system represents one of few systems which have the options of 
classifying the causes separately. According to the PCNE classification more than one cause 
can be assigned for each problem. A total of 255 causes (Table 5.15) were reported during 
the first home visit (average of 1.06causes/problem). This total decreased to 171 causes 
during the second home visit (1.05causes/problem). The "manifested side-effects" were the 
main cause behind the identified problems in both groups (14.3% in the control group and 
20.7% in the intervention groups). This was followed by "unknown instructions of use and/or 
administration of the medication" and then "lack of communication between health 
professionals" in the control group. 
Poor knowledge of use of medication and lack of communication between healthcare 
professionals were the two main causes behind the problems in the patients in the control 
group during the second home visit. This finding demonstrates the importance of the 
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patient's education after discharge from the hospital and the interface liaison between the 
primary and the secondary healthcare professionals which was offered to the patients of the 
intervention group. 
While the 240 detected drug therapy problems during the first home visit generated a total of 
97 interventions, the 166 problems identified during the second home visit generated only 26 
interventions which were grouped into 10 categories (Table 5.17). It was very difficult to 
report the interventions performed for the patients of the control group and the only source 
was what the patients themselves reported. All the interventions performed by the 
investigator were performed by oral information in all the study group patients. It is obvious 
that one type of problems may lead to several kinds of interventions. As mentioned 
previously, to avoid ethical dilemmas, the investigator reported potential serious problems 
identified in the control group to senior clinical pharmacist in the Elderly Care Unit in St 
Thomas' Hospital. 
Two categories of interventions were dominant "patient medication counselling" and 
`prescriber'informed only'. ` vement inpatient understanding of the therapy" which is 
quite similar to "patient mea n counselling" reported to be the main intervention in a 
study by Anderson et al. (20C this study, pharmacy staff in randomly selected Swedish 
community pharmacies used a f-reporting system to register the number and the type of 
the interventions made in relation to medication-related problems. In the Anderson et al. 
study, the MRPs and the corresponding interventions were grouped in relation to the 
prescribed medicines, OTC medicines and persons seeking advice without buying any 
medicines. 
Informing the prescriber of MRPs is the second most important intervention and about 34% 
(17/50) of the intervention group patients required such contact at the first home visit. This 
represents the scale of problems attributed to interface issues. There are two inferences to be 
made: 
1, The contact resulted in a significant reduction of problems as on the second home 
visit as the prescriber needed to be contacted on only four occasions. 
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2. The system of passing information to the prescriber on discharge was not adequate. 
Interventions of low frequency fell under the category others and interventions performed at 
drug level. The PCNE system did not provide special category for interventions at the 
pharmacist's level so all the interventions involving the community pharmacists were 
categorized under others and this was recorded in only four occasions (three during the first 
home visit) where the investigator needed to contact the pharmacist for clarification. One 
pharmacist was contacted to dispense 20mg Fnisemide to be taken once a day rather than 
half tablet of the 40mg. Another pharmacist was contacted to inform him of the wrong 
strength of inhaler dispensed. The third pharmacist was contacted to arrange delivery of the 
medication to housebound patient and finally to report that a wrong antidepressant was 
dispensed. 
One of the aims of this study was to liaise with the community pharmacists and to involve 
them in the medication management process, and although most of the pharmacists who were 
contacted by the investigator stated that they would like to receive relevant information about 
patients attending their pharmacies when discharged from hospital, a weak response was 
noted during the study. Three community pharmacists only interacted with the researcher, 
two during the first home visit. In two cases the community pharmacists contacted the 
investigator to clarify and confirm the changes to a patient's medication post hospital 
discharge after they received a copy of the TTO with the new discharge medication. The 
third case was a home visit made by the community pharmacist to his patient to check 
discrepancies in the strength of the Beclomethasone inhaler he dispensed and to supply the 
patient with the correct one. The investigator phoned this pharmacist to inform him about the 
discrepancies between the strength of the inhaler prescribed and that already had been 
dispensed. 
These findings would lead to the conclusion that the community pharmacists seldom 
participate in the process of medication review and medicine management for patients 
recently discharged from the hospital, although they were contacted by the investigator as 
early in the discharge process and were given the chance to intervene by sending them copies 
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of the TTOs and the other information they may need to monitor the difference between 
hospital discharge information and GPs' prescriptions. This may be due to insufficient time 
for the pharmacist to contribute in this process or obtain the funding to provide other services 
(Bellingnan and Wiseman, 1996). It can be also concluded that the main contribution to the 
differences in the interface issue between the control and the intervention group occurred 
mainly due to better liaison with the GPs rather than community pharmacists. 
PCNE as a system was used in this study to illustrate the effect of pharmaceutical care and 
medication review on lowering the number of the identified medication-related problems 
between the intervention and the control group as well as indicating where interventions have 
been made to resolve these MRPs. 
6.4.6.2 Medicine and Service Related Classification 
As mentioned previously (Chapter 2), the medicine and service-related problem classification 
system is a novel system inspired from another classification used in studies carried out by 
Dean and Barber, (1999) and Gordon et al., (1999) and was adopted in the present study to 
assess the importance of MRPs. There is no published evidence that this classification has 
been used previously in the same context. In this classification system, medication-related 
problems are classified into two major classes according to their sources: those with 
medicine-related effects (depending on the degree of severity) and those with services-related 
effects. Each class is divided into various subclasses and each subclass was given a score 
which was used to weight the medication-related problems quantitatively. In the medicine- 
related category, the minor, moderate and severe scale was used. One of the advantages of 
using this scale is the premise that the scale is simple to use if there are large numbers of 
MRPs for which the significance needs to be measured; this is in addition to the fact that this 
scale enables the investigator to measure the severity of the identified MRPs (Balestrini et 
al., 1999). 
It was found that the two groups (control and intervention) had equal numbers of patients 
suffering from the medicine-related problems during the first assessment, but after reviewing 
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the intervention patients' regimens, this number decreased to almost half during the second 
home visit (Appendix XXIII). 
When the patients of the two groups were compared for the number of identified MRPs in 
each class, it was found that the total numbers of problems discovered was higher in the 
patients of the control group compared to the intervention group during both home visits and 
this supports the results obtained from he PCNE system. When the average number of the 
identified problems was calculated, it was found that the average of the MRPs identified in 
the patients of the control group was higher than that identified in the intervention group 
(1.74problems/patient vs. 1.48problems/patient) during the first home visit. The average 
number of the problems decreased by almost a third for the patients in the intervention group 
(0.98 problems/patient) while moving from the first to the second home visit. 
This dramatic decrease may be attributed to the significant decline in the number of the 
moderate problems identified in the intervention group from the first to the second home 
visit. Patients of the intervention group showed less severe problems during the first home 
visit compared to the control group. This may be due to the immediate communication 
between the investigator and the GPs which may have given them a chance to overcome 
errors. During the second home visit, the number of the severe problems was almost the same 
for both groups; this would confirm the explanation given above, as GPs of the control group 
patients needed a longer time to receive any changes made to their patients' medications. 
The second class of this system is the "service-related problems". Any problem identified can 
be classified under both medicine and service-related problems. The average numbers of 
identified problems for all the patients in both the control and the intervention groups during 
the first home visit were 1.73 problems/patient and 1.44 problems/patient respectively. The 
average number of problems in the control group (2.07 problems/patient) was almost double 
that identified in the intervention group (0.9 problems/patient) during the second visit ('Table 
5.19). 
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Results show that patients' knowledge and compliance were the two main problems for 
patients of both groups during the two domiciliary visits. While the number of knowledge 
problems identified in the intervention patients decreased significantly, the compliance issues 
did not show the same dramatic decline pattern. This finding confirms the absence of a 
positive relation between patients' knowledge and adherence to their regimens. In this study, 
intentional and unintentional non-compliance (forgetting to take medicines) were analysed 
together as one problem because patients do not normally admit their intentional non- 
adherence. Berardo et al. (1994) identified a high proportion of compliance/adherence 
problems in elderly patients who were interviewed about their medications. Similar results 
were reported by Schneider and Barber, (1996) and Foulsham and Goodyer, (1999). Several 
reasons for poor adherence emerged from the home visits including: forgetfulness, poor 
understanding of dosage instructions, fear of the danger of addiction or dependence or side 
effects, loss of confidence in the efficacy of the medicine or belief that there is no need for 
the medicine. 
Physical problems were defined as any personal difficulties that may have affected managing 
the medication effectively. This category included patient's ability to obtain the medicines 
from containers or packs, to use the inhalers properly and sight problems which may affect 
reading labels. There were little differences between groups in the level of physical problems 
during the six-week period of the study. 
Interface issues are any problem demonstrated due to poor communication between the 
primary and secondary care units. This can result in reissuing of a previous prescription when 
the drugs may no longer be required or have been changed, or not prescribing a new therapy 
initiated in the hospital. Some issues are also related to the lack of monitoring illness or 
reviewing medicines. During the first home visit, interface problems in the intervention 
group were about half of those identified in the control group; this emphasizes the 
importance of communication between the different healthcare professionals in the different 
settings (Tables 5.19 and Appendix X XIV). 
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One of the interface issues reported in this study was the absence of clear explanations for 
medication changes from the hospital, leading to patients reverting to pre-admission 
medication. Although GPs and community pharmacists were informed about the study and 
the change to their patients' medication, six patients (Appendix )OV) of the intervention 
group had interface issues during the first home visit and the GPs were contacted again by 
phone to report these changes. The number of patients with interface issues decreased in both 
groups during the second home visit to almost the same for both groups. For the intervention 
group this may be due to the phone calls made by the investigator to confirm the changes 
happened. For the control group patients this may be attributed to the letters sent by the 
hospital which may take more than two week to reach the GPs. These results may indicate 
that such problem can generally be resolved post discharge but can be prevented by good and 
prompt communication between the secondary and primary care settings immediately post 
hospital discharge. 
Another interface issues involved different brands of the same drug being used which could 
result in patients taking both not realizing that they were doubling the dose, e. g., one patient 
was taking Diamicron before his hospital admission and on discharge he was prescribed the 
generic Gliclazide, resulting in the patient was taking both as two different drugs for 
diabetes. 
The third inter&ce issues reported in the present study was reusing (not re-prescribing) 
discontinued medication. One patient was taking Frumil before being admitted to the hospital 
and this was stopped as it contributed to her fall which resulted in her hospital admission. 
Although Frumil was stopped and the GP did not re-prescribe it, the patient insisted on using 
the old stock she had at home and her excuse was that the GP had not informed her about this 
change and she would not stop anything without consulting the GP. The investigator phoned 
the GP to confirm the changes which he was already aware of (through the letter sent to him 
by the investigator) and to inform him about the importance of re-counselling the patient 
regarding the changes that happened to her medication. All these examples demonstrate the 
need to provide the GPs with the information on drugs on discharge, supply, dosage or 
strength changes or discontinuation of certain medication which in turn would help smooth 
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the process of transfer of the patient from the secondary to the primary care. This confirms 
what Sexton et al. (2000) reported: "Effective communication between the secondary and 
primary care is essential for safe and successful prescribing of medication therapy post 
hospital discharge". Lack of such communication may lead to inappropriate prescribing, 
change of formulation or unintentional discontinuation of therapy (Duggan et al., 1998). 
As mentioned previously, although pharmacists on both sides of the interface showed 
enthusiasm to improve communication and to facilitate medicine management across the 
interface, little was offered by the community pharmacists who were given the chance to 
intervene. This may encourage the introduction of primary/secondary care interface 
pharmacists. This role has already started in some hospitals and primary care trusts, e. g., 
Kensington and Chelsea PCT and Hull Royal infirmary where the pharmacist spends half 
his/her time working on interface issues and the other half as a clinical pharmacist 
(Bellingham, 2004). 
All the above mentioned issues suggest that patients are at risk of problems concerning their 
medication when they move between care settings and lack of communication can be one of 
the factors underlying this problem The possible solution to overcome these problems would 
be to follow-up patients after discharge into the community to identify any discrepancies and 
liaise with GPs. 
There was a significant decline in the percent of the identified problems among the patients 
receiving medication review (intervention) and this again cross validates the PCNE system, 
where domiciliary visits can strongly reduce the percent of the MRPs identified in primary 
care. It was difficult to compare the results obtained in this study with other studies because 
of the differences in the classification systems applied. 
A weak point of this section is the fact that the process of identification of the MRPs 
depended mainly on an observational experience and non-structured patient interview which 
is more subjective and may be a source of bias. A more structured interview should be 
designed to guarantee the consistency of the process of identifying the MRPs. 
265 
CHAPTER 6 DISCUSSION Identification & Classification of Medication Related Problems 
To ensure the usability of this classification system, the reliability of the system was 
measured using inter-rater reliability where more than one investigator or rater was involved 
in assessing the new system and the degree of agreement between the two raters is assessed. 
This was performed by a second assessor independently rating the problems identified. All 
the identified problems were written down as a blind electronic copy (Appendix IX) and 
handed to the second investigator with a copy of the different codes to be used in this coding 
process. 
After measuring all the outcomes, and comparing these outcomes during both the first and 
the second home visits, it would be useful to mention that most of the improvements were 
reported during the first home visit rather than the second visit, but it was important to 
conduct the second home visit to report the effects of the interventions conducted during the 
first assessment, as most of the identified MRPs were intervened during this assessment and 
the results were noted during the second assessment. Because of the time limit of this study, 
each patient was reviewed over a period of six weeks from the day of discharge although the 
National Service Framework for Older Patients recommended that all the patients aged 75 
years and over should be reviewed annually and those on four or more medications should 
receive a biannual review. As the average age of the patients in this study was over 75 and 
the average number of medication was 8 medicines/patients, so all the patients should receive 
a third home visit six months post hospital discharge. 
6.4.7 Comparison to Other Similar Studies 
Direct comparisons of the results to UK studies concerning discharged medication is not 
straightforward as most have focused very specifically on interface issues. From the previous 
discussion it does appear that the range of MRPs after discharge are very much the same as 
might be expected in an elderly population, many relating to patient understanding, coping 
with complex medicines and using medication no longer prescribed. However, the range of 
true clinical problems was less in certain categories. For instance, Foulsham and Goodyer 
(1999) found that 20% of patients visited had drug choice problems compared to only 1-2% 
in the present study. Similarly, 60% had administration problems compared to 22% in the 
present study. Even knowledge-related problems were at a lower level with 60% in the 
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Foulsham and Goodyer (1999) study compared to 50% in the present study. This is probably 
related to recent discharge, in that patients will have a higher degree of awareness of 
medication issues whilst in hospital and that clinical and administration issues would have 
been reviewed and resolved in a higher proportion than those not recently discharged. 
Therefore, no detailed comparisons will be described in this section concerning MRPs in 
general within the elderly population. There now follows a more detailed examination of this 
issue related to UK discharge schemes focusing mainly on the interface issues. 
Coleman et al. (2001) assessed errors in discharge advice notes and transcription errors to the 
GP prescribing systems. If the assumption is made that these would eventually translate into 
prescription errors then a comparison to the control group during the first home visit can be 
made. They noted an overall level of such problems as 12% in their study, half the level in 
the present study. The types of problems were similar to those described in Appendix XXVI. 
In terms of old medication not stopped this was 2% compared to 10% in the present study, 
for prescription not changed 3% vs. 6% and incomplete list from the hospital 1% vs. 2%. One 
point not reported in the Coleman et al. (2001) study is the situation where the hospital had 
failed to note regular medications on admission which was an element in 4 cases in the 
present study. This is an important point as there were fewer cases due to this in the 
intervention group. It is probably a result of information sent to the GP/CP in the intervention 
group resulting in a review of the patient's medication, and the advice to patients to 
discontinue any medications taken before discharge unless specifically on the discharge 
medication list. The much lower incidence of interface issues is probably due to the Coleman 
et al. (2001) study involving younger patients on less complex regimens. 
Burns et at (1992) simply classified their interface issues concerning the elderly as to 
whether the GP had made an addition or omission not intended by the hospital, this form of 
classification also included items added but which the hospital were unaware on admission. 
Of the prescriptions issued 2 weeks post hospital discharge 30% had additions and 22% 
omissions. If classified in the same way, the present study would give a value of only 4% 
omissions and 22% additions. This is probably because the Bums et at (1992) study 
calculated the percentage of patients with new prescriptions, whereas this was not assessed in 
267 
CHAPTER 6DISCUSSION Identification & Classification of Medication Related Problems 
the present study and the calculated values of 4% and 22% assume that all patients had a new 
prescription at 2 weeks. This may not be the case and the data was not recorded. The fording 
is consistent in that the additions reported were either what was intended or known to the 
hospital before discharge were a bigger problem than omissions. This trend seems to be 
confirmed by Cochrane et al. (1992a) where they identified 20% of patients had a drug 
stopped compared to 40% having a new drug on returning home. This very high rate of new 
drugs included logical drug substitutions, such as generic/proprietary changes and changes 
for new conditions since discharge not included as problems in the present study. 
The intervention group on first visit had fewer interface issues than controls comprising of 
just 12% of patients. This consisted of 3 patients where an old drug was re-prescribed, 3 
where medication had not been reported on admission and one dose change (Appendix 
XXVI). It does appear that the improved communication and possibly discharge counselling 
reduced the incidence of such issues. This seems to be somewhat better than the intervention 
by Binyon (1994) which involved pharmaceutical care plans and 16% were still taking 
unintended medication. They did record a large number of discrepancies as a result of a 
change in dosage instructions e. g., one in the morning to one daily. This did not seem to be a 
common problem in the current study and may be a result of the fairly recent widespread 
introduction of computerized GP prescribing systems. 
Pickrell et al. (2001) study did not report the details of discrepancies as a result of the 
seamless care study, but the overall level was 11 % of drugs in the intervention group, a 
considerable reduction compared to 70% in controls. However, this involved just 15 patients 
in each group and included minor discrepancies such as generic/proprietary changes. 
The question of the actual impact of discrepancies was investigated by Duggan et al. (1998) 
where a panel judged the importance in a group receiving a seamless care package. Overall, 
32% in the intervention group and 52% in the control group had some kind of discrepancy. 
This was judged by the panel as just 1.6% in the intervention and 3.2% in the control group 
as having a definite adverse effect on the patient. It is therefore likely that the figures 
reported in the present study would be judged to be lower in terms of clinical significance. 
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This must be taken in the context that Duggan et aL (1998) included more categories of 
minor discrepancies than the present study. 
Smith et al. (1997) observed a very high number of discrepancies in their study of around 
50%, although again the criteria for judging them are not clear. They found no difference in 
the intervention group in which information was supplied to the patients to pass on to the GP 
or community pharmacist. This is different to the present study where information was sent 
directly. A-Rashid et al. (2001) study reported discrepancies in 25% of patients in the control 
group at first home visit compared to 5% in the intervention group. The study was similar to 
the present one but they did not report discrepancies at the second visit. 
In summary, it is quite difficult to compare levels of interface issues across the different 
studies due to the very different criteria set to judge such problems. The system used in the 
present study really only examined issues where a drug should have been discontinued, was 
omitted or the hospital was unaware on admission. There is a broad agreement with other 
studies that as assessed two weeks after discharge the interventions do reduce such problems. 
It may have also been useful to have gathered data on more minor discrepancies such as 
propriety/generic name changes. No other study seems to have examined the impact of the 
domiciliary visit on resolving interface issues, but the findings in this study was that six 
weeks after hospital discharge most cases had been resolved with or without an intervention. 
In terms of MRPs in general the findings agree with others that there are a considerable range 
and numbers that benefit from a domiciliary visit, but the taking of old medications 
discontinued by the hospital is a specific issue for the recently discharged patient and may be 
helped by a visit soon after discharge 
6 . 4.8 Inter-rater reliability 
All the identified MRPs were independently rated by two raters and the test-retest reliability 
was studied by calculating the degree of agreement between the two raters for each category 
during both domiciliary visits using the intra-rater (Kappa Coefficient x). The kappa 
coefficient is used where 2 observers classify cases according to whether some finding (in the 
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present study, an error) is present or absent. It was more convenient to perform this test on 
each category separately rather than performing it on all the categories . simultaneously using 
one 10 X 10 matrix. This may be attributed to the variation in the number of cases in each 
category. Also, it was more accurate to perform the test on each study group separately to 
find out if there was any bias from the main investigator during the process of rating as she 
was not blind during this process. There is no value of Kappa that can be regarded 
universally as good or poor agreement but a general guideline (Table 4.1) can be used for 
interpretation of its values. The raters showed a substantial level of agreement when they 
rated the severity of the identified MRPs. According to Landis and Kock (1976), the strength 
of agreement associated with Kappa coefficient between 0.8 and 1 is almost perfect and 
substantial between 0.6 and 0.8. The degree of agreement between the two raters varied 
between fair to very good for both the first and second home visits with regard to the 
medicine-related category with an average of 0.53 (moderate). For the service-related 
category, degree of agreement varied from moderate to very good (Table 5.19) with an 
average of 0.78 (good agreement). Although arbitrary, these divisions provide useful 
benchmarks for discussing the relative strength of agreement between raters. In the light of 
these categories, the present results show that the two raters were able to use this 
classification system with a substantial level of agreement (on average) and moderate to very 
good as the degree of agreement between the two raters for the intervention group suggests 
that the main investigator was not biased during the coding process. 
Due to limited resources, the second rater was the main supervisor of this study which may 
be a potential source of bias. The only approach being adopted to overcome this potential 
bias was to offer blind data to the second investigator (the second rater was not aware which 
patient was control and which was intervention) and the moderate degree of agreement 
results do not suggest any source of bias introduced. The main source of variation between 
the scores of the two raters is likely to be related to two factors: firstly, the variation in the 
clinical experience between the two raters and secondly, the subjective nature of the 
classification system makes it difficult to get a perfect degree of agreement. Finally, the 
variation in the interpretation of the problems is due to variation of the sources from which 
raters obtained their information about the patients' problems. The first rater who is the main 
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investigator had direct contact with the patient and with the problems they suffered and she 
was the one who recorded all the problems and summarized them, while the second rater 
classified the problems according to the written details provided to him. To overcome this 
problem, it would be useful if all the home visits were audio-recorded. Also, it would be 
useful if an expert panel can be elected to carry out the process of the rating or at least to 
have a third party sharing in the process of rating. The other recognized approach is the use 
of a panel to judge the nature and severity of such problems as has been used by a number of 
other studies (Duggan et al., 1998 and Dean and Barber, 1999). This was outside of the 
resources of this study. 
The final message is that a single coefficient (such as kappa) is not necessarily a complete 
description of the relationship between the judgements made by 2 raters. Feinstein and 
Cicchetti (1990) proposed separate indices of positive and negative agreement, and 
demonstrated that kappa is a weighted sum of these 2 quantities. Using 2 indices can reveal, 
for example, that judges agree about the absence of an error, but not on its presence. This 
approach may be seen as analogous to the use of 2 indices, sensitivity and specificity, to 
evaluate the performance of diagnostic tests. It is believed that broader use of the 2-index 
approach to inter-rater reliability is warranted. 
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6.5 Rate of Hospital Readmissions 
Rate of Hospital Readmissions 
Out of the 122 recruited patients, 53 (43.44%) were readmitted to the hospital at one or more 
points during the period of this study (six months). Nine patients (7.4%) were readmitted to 
the hospital due to MRPs. This percent is less than that reported in Col et al. study (1990) 
where 28.2% of the 315 interviewed elderly patients were admitted to the hospital because of 
MRPs. Three (2.5%) cases (one in the intervention group) were related to ADRs (the 
intervention patient had bleeding due Warfarin and vomiting due to Digoxin. the second 
patient had a fall due to diuretics and the third was admitted because of diarrhoea secondary 
to Antibiotics used). This fording was less than that (6.3%) found in the Lindley et al. (1992) 
study, where the extent to which ADRs in elderly patients admitted to hospital due to 
inappropriate prescribing was determined. Warfarin was one of the medicines most often 
implicated in adverse drug reactions hospitalisation in the Col et al. study (1990). Another 
two drug-related hospital readmissions (one in each group) were due to therapeutic failure 
(angina was not controlled in one patient, and the hypertension was not controlled in the 
second patient). The remaining 4 cases (1 in the intervention group) were correlated to 
patient's non-adherence to the treatment regimen (3 cases were exacerbation of COPD due to 
underuse of inhaler or nebulisers, and 1 case was admitted because of pulmonary oedema 
secondary to drug omission). 
There was no significant difference (Table 5.21) between the two groups with respect to the 
number of hospital readmissions and the number of patients readmitted during the period of 
six months. It was difficult to carry statistical analysis on the number of admissions related to 
medicines between the two groups but it was clear that there were fewer drug-related 
readmissions among the intervention group which indicated that hospital discharge planning 
and patient's education may have positive effect on reducing rate of medication related 
hospital readmissions. 
As a final summary of this project, it can be concluded that, hospital discharge counselling 
and a follow-up visits at home post hospital discharge, would ensure that the correct 
medication is being used and the medicines left at home have not been restarted. Compliance 
and patient knowledge could be rechecked and any medication-related problems experienced 
could be monitored and solved. 
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to Limit Research Bias 
This section will discuss three areas of potential bias associated with the present study; 
selection bias, observer bias and participant bias. Some of these areas have been mentioned 
in other sections in the context of the study limitations. They will be considered in terms of a 
description of the sources of the bias and steps that have been taken to limit such bias as well 
as the reasons why any of such limitation could not be easily undertaken. 
6.6.1 Selection Bias 
This may occur when the characteristics of any group differ sufficiently from the other, such 
that they would have a chance of showing differences between them in terms of the various 
outcomes at the baseline. The other aspect of selection bias is that the subjects are not 
representative of the general population, so limiting the application of the results of the study. 
There is also concern that unusual characteristics of the bias selection are not fully identified. 
The selection process of subjects in this study depended to a large extent on the resources 
available to the researcher. The project was time and resource limited and dependent upon a 
single researcher. This meant that a single site only could be used and recruitment process 
performed within the time available to the researcher. To limit any selection bias, the whole 
population of elderly patients meeting the inclusion criteria (Section 4.5.1) was approached 
for inclusion. This meant that patients were not just approached from the care of the elderly 
wards but also from the other general medical wards. It is also possible that if the researcher 
was only available at certain fixed days then a selection bias of the type of patients 
discharged on those days could have occurred. Therefore, care was taken from the researcher 
to be available whenever discharge was planned Monday to Friday every week. 
By the preceding comparison to other studies, no particular selection bias seems to have been 
identified. As described in the earlier sections of the discussion, the age range, sex 
distribution, range of chronic diseases and medication does seem to be similar to elderly 
populations previously studied regarding medication discharge. The number of discharge 
medicines seems to be higher than some others but this does seem to apply to elderly patients 
with chronic condition at the hospital site. From what is proven regarding general levels of 
compliance, medication knowledge and type and numbers of medication-related problems, 
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there does again appear to be no major differences to other similar studies. It is therefore, 
safe to assume that no selection bias in this respect has been introduced. 
The standard approach to ensure selection of matched groups for comparison is by 
randomization as was performed in this study. Again, there does not appear to be any major 
differences between the two groups in terms of the baseline measure taken before 
intervention. One of the NfW measures did statistically differ although it is hard to justify the 
impact of the differences in terms of the various outcome measures. It is also unfortunately 
clear that compliance could not be measured before any intervention. A tablet count could 
not be performed in the hospital, but the study particularly encompassed pre-discharge 
counselling. It is possible that one group was an inherently "different complier" to the other, 
though there is no reason to suppose that to be the case. 
6.6.2 Observer Bias 
The study was not blinded in any respect and would be expected to be a source of number of 
areas of bias as group allocation was known to the observer. It has to be pointed out that even 
if a blinded observer visited subjects it is possible that they would become aware of group 
allocation. For instance, a participant may well describe the counselling session when being 
administered the knowledge questionnaire. The only way to limit much of the observer bias 
may be introduced within the limited resources of the study was to ensure a standardized 
approach to the assessment process and minimize observer's judgments concerning the range 
of quantitative data gathering. 
The knowledge questionnaire was structured such that correct/ incorrect responses were 
recorded. It would have been preferable if the questionnaire was self-administered but this 
proved not to be possible in view of frailty of many of the participants and response rate 
would have been poor. The impact of the counselling session does appear to be similar to 
other studies as discussed earlier in this chapter. 
Tablet counting is an objective measure and the results obtained were so similar to other 
studies, both blinded and non-blinded. It is reasonable to assume that this was not a major 
source of error in the compliance assessment process. 
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Both the NHP and the SIMS are well validated questionnaires that require no judgment by the 
interviewer in recording responses. There is no reason to suppose any suspected observer 
bias to be introduced, but this can not be ruled out and only avoided by blind assessor. 
There are some potential areas of observer bias associated with the identification of various 
MRPs, much relied on the investigator identifying particular problems associated with the 
patients' medication. It is possible that, another rater may have not recognized such problems 
as being presented or perhaps noted additional ones. Further more, the investigator may have 
been biased into reporting a greater number of problems in the control group and less in the 
intervention group. This was minimized by having a second blinded rater reviewed all of the 
cases and recorded judgments according to the classification system being used (section 
2.3.7). In order to accomplish this, all the cases were recorded in a standard format 
identifying the medication list, medical condition as known on discharge and general 
findings on the home visits. This does still rely on the observation of the main investigator. 
For instance, to record the judgment of a MRP being an `inappropriate dose' the researcher 
might recorded `patient taking old stock of medication at different dosage to that on 
discharge' and introducing a potential source for bias. On the other hand, for areas such as 
drug interaction, contraindication, no explicit statements needed to be made by the 
investigator. 
In conclusion, within the limitations of the present study, some of the observer's bias was 
unavoidable. However, consistency of results with other similar studies might suggest this to 
be minimal. 
6.6.3 Participant Bias 
There are a few areas where participant knowledge of the assessment may bias their 
responses. One of the most important in this study concerns the assessment of compliance via 
tablet counts; where study subjects may be tempted to remove tablets just before the home 
visits in a trial to mask potential non-compliance. This can be minimized by not making the 
subjects aware of the tablet counting process. This was achieved by Raynor et al. (1993), 
where tablets were removed for latter counting and subjects were told that was being done to 
provide them with a fresh supply. Such an approach could not be adopted in this study as it 
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was the intention to record GP issued prescriptions to examine interface issues. However, it 
was not mentioned specifically to the patients the purpose of the tablet count. When patients 
were asked to show their medication, the explanation given to them was to record what they 
were keeping at home and `to make sure they had a sufficient supply'. As for the observer 
bias the case agreement with other studies might suggest that this is not a major source of 
error. 
The other source of participant bias lies in the response to questionnaire where it could be 
argued that the patients of the intervention group have built up a better rapport with the 
investigator, thus responding in a way that could tend to `please' her rather than be an honest 
response. This is particularly true of the SIMS questionnaire where the intervention group 
were questioned specifically about the quality of medication information by the same person 
who had also provided the counselling. There is little that could have been done to minimize 
this other than involving an independent assessor to conduct the questionnaire during the 
home visit. The results must therefore be taken with caution and viewed as a pilot for future 
work. 
The same argument may not be applied to the 1VHP as the investigator gave no direct 
information or offered counselling regarding the various aspects of health issues covered by 
the instrument. The investigator built up a similar rapport between the two groups other than 
discussion of the medication. Thus, a quite similar amount of time was spent in the 
assessment process and conversations unrelated to medication. Therefore, there is little 
reason to support that the intervention group would try to present a different health status 
than the control group in order to give a different impression to the interviewer. 
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6.7 Ethical Issues 
The most problematic area of ethical concerns was that of non-intervention in the control 
group. This arose when a MRP was identified during the domiciliary visits within the control 
group where some interventions were necessary. In all such cases, the problems were 
referred to the clinical pharmacist based at the hospital. In most cases, she judged the 
problems were non urgent and no action was taken until the second home visit. In a few 
cases, action did need to be taken. There was also the situation were on questioning there 
were obvious and potentially important gaps in knowledge were observed e. g., concerning 
drug regimen and they had to be corrected by the researcher. These factors may partially 
explain the shift in improvement regarding knowledge and level of MRPs in the control 
group, though to a lesser degree than the intervention group. 
The other important area is in comparing the intervention to the usual care i. e., control group 
patients were deprived of the service. This was discussed with senior hospital staff before 
commencing the study. It was concluded that whilst it was desirable to offer a full medication 
discharge service to all elderly patients, there were not currently the resources to do so 
although the results of the study may encourage further funding. Therefore, this was a service 
provided over and above that given in most hospital in the UK A further related point is that 
the clinical staff were not fully aware of the nature of the study. This was done to minimize 
the potential variable of an increased intervention in the control group by hospital staff. It 
could be argued that is unethical as it is possible all patients may benefit simply from this 
increased awareness. In addition, it is also possible that any increased activity by the hospital 
would fall after few weeks as the novelty of the researcher activities declined. This has not 
been well studied and it was decided that removing the variable would yield more reliable 
data with very little impact on patient's care. However, a general outline of the project was 
presented to all the relevant medical and healthcare professionals in the investigated wards 
e. g., consultants, senior staff nurses and senior pharmacist during one of the regular monthly 
wards meetings informing them about the nature of the study. These meeting did not 
normally involve the basic grade pharmacists or the regular staff nurses. 
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6.8 The Implication of the Study for the Health Service 
The importance of the medicine management approach to patient discharge is well described 
in the Department of Health Document "discharge from hospital: pathway, process and 
practice" (2003). An appendix in this document described the importance of medicines 
management at two levels; the process within the hospital whereby an accurate medication 
history is obtained and the patient prepared for discharge and the interface issues concerning 
communication of information. It describes the approach to the discharge process in relation 
to medicines as well as the common problems encountered such as confusion concerning 
communication of information to the GP. The report describes how better use could be made 
of pharmacists and pharmacy technicians which facilitates the process. Examples are given 
regarding counselling of patients before discharge and pharmacists generated information 
letters to GPs and community pharmacists similar to the strategies involved in this study. 
They also describe how community pharmacists can follow-up recently discharged patients 
and visit them to resolve potential problems and although they imply that this is an 
established service in some part of the UK, there is little evidence that this is the case. 
Therefore, the DoH has recently recognized the areas covered in the present study which are 
of direct relevance to the provision of an NHS service concerning discharge medication. One 
point not considered by the DoH document was the possibility of hospital-based liaison 
worker visiting patients in their own homes, as was examined in this study. When 
considering the implication of the findings of this study for service, a number of points need 
to be addressed: 
9 What are the benefits of the pre-discharge counselling process? 
9 What advantages can be identified concerning the extra information sent to GPs and 
community pharmacists? 
" Was there any advantage in a hospital based liaison worker visiting two weeks post 
hospital discharge? 
" What level of pharmacy practitioner would deliver the service? 
These points can be considered from the various outcome measures. 
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There were measurable benefits from discharge counselling in terms of patient knowledge 
and compliance. However, at two weeks post hospital discharge compliance rates were 
reasonably high in the absence of counselling but the numbers falling between the 85%- 
115% range in the control group compared to intervention would seem to make counselling 
session worthwhile. Knowledge was also high in a number of areas seen in the absence of 
counselling although it improved overall as a result of the provided service. Perhaps more 
attention could be given to those areas of knowledge that were very poor, such as side 
effects. It is also likely that MRPs were reduced as a result of this counselling as related to 
areas such patient's understanding and discontinuing old stock of medication they were 
taking at home. The latter point was seen in the fewer incidences of inappropriate drugs and 
doses in the counselled group at two weeks post hospital discharge. 
The extra information sent to GP and pharmacist may have also had important benefits two 
weeks post hospital discharge in terms of interface issues. Although it is true that a number 
of problems resulted from poor information on admission and the hospital being unaware of 
the regular home medication, it is likely that the advice to take no medication which had not 
been prescribed on discharge unless confirmed specifically by the GP helped the situation 
seen by the much lower incidence of this class of problem in the intervention group. 
However, it does highlight the need to improve medication history taking on admission. It 
can not be identified from this study that letters to the community pharmacists added any 
specific advantage, but their activities were not specifically recorded and further studies 
would be recommended with this aspect. 
It is less clear whether a hospital-based liaison worker offered any specific advantage to the 
service. Further home counselling seemed to maintain compliance levels high for a further 
four weeks, but the longer term maintenance was not assessed. May be it is worth carrying 
further investigation for longer period of time to study the effect on the long-term 
compliance. It is likely that over a year this would fall back to that of the control group. 
Similarly, no particular advantage in improving patients' knowledge was observed during the 
second assessment although again maintained at the high level for a further month. In terms 
of MRPs, it is quite difficult to draw firm conclusion regarding the role of the hospital-based 
liaison worker. Certainly, in many categories there seems to be a trend for further reducing 
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the incidences of MRPs by a domiciliary visits and this may also be a result of the quite high 
number of interventions where the GPs needed to be contacted in the intervention group. 
However, there is also a general decline in the incidence of some NIRPs in the control group, 
though not as great as that in the intervention. One factor may be that after the two week 
period, the discharge letters eventually did get through to the GP system and thus, certain 
issues are resolved. Evidence for this can be seen in the same levels of interface issues for 
control and intervention groups at six weeks. In addition, some of the interventions made by 
the researcher at two weeks did not relate to specific discharge issues but other problems 
identified since discharge. It is debatable whether a community pharmacist or other workers 
would have identified similar problems as opposed to a specific liaison worker. Overall, it 
does appear that a home visit has some benefits in terms of MRPs but many interface issues 
are resolved without such visits. 
There was about half the numbers of drug related re-admissions in the intervention group i. e., 
three in the intervention compared to six for the control, If this was true reduction, it could 
provide strong economic justification for the system. This can be confirmed by a much larger 
study. 
The investigator was trained to the level of proficiency of a junior pharmacist/ senior 
technician. Some problems were identified that needed the specific intervention of a more 
senior clinical pharmacist, although most of the activities could be accomplished without any 
direct involvement of such a person. It was however, very useful to the researcher to have 
access to a senior colleague regarding certain problems identified during the domiciliary 
visit. The important message is that the service can be delivered relatively economically with 
junior staff. 
In summary, the implications for the service are: 
I. A 15 minute counselling session should be incorporated into the discharge plan for 
elderly patients and this can be accomplished by junior staff. It should be conducted to 
a set pro-forma as in this study. 
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2. Letters describing the intended discharge medication and those medications 
discontinued should be sent to GP and nominated community pharmacist. This can also 
be performed by junior pharmacy staff. 
3. A visit should be made to elderly patients at two weeks post hospital discharge but 
there is no need to generally counsel the patients unless there are specific issues 
regarding knowledge/compliance and likely this should reduce the time spent during 
each visit. 
4. The main focus of the domiciliary visits should be in identifying the MRPs, particularly 
as they relate to the use of older stocks of medication and other issues that have arisen 
recently since discharge. 
5. The study could identify no particular advantage of a liaison pharmacist worker in the 
process of domiciliary post discharge as many of the interventions did not require a 
specific contact with the hospital. The domiciliary visits could be equally performed by 
community-based pharmacist. 
6. It would be recommended that trusts concentrate resources on effective discharge 
counselling and improved communication to GPs/CPs rather than an outreach liaison 
worker. This study is the first to identify and classify the full range of MRPs reduced by 
such a system at two weeks post discharge. 
281 
CHAPTER SEVENDISCUSSION Limitation and implication of the Study for Future Research 
6.9 Limitations and Implications of the Study for Future Research 
The issues of the limitations of the study and implications for future research have been 
discussed through this chapter. For clarity these are summarized as bullet points below with a 
cross references to the relevant sections: 
1. The study was restricted to one hospital and one health authority; therefore it cannot be 
assumed that the results are representative of other hospitals and other health authorities 
(Section 6.2.1.7). 
2. Because of the time limit of this study, each patient was reviewed over a period of six 
weeks from the day of hospital discharge but the National Service Framework for Older 
People recommended that all patients aged 75 and over should be reviewed annually 
and those on four and more medications should receive a twice yearly review (Section 
6.4.6). 
3. The limitations of tablet counts in measuring compliance have been previously 
described. It was less convenient to use this technique alone in this study and should 
involve more than one type of assessment to support the results obtained by the tablet 
counts. Patient's self-reporting can be a useful tool in assessing patient's non-adherence 
which is one type of the MRPs (Section 6.4.2.3). 
4. The system used to assess knowledge was not fully validated, but this is also true of 
most similar studies (Section 6.4.3.3). 
5. In this study, the same person intervened and assessed the patients' outcomes, which 
made the study non-blinded (Section 6.4.3.3). The only step that could be taken to 
minimize the suspected bias was to use structured questionnaires. Regarding the 
identified A Ws, two raters assessed the type and severity of these problems to 
minimize the bias. 
6. Calculating the percent of the patients' knowledge and compliance for the total number 
of medication prescribed/patient was not the most accurate way of comparison due to 
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the great variation between the numbers of medication each patient was prescribed 
(Section 6.4.3.3). 
7. It was difficult to ascertain whether the questionnaires measured satisfaction with the 
programme per se or alternatively with the key role played by the investigator in the 
delivery and the management of the programme. This limitation is common to many 
patient satisfaction questionnaires and the researcher had no alternative but to 
administer the questionnaire herself (Section 6.4.5). 
8. Due to the average medication number of 8 on discharge, it was difficult to calculate 
the SIMS score for each prescribed medicine as meant to be and a single administration 
to express the average satisfaction with the information of all of the medication patients 
were taking was performed, which is less accurate than calculating it for each item 
(Section 6.4.5). 
9. The process of identification of the MRPs depended mainly on an observational 
experience and non-structured patient interview which is more subjective and may be a 
source of bias. A more structured interview should be designed to guarantee the 
consistency of the process of identifying the MRPs (section 6.4.6). 
10. Due to limited resources, the second rater was the main supervisor of this study which 
may be a potential source of bias. The only approach being adopted to overcome this 
potential bias was offering blind data to the second investigator (the second rater was 
not aware which patient was control and which was intervention). Variation in the 
degree of agreement between the two raters may be attributed to different sources of 
information available to both raters. It would be more useful if the domiciliary visits 
were audio-recorded. Also, it would be useful if a third party shared in the process of 
rating or using a professional panel (Section 6.4.8). 
In general terms, the study has confirmed the usefulness of pre-discharge counselling as 
found by others. Future research will need to assess the added benefit of medication history 
taking on admission and then assess the full range of MRPs as in the present study. Further 
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work is also needed to identify the potential benefits of community-based pharmacist or 
technician visiting at two weeks post discharge after a patient has had a complete pre- 
discharge counselling service, again assessed in terms of full range of MRPs. 
There are some interesting findings regarding the outcomes of the NIP and this need to be 
confirmed in a large study. It would be useful to examine other quality of life instruments in 
this context. The calculated compliance represents an absolute figure; it would be also 
interesting to examine the effect of patients' beliefs on their compliance and its effect on the 
medication-taking behaviour. Much work is needed to standardize methods of assessing 
medication knowledge and also classify types of interface issues. 
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Summary 
¢ The pharmacist medication counselling programme provided a significant increase in 
patient adherence to and knowledge about the prescribed medication in comparison to 
the patients of the control group. Patient's knowledge was significantly improved 
during the first home visit which emphasizes the importance of counselling prior to 
hospital discharge. 
¢ To improve patient compliance and knowledge of their medication, verbal instruction 
in addition to supplementary written information may prove to be helpful. 
¢ Although patients showed a fairly high level of compliance, medication review and 
patient education in the community can still improve a patient's compliance with 
medication in the short term. 
¢ Patient education prior to and post hospital discharge has little impact on a patient's 
quality of life. 
> Counselled patients showed higher satisfaction with the information provided prior to 
hospital discharge than the control group. 
¢ Patients of the control group showed higher numbers of MRPs compared to the 
intervention group patients during both the first and the second assessments. 
> Side-effects were reported to be high in the intervention group as the process of 
counselling itself may raise patients' awareness of side-effects. 
¢ Insufficient awareness of health and the disease was the most common group of 
problems that patients of the control group suffered from during both the first and the 
second visits. 
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> The two main intervention categories performed to resolve the identified problems 
were "patient medication counselling" and "prescriber informed only". Both 
categories were related mainly to service-related problems rather than clinical-related 
problems. The first intervention dealt with patient knowledge and the second dealt 
with interface issues. 
> Communication between the investigator and the GPs managed to resolve various 
interface issues from reissuing old medications to discontinuation of new medications 
prescribed in the hospital to duplication of medications. 
¢A moderate degree of agreement between two different raters proved that medicine 
and service-related classification is a valid and reliable system to be used as a MRPs 
classification system. 
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Conclusion 
Conclusion 
LA compliance level >85% was found for the patients educated prior to hospital 
discharge in comparison to 75% for patients who did not receive any structured 
counselling. This supports the Alternative Hypothesis which states: "Patients who 
undertake structured discharge scheme have better compliance to medication two and 
six weeks post hospital discharge compared to the control group". 
2. The absence of any significant changes in the patient's quality of life criteria although 
they received hospital discharge counselling, supports the Null Hypothesis which 
states: "Patients who undertake structured discharge scheme show no difference in 
their quality of life post hospital discharge compared to the control group". 
3. A 20% increment in patients' knowledge total score for the patients who received 
counselling sessions prior to hospital discharge, in comparison to only a 5% 
increment in those patients who did not receive any structured education, supports the 
Alternative Hypothesis which states: "Patients who receive intensive education 
session prior to and two weeks after hospital discharge show improvement in their 
medication knowledge about their medication post hospital discharge in comparison 
to the control patients who receive no further education". 
4. Patient knowledge improved after counselling at discharge, but little improvement 
observed after the first home visit. Therefore, counselling post discharge to improve 
medication knowledge may have little benefit. 
5. SIMS average score of 8 for the patients who received structured education in 
comparison with an average score of 1 for non-counselled patients supports the 
Alternative Hypothesis which states: "Structured planned discharge schemes have a 
positive effect on patient's satisfaction for the intervention group compared to the 
control group two weeks post hospital discharge". 
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6. Patients who received the structured discharge scheme and medication review showed 
significant differences regarding the numbers and the types of the medication- 
related problems and the intervention they experienced compared to the control 
group two and six weeks after hospital discharge. 
7. On discharge from the study site, there were relatively few instances of many 
clinically-related problems such as interactions, contraindications and inappropriate 
therapy. This may represent good attention to pharmaceutical care pre discharge. 
8. There was a significant reduction of potential MRPs in the intervention group which 
could be attributed to a poor knowledge of health and disease. This may be a 
reflection of the counselling process. 
9. There appears to be a slight increase in reporting ADRs in the intervention group. 
This may be due to improvement in patient knowledge regarding such problem. 
10. About 25% of the patients in the control group had identifiable interface issues two 
weeks post hospital discharge, but only 12% of the intervention had such problem. 
However, at the second visit about 10% had such problem in either group. This may 
indicate that such problems are generally resolved post discharge but may be 
prevented by good communication and counselling pre discharge. 
11. For the intervention group, the prescriber was contacted concerning MRPs for 34% of 
the patients after the first home visit and about 10% at the second home visit. 
12. Structured discharge counselling with a single follow-up visit is to be recommended 
to resolve interface, compliance and patient education issues. 
13. The study produced an effective tool for use in counselling patients both pre and post 
discharge. 
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14. The study produced a validated novel system for identifying and quantifying a range 
of medication-related problems related to the discharge processes. 
15. Closer communication is required between the hospital and the community health 
care professionals to ensure the continuation of the correct treatment. 
16. Patient's follow-up after discharge into the community and liaising with General 
Practitioners has the benefit of reducing any discrepancies between the medications 
prescribed in the hospital and those prescribed in the community. 
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Mental Status Questionnaire 




Time (to nearest hour) 0/1 
Name & Address for 5 minutes recall 
This should be repeated by the patient to ensure it has been heard correctly 
Mrs. John Brown 0/1/2 
42 West Street 0/1/2 
Gateshead 0/1 
Day of the Week 0/1 
Day (correct day of the month) 0/1 
Month 0/1 
Year 0/1 
Place: Type of Place (i. e. Hospital) 0/1 
Name of hospital 0/1 
Name of Ward 0/1 
Name of town 0/1 
Recognition of Two Persons (doctor, Nurse, ect. ) 0/1/2 
Date of Birth (day & month sufficient) 0/1 
Place of Birth (town) 0/1 
School Attended 0/1 
Former Occupation 0/1 
Name of Wife, Sib or Next of kin 0/1 
Date of World War I (year Sufficient) 0/1 
Date of World War II (year Sufficient) 0/1 
Name of Present Prime Minster 0/1 
Months of Years Backward 0/1/2 
Count 1-20 0/l/2 




Patient Counselling Check List 
No: Ward: Bed: 
Name: 
DOB: / /19 DOA: / /200 
Date: / /200 
Gender: D Male[] Female 
Address: 
Postal Code: 110011 0EIII 
Tel No: 
Name of GP: 
Address of GP: 
Phone Number: 
Address of Community Pharmacy: 
Phone number: 
Diagnosis/Drug Sensitivity/Allergy 
Date of Planned Discharge: / /200 
Time: 
Date of Writing TTO: / /200 
Time of writing TTO: 
Discharged Patient is: 
Q Medication self-administering 
El Medication Supervised 
Destination: 
Q Home Q Nursing Home 
DResidential Home LiCommunity centre 
Q Others 
Date of Dispensing TTO: / /200 




b. c. d. 
f. g. h. 




Date of Counselling: / /200 Time counselling started: Time counselling 
finished: 
Information Given: 
Drug 1 Drug 2 Drug 3 Drug 4 Drug 5 Drug 6 Drug 7 Drug 8 Drug 9 Drug 10 
Name: Q Q Q QQ Q Q Q Q Q 
Why: Q Q Q QQ Q Q Q Q Q 
New Medicines 
Q Q Q QQ Q Q Q Q Q 
Strength: Q Q Q QQ Q 0 Q Q Q 
Dose & Frequency 
Q Q Q QQ Q Q Q Q Q 
Time (how should it be timed with meals & other medications): 
Q Q Q QQ Q Q Q Q Q 
Instructions & Precautions: 
Q Q Q QQ Q Q Q Q Q 
Common Side Effects & What to do if they occur: 
Q Q Q QQ Q Q Q Q Q 
Duration of courses 
Q Q Q QQ Q Q Q Q Q 
Forgotten DoseQ Q Q QQ Q D Q Q Q 
Further Supply: Q Disposing: Q Written Information: Q 
The Same Pharmacy: Q Regular Visits to GP: Q Stop Old Medication: Q 
Give Patient Opportunity to Ask(Write What the patient will ask) 
Patient Recall: 
Repeat Purpose of each Medication: 
Q Correct 0 Incorrect Q Some 
Repeat Dosage Instruction- 
D Correct 13 Incorrect O Some 





Nottingham Health Profile 
No. Name: Date: Visit No. 
Listed below are some problems people may have daily. Look down the list & put a tick in the box 
under YES for any problem you have at the moment. Tick the box under NO for any problem you 
don't have. Please answer every question. If you are not sure whether to answer YES or NO, tick 
whichever answer you think is more true at the moment: 
I'm tired all at home: 0 Yes 0 No 
I Have pain at night 0 Yes 0 No 
Things are getting me down 0 Yes D No 
I have unbearable pain 0 Yes 0 No 
I take tablets to help me sleep 0 Yes U No 
I've forgotten what is like to enjoy myself 0 Yes 0 No 
I'm feeling on edge Q Yes D No 
I fmd it painful to change position Q Yes Q No 
I feel lonely 0 Yes Q No 
I can only walk about indoors Q Yes 11 No 
Ifmd" it hard to bend DYes QNo 
Everything is an effort Q Yes Q No 
I'm waking up in the early hours of the morning 0 Yes Q No 
I'm unable to walk at all Q Yes 0 No 
I'm finding it hard to make contact with people 0 Yes Q No 
Remember if you are not sure whether to answer "Yes" or "No" to a problem, tick whichever answer 
You think more true to the moment. 
The days seem to drag Q Yes Q No 
I have troubles getting up & downstairs/steps 11 Yes 0 No 
I find it hard to reach for things Q Yes Q No 
I'm in pain when I walk 0 Yes Q No 
I lose my temper easily these days Q Yes Q No 
I feel there is nobody I'm close to El Yes Q No 
I lie awake for most of the night Q Yes Q No 
I feel as if I'm losing control Q Yes Q No 
I'm in pain when I'm standing Q Yes Q No 
I find it hard to dress myself 0 Yes 13 No 
I soon run of energy 0 Yes Q No 
I find it hard to stand for long (e. g. at the kitchen sink, waiting for the bus) 
Q Yes Q No 
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I'm in constant pain 0 Yes 0 No 
It takes me a long time to get to sleep 0 Yes 0 No 
I feel I'm a burden to people 0 Yes 0 No 
Worry is keeping me awake at night 0 Yes 0 No 
I feel that life is not worth living 0 Yes 0 No 
I sleep badly at night 0 Yes 0 No 
I'm finding it hard to get on the people 0 Yes 0 No 
I need help to walk about outside (e. g. walking aid or someone to support me) 
0Yes El No 
I'm in pain when going up & down stairs/steps 0 Yes O No 
I wakeup feeling depressed 0 Yes 0 No 
I'm in pain when I'm sitting 0 Yes 0 No 
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Scoring System- Nottingham Health Profile 
Code Question Weighting Code Question Weighting 
EN 1 1 39.26 EM 4 20 9.76 
P1 2 12.91 S03 21 20.13 
EM 1 3 10.47 SL 3 22 27.26 
P2 4 19.74 EM 6 23 13.99 
SL1 5 22.37 P5 24 8.96 
EM 2 6 9.31 PM 6 25 12.61 
EM 3 7 7.22 EN 3 26 24.00 
P3 8 9.99 PM 7 27 11.20 
Sol 9 20.01 P6 28 20.86 
PM 1 10 11.54 SL 4 29 16.10 
PM 2 11 10.57 S04 30 22.53 
EN 2 12 36.80 EM 7 31 13.95 
SL 2 13 12.57 EM 8 32 16.21 
PM 3 14 21.30 SL 5 33 21.70 
S03 15 19.36 S05 34 15.97 
EM 4 16 7.08 PM 8 35 12.64 
PM 4 17 10.79 P7 36 5.83 
PM 5 18 9.30 EM 9 37 12.01 





No: Name: Date: Time: 
Were you taking any pills/tablets before coming to /after leaving the hospital? 
Q Yes Q No 
Do you remember how many types ofpills you were taking? 
Q Yes Q No 
Do you know the names of the medicines you are taking? 
0 Yes 0 No USome 
Drug 1: 
............................ Drug 2:........................... . Drug 3: 
............................ Drug 4: ............................ Drug 5: 
............................ Drug 6:............................ Drug 7: 
............................ Drug 8:............................ Drug 9: 
............................ Drug 10: ........................ 
Do you know the reasons for taking the medicines? 
Q Yes Q No LiSome 
Drug 1: 
............................ Drug 2:............................ Drug 3: 
............................ Drug 4:............................ Drug 5: 
............................ Drug 6:............................ Drug 7: 
............................ Drug 8:............................ Drug 9: 
............................ Drug 10........................ . 
Do you know what the medicines look like? 
Q Yes 0 No 
Drug 1: 
............................ Drug 3: 
............................ Drug 5: 
............................ Drug 7: 




............................ Drug 4: 
............................ Drug 6: 
............................ Drug 8: 
............................ Drug 10: 
........................ 
Have any of your medicines been altered since admission to the ward/discharge? 
Q Yes Q No Q1 don't know 
Have you been prescribed any new medication since hospital admission/ discharge? 
Q Yes Q No QI don't know 
Do you know the Strengths of the medicines? 
O Yes 0 No 
Drug 1: 
............................ Drug 3: 
............................ Drug 5: 
............................ Drug 7: 




............................ Drug 4: 
............................ Drug 6 
............................ Drug 8: 
............................ Drug 10: 
........................ 
Do you take your tablets at special time each day: 
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Q Yes Q No 
Do you know the quantities of the medicines taken with each dose? 
0 Yes 0 No Q Some 
Drug 1: ............................ 
Drug 2: 
............................ 
Drug 3: ............................ 
Drug 4: 
............................ 
Drug 5:.. .......................... 
Drug 6:............................ 
Drug 7 ............................ 
Drug 8:............................ 
Drug 9: ............................ 
Drug 10:........................ 
Do you know the times of administration? 
D Yes Q No 
Drug 1: 
............................ Drug 3: 
............................ Drug 5: 
............................ Drug 7: 




............................ Drug 4: 
............................ Drug 6: 
............................ Drug 8: 
............................ Drug 10: 
........................ 
Do you know any specific instructions regarding the medicines? 


















Do you know any medication shouldn't be taken in conjunction with yours? 
Q Yes Q No Q Some 
Do you know the most common or most serious side effects? 

















Do you know what to do if side-effects occur? 
Q Yes Q No 
Do you know what to do if you forget to take drugs? 

















Can you read this label? 
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Q Yes 0 No 
Can you open this bottle? 
Q Yes Q No 
Can you count out 3 pills? 
D Yes Q No 
Do you know that your pills will only last 14/30/90 days and that you must see your own 
doctor? 
Q Yes Q No 
Do you know how to obtain a new supply of medicines? 
0 Yes Q No 
Do you get your own prescription from: 
Q Chemist Q GP 
Do you see your GP regularly? 
Q Yes Q No 
Do you usually visit more than one pharmacy? 
Q Yes Q No Q Sometimes 
Can you get to your chemist? 
Q Yes 0 No 
Does any one help you take your medicines? 
Q Yes 0 No 0 Sometimes 
If yes or sometimes, what does this help involve? 
How do you remember to take your medications? 




Satisfaction with Information about Medicines Scale (SIMS) 
We would like to ask you about the information you have received about your medicines. 
Please rate the information you have received about each of the following aspects of your 
medicines. If you use more than one medicine, please give your overall feeling about 












1. What your medicine is called 
2. What your medicine is for 
3. What it does 
4. How it works 
5. How long it will take to act 
6. How you can tell if it is working 
7. How long you will need to be on your medicine 
8. How to use your medicine 
9. How to get a further supply 
10. Whether the medicine has any unwanted 
effects (side effects) 
11. What are the risks of you getting side effects 
12. What you should do if you experience 
unwanted side effects 
13. Whether I can drink alcohol whilst taking this 
medicine 
14. Whether the medicine interferes with other 
medicines 
15. Whether the medication will make me feel 
drowsy 
16. Whether the medication will affect my sex life 
17. What you should do if you forget to take a dose 
Other information (please specify below) 
Action and Usage sub-scale: items 1-9 




PCNE Classification scheme for Drug-Related Problems V4 
The Problems 
Each problem should be coded separately, but there may be more causes or interventions to 
one problem. 
Primary Domain Code Problem 
1. Adverse reactions P1.1 Side effect suffered (non-allergic) 
Patient suffers from an P1.2 Side effect suffered (allergic) 
adverse drug event P1,3 Toxic effects suffered 
2. Drug choice problem P2.1 Inappropriate drug (not most appropriate for indication) 
Patient gets or is going to P2.2 Inappropriate drug form (not most appropriate for indication) 
get a wrong (or no drug) P2.3 Inappropriate duplication of therapeutic group or active drug for his/her disease ingredient 
and/or condition P2.4 Contra-indication for drug (incl. Pregnancy/breast feeding) 
P2.5 No clear indication for drug use 
P2.6 No drug prescribed but clear indication 
3. Dosing problem P3.1 Drug dose too low or dosage regime not frequent enough 
Patient gets more or less P3.2 Drug dose too high or dosage regime too frequent 
than the amount of drug p3.3 Duration of treatment too short he/she requires P3.4 Duration of treatment too long 
4. Drug use problem P4.1 Drug not taken/administered at all 
Wrong or no drug P4.2 Wrong drug taken/administered 
taken/administered 
5. Interactions P5.1 Potential interaction 
There is a manifest or 
potential drug-drug or drug- 
P5.2 Manifest interaction 
interaction food 
6. Others P6.1 Patient dissatisfied with therapy despite taking drug(s) correctly 
P6.2 Insufficient awareness of health and diseases (possibly leading 
to future problems) 
P6.3 Unclear complaints. Further clarification necessary 




PCNE Classification Scheme for Drug Related Problems V4 
The Causes 
N. B. One problem can have more causes 
Primary Domain Code Cause 
1. Drug/Dose selection C1.1 Inappropriate drug selection 
The cause of the DRP is related C1.2 Inappropriate dosage selection to the selection of the drug 
and/or dosage schedule 
C13 More cost-effective drug available 
C1.4 Pharmacokinetic problems, incl. ageing/deterioration in 
organ function and interactions 
C1.5 Synergistic/preventive drug required and not given 
C1.6 Deterioration/improvement of disease state 
C1.7 New symptom or indication revealed/presented 
C1.8 Manifest side effect, no other cause 
2. Drug use process C2.1 Inappropriate timing of administration and/or dosing 
The cause of the DRP can be intervals 
related to the way the patient C2.2 Drug underused/ under-administered 
uses the drug, in spite of proper C2.3 Drug overused/ over-administered 
dosage instructions (on the C2.4 Therapeutic drug monitoring required 
label) C25 Drug abused (unregulated overuse) 
C2.6 Patient unable to use drug/form as directed 
3. Information C3.1 Instructions for use/taking not known 
The cause of the DRP can be C3.2 Patient unaware of reason for drug treatment 
related to a lack or C3.3 Patient has difficulties reading/understanding Patient 
misinterpretation of information formation Form/Leaflet 
C3.4 Patient unable to understand local language 
C35 Lack of communication between healthcare professionals 
4. Patient/Psychological C4.1 Patient forgets to use/take drug 
The cause of the DRP can be C4.2 Patient has concerns with drugs 
related to the personality of the C4.3 Patent suspects side-effect 
patient. C4.4 Patient unwilling to carry financial costs 
C4.5 Patient unwilling to bother physician 
C4.6 Patient unwilling to change drugs 
C4.7 Patient unwilling to adapt life-style 
C4.8 Burden of therapy 
C4.9 Treatment not in line with health beliefs 
5. Logistics C5.1 Prescribed drug not available 
The cause of the DRP can be C5.2 Prescribing error (only in case of slip of the pen) 
related to the logistics of the C5.3 Dispensing error (wrong drug or dose dispensed) 
prescribing or dispensing 
mechanism 
6. Others C6.1 Other reason; specify 




PCNE Classification scheme for Drug-Related Problems V4 
The Interventions 
N. B. One problem can lead to more interventions 
Primary Domain Code Intervention 
No intervention 10.0 No Intervention 
1. At prescriber level I1.! Prescriber informed only 
11.2 Prescriber asked for information 
11.3 Intervention proposed, approved by Prescriber 
11.4 Intervention proposed, not approved by Prescriber 
11.5 Intervention proposed, outcome unknown 
2. At patient/carer level 12.1 Patient (medication) counselling 
12.2 Written information provided only 
12.3 Patient referred to prescriber 
12.4 Spoken to family member/caregiver 
3. At drug level 13.1 Drug changed to .... 
13.2 Dosage changed to .... 
I3.3 Formulation changed to..... 
4. Other intervention or activity 14.1 Other intervention (specify) 








Medications on Discharge Diagnosis on Discharge 
Biso rolol20m OD H ertension Amlodi ine 5mg OD yp 
Bendrofluazide 2.5mg OD 
Simvastatin 10m ON H rcholesteroleamia 
Paracetamol 500mg QDS Severe Osteoarthritis Spine 
DHC 30mg PRN MAX TDS 
Lansoprazole 30mg OM Minor Reflux Oesophagitis 
Gaviscon 10mis PRN Max TDS Hiatus Hernia 
Problems on Discharge 
Patient is sensitive to NSAIDs, causing her GI bleeding. 
Findings during home visits 
First Home visit (two weeks after discharge) 
Repeated Medication Compliance% 
Paracetamol 500m ii QDS PRN 
Tramadol 50m I ON 50 
Amlodi ine 5mg OD 100 
Bendrofluazide 2.5mg OD 100 
Biso rolol10m OD 100 
Lansoprazole 30mg OD 100 
Simvastatin 10mg ON 100 
Gaviscon PRN PRN 
> Pain was not controlled: Gp prescribed Tramadol together with the DHC. 
> Feeling sick with the Tramadol and the DHC: she stopped both of them. 
>I found the patient was taking DHC regularly instead of when required and it caused 
nausea and vomiting, she contacted her GP and replaced the DHC with Tramadol but also 
caused nausea and vomiting, so she stopped it as well. 
> She is using Senna (OTC) I OD. 
> She does not feel and GIT problems: GP stopped Gaviscon. 
Drug Related Problems 




II. Second Home Visit (six weeks after discharge) 
Repeated Medication Compliance% 
Paracetamol 500m ii QDS Pm 
Tramadol 500m I ON 100 
Amlodipine 5mg OD 100 
Bendrofluazide 2.5mg OD 100 
Bisoprolol Omg OD 100 
Lansoprazole 30mg OD 100 
Simvastatin 10m ON 100 
Gaviscon PRN PRN 
¢ She got a new tense machine: she reduced the doses of the pain killers to half 
¢ She doesn't feel any sickness with the Tramadol any more. 
Drug Related Problems: 
Quantifying the DRPs: 




Q Problems not controlled. 
o Problems controlled. 
Q Some problems were controlled. 
Q Further Intervention. 
Q Readmission to the Hospital Before the Second Home Visit. 
Q Died 
Endpoint: 
¢ Nausea and vomiting disappeared after regular use of Tramadol. 
¢ Pain was much controlled- 
> No hospital readmission during the first six weeks 
Rate of Hospital Readmission during Six Months: 
None 
Nottintham Health Profile 
Pain Energy Emotion Sleep Social Isolation Physical Mobility 
Before Discharge 75.3 60.80 00 00 00 87.34 
2 weeks 69.77 00 00 00 00 87.34 




Name Reason Shape Strength Dose Time Instructions Side effects 
Before Discharge 71.4 57.1 71.4 42.9 14.3 71.4 00 00 
2 weeks 100 100 100 00 100 100 14.3 00 
6weeks 100 66.7 100 16.7 100 100 50 00 
Transportation time to the nearest half an hour: 
First Home Visit: 1 his. 
Second Home Visit: 1 hrs. 
Length of the home visit to the nearest Half an Hour: 
First Home Visit: 2 hrs. 
Second Home Visit: 1.5 hrs. 
No of GP visits 
One visit one week after discharge from the hospital. 
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Patient No.: 8 
Sex: Male 
Age. 80 
Medications On Discharge Diagnosis on Discharge 
Aspirin 75mg OD TIA 
Warfarin as directed 
S albutamol Inhaler 100 ii PRN SOB 
Tamsulosin 400mcg OD Prostatic Hyperplasia 
Frusemide 40mg ii OD H e t i Lisinopril 2.5mg OD yp r ens on 
Digoxin 125mcg OD AF 
Problems on Discharge: 
Patient is allergic to Penicillin. 
Findings during the home visits: 
1. First Home Visit (After Two Weeks): 
Repeated Medications Compliance 
Aspirin 75mg OD -- 
Warfarin as directed -- 
Tamsulosin 400mcg OD -- 
Co-amilofruse 5140 ii OD -- 
Lisino ril 2 5m OD -- 
Di oxin 125mc OD -- 
¢ Patient was using an old stock of his medication, so measuring compliance was very difficult 
in addition that he kept part of his medication at his daughter house where he goes there every 
weekend. 
¢ Patient was using Co-amilofiuse instead of frusemide and he thought that both are the same. 
¢ Patient stopped using the salbutamol inhaler. 
¢ Patient is very good complier, he was making his own calendar which he marked every time 
he took him medication. 
Drug Related Problems: 




Q Contact the GP 
Q Contact the Hospital 
Q Contact the Pharmacist 




II. Second Home Visit (After Six Weeks): 
Repeated Medications Compliance 
Aspirin EC 75mg OD -- 
Warfarin as directed - 
Tamsulosin 400mc OD - 
Co-amilofruse 5/40 I OD -- 
Lisino ril2.5m OD -- 
Di oxin 125mc OD 
Aspirin dispersible 75 mg OD -- 
¢ Compliance was difficult to be calculated because patient used to spend some times at his 
daughter place and he was keeping a stock of the medication there as well. 
Drug-Related Problems: 
¢ Repeating old medication (Frumil) rather than the new one (Frusemide) ( .............. 
). 
¢ Clinical interaction between Frumil, Lisinopril and Digoxin ( ............... 
). 
Quantifvin2 the DRPs: 
Medicine-related Service-related Total 
1 S` Visit 
Visit 
Outcomes: 
Q Problems not controlled. 
Q Problems controlled. 
Q Some problems were controlled. 
Q Further Intervention. 
Q Readmission to the Hospital Before the Second Home Visit. 
Q Died 
Endpoint: 
Q Blood pressure well controlled. 
Q INR within the range. 
Rate of Hospital Re-admission During Six Month: 
Nottingham Health Profile 
Pain Energy Emotion Sleep Social Isolation Physical Mobility 
Before Discharge 00 60.8 7.22 61.53 00 65.45 
2 weeks 00 00 00 12.57 00 10.79 




Name Reason Shape Strength Dose Time Instructions Side effects 
Before Discharge 60 60 00 00 00 00 00 00 
2 weeks 66.6 50 83.3 00 100 100 00 00 
6weeks 83.33 100 100 00 100 100 16.66 00 
Transportation time: 
First Home Visit: 45 minutes. 
Second Home Visit: 45 minutes. 
Length of the home visit to the nearest Half an Hour: 
First Home Visit: 45 minutes. 
Second Home Visit: 30 minutes. 
No of GP visits: 
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St. Thomas' Hospital Ethical Committee Approval 
Guy's and St Thomas' Hospital 
NHS Trust 
ST THOMAS' HOSPITAL RESEARCH ETHICS COMMITTEE St Thomas Hospital 
Medical Committee Office Lambeth Palace Road 
Block 5, South Wing London SEI 7EH 
Chairman - Dr G du Mont 
Administrator - Ms S Hirsch 
6 December 2001 
Nirmeen Mohammed 
Ph. D Student 
Department of Pharmacy, KCL 
150 Stamford Street, 
Waterloo 
SEi 8WA 
Dear Ms Mohammed 
Tel: 020 7928 9292 
Ezt 2097 Fox 0171 9X2 8163 
St tta. hir=ch(a sttathames. nhs. uk 
EC01/188 Hospital discharge planning and interface liaison for elderly care patients Nirmeen 
Mohammed, Larry Goodyear, Russell Greene, Louise Gallard 
Thank you for addressing the queries raised by the Research Ethics Committee at its meeting on 30 October 
2001. This is satisfactory and I am happy for the study to commence. Approval extends to the Guy's site. 
Please note the following conditions to the approval: 
" The project number and the principal investigator must be clearly stated on the consent form (if applicable). If approval is given 
to named investigators only, these names must also be stated on the form. 
In the case of rescarch on paticnts, a copy of the consent form (if applicable) must be placed in the patient's medical records, 
together with a note of the date of commencement of his/her participation in the research. A label must appear on the outside 
cover of the records when the patient is participating in the research. 
Any amendments to the protocol must be notified to the committee for approval. 
Approval is for the length of time. specified in your application. if you require an extension, a letter from the principal investigator 
to the Chairman, is required to extend the research. 
The committee should he notified of any serious adverse events (please apply for standard SAE report form), or if the study is 
terminated prematurely 
The investigators must adhere to the published Guidelines of the Committee and provide the Chairman with annual progress 
reports and an end of study report. The research should start within 12 months of the date of approval. 
This project carries a reference number, noted above, which must be quoted in any future correspondence. 








St Thomas' Hospital Research Ethics Committee 
CONSENT FORM FOR PARTICIPATION IN RESEARCH PRO. IECfS & CLINICAL 
TRIAL S 
Title of Project: Hospital Discharge Planning and Liaison 
Principal Investigator: N. Mohammed Sawat Ethics Committee 
Other Investigator/s: L. Goodyer, L. Coughlan Code No: 
enrolling patients: 
Outline explanation: 
I would like to ask you to take part in a study that we are conducting. The purpose of the study is to 
see how patients take their medication & if the can benefit from any advice that is given to them 
before hospital discharge. We would also like to see whether it is of any advantage to pass 
information about you to a community pharmacist. 
If you decide to take part, then just before you go home I will ask you some questions about your 
medications and general health. You may be given some extra information about your medication. 
In addition, you may also be asked to elect a community pharmacist from whom you would like to 
obtain any medicines over the next two months. The community pharmacist will be sent a list of the 
medicines that you are going home with together with any other information that might help him in 
advising you on your medication. 
I will visit you at home after two weeks and six weeks to ask you some questions concerning your 
medication and your general health. 
I (name) 
of (address) 
hereby consent to take part in the above investigation, the nature and purpose of which have 
been explained to me. Any questions I wished to ask have been answered to my satisfaction. 
I understand that I may withdraw from the investigation at any stage without necessarily 
giving a reason for doing so and that this will in no way affect the care I receive as a patient 
SIGNED (Volunteer) Date 
(Doctor) Date 
(Witness, where appropriate) Date 
3 copies required: - one for researcher, one for patient/volnuteer. 




Protocol for Predischarge Counselling 
Aim: To encourage the understanding of and compliance with the prescribed drug regime. 
(i) Pharmacist should introduce himselflherself and ensure that the patient is not 
distracted. 
(ii) Explain that the patient is to take home medication prescribed by the doctor. 
(iii) Give advice with as much clarity as possible, using simple language. 
(iv) Explain he importance of the medication to the patient's well being. 
(v) Show each tablet or capsule to patient, indicating the name and giving an 
explanation of use. 
(vi) Go through the label with the patient, ensuring directions are understood. 
(vii) Distinguish between regular and "pm" drugs. 
(viii) IF the patient does not appear to understand the instructions, they should be 
reiterated gently but persistently, introducing a few new facts each time. 
(ix) Ensure that the patient can open the container (including sachets). 
(x) Ask if the patient usually has any "problem" with his/her tablets. 
(xi) Explain that only the hospital medicines should be used and not any that may 
already be at home. 
(xii) Avoid technical terms. 
(xiii) Always give the most important points first. 
(xiv) Repeat the important points and be specific in the advice. 
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Letter to General Practitioner 
Pharmacy Department 
Pharmacy Practice Group 
King's College London 




St. Thomas' Hospital 
The Pharmacy department at King's College London, in conjunction with the Pharmacy department 
in St. Thomas' Hospital & the Care of the Elderly department, is currently running a study concerning 
patient discharge. The primary of the study is to investigate the potential benefits of a more 
structured discharge programme concerning patient medication. 
I have identified one of your patients, Mrs/Mr ......................................... as a candidate 
for the 
study, & have planned for a home visit in the near future. 
As part of this study I shall be making two home visits to Mr. / Mrs .............. 
Who has agreed to 
take part. The propose of these visits is to assess medication usage and general quality of life. 
In addition, Mr. / Mrs .............. 
has elected a community pharmacist to whom details of their 
discharge medication is sent. They will be collecting all medication prescribed by you from this 
pharmacist over at least the next two months. 
If you feel that that such home visit may not be appropriate for this patient, or you would like further 
information about the project, then please call or write to Miss N. Mohammed Safwat in the 
Pharmacy Department. 
Sincerely, yours, 
N. Mohammed Safwat 
Ph. D. Student (Pharmacy Practice) 
King's College London 
150 Stamford Street, SE1 8NN 





Date of Birth: 
Date of Admission: Date of Discharge: 
Name of Consultant: 
Reasons of Hospital Admission 
.......................................................................................... 
........................................................................................... 


















Letter to General Practitioner 
Pharmacy Department 
Pharmacy Practice Group 
King's College London 




St. Thomas' Hospital 
The Pharmacy department at King's College London, in conjunction with the Pharmacy department 
in St. Thomas' Hospital & the Care of the Elderly department, is currently running a study concerning 
patient discharge. The primary of the study is to investigate the potential benefits of a more 
structured discharge programme concerning patient medication. 
I have identified one of your patients, Mrs/Mr ......................................... as a candidate 
for the 
study, & have planned for a home visit in the near future. 
As part of this study I shall be making two home visits to Mr. / Mrs .............. 
Who has agreed to 
take part. The propose of these visits is to assess medication usage and general quality of life. 
If you feel that that such home visit may not be appropriate for this patient, or you would like further 
information about the project, then please call or write to Miss N. Mohammed Safwat in the 
Pharmacy Department. 
Sincerely, yours, 
N. Mohammed Safwat 
Ph. D. Student (Pharmacy Practice) 
King's College London 
150 Stamford Street, SE1 8NN 





Pharmacy Practice Group 
King's College London 
150 Stamford St. 
Dear 
Letter to Community Pharmacist 
Pharmacy Department 
Elderly Care 
St. Thomas' Hospital 
The Pharmacy department at King's College London, in conjunction with the Pharmacy department 
in St. Thomas' Hospital & the Care of the Elderly department, is currently running a study concerning 
patient discharge. The primary of the study is to investigate the potential benefits of a more 
structured discharge programme concerning patient medication & the transfer of information between 
hospital & community pharmacy. 
I have identified Mrs/Mr 
........................ as a candidate 
for the study and I have planned for a 
home visit in the near future. Mrs/ Mr ........................ 
has elected your pharmacy to where details 
of his/her discharge medication will be sent. Mrs/ Mr ........................... will collect all medication 
prescribed by the GP from this pharmacy over the next two months. 
A copy of the patient's medication, which will go home with, will be sent to your. pharmacy together 
with any relevant discharge information concerning the patient medical case. 
As part of this study I shall be making two home visits to Mr. / Mrs ....................... who 
has agreed 
to take part. Propose of these visits is to assess medication usage and general quality of life. 
If you would like further information about the project, then please call or write to Miss N. 
Mohammed Safwat in the Pharmacy Department, 
Sincerely, yours, 
N. Mohammed Safwat 
Ph. D. Student (Pharmacy Practice) 
Department of Pharmacy, 
King's College London 
150 Stamford Street, SE1 8NN 





Date of Birth: 
Date of Admission: Date of Discharge: 
Name of Consultant: 
Name of GP: Phone Number: 
Reasons of Hospital Admission 
.......................................................................................... 








New Medication started Reason 








CHECKLIST OF HOME VISIT 
TWO/SIX WEEKS AFTER HOSPITSL DISCHARGE 
No: Name: Date: Group: 
No. of tablets No. of tablet °10 Medication & regimen now dispensed 











Medication related problems: 
Q ADRs 
Q Interaction 
Q Therapeutic Failure 



















Table 6.4 Frequencies and Percents of the Most Commonly Diagnosed Medical Problems 





Hypertension 30(49.2) 38(62.3) 68(55.7) 
Angina & Myocardial Infarction 27(44.3) 24(39.4) 51(41.9) 
Aterial Fibrillation 8(13.1) 14(23) 22(18) 
Heart Failure 6(9.8) 8(13.1) 14(11.5) 
Stroke &CVA 15(24.6) 14(23) 29(23.8) 
Other cardiac diseases 28(46) 32(52.5) 60(49.2) 
Gastrointestinal Problems 
Ulcers 4(6.6) 3(4.9) 7(5.7) 
Hernia 4(6.6) 4(6.6) 8(6.6) 
Others 19(31.1) 25(41) 44(36.1) 
Respiratory Problems 
COPD &Asthma 22(36.1) 20(32.8) 42(34.4) 
Other respiratory diseases 4(6.6) 5(8.2) 9(7.4) 
Infectious Problems 
UTI 9(14.8) 6(9.8) 15(12.3) 
Chest Infection 18(29.5) 16(26.2) 34(27.9) 
Other Infectious Diseases 7(11.5) 4(6.6) 11(9) 
Musculoskeletal Problems 
RA&OA 12(19.7) 16(26.2) 28(23) 
Others 12(19.7) 5(8.2) 17(13.9) 
Central Nervous Problems 
Depression 4(6.6) 5(8.2) 9(7.4) 
Other CNS Diseases 6(9.8) 4(6.6) 10(8.2) 
Endocrinological Problems 
Diabetes 16(26.2) 9(14.8) 25(20.5) 
Thyroid Diseases 7(11.5) 4(6.6) 11(9) 
Fall 9(14.8) 10(16.4) 19(15.6) 
Anemia 10(16.4) 6(9.8) 16(13.1) 
Renal Problems 10(16.4) 9(14.8) 19(15.6) 
Hepatic Problems 2(3.3) 1(1.6) 3(2.5) 
Eye Problems 3(4.9) 8(13.1) 11(9) 
Miscellaneous 41(67.2) 35(57.4) 76(62.3) 
Total No. of Recruited Patients 61 61 122 




BNF Categories and Frequencies ofMedication Prescribed on Discharge 
Category Drug or Class 
Number of Medication (%) 
Control Intervention Total 
Cardiovascular Diuretics 35 (7.3) 35 (8.1) 70 (7.7) 
Nitrates 16 (3.3) 17 (4) 33 (3.6) 
ACEIs 21(4.4) 23 (5.3) 44 (4.8) 
Calcium Channel Blockers 15 (3.1) 19 (4.4) 34 (3.7) 
Beta Blockers 10(2.1) 11(2.6) 21(2.3) 
Cardiac Glycoside 7(l. 5) 11(2.6) 18 (2) 
Anticoagulants &Antiplatelets 41(8.6) 47 (10.9) 88 (9.7) 
Lipid Regulating Drugs 17(3.6) 19 (4.4) 36 (4) 
Others 14(2.9) 14(3.3) 28(3.1) 
Total 176 (36.7) 196 (45.6) 372 (409) 
Non-Opioid Analgesics 24 (5) 26 (6) 50 (5.5) 
Central Nervous Opioid Analgesics 9 (1.9) 7 (1.6) 16(l. 8) 
Antidepressants 9(l. 9) 6(l. 4) 15(l. 7) 
Others 14(2.9) 8(19) 22(2.4) 
Total 56 (11.7) 47(10-9) 103 (11.3) 
Gastrointestinal Laxatives 26 (5.4) 19 (4.4) 45 (5) 
PPIs 30 (6.3) 21(4.9) 51(5.6) 
Others 2 (0.4) 9(2.1) 11(l. 25) 
Total 58 (12.1) 49 (11.4%) 107 (11.8) 
Respiratory Beta Agonists 29(6.1) 22(5.1) 51(5.6) 
Steroids Preparations 27 (5.6) 23 (5.3) 60 (7) 
Others 16(3.3) 16(3.8) 44(l. 9) 
Total 72 (15) 61 (14.2) 133 (14.6) 
Musculoskeletal NSAIDs 8 (1.7) 5 (1.2) 13 (1.4) 
Others 2(0.4) 7(1.6) 9(f) 
Total 10(2.1) 12(2.8) 22(2.4) 
Topical Preparation Eye/Ears/Nose/Skin 11(2.3) 14 (3.3) 25 (2.8) 
Total 11(2.3) 14 (3.3) 25(2.8) 
Endocrine Oral Hypoglycaemics 14(2.9) 4(0.9) 18 (2) 
Insulin 4(0.8) 2(0.5) 6(0.7) 
Thyroid Preparations 4 (0.8) 5 (1.2) 9 (1) 
Others 13 (2.7) 6 (1.4) 18 (2) 
Total 35(7.3) 17 (4) 51 (5.6) 
Obstetrics, Gynaecology Obstetrics & Gynaecology 3 (0.6) 1 (0.2) 4 (0.4) 
& Urinary Tract Urinary Tract 3 (0.6) 3 (0.7) 6 (0.7) 
Total 6(1.3) 4 (09) 10 (1.1) 
Miscellaneous Anti Aneamic 8 (1.7) 9 (2.1) 17 (1.9) 
Vitamins &Minerals 26 (5.4) 9 (2.1) 35 (3.9) 
Antibacterial& Antifungal 21(4.4) 12 (2.8) 33 (3.6) 




Patient Medication Knowledge Scores Assessed before Hospital Discharge 
Question Score Mean % (SD) 
Control Intervention 
Number of patients 59 60 
1. Name 46.8 (32.8) 43.4 (31.5) 
2. Purpose 63.2 (28.4) 66 (26.5) 
3. Shape 65.2(29.9) 69.9(28.2) 
4. Dose 64.9(32.1) 69.5(29.2) 
5. Time 64.7(32.0) 67.3(29.1) 
6. Strength 15.9(21.8) 21.9(30.5) 
7. Special Instructions 16.5(22.7) 14.4(20.1) 




Nottingham Health Profile Administered to both the Control and the Intervention Groups 
before Hospital Discharge 
Area 
Mean Sore (SD) 
Control Intervention 
No. of Patients 58 58 
Pain 28.7 (27.3) 22.2 (27.5) 
Energy 47.9 (37.5) 35.5 (39.0) 
Emotion 25.6 (23) 18.8 (21.9) 
Sleep 41.3 (31) 32.0 (33.4) 
Social Isolation 19.8 (20.8) 14.6 (20.0) 




Numbers of Patients Suffering from Different MRPs (According to PCNE) 
Number of Patients (%)- 
Category 1't visit 2"d Visit 
Control Intervention Control Intervention 
Side effect 13(26.5) 17(34) 10(25.7) 14(35) 
Inappropri ate drug or form (not most 3(6.1) 3(6) 3(7.7) 2(5) 
Inappropriate duplication of therapeutic 1(2.0) 2(4) 2(5.1) 1(2.5) 
Contra-indication for drug 4(8.2) 2(4) 1(2.6) 2(5) 
No clear indication for drug use 2(4.1) 0 3(7.7) 0 
No drug prescribed but clear indication 7(14.3) 3(6) 2(5.1) 1 (2.5) 
Drug dose too low or regimen not frequent 10(20.4) 10(20) 10(25.6) 8(20) 
Drug dose too high or dosage regimen too 6(12.2) 3(6) 6(15.4) 2(5) 
Drug not taken/administered at all 16(32.7) 11(22) 8(20.5) 9(22.5) 
Wrong drug taken/administered 10(20.4) 6(12) 9(23.1) 5(12.5) 
Potential interaction 2(4.1) 3(6) 4(10.2) 2(5) 
Patient dissatisfied despite taking drugs 7(14.3) 9(18) 7(17.9) 4(10) 
Insufficient awareness of health and disease 20(40.8) 14(28) 18(46.2) 4(10) 
Unclear complaints, clarification necessary 7(14.3) 5(10) 7(17.9) 4(10) 
Therapy failure for unknown reason 3(6.1) 2(4) 4(10.2) 2(5) 
Number of Patients 49 50 39 40 
*Column percent was calculated by dividing the number of patients suffered from individual problem by 




Numbers of Patients of Both the Control and the Intervention Groups Who Sufered from 
One or More MRPs 
Number of Patients (%)*. 
Category is, visit 2" Visit 
Control Intervention Control Intervention 
Minor 22 (44.9) 25 (50) 21 (53.8) 13 (32.5) 
Moderate 25 (51) 25 (50) 21 (53.8) 11 (27.5) 
Sever 14 (28.6) 11(22) 10 (25.6) 9(22.5) 
Total 61 61 52 33 
No. of Patient Monitored 49 50 39 40 
*Column percent calculated by dividing the numbers of the problems identified in each problem category 




Numbers of Patients of Both the Control and the Intervention Groups Who Suffered from 
One or More Different Service Related Problems 
Number of Patients (%)* 
Category 1" visit 2° Visit 
Control Intervention Control Intervention 
Polypharmacy 0 (0) 6 (12) 2 (5.1) 1(2.5) 
Interface Issues 13 (24.5) 6 (12) 5 (12.8) 4 (10) 
Patient Knowledge 24(49) 23 (46) 20 (51.3) 8(20) 
Physical Difficulty 7 (14.3) 7 (14) 6 (15.4) 3 (7.5) 
Label Problems 3(6.1) 3(6) 5(12.8) 2(5) 
Compliance & Memory 23 (46.9) 16 (32) 18 (46.2) 13 (32.5) 
Storage Problems 6 (12.2) 3 (6) 6 (15.4) 1 (2.5) 
No. of Patient 49 50 39 40 
*Column percent calculated by dividing the numbers of the problems identified in each problem category 




Number of the MRPs during the First Home Visit as Rated by Different Investigators 




LG NMS Kappa Strength of LG NMS Kappa Strength 
Minor 26 29 0.7 Good 27 32 0.54 Moderate 
Moderate 45 36 0.5 Moderate 39 31 0.28 Fair 
Severe 20 20 0.4 Fair 6 11 0.5 Moderate 
Average Kappa Score 0.53 Moderate 0.44 Moderate 
0.48 Moderate 
Total No. of Problems 91 85 12 74 
Number of the MRPs during the Second Home Visit as Rated by Different Investigators 
Total Number of Problems 
2" visit 
Category Control Intervention 
LG NMS Kappa Strength of LG NMS Kappa Strength of 
Agreement Agreement 
Minor 19 22 0.47 Moderate 19 16 0.6 Moderate 
Moderate 26 30 0.43 Moderate 15 14 0.65 Good 
Sever 16 10 0.42 Moderate 9 9 0.86 Very Good 
Average Kappa Score 0.44 Moderate 0.7 Good 
0.57 Moderate 
Total No. of Problems 61 62 43 39 
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Total Number of Problems 
1 51 visit 
Intervention 
Strength LG NMS Kappa Strength 
Polypharmacy 0 0 1 Very Good 4 6 0.78 Good 
Interface Issues 15 13 0.7 Good 9 6 0.78 Good 
Patient Knowledge 21 24 0.43 Moderate 7 23 0.46 Moderate 
Physical Difficulty 7 7 1 Very Good 7 7 0.91 Very Good 
Label Problems 4 3 0.85 Very Good 3 3 1 Very Good 
Compliance & Memory 26 23 0.76 Good 16 16 0.73 Good 
Storage Problems 4 6 0.78 Good 4 3 0.85 Very Good 
Average Kappa Score 0.79 Good 0.78 Good 
0.79 Good 
Total No. of Patients 73 76 51 64 
Number of the Service Related Problems during the Second Home Visit as Rated by 
Different Investigators 








Compliance and Memory 
Storage Problems 
Average Kappa Score 
Total No. of Patients 
Control Intervention 
LG NMS Kapp 
1 2 0.51 
6 5 0.64 
10 20 0.46 
6 6 1 
8 5 0.8 
26 18 0.8 
7 6 0.79 
0.71 
64 62 
Strength LG NMS Kapp 
Moderate 1 I 1 
Good 5 4 0.63 
Moderate 9 8 0.86 
Very Good 3 3 1 
Good 4 2 0.64 
Good 16 13 0.76 
Good 1 1 1 
Good 0.84 














Interventions Done at the Prescriber Level for the Intervention Group 
First Home Visit 
Patient 5 
GP was sent another copy of the TTO and the changes happened to the patient's medication 
Patient 7 
GP was contacted to confirm the changes happened to the patient's medication, as patient kept both 
new and old medication and was not sure which one to use. 
Patient 14 
Investigator contacted the consultant to query about the reason of stopping the Naproxen and the 
possibilities of put the patient on Naproxen back as it was the only medicine controlling patient's 
pain. Consultant explained the reason for stopping it and said it was stopped as a cautious step 
because the patient has recent pacemaker operation and he can take Naproxen again. 
GP was contacted to prescribe Frusemide as 20mg OD rather than half tablet of the 40mg OD. 
Patient 16 
GP was contacted to confirm the changes happened to the patient medication, as old medications 
were re-prescribed. 
Patient had difficulties swallowing Paracetamol table, so GP was contacted to prescribe Paracetamol 
caplet or capsule instead. 
Patient 20 
Patient suffered from hematurea, GP was informed and he advised to stop the Warfarin till the INR 
being checked again. 
Patient suffered from UTI and when the GP was contacted he prescribed Trimethoprim. 
Patient suffered from Nausea since she started the Digoxin, when GP contacted he advised to stop the 
Digoxin. 
Patient 21 
GP decided suddenly to stop Rohypnol which the patient was on it for more than 10 years. GP was 
contacted to re-prescribing it again and trying to reduce the dose rather than stopping it suddenly. 
Patient suffered from Nausea because of the Co-proxamol. GP was contacted to change it and 
Paracetamol was prescribed instead. 
Patient 23 
Consultant was contacted regarding the Irbesartan which the patient stopped by mistake. The 
consultant confirmed that the patient should restart it again which she did. 
Patient 32 
Patient was prescribed 5mg Bendrofluazide instead for 2.5mg. GP was contact and he said it was a 




GP was contacted to inform him regarding patient's poor memory and the effect of this on patient's 
compliance. 
Patient 40 
Consultant was contacted regarding the Oedema patients suffered and he recommended prescribing a 
diuretic. 
GP was contacted to prescribe a suitable diuretic for the Oedema. Bendrofluazide 2.5mg PRN was 
prescribed. 
Patient 44 
Patient left the hospital with Frusemide 80mg OD but the one dispensed from the Pharmacy had label 
of 40mg OD. GP was contacted to confirm if this was intentional or just a mistake. GP confirmed it 
was a mistake and patient was told to take two tablets. 
Patient 47 
Stroke patient suffered from incontinence. Stroke Unit was contacted and an outpatient appointment 
was arranged. 
GP was contacted regarding patient's poor memory and the effect of that on her adherence. 
Patient 48 
Quinine Sulphate found among patients medication although it was not prescribed during the hospital 
stay and was not included in the drug history list. GP was contact to query about this, and he 
confirmed that the patient was suffering from night cramps and was on Quinine Sulphate before the 
admission. 
GP was contacted to prescribe Paracetamol as Caplet or Capsule instead of Tablet which patient had 
difficulties in Swallowing 
Patient 57 
Patient was dispensed 2mg Lorazepam instead of 0.5mg. GP was contacted to query about the 
discrepancy. GP confirmed it was a mistake, and the 0.5mg was prescribed again. 
Patient 63 
GP was contacted to confirm that Frumil (which was contribution factor for hospital admission 
because of fall) was stopped, and to convince the patient to stop using it, as the patient insisted on 
continue taking it as long her GP didn't advise her to stop it. 
Patient 65 
Patient was contacted regarding the newly prescribed medicines during the hospital stay and to 
arrange medication delivery to the housebound patient. 
Patient 83 
GP was contacted to attract her attention to the importance of monitoring Theophylline level which 
was newly prescribed to the patient. An appointment was arranged for the patient. 
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Second Home Visit 
Patient 53 
GP was contacted to start the patient on Nebuliser (as patient requested). 
Patient 83 
GP was contacted to arrange medication delivery to the patient or prescribe medication enough for 
three months rather than one month. 
Patient 102 
GP was contacted to query about the reason behind not re-prescribing Ranitidine and GP confirmed it 
was a mistake. 
Patient 119 
Simvastatin was prescribed by the GP as 20mg BD rather than 40mg OD (which was prescribed by 
the hospital). GP confirmed it meant to be 20mg OD as 40mg was too much for her and she felt tired 




Different Interface Problems Identified in Patients of Both Groups during Both 
Home Visits 
First Home Visit 
Control Group Patients 
Patient 2 
Patient was prescribed Fosamax and Adcal during his hospital stay but this was not 
repeated to him post hospital discharge. 
Patient 8 
Frumil was stopped during the hospital stay and Frusemide was prescribed instead but 
this wasn't applied in the community and the patient was still on Frumil. 
Patient 11 
Patient had history of night cramps and was on Quinine sulphate before his hospital 
admission but this was not reported among the admission medication. The second 
problem is that the patient was using Ranitidine 300mg when required for heart bum 
before hospital admission and it was not on his TTO but the patient was still using it 
without prescription depending on an old stock he kept he kept at home. 
Patient 15 
Patient had history of angina and was on GTN before hospital admission but was not 
reported among the admission medication but the patient had already her GTN spray at 
home and was using it when in need. 
Patient 31 
Patient was on Salbutamol before admission but was not reported among admission 
medication but the patient repeated it from the GP. 
Patient 37 
Patient was diabetic and on Insulin but was not reported in her DH. 
Patient 50 
Patient was on GTN and Didronel before hospital admission but both were not reported 
among the admission medication. Patient got them during the hospital stay through the 
repeat prescription. 
Patient 56 
Patient was on Amitryptylline before hospital admission and wasn't reported among the 




Lansoprazole was stopped during the hospital stay and was replaced with Omeprazole but 
stopped Lansoprazole was re-issued in the community. 
Patient 94 
Presence of extra medication in the Dossett Box which were not in the TTO list and 
couldn't find out what were they as they were not written in the card. 
Patient 101 
All old medication including the stopped ones were repeated during the first home visit. 
Patient 103 
Patient was not given a copy of the TTO, and when she went to visit her consultant 
during the outpatient clinic, the consultant didn't have a copy of the TTO as well and he 
couldn't tell what she was on and why. The second problem is lack of communication 
between the smoking cessation pharmacist in the hospital and the GP, so the patient 
didn't start her sessions till the first home visit. 
Patient 111 
Patient was taking Moduretic and Amitriptylline although they were stopped in the Hospital. 
The second problem was lack of the information taken during the admission as the patient 
was using Becotide Inhaler before hospital admission, but could not find anything regarding 
it in her Drug History. Also using Ferrous Sulphate tablets and she said it was for Anemia, 
but I could not find anything regarding it in her History. The third problem is Prednisolone 
wasn't among her medication and she did not put for repeat although it was mentioned to be 
repeated after the Hospital discharge. 
Intervention -Group 
Patient 5 
GP repeated the old stopped medications (Bendrofluazide and Carbamazepine) together 
with new medications. 
Patient 16 
Repeating of old prescription only without any of the new medications or the inhalers. 
Patient 26 
Patient was on Diclofenac for back pain before hospital admission but it was not reported 
in DH and she was using old stock she was keeping at home. 
Patient 32 
Repeating old strength of Bendrofluazide. 
Patient 48 





Patient said she was on Diazepam before admission for depression but was not on her 
drug history. 
Second Home Visit 
Control Group 
Patient 2 
Patient was prescribed Fosamax and Adcal during his hospital stay but this was not 
repeated to him post hospital discharge. 
Patient 8 
Frumil was stopped during the hospital stay and Frusemide was prescribed instead but 
this wasn't applied in the community and the patient was still on Frumil 
Patient 70 
Lansoprazole was stopped during the hospital stay and was replaced with Omeprazole but 
stopped Lansoprazole was re-issued in the community. 
Patient 94 
Presence of extra medication in the Dossett Box which were not in the TTO list and 
couldn't find out what were they as they were not written in the card. 
Patient 111 
Patient was taking Moduretic and Amitriptylline although they were stopped in the 
Hospital. The second problem was not repeating Prednisolone although it was mentioned 
to be repeated after the Hospital discharge. 
Intervention Group 
Patient 53 
Patient changed his accommodation and there was poor communication between the 
hospital and both the old and the new GP regarding patient's medication. 
Patient 65 
Adcal was prescribed in the hospital as ii OD but it was re-prescribed in the community 
as i BD (as before admission). 
Patient 102 
She was prescribed Ranitidine regularly during her hospital stay but was not repeated for 
her post discharge. 
Patient 112 
Patient said he was on Calcichew before admission but nothing was reported on her 
admission DH. 
365 
